pub_id,protocol,rx,rx_code,product1_route,product2_route,product3_route,product1_rx,product2_rx,product3_rx,product1_dose,product2_dose,product3_dose,rx_flag,rx_flag_com,grp,PTID,arm,control,prot,labid,assayid,visitno,drawdt,testdt,poscrit,cutoff,max_cutoff,titer,titer_num,log_titer,response,positivity_method,filt_flag,reason,calcdt,termdt,concunits,labfile,protnum,assay,subtype,specid,assayrun,reliable,replace,comments,type_of_data,moddt,assaytyp,celltype,infunits,filedate,network,hostcell,backbone,interpretmethod,virustype,virusdilution,method,harvestdate,virusid,incubation,experimenter,platenum,mablotnum,initdilution,dilutionfactor,filename,sub_proj_number,lab_code,ldo_qc,pastterm,vdtbeg,vdtend,out_win,visitday,not_exp,isolate,enrolldt,fnresult,dxdt,dxvisit,hiv_source,last_neg_dt,hivcutoffdt,first_pos_dt,pos_assay,days_to_last_neg,days_to_first_pos,fnresultx,HIRdgdt,HIRsrdt,hiv_supplemental_reason,hiv_reason,rx_code_orig,celltier
100-053,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64003-3,T1,0,v100,DU,CJ11-50,10.0,22JUL2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BC20DYKC-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,1,,10,3,P20151111;3415-1.xls,,,0,,19JUL2015,30JUL2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-111,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64006-5,T1,0,v100,DU,CJ11-50,10.0,29JUL2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20F09P-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,1,,10,3,P20151111;3415-1.xls,,,0,,26JUL2015,06AUG2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-031,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64009-0,T1,0,v100,DU,CJ11-50,10.0,23JUL2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20DYTL-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,1,,10,3,P20151111;3415-1.xls,,,0,,23JUL2015,03AUG2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-209,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64013-9,T1,0,v100,DU,CJ11-50,10.0,28JUL2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20DZVV-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,1,,10,3,P20151111;3415-1.xls,,,0,,25JUL2015,05AUG2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-158,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64021-4,T1,0,v100,DU,CJ11-50,10.0,03AUG2015,11NOV2015,50,10,10,23,23,1.361727836,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20F17D-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,2,,10,3,P20151111;3416-1-1.xls,,,0,,01AUG2015,12AUG2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-215,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64029-9,T1,0,v100,DU,CJ11-50,10.0,25AUG2015,11NOV2015,50,10,10,48,48,1.6812412374,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20F8HS-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,2,,10,3,P20151111;3416-1-1.xls,,,0,,14AUG2015,25AUG2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-231,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64031-7,T1,0,v100,DU,CJ11-50,10.0,27AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20F8ZN-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,2,,10,3,P20151111;3416-1-1.xls,,,0,,21AUG2015,01SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-091,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64033-4,T1,0,v100,DU,CJ11-50,10.0,08SEP2015,11NOV2015,50,10,10,28,28,1.4471580313,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20FD4N-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,2,,10,3,P20151111;3416-1-1.xls,,,0,,04SEP2015,15SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-077,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64036-9,T1,0,v100,DU,CJ11-50,10.0,18AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20F5SG-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,3,,10,3,P20151111;3417.xls,,,0,,14AUG2015,25AUG2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-136,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64045-2,T1,0,v100,DU,CJ11-50,10.0,13AUG2015,11NOV2015,50,10,10,647,647,2.8109042807,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20F4C6-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,3,,10,3,P20151111;3417.xls,,,0,,13AUG2015,24AUG2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-227,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64053-1,T1,0,v100,DU,CJ11-50,10.0,19AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CC20F676-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,3,,10,3,P20151111;3417.xls,,,0,,16AUG2015,27AUG2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-160,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64054-4,T1,0,v100,DU,CJ11-50,10.0,26AUG2015,11NOV2015,50,10,10,177,177,2.2479732664,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20F8R9-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,3,,10,3,P20151111;3417.xls,,,0,,21AUG2015,01SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-155,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64055-9,T1,0,v100,DU,CJ11-50,10.0,20AUG2015,11NOV2015,50,10,10,31,31,1.4913616938,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20F6C4-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,4,,10,3,P20151111;3418.xls,,,0,,14AUG2015,25AUG2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-177,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64057-8,T1,0,v100,DU,CJ11-50,10.0,02SEP2015,11NOV2015,50,10,10,20,20,1.3010299957,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FBT0-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,4,,10,3,P20151111;3418.xls,,,0,,23AUG2015,03SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-052,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64062-2,T1,0,v100,DU,CJ11-50,10.0,03SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FC68-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,4,,10,3,P20151111;3418.xls,,,0,,28AUG2015,08SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-247,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64063-5,T1,0,v100,DU,CJ11-50,10.0,08SEP2015,11NOV2015,50,10,10,42,42,1.6232492904,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20FD2Q-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,4,,10,3,P20151111;3418.xls,,,0,,04SEP2015,15SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-126,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64066-3,T1,0,v100,DU,CJ11-50,10.0,08SEP2015,11NOV2015,50,10,10,30,30,1.4771212547,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20FD3H-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,5,,10,3,P20151111;3419.xls,,,0,,04SEP2015,15SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-225,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64067-4,T1,0,v100,DU,CJ11-50,10.0,08SEP2015,11NOV2015,50,10,10,27,27,1.4313637642,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FD43-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,5,,10,3,P20151111;3419.xls,,,0,,04SEP2015,15SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-148,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64069-7,T1,0,v100,DU,CJ11-116,10.0,14SEP2015,07JAN2016,50,10,10,29,29,1.4623979979,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20FGVK-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,1,,10,3,CJ20160107;3933.xls,,,0,,12SEP2015,23SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-163,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64077-9,T1,0,v100,DU,CJ11-50,10.0,07SEP2015,11NOV2015,50,10,10,70,70,1.84509804,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20FCJ1-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,5,,10,3,P20151111;3419.xls,,,0,,29AUG2015,09SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-073,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64080-3,T1,0,v100,DU,CJ11-50,10.0,31AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FB33-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,5,,10,3,P20151111;3419.xls,,,0,,28AUG2015,08SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-184,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64087-7,T1,0,v100,DU,CJ11-50,10.0,07SEP2015,11NOV2015,50,10,10,116,116,2.0644579892,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20FCJR-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,6,,10,3,P20151111;3420.xls,,,0,,06SEP2015,17SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-170,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64095-4,T1,0,v100,DU,CJ11-116,10.0,08OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20FQ3V-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,1,,10,3,CJ20160107;3933.xls,,,0,,01OCT2015,12OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-038,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64105-9,T1,0,v100,DU,RP-02-19,10.0,17NOV2015,07JAN2016,50,10,10,144,144,2.1583624921,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20G4TX-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,1,,10,3,RP20160107;3913-1.xls,,,0,,14NOV2015,25NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-123,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64117-3,T1,0,v100,DU,CJ11-116,10.0,17SEP2015,07JAN2016,50,10,10,12,12,1.079181246,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20FJ00-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,1,,10,3,CJ20160107;3933.xls,,,0,,13SEP2015,24SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-061,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64119-8,T1,0,v100,DU,CJ11-116,10.0,30SEP2015,07JAN2016,50,10,10,15,15,1.1760912591,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20FMJ0-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,1,,10,3,CJ20160107;3933.xls,,,0,,26SEP2015,07OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-128,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64129-6,T1,0,v100,DU,CJ11-116,10.0,06OCT2015,07JAN2016,50,10,10,119,119,2.0755469614,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20FPD4-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,2,,10,3,CJ20160107;3934.xls,,,0,,03OCT2015,14OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-108,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64130-3,T1,0,v100,DU,CJ11-116,10.0,06OCT2015,07JAN2016,50,10,10,15,15,1.1760912591,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20FPDG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,2,,10,3,CJ20160107;3934.xls,,,0,,02OCT2015,13OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-097,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64135-8,T1,0,v100,DU,CJ11-116,10.0,28SEP2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20FLTC-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,2,,10,3,CJ20160107;3934.xls,,,0,,26SEP2015,07OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-129,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64139-4,T1,0,v100,DU,CJ11-116,10.0,26OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20FWKL-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,2,,10,3,CJ20160107;3934.xls,,,0,,16OCT2015,27OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-058,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64150-0,T1,0,v100,DU,RP-02-19,10.0,11NOV2015,07JAN2016,50,10,10,38,38,1.5797835966,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20G3JT-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,1,,10,3,RP20160107;3913-1.xls,,,0,,07NOV2015,18NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-151,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64154-2,T1,0,v100,DU,RP-02-19,10.0,02NOV2015,07JAN2016,50,10,10,22,22,1.3424226808,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20FXYX-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,1,,10,3,RP20160107;3913-1.xls,,,0,,25OCT2015,05NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-002,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64156-9,T1,0,v100,DU,RP-02-19,10.0,02NOV2015,07JAN2016,50,10,10,15,15,1.1760912591,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20FXZQ-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,1,,10,3,RP20160107;3913-1.xls,,,0,,25OCT2015,05NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-194,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64166-1,T1,0,v100,DU,RP-02-19,10.0,17NOV2015,07JAN2016,50,10,10,27,27,1.4313637642,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20G4VL-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,2,,10,3,RP20160107;3914.xls,,,0,,14NOV2015,25NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-157,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64167-2,T1,0,v100,DU,RP-02-19,10.0,10NOV2015,07JAN2016,50,10,10,27,27,1.4313637642,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20G20B-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,2,,10,3,RP20160107;3914.xls,,,0,,06NOV2015,17NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-025,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64172-9,T1,0,v100,DU,RP-02-19,10.0,12NOV2015,07JAN2016,50,10,10,23,23,1.361727836,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BC20G3X4-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,2,,10,3,RP20160107;3914.xls,,,0,,06NOV2015,17NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-137,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64002-3,T1,0,v100,DU,CJ11-50,10.0,28AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HA60BCRM-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,6,,10,3,P20151111;3420.xls,,,0,,21AUG2015,01SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-064,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64007-0,T1,0,v100,DU,CJ11-50,10.0,14SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JA60BDHQ-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,6,,10,3,P20151111;3420.xls,,,0,,10SEP2015,21SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-131,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64008-8,T1,0,v100,DU,CJ11-50,10.0,14SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AA60BDJC-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,6,,10,3,P20151111;3420.xls,,,0,,07SEP2015,18SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-109,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64028-0,T1,0,v100,DU,CJ11-116,10.0,21OCT2015,07JAN2016,50,10,10,41,41,1.6127838567,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BA60BFB3-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,3,,10,3,CJ20160107;3935.xls,,,0,,17OCT2015,28OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-187,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64029-3,T1,0,v100,DU,CJ11-116,10.0,26OCT2015,07JAN2016,50,10,10,20,20,1.3010299957,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AA60BFG6-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,3,,10,3,CJ20160107;3935.xls,,,0,,19OCT2015,30OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-090,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64030-6,T1,0,v100,DU,CJ11-116,10.0,27OCT2015,07JAN2016,50,10,10,42,42,1.6232492904,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FA60BFGQ-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,3,,10,3,CJ20160107;3935.xls,,,0,,23OCT2015,03NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-130,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64034-8,T1,0,v100,DU,RP-02-19,10.0,10NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EA60BG09-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,2,,10,3,RP20160107;3914.xls,,,0,,06NOV2015,17NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-105,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64036-3,T1,0,v100,DU,RP-02-19,10.0,13NOV2015,07JAN2016,50,10,10,83,83,1.9190780924,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EA60BG4G-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,2,,10,3,RP20160107;3914.xls,,,0,,09NOV2015,20NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-140,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64037-4,T1,0,v100,DU,RP-02-19,10.0,16NOV2015,07JAN2016,50,10,10,26,26,1.414973348,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EA60BG8C-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,3,,10,3,RP20160107;3915.xls,,,0,,12NOV2015,23NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-138,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64038-9,T1,0,v100,DU,CJ11-116,10.0,04NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HA60BFT3-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,3,,10,3,CJ20160107;3935.xls,,,0,,31OCT2015,11NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-084,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64039-7,T1,0,v100,DU,CJ11-116,10.0,27OCT2015,07JAN2016,50,10,10,33,33,1.5185139399,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DA60BFH3-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,3,,10,3,CJ20160107;3935.xls,,,0,,23OCT2015,03NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-198,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64040-3,T1,0,v100,DU,RP-02-19,10.0,17NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KA60BGC1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,3,,10,3,RP20160107;3915.xls,,,0,,07NOV2015,18NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-228,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64044-0,T1,0,v100,DU,RP-02-19,10.0,24NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BA60BGLK-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,3,,10,3,RP20160107;3915.xls,,,0,,14NOV2015,25NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-181,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64050-8,T1,0,v100,DU,CJ11-116,10.0,02NOV2015,07JAN2016,50,10,10,58,58,1.7634279936,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HA60BFPN-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,4,,10,3,CJ20160107;3936.xls,,,0,,31OCT2015,11NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-085,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64051-4,T1,0,v100,DU,CJ11-116,10.0,06NOV2015,07JAN2016,50,10,10,39,39,1.591064607,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DA60BFVX-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,4,,10,3,CJ20160107;3936.xls,,,0,,02NOV2015,13NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-063,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64053-7,T1,0,v100,DU,RP-02-19,10.0,20NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KA60BGGQ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,3,,10,3,RP20160107;3915.xls,,,0,,16NOV2015,27NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-235,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64054-5,T1,0,v100,DU,CJ11-116,10.0,09NOV2015,07JAN2016,50,10,10,115,115,2.0606978404,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AA60BFY7-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,4,,10,3,CJ20160107;3936.xls,,,0,,05NOV2015,16NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-001,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64061-7,T1,0,v100,DU,CJ11-116,10.0,09NOV2015,07JAN2016,50,10,10,11,11,1.0413926852,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DA60BFYY-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,4,,10,3,CJ20160107;3936.xls,,,0,,07NOV2015,18NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-083,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64062-8,T1,0,v100,DU,RP-02-19,10.0,13NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EA60BG5Y-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,3,,10,3,RP20160107;3915.xls,,,0,,09NOV2015,20NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-145,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64066-9,T1,0,v100,DU,RP-02-19,10.0,11NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KA60BG31-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,4,,10,3,RP20160107;3916.xls,,,0,,06NOV2015,17NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-127,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64068-3,T1,0,v100,DU,RP-02-19,10.0,24NOV2015,07JAN2016,50,10,10,27,27,1.4313637642,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AA60BGMS-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,4,,10,3,RP20160107;3916.xls,,,0,,19NOV2015,30NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-044,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64069-1,T1,0,v100,DU,RP-02-19,10.0,16NOV2015,07JAN2016,50,10,10,59,59,1.7708520116,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GA60BG7M-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,4,,10,3,RP20160107;3916.xls,,,0,,12NOV2015,23NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-132,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64070-7,T1,0,v100,DU,RP-02-19,10.0,13NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FA60BG5H-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,4,,10,3,RP20160107;3916.xls,,,0,,09NOV2015,20NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-048,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64073-6,T1,0,v100,DU,RP-02-19,10.0,16NOV2015,07JAN2016,50,10,10,52,52,1.7160033436,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EA60BG9D-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,4,,10,3,RP20160107;3916.xls,,,0,,12NOV2015,23NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-092,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64075-4,T1,0,v100,DU,RP-02-19,10.0,17NOV2015,07JAN2016,50,10,10,26,26,1.414973348,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JA60BGCG-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,5,,10,3,RP20160107;3917.xls,,,0,,13NOV2015,24NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-218,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64076-2,T1,0,v100,DU,RP-02-19,10.0,16NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JA60BG9S-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,5,,10,3,RP20160107;3917.xls,,,0,,12NOV2015,23NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-179,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64082-4,T1,0,v100,DU,RP-02-19,10.0,10NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BA60BG19-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,5,,10,3,RP20160107;3917.xls,,,0,,06NOV2015,17NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-040,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64089-5,T1,0,v100,DU,RP-02-19,10.0,27NOV2015,07JAN2016,50,10,10,24,24,1.3802112417,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FA60BGP5-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,6,,10,3,RP20160107;3918.xls,,,0,,21NOV2015,02DEC2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-022,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64001-8,T1,0,v100,DU,CJ11-116,10.0,21SEP2015,07JAN2016,50,10,10,71,71,1.8512583487,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HAT054TG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,5,,10,3,CJ20160107;3937.xls,,,0,,20SEP2015,01OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-066,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64002-9,T1,0,v100,DU,CJ11-50,10.0,17SEP2015,11NOV2015,50,10,10,34,34,1.531478917,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GAT054MG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,6,,10,3,P20151111;3420.xls,,,0,,12SEP2015,23SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-142,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64004-1,T1,0,v100,DU,CJ11-116,10.0,22OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AAT057TJ-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,5,,10,3,CJ20160107;3937.xls,,,0,,16OCT2015,27OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-236,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64006-5,T1,0,v100,DU,CJ11-50,10.0,17SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BAT054L4-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,7,,10,3,P20151111;3421.xls,,,0,,13SEP2015,24SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-120,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64007-6,T1,0,v100,DU,CJ11-50,10.0,17SEP2015,11NOV2015,50,10,10,19,19,1.278753601,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DAT054KS-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,7,,10,3,P20151111;3421.xls,,,0,,13SEP2015,24SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-029,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64009-0,T1,0,v100,DU,CJ11-116,10.0,21SEP2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HAT054TT-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,5,,10,3,CJ20160107;3937.xls,,,0,,17SEP2015,28SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-107,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64010-5,T1,0,v100,DU,CJ11-116,10.0,22SEP2015,07JAN2016,50,10,10,11,11,1.0413926852,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JAT0550X-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,5,,10,3,CJ20160107;3937.xls,,,0,,18SEP2015,29SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-113,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64012-3,T1,0,v100,DU,CJ11-116,10.0,21SEP2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BAT054V4-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,5,,10,3,CJ20160107;3937.xls,,,0,,20SEP2015,01OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-234,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64016-4,T1,0,v100,DU,CJ11-116,10.0,21SEP2015,07JAN2016,50,10,10,68,68,1.8325089127,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CAT054VG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,6,,10,3,CJ20160107;3938.xls,,,0,,20SEP2015,01OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-059,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64017-0,T1,0,v100,DU,CJ11-116,10.0,28SEP2015,07JAN2016,50,10,10,16,16,1.2041199827,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AAT05585-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,6,,10,3,CJ20160107;3938.xls,,,0,,24SEP2015,05OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-023,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64021-4,T1,0,v100,DU,CJ11-116,10.0,28SEP2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AAT0557V-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,6,,10,3,CJ20160107;3938.xls,,,0,,24SEP2015,05OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-201,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64029-9,T1,0,v100,DU,CJ11-116,10.0,12OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AAT056K1-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,7,,10,3,CJ20160107;3939.xls,,,0,,08OCT2015,19OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-076,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64031-7,T1,0,v100,DU,CJ11-116,10.0,26OCT2015,07JAN2016,50,10,10,95,95,1.9777236053,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JAT057ZR-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,7,,10,3,CJ20160107;3939.xls,,,0,,22OCT2015,02NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-204,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64035-6,T1,0,v100,DU,CJ11-116,10.0,26OCT2015,07JAN2016,50,10,10,61,61,1.785329835,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KAT057X1-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,7,,10,3,CJ20160107;3939.xls,,,0,,22OCT2015,02NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-230,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64036-9,T1,0,v100,DU,CJ11-116,10.0,02NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DAT058FR-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,7,,10,3,CJ20160107;3939.xls,,,0,,29OCT2015,09NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-011,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64037-5,T1,0,v100,DU,CJ11-116,10.0,27OCT2015,07JAN2016,50,10,10,194,194,2.2878017299,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AAT0584C-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,8,,10,3,CJ20160107;3940-1.xls,,,0,,23OCT2015,03NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-161,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64038-3,T1,0,v100,DU,CJ11-116,10.0,19OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KAT05797-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,8,,10,3,CJ20160107;3940-1.xls,,,0,,15OCT2015,26OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-180,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64041-3,T1,0,v100,DU,RP-02-19,10.0,07NOV2015,07JAN2016,50,10,10,54,54,1.7323937598,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BAT05967-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,6,,10,3,RP20160107;3918.xls,,,0,,02NOV2015,13NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-116,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64043-8,T1,0,v100,DU,RP-02-19,10.0,10NOV2015,07JAN2016,50,10,10,28,28,1.4471580313,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DAT059JJ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,6,,10,3,RP20160107;3918.xls,,,0,,06NOV2015,17NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-079,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64044-6,T1,0,v100,DU,CJ11-116,10.0,23OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KAT057VG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,8,,10,3,CJ20160107;3940-1.xls,,,0,,19OCT2015,30OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-192,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64045-2,T1,0,v100,DU,RP-02-19,10.0,11NOV2015,07JAN2016,50,10,10,24,24,1.3802112417,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EAT059Q1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,6,,10,3,RP20160107;3918.xls,,,0,,09NOV2015,20NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-146,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64050-2,T1,0,v100,DU,RP-02-19,10.0,11NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FAT059TS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,6,,10,3,RP20160107;3918.xls,,,0,,07NOV2015,18NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-006,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64051-5,T1,0,v100,DU,RP-02-19,10.0,09NOV2015,07JAN2016,50,10,10,54,54,1.7323937598,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DAT0598R-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,7,,10,3,RP20160107;3919.xls,,,0,,05NOV2015,16NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-007,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64053-1,T1,0,v100,DU,RP-02-19,10.0,09NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BAT059C4-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,7,,10,3,RP20160107;3919.xls,,,0,,05NOV2015,16NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-081,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64054-4,T1,0,v100,DU,RP-02-19,10.0,10NOV2015,07JAN2016,50,10,10,120,120,2.079181246,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JAT059KL-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,7,,10,3,RP20160107;3919.xls,,,0,,06NOV2015,17NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-172,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64056-7,T1,0,v100,DU,RP-02-19,10.0,16NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FAT05B6R-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,7,,10,3,RP20160107;3919.xls,,,0,,12NOV2015,23NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-205,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64057-8,T1,0,v100,DU,RP-02-19,10.0,11NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HAT059VK-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,7,,10,3,RP20160107;3919.xls,,,0,,06NOV2015,17NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-202,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64060-6,T1,0,v100,DU,RP-02-19,10.0,21NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BAT05BWD-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,8,,10,3,RP20160107;3920.xls,,,0,,17NOV2015,28NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-119,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64062-2,T1,0,v100,DU,RP-02-19,10.0,18NOV2015,07JAN2016,50,10,10,11,11,1.0413926852,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JAT05BLC-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,8,,10,3,RP20160107;3920.xls,,,0,,14NOV2015,25NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-101,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64072-7,T1,0,v100,DU,RP-02-19,10.0,19NOV2015,07JAN2016,50,10,10,22,22,1.3424226808,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FAT05BS4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,8,,10,3,RP20160107;3920.xls,,,0,,19NOV2015,30NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-050,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64003-1,T1,0,v100,DU,CJ11-116,10.0,02SEP2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,B7Q0HRJ1-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,8,,10,3,CJ20160107;3940-1.xls,,,0,,29AUG2015,09SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-150,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64005-9,T1,0,v100,DU,CJ11-116,10.0,01SEP2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,G7Q0HR6B-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,9,,10,3,CJ20160107;3941.xls,,,0,,28AUG2015,08SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-114,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64006-7,T1,0,v100,DU,CJ11-116,10.0,18SEP2015,07JAN2016,50,10,10,27,27,1.4313637642,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,B7Q0HT5Y-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,9,,10,3,CJ20160107;3941.xls,,,0,,14SEP2015,25SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-190,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64007-8,T1,0,v100,DU,CJ11-116,10.0,05OCT2015,07JAN2016,50,10,10,46,46,1.6627578317,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0HVGX-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,9,,10,3,CJ20160107;3941.xls,,,0,,01OCT2015,12OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-248,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64011-0,T1,0,v100,DU,CJ11-116,10.0,23SEP2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0HTJJ-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,9,,10,3,CJ20160107;3941.xls,,,0,,18SEP2015,29SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-042,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64017-3,T1,0,v100,DU,CJ11-116,10.0,06OCT2015,07JAN2016,50,10,10,61,61,1.785329835,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,G7Q0HVRV-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,9,,10,3,CJ20160107;3941.xls,,,0,,03OCT2015,14OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-078,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64018-5,T1,0,v100,DU,CJ11-116,10.0,02OCT2015,07JAN2016,50,10,10,13,13,1.1139433523,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HVCC-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,10,,10,3,CJ20160107;3942.xls,,,0,,01OCT2015,12OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-242,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64019-8,T1,0,v100,DU,RP-02-19,10.0,10NOV2015,07JAN2016,50,10,10,12,12,1.079181246,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0HZFL-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,8,,10,3,RP20160107;3920.xls,,,0,,07NOV2015,18NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-071,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64022-3,T1,0,v100,DU,CJ11-116,10.0,23OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HXFC-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,10,,10,3,CJ20160107;3942.xls,,,0,,23OCT2015,03NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-070,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64025-1,T1,0,v100,DU,CJ11-116,10.0,26OCT2015,07JAN2016,50,10,10,39,39,1.591064607,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0HXGY-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,10,,10,3,CJ20160107;3942.xls,,,0,,23OCT2015,03NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-134,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64026-4,T1,0,v100,DU,RP-02-19,10.0,09NOV2015,07JAN2016,50,10,10,103,103,2.0128372247,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,D7Q0HZB7-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,9,,10,3,RP20160107;3921.xls,,,0,,05NOV2015,16NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-219,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64028-8,T1,0,v100,DU,CJ11-116,10.0,27OCT2015,07JAN2016,50,10,10,83,83,1.9190780924,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0HXTF-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,10,,10,3,CJ20160107;3942.xls,,,0,,26OCT2015,06NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-176,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64029-6,T1,0,v100,DU,RP-02-19,10.0,10NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HZFG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,9,,10,3,RP20160107;3921.xls,,,0,,07NOV2015,18NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-135,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64031-9,T1,0,v100,DU,RP-02-19,10.0,02NOV2015,07JAN2016,50,10,10,10,10,1,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HYLD-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,9,,10,3,RP20160107;3921.xls,,,0,,24OCT2015,04NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-103,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64036-6,T1,0,v100,DU,CJ11-116,10.0,30OCT2015,07JAN2016,50,10,10,24,24,1.3802112417,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,F7Q0HYBJ-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,11,,10,3,CJ20160107;3943.xls,,,0,,29OCT2015,09NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-169,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64037-7,T1,0,v100,DU,RP-02-19,10.0,12NOV2015,07JAN2016,50,10,10,50,50,1.6989700043,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0HZWP-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,9,,10,3,RP20160107;3921.xls,,,0,,08NOV2015,19NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-165,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64041-1,T1,0,v100,DU,RP-02-19,10.0,01DEC2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0J1Q0-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,9,,10,3,RP20160107;3921.xls,,,0,,26NOV2015,07DEC2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-183,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64044-8,T1,0,v100,DU,CJ11-116,10.0,30OCT2015,07JAN2016,50,10,10,62,62,1.7923916895,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,F7Q0HY9Q-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,11,,10,3,CJ20160107;3943.xls,,,0,,29OCT2015,09NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-188,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64046-3,T1,0,v100,DU,RP-02-19,10.0,17NOV2015,07JAN2016,50,10,10,17,17,1.2304489214,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0J09C-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,10,,10,3,RP20160107;3922.xls,,,0,,17NOV2015,28NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-054,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64047-4,T1,0,v100,DU,RP-02-19,10.0,03NOV2015,07JAN2016,50,10,10,23,23,1.361727836,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HYR2-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,10,,10,3,RP20160107;3922.xls,,,0,,29OCT2015,09NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-239,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64054-2,T1,0,v100,DU,CJ11-116,10.0,28OCT2015,07JAN2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,F7Q0HXZP-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,11,,10,3,CJ20160107;3943.xls,,,0,,26OCT2015,06NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-098,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64062-0,T1,0,v100,DU,RP-02-19,10.0,03NOV2015,07JAN2016,50,10,10,15,15,1.1760912591,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0HYRQ-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,11,,10,3,RP20160107;3923.xls,,,0,,30OCT2015,10NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-216,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64064-5,T1,0,v100,DU,RP-02-19,10.0,12NOV2015,07JAN2016,50,10,10,49,49,1.69019608,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0J015-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,11,,10,3,RP20160107;3923.xls,,,0,,09NOV2015,20NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-185,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64065-3,T1,0,v100,DU,RP-02-19,10.0,12NOV2015,07JAN2016,50,10,10,39,39,1.591064607,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0HZXY-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,11,,10,3,RP20160107;3923.xls,,,0,,08NOV2015,19NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-102,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64067-2,T1,0,v100,DU,RP-02-19,10.0,17NOV2015,07JAN2016,50,10,10,49,49,1.69019608,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0J09F-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,11,,10,3,RP20160107;3923.xls,,,0,,13NOV2015,24NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-112,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64070-4,T1,0,v100,DU,RP-02-19,10.0,16NOV2015,07JAN2016,50,10,10,16,16,1.2041199827,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,D7Q0J03Q-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,12,,10,3,RP20160107;3924-1-1.xls,,,0,,05NOV2015,16NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-082,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64074-1,T1,0,v100,DU,RP-02-19,10.0,16NOV2015,07JAN2016,50,10,10,29,29,1.4623979979,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,F7Q0J039-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,12,,10,3,RP20160107;3924-1-1.xls,,,0,,12NOV2015,23NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-197,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64084-3,T1,0,v100,DU,RP-02-19,10.0,18NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,B7Q0J0MY-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,12,,10,3,RP20160107;3924-1-1.xls,,,0,,15NOV2015,26NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-232,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64085-5,T1,0,v100,DU,RP-02-19,10.0,01DEC2015,07JAN2016,50,10,10,17,17,1.2304489214,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0J1QW-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,13,,10,3,RP20160107;3925.xls,,,0,,20NOV2015,01DEC2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-003,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64002-4,T1,0,v100,DU,CJ11-116,10.0,13OCT2015,07JAN2016,50,10,10,26,26,1.414973348,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HWBJ-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,11,,10,3,CJ20160107;3943.xls,,,0,,08OCT2015,19OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-152,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64006-0,T1,0,v100,DU,CJ11-116,10.0,14SEP2015,07JAN2016,50,10,10,15,15,1.1760912591,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0HSJ4-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,12,,10,3,CJ20160107;3944.xls,,,0,,06SEP2015,17SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-220,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64009-5,T1,0,v100,DU,CJ11-116,10.0,15OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HWQB-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,12,,10,3,CJ20160107;3944.xls,,,0,,11OCT2015,22OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-125,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64010-0,T1,0,v100,DU,CJ11-116,10.0,14SEP2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HSMB-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,12,,10,3,CJ20160107;3944.xls,,,0,,05SEP2015,16SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-233,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64011-7,T1,0,v100,DU,CJ11-116,10.0,22SEP2015,07JAN2016,50,10,10,95,95,1.9777236053,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,G7Q0HTGD-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,12,,10,3,CJ20160107;3944.xls,,,0,,18SEP2015,29SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-186,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64016-9,T1,0,v100,DU,CJ11-116,10.0,27OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,08MAR2016,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,D7Q0HXNV-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,13,,10,3,CJ20160107;3945.xls,,,0,0,18OCT2015,29OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-039,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64017-5,T1,0,v100,DU,CJ11-116,10.0,29SEP2015,07JAN2016,50,10,10,46,46,1.6627578317,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0HTWM-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,13,,10,3,CJ20160107;3945.xls,,,0,,26SEP2015,07OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-013,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64018-3,T1,0,v100,DU,RP-02-19,10.0,20NOV2015,07JAN2016,50,10,10,399,399,2.6009728957,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,F7Q0J0YX-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,13,,10,3,RP20160107;3925.xls,,,0,,17NOV2015,28NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-121,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64020-3,T1,0,v100,DU,CJ11-116,10.0,06OCT2015,07JAN2016,50,10,10,78,78,1.8920946027,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0HVPF-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,13,,10,3,CJ20160107;3945.xls,,,0,,01OCT2015,12OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-087,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64023-2,T1,0,v100,DU,CJ11-116,10.0,21OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HX1W-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,13,,10,3,CJ20160107;3945.xls,,,0,,16OCT2015,27OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-100,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64025-8,T1,0,v100,DU,CJ11-116,10.0,13OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HWBG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,14,,10,3,CJ20160107;3946.xls,,,0,,08OCT2015,19OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-069,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64026-6,T1,0,v100,DU,RP-02-19,10.0,07NOV2015,07JAN2016,50,10,10,86,86,1.9344984512,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HZ6R-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,13,,10,3,RP20160107;3925.xls,,,0,,03NOV2015,14NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-206,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64033-9,T1,0,v100,DU,CJ11-116,10.0,20OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,08DEC2015,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0HWYC-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,14,,10,3,CJ20160107;3946.xls,,,0,0,15OCT2015,26OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-047,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64035-1,T1,0,v100,DU,RP-02-19,10.0,05NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0HZ01-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,14,,10,3,RP20160107;3926.xls,,,0,,01NOV2015,12NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-089,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64038-8,T1,0,v100,DU,RP-02-19,10.0,25NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0J17P-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,14,,10,3,RP20160107;3926.xls,,,0,,20NOV2015,01DEC2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-139,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64041-8,T1,0,v100,DU,RP-02-19,10.0,10NOV2015,07JAN2016,50,10,10,16,16,1.2041199827,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0HZFB-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,14,,10,3,RP20160107;3926.xls,,,0,,06NOV2015,17NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-080,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64042-9,T1,0,v100,DU,CJ11-116,10.0,26OCT2015,07JAN2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0HXGW-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,14,,10,3,CJ20160107;3946.xls,,,0,,22OCT2015,02NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-210,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64046-5,T1,0,v100,DU,CJ11-116,10.0,27OCT2015,07JAN2016,50,10,10,31,31,1.4913616938,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HXNS-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,14,,10,3,CJ20160107;3946.xls,,,0,,23OCT2015,03NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-162,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64048-2,T1,0,v100,DU,RP-02-19,10.0,12NOV2015,07JAN2016,50,10,10,30,30,1.4771212547,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0J00K-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,14,,10,3,RP20160107;3926.xls,,,0,,05NOV2015,16NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-246,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64051-0,T1,0,v100,DU,RP-02-19,10.0,11NOV2015,07JAN2016,50,10,10,13,13,1.1139433523,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0HZP9-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,15,,10,3,RP20160107;3927.xls,,,0,,07NOV2015,18NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-223,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64053-6,T1,0,v100,DU,RP-02-19,10.0,11NOV2015,07JAN2016,50,10,10,20,20,1.3010299957,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,F7Q0HZQD-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,15,,10,3,RP20160107;3927.xls,,,0,,07NOV2015,18NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-028,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64055-4,T1,0,v100,DU,RP-02-19,10.0,05NOV2015,07JAN2016,50,10,10,84,84,1.9242792861,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0HZ03-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,15,,10,3,RP20160107;3927.xls,,,0,,01NOV2015,12NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-244,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64059-8,T1,0,v100,DU,RP-02-19,10.0,20NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,D7Q0J0Y2-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,15,,10,3,RP20160107;3927.xls,,,0,,17NOV2015,28NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-153,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64061-6,T1,0,v100,DU,RP-02-19,10.0,07NOV2015,07JAN2016,50,10,10,43,43,1.6334684556,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HZ5Y-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,16,,10,3,RP20160107;3928.xls,,,0,,03NOV2015,14NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-015,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64063-0,T1,0,v100,DU,RP-02-19,10.0,19NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0J0WN-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,16,,10,3,RP20160107;3928.xls,,,0,,14NOV2015,25NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-252,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64064-3,T1,0,v100,DU,RP-02-19,10.0,23NOV2015,07JAN2016,50,10,10,47,47,1.6720978579,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0J0ZW-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,16,,10,3,RP20160107;3928.xls,,,0,,19NOV2015,30NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-211,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64068-4,T1,0,v100,DU,RP-02-19,10.0,10NOV2015,07JAN2016,50,10,10,16,16,1.2041199827,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0HZFD-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,16,,10,3,RP20160107;3928.xls,,,0,,07NOV2015,18NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-147,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64069-2,T1,0,v100,DU,RP-02-19,10.0,16NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0J02X-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,17,,10,3,RP20160107;3929.xls,,,0,,05NOV2015,16NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-168,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64071-1,T1,0,v100,DU,RP-02-19,10.0,12NOV2015,07JAN2016,50,10,10,44,44,1.6434526765,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HZZT-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,17,,10,3,RP20160107;3929.xls,,,0,,08NOV2015,19NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-203,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64072-2,T1,0,v100,DU,RP-02-19,10.0,12NOV2015,07JAN2016,50,10,10,88,88,1.9444826722,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0HZYT-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,17,,10,3,RP20160107;3929.xls,,,0,,08NOV2015,19NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-167,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64074-8,T1,0,v100,DU,RP-02-19,10.0,18NOV2015,07JAN2016,50,10,10,34,34,1.531478917,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0J0LW-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,17,,10,3,RP20160107;3929.xls,,,0,,17NOV2015,28NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-224,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64075-0,T1,0,v100,DU,RP-02-19,10.0,19NOV2015,07JAN2016,50,10,10,11,11,1.0413926852,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0J0W8-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,18,,10,3,RP20160107;3930.xls,,,0,,13NOV2015,24NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-226,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64077-4,T1,0,v100,DU,RP-02-19,10.0,19NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0J0QS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,18,,10,3,RP20160107;3930.xls,,,0,,15NOV2015,26NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-020,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64079-7,T1,0,v100,DU,RP-02-19,10.0,03DEC2015,07JAN2016,50,10,10,41,41,1.6127838567,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,B7Q0J1WG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,18,,10,3,RP20160107;3930.xls,,,0,,27NOV2015,08DEC2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-065,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64001-1,T1,0,v100,DU,CJ11-50,10.0,07SEP2015,11NOV2015,50,10,10,36,36,1.5563025008,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20FCQ6-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,7,,10,3,P20151111;3421.xls,,,0,,05SEP2015,16SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-018,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64002-2,T1,0,v100,DU,CJ11-116,10.0,15SEP2015,07JAN2016,50,10,10,62,62,1.7923916895,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BC20FHFQ-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,15,,10,3,CJ20160107;3947.xls,,,0,,14SEP2015,25SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-096,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64004-8,T1,0,v100,DU,CJ11-116,10.0,23OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20FW3Z-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,15,,10,3,CJ20160107;3947.xls,,,0,,22OCT2015,02NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-249,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64006-3,T1,0,v100,DU,CJ11-116,10.0,22SEP2015,07JAN2016,50,10,10,20,20,1.3010299957,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FK9S-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,15,,10,3,CJ20160107;3947.xls,,,0,,20SEP2015,01OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-010,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64009-7,T1,0,v100,DU,CJ11-116,10.0,22SEP2015,07JAN2016,50,10,10,25,25,1.3979400087,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20FKKP-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,15,,10,3,CJ20160107;3947.xls,,,0,,20SEP2015,01OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-222,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64018-1,T1,0,v100,DU,CJ11-116,10.0,30SEP2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FMJB-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,16,,10,3,CJ20160107;3948.xls,,,0,,26SEP2015,07OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-046,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64022-7,T1,0,v100,DU,CJ11-116,10.0,16OCT2015,07JAN2016,50,10,10,21,21,1.3222192947,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FS71-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,16,,10,3,CJ20160107;3948.xls,,,0,,12OCT2015,23OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-037,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64030-7,T1,0,v100,DU,CJ11-116,10.0,09OCT2015,07JAN2016,50,10,10,23,23,1.361727836,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20FQ9L-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,16,,10,3,CJ20160107;3948.xls,,,0,,01OCT2015,12OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-251,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64033-6,T1,0,v100,DU,CJ11-116,10.0,19OCT2015,07JAN2016,50,10,10,35,35,1.5440680444,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20FSKN-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,16,,10,3,CJ20160107;3948.xls,,,0,,12OCT2015,23OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-099,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64034-9,T1,0,v100,DU,CJ11-116,10.0,08OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20FQ46-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,16,,10,3,CJ20160107;3948.xls,,,0,,03OCT2015,14OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-032,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64038-5,T1,0,v100,DU,CJ11-116,10.0,26OCT2015,07JAN2016,50,10,10,17,17,1.2304489214,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FWHM-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,17,,10,3,CJ20160107;3949.xls,,,0,,22OCT2015,02NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-245,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64039-8,T1,0,v100,DU,CJ11-116,10.0,15OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FRV7-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,17,,10,3,CJ20160107;3949.xls,,,0,,08OCT2015,19OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-057,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64042-6,T1,0,v100,DU,CJ11-116,10.0,22OCT2015,07JAN2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FVNV-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,17,,10,3,CJ20160107;3949.xls,,,0,,17OCT2015,28OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-055,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64043-1,T1,0,v100,DU,CJ11-116,10.0,14OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20FRFF-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,17,,10,3,CJ20160107;3949.xls,,,0,,12OCT2015,23OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-021,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64046-7,T1,0,v100,DU,RP-02-19,10.0,04NOV2015,07JAN2016,50,10,10,25,25,1.3979400087,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20FZ1Z-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,18,,10,3,RP20160107;3930.xls,,,0,,01NOV2015,12NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-156,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64049-3,T1,0,v100,DU,CJ11-116,10.0,14OCT2015,07JAN2016,50,10,10,170,170,2.2304489214,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20FRCW-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,17,,10,3,CJ20160107;3949.xls,,,0,,10OCT2015,21OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-014,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64054-6,T1,0,v100,DU,CJ11-116,10.0,23OCT2015,07JAN2016,50,10,10,12,12,1.079181246,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20FW4N-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,18,,10,3,CJ20160107;3950.xls,,,0,,16OCT2015,27OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-240,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64062-9,T1,0,v100,DU,CJ11-116,10.0,27OCT2015,07JAN2016,50,10,10,82,82,1.9138138524,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CC20FWTX-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,18,,10,3,CJ20160107;3950.xls,,,0,,23OCT2015,03NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-171,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64063-3,T1,0,v100,DU,CJ11-116,10.0,14OCT2015,07JAN2016,50,10,10,116,116,2.0644579892,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20FRDV-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,18,,10,3,CJ20160107;3950.xls,,,0,,10OCT2015,21OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-068,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64064-1,T1,0,v100,DU,CJ11-116,10.0,27OCT2015,07JAN2016,50,10,10,72,72,1.8573324964,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20FWX6-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,18,,10,3,CJ20160107;3950.xls,,,0,,23OCT2015,03NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-062,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64065-7,T1,0,v100,DU,CJ11-116,10.0,13OCT2015,07JAN2016,50,10,10,107,107,2.0293837777,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FQWN-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,19,,10,3,CJ20160107;3951.xls,,,0,,12OCT2015,23OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-036,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64066-5,T1,0,v100,DU,CJ11-116,10.0,16OCT2015,07JAN2016,50,10,10,38,38,1.5797835966,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CC20FS6F-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,19,,10,3,CJ20160107;3951.xls,,,0,,10OCT2015,21OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-095,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64071-4,T1,0,v100,DU,CJ11-116,10.0,21OCT2015,07JAN2016,50,10,10,68,68,1.8325089127,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20FTPM-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,19,,10,3,CJ20160107;3951.xls,,,0,,17OCT2015,28OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-212,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64072-0,T1,0,v100,DU,RP-02-19,10.0,02NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CC20FY0T-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,18,,10,3,RP20160107;3930.xls,,,0,,29OCT2015,09NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-072,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64074-5,T1,0,v100,DU,CJ11-116,10.0,20OCT2015,07JAN2016,50,10,10,43,43,1.6334684556,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BC20FSTR-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,19,,10,3,CJ20160107;3951.xls,,,0,,15OCT2015,26OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-229,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64076-1,T1,0,v100,DU,RP-02-19,10.0,07NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CC20G182-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,19,,10,3,RP20160107;3931.xls,,,0,,29OCT2015,09NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-217,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64077-2,T1,0,v100,DU,CJ11-116,10.0,29OCT2015,07JAN2016,50,10,10,13,13,1.1139433523,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20FXCG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,20,,10,3,CJ20160107;3952.xls,,,0,,25OCT2015,05NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-149,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64078-6,T1,0,v100,DU,CJ11-116,10.0,21OCT2015,07JAN2016,50,10,10,16,16,1.2041199827,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20FTPZ-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,20,,10,3,CJ20160107;3952.xls,,,0,,16OCT2015,27OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-017,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64085-1,T1,0,v100,DU,CJ11-116,10.0,20OCT2015,07JAN2016,50,10,10,17,17,1.2304489214,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FSV2-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,20,,10,3,CJ20160107;3952.xls,,,0,,17OCT2015,28OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-074,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64086-4,T1,0,v100,DU,CJ11-116,10.0,30OCT2015,07JAN2016,50,10,10,23,23,1.361727836,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CC20FXJC-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,21,,10,3,CJ20160107;3953.xls,,,0,,26OCT2015,06NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-124,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64089-6,T1,0,v100,DU,CJ11-116,10.0,28OCT2015,07JAN2016,50,10,10,20,20,1.3010299957,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FX1S-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,21,,10,3,CJ20160107;3953.xls,,,0,,25OCT2015,05NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-004,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64095-6,T1,0,v100,DU,CJ11-116,10.0,27OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BC20FWWD-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,21,,10,3,CJ20160107;3953.xls,,,0,,23OCT2015,03NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-182,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64097-5,T1,0,v100,DU,RP-02-19,10.0,06NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20G0Z4-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,19,,10,3,RP20160107;3931.xls,,,0,,05NOV2015,16NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-034,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64107-1,T1,0,v100,DU,RP-02-19,10.0,07NOV2015,07JAN2016,50,10,10,14,14,1.1461280357,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20G18P-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,19,,10,3,RP20160107;3931.xls,,,0,,03NOV2015,14NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-115,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64113-4,T1,0,v100,DU,CJ11-116,10.0,30OCT2015,07JAN2016,50,10,10,16,16,1.2041199827,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FXJP-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,21,,10,3,CJ20160107;3953.xls,,,0,,29OCT2015,09NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-144,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64118-3,T1,0,v100,DU,RP-02-19,10.0,10NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20G20Y-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,19,,10,3,RP20160107;3931.xls,,,0,,07NOV2015,18NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-189,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64125-8,T1,0,v100,DU,RP-02-19,10.0,12NOV2015,07JAN2016,50,10,10,73,73,1.8633228601,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20G3XF-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,19,,10,3,RP20160107;3931.xls,,,0,,12NOV2015,23NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-141,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64001-8,P2,1,v100,DU,CJ11-50,10.0,23JUL2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20DZ2F-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,1,,10,3,P20151111;3415-1.xls,,,0,,23JUL2015,03AUG2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-056,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64028-6,P2,1,v100,DU,CJ11-50,10.0,04AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BC20F1PR-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,2,,10,3,P20151111;3416-1-1.xls,,,0,,02AUG2015,13AUG2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-154,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64047-1,P2,1,v100,DU,CJ11-50,10.0,17AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20F5F9-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,3,,10,3,P20151111;3417.xls,,,0,,13AUG2015,24AUG2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-041,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64059-3,P2,1,v100,DU,CJ11-50,10.0,19AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20F64B-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,4,,10,3,P20151111;3418.xls,,,0,,15AUG2015,26AUG2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-196,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64085-8,P2,1,v100,DU,CJ11-50,10.0,07SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20FCQJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,48,Jennifer Martin,5,,10,3,P20151111;3419.xls,,,0,,04SEP2015,15SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-200,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64086-6,P2,1,v100,DU,CJ11-116,10.0,15SEP2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20FHG1-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,1,,10,3,CJ20160107;3933.xls,,,0,,12SEP2015,23SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-122,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64121-2,P2,1,v100,DU,CJ11-116,10.0,29SEP2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CC20FM29-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,2,,10,3,CJ20160107;3934.xls,,,0,,26SEP2015,07OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-199,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64165-3,P2,1,v100,DU,RP-02-19,10.0,09NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20G1N0-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,1,,10,3,RP20160107;3913-1.xls,,,0,,05NOV2015,16NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-104,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64052-0,P2,1,v100,DU,CJ11-116,10.0,06NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EA60BFW9-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,4,,10,3,CJ20160107;3936.xls,,,0,,02NOV2015,13NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-086,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64077-3,P2,1,v100,DU,RP-02-19,10.0,24NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CA60BGKV-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,5,,10,3,RP20160107;3917.xls,,,0,,13NOV2015,24NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-012,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64078-5,P2,1,v100,DU,RP-02-19,10.0,19NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HA60BGF7-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,5,,10,3,RP20160107;3917.xls,,,0,,14NOV2015,25NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-214,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64018-8,P2,1,v100,DU,CJ11-116,10.0,23SEP2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,08APR2016,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CAT0552W-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,6,,10,3,CJ20160107;3938.xls,,,0,0,19SEP2015,30SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-238,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64027-2,P2,1,v100,DU,CJ11-116,10.0,27OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HAT0584P-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,6,,10,3,CJ20160107;3938.xls,,,0,,23OCT2015,03NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-175,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64030-0,P2,1,v100,DU,CJ11-116,10.0,18SEP2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EAT054PV-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,7,,10,3,CJ20160107;3939.xls,,,0,,14SEP2015,25SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-045,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64068-9,P2,1,v100,DU,RP-02-19,10.0,26NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FAT05CFM-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,8,,10,3,RP20160107;3920.xls,,,0,,22NOV2015,03DEC2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-191,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64024-7,P2,1,v100,DU,CJ11-116,10.0,26OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0HXHD-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,10,,10,3,CJ20160107;3942.xls,,,0,,24OCT2015,04NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-164,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64045-0,P2,1,v100,DU,RP-02-19,10.0,16NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,B7Q0J06D-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,10,,10,3,RP20160107;3922.xls,,,0,,14NOV2015,25NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-008,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64049-7,P2,1,v100,DU,RP-02-19,10.0,02NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0HYLY-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,10,,10,3,RP20160107;3922.xls,,,0,,29OCT2015,09NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-016,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64051-7,P2,1,v100,DU,RP-02-19,10.0,18NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0J0N9-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,10,,10,3,RP20160107;3922.xls,,,0,,17NOV2015,28NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-033,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64059-1,P2,1,v100,DU,RP-02-19,10.0,12NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,B7Q0HZVY-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,11,,10,3,RP20160107;3923.xls,,,0,,07NOV2015,18NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-241,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64069-9,P2,1,v100,DU,RP-02-19,10.0,10NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HZFJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,12,,10,3,RP20160107;3924-1-1.xls,,,0,,05NOV2015,16NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-159,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64073-3,P2,1,v100,DU,CJ11-116,10.0,27OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,D7Q0HXSP-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,11,,10,3,CJ20160107;3943.xls,,,0,,26OCT2015,06NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-049,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64083-0,P2,1,v100,DU,RP-02-19,10.0,17NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0J0CK-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,12,,10,3,RP20160107;3924-1-1.xls,,,0,,14NOV2015,25NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-024,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64008-7,P2,1,v100,DU,CJ11-116,10.0,22SEP2015,07JAN2016,50,10,10,13,13,1.1139433523,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HTD1-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,12,,10,3,CJ20160107;3944.xls,,,0,,18SEP2015,29SEP2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-143,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64021-9,P2,1,v100,DU,CJ11-116,10.0,01OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,G7Q0HV6Q-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,13,,10,3,CJ20160107;3945.xls,,,0,,01OCT2015,12OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-009,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64024-0,P2,1,v100,DU,CJ11-116,10.0,21OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FTQC-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,14,,10,3,CJ20160107;3946.xls,,,0,,16OCT2015,27OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-094,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64031-2,P2,1,v100,DU,RP-02-19,10.0,07NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HZ68-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,13,,10,3,RP20160107;3925.xls,,,0,,03NOV2015,14NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-026,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64034-7,P2,1,v100,DU,RP-02-19,10.0,04NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,B7Q0HYZ4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,13,,10,3,RP20160107;3925.xls,,,0,,31OCT2015,11NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-166,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64050-7,P2,1,v100,DU,RP-02-19,10.0,04NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,F7Q0HYV7-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,14,,10,3,RP20160107;3926.xls,,,0,,31OCT2015,11NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-005,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64057-3,P2,1,v100,DU,RP-02-19,10.0,04NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0HYVZ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,15,,10,3,RP20160107;3927.xls,,,0,,30OCT2015,10NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-133,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64060-1,P2,1,v100,DU,RP-02-19,10.0,07NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0HZ5H-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,16,,10,3,RP20160107;3928.xls,,,0,,03NOV2015,14NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-195,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64070-6,P2,1,v100,DU,RP-02-19,10.0,09NOV2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20G1M1-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,47,Renia Passie,17,,10,3,RP20160107;3929.xls,,,0,,07NOV2015,18NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-043,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64017-7,P2,1,v100,DU,CJ11-116,10.0,13OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FQTX-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,15,,10,3,CJ20160107;3947.xls,,,0,,10OCT2015,21OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-174,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64052-4,P2,1,v100,DU,CJ11-116,10.0,23OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20FW49-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,18,,10,3,CJ20160107;3950.xls,,,0,,19OCT2015,30OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-067,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64073-7,P2,1,v100,DU,CJ11-116,10.0,22OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20FVG5-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,19,,10,3,CJ20160107;3951.xls,,,0,,18OCT2015,29OCT2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-213,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64079-9,P2,1,v100,DU,CJ11-116,10.0,28OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20FX13-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,20,,10,3,CJ20160107;3952.xls,,,0,,24OCT2015,04NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-250,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64080-5,P2,1,v100,DU,CJ11-116,10.0,28OCT2015,07JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FX2K-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,02MAY2013,5557,49,Jennifer Martin,20,,10,3,CJ20160107;3952.xls,,,0,,24OCT2015,04NOV2015,0,182,0,CH0505.w4.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-053,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64003-3,T1,0,v100,SA,151207-TH-HVTN100,10.0,22JUL2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20DYKC-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,6,,10,3,TH;20151209;12631;MN;PLATE6.xl,,,0,,19JUL2015,30JUL2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-111,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64006-5,T1,0,v100,SA,151207-TH-HVTN100,10.0,29JUL2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20F09P-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,6,,10,3,TH;20151209;12631;MN;PLATE6.xl,,,0,,26JUL2015,06AUG2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-031,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64009-0,T1,0,v100,SA,151207-TH-HVTN100,10.0,23JUL2015,07DEC2015,50,10,10,88,88,1.9444826722,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20DYTL-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151209;12633;MN;PLATE1.xl,,,0,,23JUL2015,03AUG2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-209,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64013-9,T1,0,v100,SA,151207-TH-HVTN100,10.0,28JUL2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20DZVV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151209;12633;MN;PLATE1.xl,,,0,,25JUL2015,05AUG2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-158,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64021-4,T1,0,v100,SA,151207-TH-HVTN100,10.0,03AUG2015,07DEC2015,50,10,10,43,43,1.6334684556,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F17D-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151209;12633;MN;PLATE1.xl,,,0,,01AUG2015,12AUG2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-215,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64029-9,T1,0,v100,SA,151207-TH-HVTN100,10.0,25AUG2015,07DEC2015,50,10,10,306,306,2.4857214265,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8HS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151209;12634;MN;PLATE2.xl,,,0,,14AUG2015,25AUG2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-231,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64031-7,T1,0,v100,SA,151207-TH-HVTN100,10.0,27AUG2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8ZN-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151209;12634;MN;PLATE2.xl,,,0,,21AUG2015,01SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-091,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64033-4,T1,0,v100,SA,151207-TH-HVTN100,10.0,08SEP2015,07DEC2015,50,10,10,145,145,2.1613680022,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD4N-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151209;12634;MN;PLATE2.xl,,,0,,04SEP2015,15SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-077,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64036-9,T1,0,v100,SA,151207-TH-HVTN100,10.0,18AUG2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20F5SG-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,6,,10,3,TH;20151209;12631;MN;PLATE6.xl,,,0,,14AUG2015,25AUG2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-136,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64045-2,T1,0,v100,SA,151207-TH-HVTN100,10.0,13AUG2015,07DEC2015,50,10,10,50,50,1.6989700043,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F4C6-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151209;12634;MN;PLATE2.xl,,,0,,13AUG2015,24AUG2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-227,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64053-1,T1,0,v100,SA,151227-TH-HVTN100,10.0,19AUG2015,27DEC2015,50,10,10,30,30,1.4771212547,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20F676-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151229;12757;MN;PLATE3.xl,,,0,,16AUG2015,27AUG2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-160,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64054-4,T1,0,v100,SA,151207-TH-HVTN100,10.0,26AUG2015,07DEC2015,50,10,10,337,337,2.5276299009,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8R9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151209;12628;MN;PLATE3.xl,,,0,,21AUG2015,01SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-155,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64055-9,T1,0,v100,SA,151207-TH-HVTN100,10.0,20AUG2015,07DEC2015,50,10,10,111,111,2.0453229788,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F6C4-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151209;12628;MN;PLATE3.xl,,,0,,14AUG2015,25AUG2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-177,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64057-8,T1,0,v100,SA,151207-TH-HVTN100,10.0,02SEP2015,07DEC2015,50,10,10,75,75,1.8750612634,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FBT0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151209;12628;MN;PLATE3.xl,,,0,,23AUG2015,03SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-052,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64062-2,T1,0,v100,SA,151207-TH-HVTN100,10.0,03SEP2015,07DEC2015,50,10,10,296,296,2.4712917111,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FC68-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151209;12628;MN;PLATE3.xl,,,0,,28AUG2015,08SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-247,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64063-5,T1,0,v100,SA,151207-TH-HVTN100,10.0,08SEP2015,07DEC2015,50,10,10,56,56,1.748188027,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FD2Q-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151209;12629;MN;PLATE4.xl,,,0,,04SEP2015,15SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-126,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64066-3,T1,0,v100,SA,151207-TH-HVTN100,10.0,08SEP2015,07DEC2015,50,10,10,135,135,2.1303337685,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD3H-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151209;12629;MN;PLATE4.xl,,,0,,04SEP2015,15SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-225,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64067-4,T1,0,v100,SA,151207-TH-HVTN100,10.0,08SEP2015,07DEC2015,50,10,10,65,65,1.8129133566,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FD43-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151209;12629;MN;PLATE4.xl,,,0,,04SEP2015,15SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-148,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64069-7,T1,0,v100,SA,151221-TH-HVTN100,10.0,14SEP2015,21DEC2015,50,10,10,45,45,1.6532125138,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FGVK-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151223;12730;MN;PLATE1-1-,,,0,,12SEP2015,23SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-163,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64077-9,T1,0,v100,SA,151207-TH-HVTN100,10.0,07SEP2015,07DEC2015,50,10,10,67,67,1.8260748027,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FCJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151209;12629;MN;PLATE4.xl,,,0,,29AUG2015,09SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-073,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64080-3,T1,0,v100,SA,151207-TH-HVTN100,10.0,31AUG2015,07DEC2015,50,10,10,45,45,1.6532125138,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FB33-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151209;12629;MN;PLATE4.xl,,,0,,28AUG2015,08SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-184,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64087-7,T1,0,v100,SA,151207-TH-HVTN100,10.0,07SEP2015,07DEC2015,50,10,10,412,412,2.614897216,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FCJR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20151209;12630;MN;PLATE5.xl,,,0,,06SEP2015,17SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-170,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64095-4,T1,0,v100,SA,151221-TH-HVTN100,10.0,08OCT2015,21DEC2015,50,10,10,22,22,1.3424226808,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FQ3V-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151223;12731;MN;PLATE2-1-,,,0,,01OCT2015,12OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-038,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64105-9,T1,0,v100,SA,151229-TH-HVTN100,10.0,17NOV2015,29DEC2015,50,10,10,1363,1363,3.1344958558,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G4TX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151231;12786;MN;PLATE2.xl,,,0,,14NOV2015,25NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-123,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64117-3,T1,0,v100,SA,151221-TH-HVTN100,10.0,17SEP2015,21DEC2015,50,10,10,30,30,1.4771212547,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FJ00-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151223;12731;MN;PLATE2-1-,,,0,,13SEP2015,24SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-061,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64119-8,T1,0,v100,SA,151221-TH-HVTN100,10.0,30SEP2015,21DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FMJ0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151223;12731;MN;PLATE2-1-,,,0,,26SEP2015,07OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-128,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64129-6,T1,0,v100,SA,151221-TH-HVTN100,10.0,06OCT2015,21DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FPD4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151223;12731;MN;PLATE2-1-,,,0,,03OCT2015,14OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-108,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64130-3,T1,0,v100,SA,151221-TH-HVTN100,10.0,06OCT2015,21DEC2015,50,10,10,172,172,2.2355284469,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FPDG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151223;12732;MN;PLATE3-1.,,,0,,02OCT2015,13OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-097,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64135-8,T1,0,v100,SA,151221-TH-HVTN100,10.0,28SEP2015,21DEC2015,50,10,10,26,26,1.414973348,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FLTC-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151223;12732;MN;PLATE3-1.,,,0,,26SEP2015,07OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-129,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64139-4,T1,0,v100,SA,151228-TH-HVTN100,10.0,26OCT2015,28DEC2015,50,10,10,174,174,2.2405492483,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FWKL-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151230;12774;MN;PLATE4.xl,,,0,,16OCT2015,27OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-058,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64150-0,T1,0,v100,SA,151229-TH-HVTN100,10.0,11NOV2015,29DEC2015,50,10,10,219,219,2.3404441148,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20G3JT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151231;12786;MN;PLATE2.xl,,,0,,07NOV2015,18NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-151,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64154-2,T1,0,v100,SA,151229-TH-HVTN100,10.0,02NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FXYX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151231;12786;MN;PLATE2.xl,,,0,,25OCT2015,05NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-002,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64156-9,T1,0,v100,SA,160106-TH-HVTN100,10.0,02NOV2015,06JAN2016,50,10,10,77,77,1.8864907252,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FXZQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,2,,10,3,TH;20160108;12842;MN;PLATE2.xl,,,0,,25OCT2015,05NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-194,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64166-1,T1,0,v100,SA,151229-TH-HVTN100,10.0,17NOV2015,29DEC2015,50,10,10,148,148,2.1702617154,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G4VL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151231;12787;MN;PLATE3-1.,,,0,,14NOV2015,25NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-157,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64167-2,T1,0,v100,SA,160106-TH-HVTN100,10.0,10NOV2015,06JAN2016,50,10,10,161,161,2.206825876,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G20B-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,1,,10,3,TH;20160108;12840;MN;PLATE1.xl,,,0,,06NOV2015,17NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-025,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64172-9,T1,0,v100,SA,160106-TH-HVTN100,10.0,12NOV2015,06JAN2016,50,10,10,95,95,1.9777236053,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20G3X4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,2,,10,3,TH;20160108;12842;MN;PLATE2.xl,,,0,,06NOV2015,17NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-137,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64002-3,T1,0,v100,SA,151207-TH-HVTN100,10.0,28AUG2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BCRM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20151209;12630;MN;PLATE5.xl,,,0,,21AUG2015,01SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-064,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64007-0,T1,0,v100,SA,151221-TH-HVTN100,10.0,14SEP2015,21DEC2015,50,10,10,13,13,1.1139433523,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BDHQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151223;12730;MN;PLATE1-1-,,,0,,10SEP2015,21SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-131,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64008-8,T1,0,v100,SA,151207-TH-HVTN100,10.0,14SEP2015,07DEC2015,50,10,10,109,109,2.0374264979,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BDJC-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20151209;12630;MN;PLATE5.xl,,,0,,07SEP2015,18SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-109,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64028-0,T1,0,v100,SA,160104-TH-HVTN100,10.0,21OCT2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BFB3-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20160106;12802;MN;PLATE5.xl,,,0,,17OCT2015,28OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-187,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64029-3,T1,0,v100,SA,151229-TH-HVTN100,10.0,26OCT2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFG6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151231;12787;MN;PLATE3-1.,,,0,,19OCT2015,30OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-090,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64030-6,T1,0,v100,SA,151227-TH-HVTN100,10.0,27OCT2015,27DEC2015,50,10,10,240,240,2.3802112417,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BFGQ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,7,,10,3,TH;20151229;12761;MN;PLATE7.xl,,,0,,23OCT2015,03NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-130,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64034-8,T1,0,v100,SA,160106-TH-HVTN100,10.0,10NOV2015,06JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG09-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,3,,10,3,TH;20160108;12843;MN;PLATE3.xl,,,0,,06NOV2015,17NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-105,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64036-3,T1,0,v100,SA,160106-TH-HVTN100,10.0,13NOV2015,06JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG4G-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,3,,10,3,TH;20160108;12843;MN;PLATE3.xl,,,0,,09NOV2015,20NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-140,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64037-4,T1,0,v100,SA,160106-TH-HVTN100,10.0,16NOV2015,06JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG8C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,4,,10,3,TH;20160108;12844;MN;PLATE4.xl,,,0,,12NOV2015,23NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-138,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64038-9,T1,0,v100,SA,151227-TH-HVTN100,10.0,04NOV2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFT3-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,8,,10,3,TH;20151229;12762;MN;PLATE8.xl,,,0,,31OCT2015,11NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-084,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64039-7,T1,0,v100,SA,160104-TH-HVTN100,10.0,27OCT2015,04JAN2016,50,10,10,41,41,1.6127838567,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFH3-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20160106;12801;MN;PLATE6.xl,,,0,,23OCT2015,03NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-198,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64040-3,T1,0,v100,SA,151229-TH-HVTN100,10.0,17NOV2015,29DEC2015,50,10,10,235,235,2.3710678623,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGC1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151231;12788;MN;PLATE4-1.,,,0,,07NOV2015,18NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-228,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64044-0,T1,0,v100,SA,160105-TH-HVTN100,10.0,24NOV2015,05JAN2016,50,10,10,118,118,2.0718820073,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BGLK-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20160107;12817;MN;PLATE2.xl,,,0,,14NOV2015,25NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-181,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64050-8,T1,0,v100,SA,160104-TH-HVTN100,10.0,02NOV2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFPN-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20160106;12802;MN;PLATE5.xl,,,0,,31OCT2015,11NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-085,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64051-4,T1,0,v100,SA,160108-TH-HVTN100,10.0,06NOV2015,08JAN2016,50,10,10,332,332,2.5211380837,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFVX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,24DEC2015,151224,72,Tandile Hermanus,1,,10,3,TH;20160111;12886;MN;PLATE1.xl,,,0,,02NOV2015,13NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-063,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64053-7,T1,0,v100,SA,160106-TH-HVTN100,10.0,20NOV2015,06JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGGQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,4,,10,3,TH;20160108;12844;MN;PLATE4.xl,,,0,,16NOV2015,27NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-235,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64054-5,T1,0,v100,SA,151227-TH-HVTN100,10.0,09NOV2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFY7-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,6,,10,3,TH;20151229;12760;MN;PLATE6.xl,,,0,,05NOV2015,16NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-001,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64061-7,T1,0,v100,SA,160104-TH-HVTN100,10.0,09NOV2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFYY-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20160106;12802;MN;PLATE5.xl,,,0,,07NOV2015,18NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-083,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64062-8,T1,0,v100,SA,151229-TH-HVTN100,10.0,13NOV2015,29DEC2015,50,10,10,70,70,1.84509804,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151231;12788;MN;PLATE4-1.,,,0,,09NOV2015,20NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-145,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64066-9,T1,0,v100,SA,160106-TH-HVTN100,10.0,11NOV2015,06JAN2016,50,10,10,138,138,2.1398790864,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BG31-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,4,,10,3,TH;20160108;12844;MN;PLATE4.xl,,,0,,06NOV2015,17NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-127,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64068-3,T1,0,v100,SA,160105-TH-HVTN100,10.0,24NOV2015,05JAN2016,50,10,10,61,61,1.785329835,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BGMS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20160107;12817;MN;PLATE2.xl,,,0,,19NOV2015,30NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-044,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64069-1,T1,0,v100,SA,151229-TH-HVTN100,10.0,16NOV2015,29DEC2015,50,10,10,77,77,1.8864907252,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GA60BG7M-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20151231;12789;MN;PLATE5.xl,,,0,,12NOV2015,23NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-132,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64070-7,T1,0,v100,SA,160106-TH-HVTN100,10.0,13NOV2015,06JAN2016,50,10,10,89,89,1.9493900066,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BG5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,5,,10,3,TH;20160108;12845;MN;PLATE5.xl,,,0,,09NOV2015,20NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-048,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64073-6,T1,0,v100,SA,160106-TH-HVTN100,10.0,16NOV2015,06JAN2016,50,10,10,33,33,1.5185139399,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG9D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,5,,10,3,TH;20160108;12845;MN;PLATE5.xl,,,0,,12NOV2015,23NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-092,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64075-4,T1,0,v100,SA,160106-TH-HVTN100,10.0,17NOV2015,06JAN2016,50,10,10,106,106,2.0253058653,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BGCG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,5,,10,3,TH;20160108;12845;MN;PLATE5.xl,,,0,,13NOV2015,24NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-218,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64076-2,T1,0,v100,SA,160106-TH-HVTN100,10.0,16NOV2015,06JAN2016,50,10,10,246,246,2.3909351071,1,Titer>10,,,24JUN2016,15JUN2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BG9S-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,5,,10,3,TH;20160108;12845;MN;PLATE5.xl,,,0,0,12NOV2015,23NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-179,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64082-4,T1,0,v100,SA,160104-OK-HVTN100,10.0,10NOV2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BG19-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,5,,10,3,OK;20160106;12809;MN3;PLATE5.x,,,0,,06NOV2015,17NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-040,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64089-5,T1,0,v100,SA,160105-TH-HVTN100,10.0,27NOV2015,05JAN2016,50,10,10,796,796,2.9009130677,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BGP5-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20160107;12817;MN;PLATE2.xl,,,0,,21NOV2015,02DEC2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-022,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64001-8,T1,0,v100,SA,151227-TH-HVTN100,10.0,21SEP2015,27DEC2015,50,10,10,63,63,1.7993405495,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,8,,10,3,TH;20151229;12762;MN;PLATE8.xl,,,0,,20SEP2015,01OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-066,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64002-9,T1,0,v100,SA,151207-TH-HVTN100,10.0,17SEP2015,07DEC2015,50,10,10,148,148,2.1702617154,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GAT054MG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20151209;12630;MN;PLATE5.xl,,,0,,12SEP2015,23SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-142,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64004-1,T1,0,v100,SA,160108-TH-HVTN100,10.0,22OCT2015,08JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT057TJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,24DEC2015,151224,72,Tandile Hermanus,2,,10,3,TH;20160111;12887;MN;PLATE2.xl,,,0,,16OCT2015,27OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-236,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64006-5,T1,0,v100,SA,151221-TH-HVTN100,10.0,17SEP2015,21DEC2015,50,10,10,77,77,1.8864907252,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054L4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151223;12730;MN;PLATE1-1-,,,0,,13SEP2015,24SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-120,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64007-6,T1,0,v100,SA,151221-TH-HVTN100,10.0,17SEP2015,21DEC2015,50,10,10,44,44,1.6434526765,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT054KS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151223;12730;MN;PLATE1-1-,,,0,,13SEP2015,24SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-029,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64009-0,T1,0,v100,SA,151228-TH-HVTN100,10.0,21SEP2015,28DEC2015,50,10,10,86,86,1.9344984512,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TT-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151230;12773;MN;PLATE3.xl,,,0,,17SEP2015,28SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-107,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64010-5,T1,0,v100,SA,160108-TH-HVTN100,10.0,22SEP2015,08JAN2016,50,10,10,101,101,2.0043213738,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT0550X-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,24DEC2015,151224,72,Tandile Hermanus,2,,10,3,TH;20160111;12887;MN;PLATE2.xl,,,0,,18SEP2015,29SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-113,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64012-3,T1,0,v100,SA,151228-TH-HVTN100,10.0,21SEP2015,28DEC2015,50,10,10,167,167,2.2227164711,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054V4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151230;12773;MN;PLATE3.xl,,,0,,20SEP2015,01OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-234,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64016-4,T1,0,v100,SA,151228-TH-HVTN100,10.0,21SEP2015,28DEC2015,50,10,10,110,110,2.0413926852,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT054VG-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151230;12773;MN;PLATE3.xl,,,0,,20SEP2015,01OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-059,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64017-0,T1,0,v100,SA,151228-TH-HVTN100,10.0,28SEP2015,28DEC2015,50,10,10,132,132,2.1205739312,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT05585-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151230;12773;MN;PLATE3.xl,,,0,,24SEP2015,05OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-023,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64021-4,T1,0,v100,SA,160104-TH-HVTN100,10.0,28SEP2015,04JAN2016,50,10,10,13,13,1.1139433523,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0557V-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20160106;12799;MN;PLATE1.xl,,,0,,24SEP2015,05OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-201,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64029-9,T1,0,v100,SA,151228-TH-HVTN100,10.0,12OCT2015,28DEC2015,50,10,10,27,27,1.4313637642,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT056K1-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151230;12772;MN;PLATE2.xl,,,0,,08OCT2015,19OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-076,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64031-7,T1,0,v100,SA,160104-TH-HVTN100,10.0,26OCT2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT057ZR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20160106;12799;MN;PLATE1.xl,,,0,,22OCT2015,02NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-204,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64035-6,T1,0,v100,SA,151228-TH-HVTN100,10.0,26OCT2015,28DEC2015,50,10,10,736,736,2.8668778143,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057X1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151230;12771;MN;PLATE1.xl,,,0,,22OCT2015,02NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-230,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64036-9,T1,0,v100,SA,151228-TH-HVTN100,10.0,02NOV2015,28DEC2015,50,10,10,24,24,1.3802112417,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT058FR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151230;12774;MN;PLATE4.xl,,,0,,29OCT2015,09NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-011,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64037-5,T1,0,v100,SA,160104-TH-HVTN100,10.0,27OCT2015,04JAN2016,50,10,10,338,338,2.5289167003,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0584C-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20160106;12800;MN;PLATE2-1.,,,0,,23OCT2015,03NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-161,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64038-3,T1,0,v100,SA,160104-TH-HVTN100,10.0,19OCT2015,04JAN2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT05797-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20160106;12802;MN;PLATE5.xl,,,0,,15OCT2015,26OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-180,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64041-3,T1,0,v100,SA,151229-TH-HVTN100,10.0,07NOV2015,29DEC2015,50,10,10,232,232,2.3654879849,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05967-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151231;12785;MN;PLATE1.xl,,,0,,02NOV2015,13NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-116,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64043-8,T1,0,v100,SA,151229-TH-HVTN100,10.0,10NOV2015,29DEC2015,50,10,10,273,273,2.436162647,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT059JJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151231;12785;MN;PLATE1.xl,,,0,,06NOV2015,17NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-079,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64044-6,T1,0,v100,SA,151228-TH-HVTN100,10.0,23OCT2015,28DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057VG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151230;12772;MN;PLATE2.xl,,,0,,19OCT2015,30OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-192,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64045-2,T1,0,v100,SA,160106-TH-HVTN100,10.0,11NOV2015,06JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT059Q1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,1,,10,3,TH;20160108;12840;MN;PLATE1.xl,,,0,,09NOV2015,20NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-146,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64050-2,T1,0,v100,SA,151229-TH-HVTN100,10.0,11NOV2015,29DEC2015,50,10,10,46,46,1.6627578317,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT059TS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151231;12785;MN;PLATE1.xl,,,0,,07NOV2015,18NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-006,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64051-5,T1,0,v100,SA,151229,10.0,09NOV2015,29DEC2015,50,10,10,231,231,2.3636119799,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT0598R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,7,,10,3,TH;20151231;12791;MN;PLATE7.xl,,,0,,05NOV2015,16NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-007,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64053-1,T1,0,v100,SA,151229-TH-HVTN100,10.0,09NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT059C4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,8,,10,3,TH;20151231;12792;MN;PLATE8.xl,,,0,,05NOV2015,16NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-081,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64054-4,T1,0,v100,SA,151229-TH-HVTN100,10.0,10NOV2015,29DEC2015,50,10,10,170,170,2.2304489214,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT059KL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,8,,10,3,TH;20151231;12792;MN;PLATE8.xl,,,0,,06NOV2015,17NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-172,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64056-7,T1,0,v100,SA,151229-TH-HVTN100,10.0,16NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05B6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,8,,10,3,TH;20151231;12792;MN;PLATE8.xl,,,0,,12NOV2015,23NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-205,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64057-8,T1,0,v100,SA,160106-OK-HVTN100,10.0,11NOV2015,06JAN2016,50,10,10,12,12,1.079181246,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT059VK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151224,48,Owen Karimanzira,2,,10,3,OK;20160108;12863;MN3;PLATE2.x,,,0,,06NOV2015,17NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-202,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64060-6,T1,0,v100,SA,160105-TH-HVTN100,10.0,21NOV2015,05JAN2016,50,10,10,32,32,1.5051499783,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05BWD-05,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20160107;12818;MN;PLATE3.xl,,,0,,17NOV2015,28NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-119,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64062-2,T1,0,v100,SA,151229-TH-HVTN100,10.0,18NOV2015,29DEC2015,50,10,10,122,122,2.0863598307,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT05BLC-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,8,,10,3,TH;20151231;12792;MN;PLATE8.xl,,,0,,14NOV2015,25NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-101,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64072-7,T1,0,v100,SA,160106-OK-HVTN100,10.0,19NOV2015,06JAN2016,50,10,10,15,15,1.1760912591,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05BS4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151224,48,Owen Karimanzira,1,,10,3,OK;20160108;12862;MN3;PLATE1.x,,,0,,19NOV2015,30NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-050,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64003-1,T1,0,v100,SA,160104-TH-HVTN100,10.0,02SEP2015,04JAN2016,50,10,10,13,13,1.1139433523,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HRJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20160106;12801;MN;PLATE6.xl,,,0,,29AUG2015,09SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-150,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64005-9,T1,0,v100,SA,160104-TH-HVTN100,10.0,01SEP2015,04JAN2016,50,10,10,33,33,1.5185139399,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HR6B-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20160106;12803;MN;PLATE4-1.,,,0,,28AUG2015,08SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-114,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64006-7,T1,0,v100,SA,151228-TH-HVTN100,10.0,18SEP2015,28DEC2015,50,10,10,27,27,1.4313637642,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HT5Y-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,9,,10,3,TH;20151230;12779;MN;PLATE9.xl,,,0,,14SEP2015,25SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-190,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64007-8,T1,0,v100,SA,151227-TH-HVTN100,10.0,05OCT2015,27DEC2015,50,10,10,208,208,2.318063335,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HVGX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20151229;12759;MN;PLATE5.xl,,,0,,01OCT2015,12OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-248,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64011-0,T1,0,v100,SA,160104-TH-HVTN100,10.0,23SEP2015,04JAN2016,50,10,10,28,28,1.4471580313,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HTJJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20160106;12798;MN;PLATE3-1.,,,0,,18SEP2015,29SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-042,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64017-3,T1,0,v100,SA,151118-TH-HVTN100,10.0,06OCT2015,18NOV2015,50,10,10,31,31,1.4913616938,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HVRV-13,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151120;12379;MN;PLATE2.xl,,,0,,03OCT2015,14OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-078,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64018-5,T1,0,v100,SA,151227-TH-HVTN100,10.0,02OCT2015,27DEC2015,50,10,10,86,86,1.9344984512,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HVCC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,6,,10,3,TH;20151229;12760;MN;PLATE6.xl,,,0,,01OCT2015,12OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-242,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64019-8,T1,0,v100,SA,160104-OK-HVTN100,10.0,10NOV2015,04JAN2016,50,10,10,49,49,1.69019608,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,5,,10,3,OK;20160106;12809;MN3;PLATE5.x,,,0,,07NOV2015,18NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-071,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64022-3,T1,0,v100,SA,151228-TH-HVTN100,10.0,23OCT2015,28DEC2015,50,10,10,73,73,1.8633228601,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXFC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,9,,10,3,TH;20151230;12779;MN;PLATE9.xl,,,0,,23OCT2015,03NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-070,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64025-1,T1,0,v100,SA,151228-TH-HVTN100,10.0,26OCT2015,28DEC2015,50,10,10,258,258,2.411619706,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HXGY-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,10,,10,3,TH;20151230;12780;MN;PLATE10.x,,,0,,23OCT2015,03NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-134,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64026-4,T1,0,v100,SA,160104-OK-HVTN100,10.0,09NOV2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HZB7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,5,,10,3,OK;20160106;12809;MN3;PLATE5.x,,,0,,05NOV2015,16NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-219,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64028-8,T1,0,v100,SA,151228-TH-HVTN100,10.0,27OCT2015,28DEC2015,50,10,10,55,55,1.7403626895,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXTF-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,10,,10,3,TH;20151230;12780;MN;PLATE10.x,,,0,,26OCT2015,06NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-176,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64029-6,T1,0,v100,SA,160104-OK-HVTN100,10.0,10NOV2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,6,,10,3,OK;20160106;12810;MN3;PLATE6.x,,,0,,07NOV2015,18NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-135,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64031-9,T1,0,v100,SA,160106-OK-HVTN100,10.0,02NOV2015,06JAN2016,50,10,10,72,72,1.8573324964,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HYLD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151224,48,Owen Karimanzira,6,,10,3,OK;20160108;12867;MN3;PLATE6.x,,,0,,24OCT2015,04NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-103,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64036-6,T1,0,v100,SA,151228-TH-HVTN100,10.0,30OCT2015,28DEC2015,50,10,10,52,52,1.7160033436,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYBJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,10,,10,3,TH;20151230;12780;MN;PLATE10.x,,,0,,29OCT2015,09NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-169,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64037-7,T1,0,v100,SA,151229-TH-HVTN100,10.0,12NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZWP-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,11,,10,3,TH;20151231;12795;MN;PLATE11.x,,,0,,08NOV2015,19NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-165,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64041-1,T1,0,v100,SA,160105-TH-HVTN100,10.0,01DEC2015,05JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J1Q0-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20160107;12816;MN;PLATE1.xl,,,0,,26NOV2015,07DEC2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-183,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64044-8,T1,0,v100,SA,151228-TH-HVTN100,10.0,30OCT2015,28DEC2015,50,10,10,122,122,2.0863598307,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HY9Q-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,10,,10,3,TH;20151230;12780;MN;PLATE10.x,,,0,,29OCT2015,09NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-188,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64046-3,T1,0,v100,SA,160104-OK-HVTN100,10.0,17NOV2015,04JAN2016,50,10,10,174,174,2.2405492483,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J09C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,1,,10,3,OK;20160106;12804;MN3;PLATE1.x,,,0,,17NOV2015,28NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-054,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64047-4,T1,0,v100,SA,160104-OK-HVTN100,10.0,03NOV2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HYR2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,1,,10,3,OK;20160106;12804;MN3;PLATE1.x,,,0,,29OCT2015,09NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-239,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64054-2,T1,0,v100,SA,151228-TH-HVTN100,10.0,28OCT2015,28DEC2015,50,10,10,27,27,1.4313637642,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HXZP-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,9,,10,3,TH;20151230;12779;MN;PLATE9.xl,,,0,,26OCT2015,06NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-098,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64062-0,T1,0,v100,SA,160104-OK-HVTN100,10.0,03NOV2015,04JAN2016,50,10,10,45,45,1.6532125138,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HYRQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,2,,10,3,OK;20160106;12807;MN3;PLATE2.x,,,0,,30OCT2015,10NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-216,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64064-5,T1,0,v100,SA,151229-TH-HVTN100,10.0,12NOV2015,29DEC2015,50,10,10,199,199,2.2988530764,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J015-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,11,,10,3,TH;20151231;12795;MN;PLATE11.x,,,0,,09NOV2015,20NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-185,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64065-3,T1,0,v100,SA,160106-OK-HVTN100,10.0,12NOV2015,06JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZXY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151224,48,Owen Karimanzira,3,,10,3,OK;20160108;12864;MN3;PLATE3.x,,,0,,08NOV2015,19NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-102,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64067-2,T1,0,v100,SA,151229-TH-HVTN100,10.0,17NOV2015,29DEC2015,50,10,10,52,52,1.7160033436,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J09F-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,10,,10,3,TH;20151231;12794;MN;PLATE10.x,,,0,,13NOV2015,24NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-112,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64070-4,T1,0,v100,SA,160104-OK-HVTN100,10.0,16NOV2015,04JAN2016,50,10,10,238,238,2.3765769571,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J03Q-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,4,,10,3,OK;20160106;12806;MN3;PLATE4.x,,,0,,05NOV2015,16NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-082,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64074-1,T1,0,v100,SA,160104-OK-HVTN100,10.0,16NOV2015,04JAN2016,50,10,10,351,351,2.5453071165,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J039-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,4,,10,3,OK;20160106;12806;MN3;PLATE4.x,,,0,,12NOV2015,23NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-197,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64084-3,T1,0,v100,SA,151229-TH-HVTN100,10.0,18NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J0MY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,10,,10,3,TH;20151231;12794;MN;PLATE10.x,,,0,,15NOV2015,26NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-232,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64085-5,T1,0,v100,SA,160105-TH-HVTN100,10.0,01DEC2015,05JAN2016,50,10,10,157,157,2.1958996524,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J1QW-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20160107;12816;MN;PLATE1.xl,,,0,,20NOV2015,01DEC2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-003,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64002-4,T1,0,v100,SA,151123-TH-HVTN100,10.0,13OCT2015,23NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBJ-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151125;12449;MN;PLATE1-1.,,,0,,08OCT2015,19OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-152,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64006-0,T1,0,v100,SA,151228-TH-HVTN100,10.0,14SEP2015,28DEC2015,50,10,10,28,28,1.4471580313,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HSJ4-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,8,,10,3,TH;20151230;12778;MN;PLATE8.xl,,,0,,06SEP2015,17SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-220,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64009-5,T1,0,v100,SA,151123-TH-HVTN100,10.0,15OCT2015,23NOV2015,50,10,10,14,14,1.1461280357,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWQB-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151125;12449;MN;PLATE1-1.,,,0,,11OCT2015,22OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-125,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64010-0,T1,0,v100,SA,160104-TH-HVTN100,10.0,14SEP2015,04JAN2016,50,10,10,16,16,1.2041199827,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HSMB-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20160106;12803;MN;PLATE4-1.,,,0,,05SEP2015,16SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-233,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64011-7,T1,0,v100,SA,160104-TH-HVTN100,10.0,22SEP2015,04JAN2016,50,10,10,209,209,2.3201462861,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HTGD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20160106;12798;MN;PLATE3-1.,,,0,,18SEP2015,29SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-186,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64016-9,T1,0,v100,SA,151228-TH-HVTN100,10.0,27OCT2015,28DEC2015,50,10,10,91,91,1.9590413923,1,Titer>10,,,24JUN2016,08MAR2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXNV-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,8,,10,3,TH;20151230;12778;MN;PLATE8.xl,,,0,0,18OCT2015,29OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-039,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64017-5,T1,0,v100,SA,160122-TH-HVTN100,10.0,29SEP2015,22JAN2016,50,10,10,37,37,1.5682017241,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HTWM-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,1,,10,3,TH;20160124;13055;MN;PLATE1.xl,,,0,,26SEP2015,07OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-013,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64018-3,T1,0,v100,SA,151229-TH-HVTN100,10.0,20NOV2015,29DEC2015,50,10,10,2173,2173,3.3370597263,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J0YX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,9,,10,3,TH;20151231;12793;MN;PLATE9.xl,,,0,,17NOV2015,28NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-121,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64020-3,T1,0,v100,SA,151227-TH-HVTN100,10.0,06OCT2015,27DEC2015,50,10,10,429,429,2.6324572922,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HVPF-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20151229;12759;MN;PLATE5.xl,,,0,,01OCT2015,12OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-087,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64023-2,T1,0,v100,SA,151228-TH-HVTN100,10.0,21OCT2015,28DEC2015,50,10,10,62,62,1.7923916895,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HX1W-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,6,,10,3,TH;20151230;12776;MN;PLATE6.xl,,,0,,16OCT2015,27OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-100,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64025-8,T1,0,v100,SA,151227-TH-HVTN100,10.0,13OCT2015,27DEC2015,50,10,10,56,56,1.748188027,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBG-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20151229;12759;MN;PLATE5.xl,,,0,,08OCT2015,19OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-069,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64026-6,T1,0,v100,SA,160122-TH-HVTN100,10.0,07NOV2015,22JAN2016,50,10,10,1049,1049,3.0207754882,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,1,,10,3,TH;20160124;13055;MN;PLATE1.xl,,,0,,03NOV2015,14NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-206,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64033-9,T1,0,v100,SA,151228-TH-HVTN100,10.0,20OCT2015,28DEC2015,50,10,10,31,31,1.4913616938,1,Titer>10,,,24JUN2016,08DEC2015,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HWYC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,7,,10,3,TH;20151230;12777;MN;PLATE7.xl,,,0,0,15OCT2015,26OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-047,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64035-1,T1,0,v100,SA,151229-TH-HVTN100,10.0,05NOV2015,29DEC2015,50,10,10,33,33,1.5185139399,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ01-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,9,,10,3,TH;20151231;12793;MN;PLATE9.xl,,,0,,01NOV2015,12NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-089,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64038-8,T1,0,v100,SA,160105-TH-HVTN100,10.0,25NOV2015,05JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J17P-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20160107;12817;MN;PLATE2.xl,,,0,,20NOV2015,01DEC2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-139,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64041-8,T1,0,v100,SA,160104-OK-HVTN100,10.0,10NOV2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFB-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,4,,10,3,OK;20160106;12806;MN3;PLATE4.x,,,0,,06NOV2015,17NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-080,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64042-9,T1,0,v100,SA,160105-TH-HVTN100,10.0,26OCT2015,05JAN2016,50,10,10,25,25,1.3979400087,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HXGW-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20160107;12818;MN;PLATE3.xl,,,0,,22OCT2015,02NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-210,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64046-5,T1,0,v100,SA,160104-TH-HVTN100,10.0,27OCT2015,04JAN2016,50,10,10,128,128,2.1072099696,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXNS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20160106;12798;MN;PLATE3-1.,,,0,,23OCT2015,03NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-162,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64048-2,T1,0,v100,SA,151229-TH-HVTN100,10.0,12NOV2015,29DEC2015,50,10,10,233,233,2.367355921,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J00K-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,9,,10,3,TH;20151231;12793;MN;PLATE9.xl,,,0,,05NOV2015,16NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-246,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64051-0,T1,0,v100,SA,160105-TH-HVTN100,10.0,11NOV2015,05JAN2016,50,10,10,57,57,1.7558748557,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZP9-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20160107;12816;MN;PLATE1.xl,,,0,,07NOV2015,18NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-223,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64053-6,T1,0,v100,SA,160104-OK-HVTN100,10.0,11NOV2015,04JAN2016,50,10,10,29,29,1.4623979979,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HZQD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160106;12805;MN3;PLATE3.x,,,0,,07NOV2015,18NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-028,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64055-4,T1,0,v100,SA,160104-OK-HVTN100,10.0,05NOV2015,04JAN2016,50,10,10,466,466,2.6683859167,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZ03-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,4,,10,3,OK;20160106;12806;MN3;PLATE4.x,,,0,,01NOV2015,12NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-244,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64059-8,T1,0,v100,SA,160104-OK-HVTN100,10.0,20NOV2015,04JAN2016,50,10,10,20,20,1.3010299957,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J0Y2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,1,,10,3,OK;20160106;12804;MN3;PLATE1.x,,,0,,17NOV2015,28NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-153,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64061-6,T1,0,v100,SA,160104-OK-HVTN100,10.0,07NOV2015,04JAN2016,50,10,10,132,132,2.1205739312,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160106;12805;MN3;PLATE3.x,,,0,,03NOV2015,14NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-015,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64063-0,T1,0,v100,SA,160104-OK-HVTN100,10.0,19NOV2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J0WN-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160106;12805;MN3;PLATE3.x,,,1,,14NOV2015,25NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-252,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64064-3,T1,0,v100,SA,160105-TH-HVTN100,10.0,23NOV2015,05JAN2016,50,10,10,32,32,1.5051499783,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0ZW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20160107;12816;MN;PLATE1.xl,,,0,,19NOV2015,30NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-211,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64068-4,T1,0,v100,SA,160104-OK-HVTN100,10.0,10NOV2015,04JAN2016,50,10,10,219,219,2.3404441148,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZFD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,4,,10,3,OK;20160106;12806;MN3;PLATE4.x,,,0,,07NOV2015,18NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-147,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64069-2,T1,0,v100,SA,160104-OK-HVTN100,10.0,16NOV2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J02X-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,1,,10,3,OK;20160106;12804;MN3;PLATE1.x,,,0,,05NOV2015,16NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-168,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64071-1,T1,0,v100,SA,160104-OK-HVTN100,10.0,12NOV2015,04JAN2016,50,10,10,312,312,2.494154594,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZZT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,1,,10,3,OK;20160106;12804;MN3;PLATE1.x,,,0,,08NOV2015,19NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-203,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64072-2,T1,0,v100,SA,151229-TH-HVTN100,10.0,12NOV2015,29DEC2015,50,10,10,1322,1322,3.1212314551,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZYT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,10,,10,3,TH;20151231;12794;MN;PLATE10.x,,,0,,08NOV2015,19NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-167,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64074-8,T1,0,v100,SA,160104-OK-HVTN100,10.0,18NOV2015,04JAN2016,50,10,10,602,602,2.7795964913,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J0LW-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160106;12805;MN3;PLATE3.x,,,0,,17NOV2015,28NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-224,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64075-0,T1,0,v100,SA,160104-OK-HVTN100,10.0,19NOV2015,04JAN2016,50,10,10,182,182,2.260071388,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J0W8-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,2,,10,3,OK;20160106;12807;MN3;PLATE2.x,,,0,,13NOV2015,24NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-226,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64077-4,T1,0,v100,SA,160104-OK-HVTN100,10.0,19NOV2015,04JAN2016,50,10,10,153,153,2.1846914308,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J0QS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,2,,10,3,OK;20160106;12807;MN3;PLATE2.x,,,0,,15NOV2015,26NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-020,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64079-7,T1,0,v100,SA,160105-TH-HVTN100,10.0,03DEC2015,05JAN2016,50,10,10,91,91,1.9590413923,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J1WG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20160107;12816;MN;PLATE1.xl,,,0,,27NOV2015,08DEC2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-065,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64001-1,T1,0,v100,SA,151207-TH-HVTN100,10.0,07SEP2015,07DEC2015,50,10,10,15,15,1.1760912591,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FCQ6-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,6,,10,3,TH;20151209;12631;MN;PLATE6.xl,,,0,,05SEP2015,16SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-018,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64002-2,T1,0,v100,SA,151221-TH-HVTN100,10.0,15SEP2015,21DEC2015,50,10,10,21,21,1.3222192947,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FHFQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151223;12732;MN;PLATE3-1.,,,0,,14SEP2015,25SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-096,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64004-8,T1,0,v100,SA,151221-TH-HVTN100,10.0,23OCT2015,21DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FW3Z-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151223;12732;MN;PLATE3-1.,,,0,,22OCT2015,02NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-249,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64006-3,T1,0,v100,SA,151221-TH-HVTN100,10.0,22SEP2015,21DEC2015,50,10,10,115,115,2.0606978404,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FK9S-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151223;12732;MN;PLATE3-1.,,,0,,20SEP2015,01OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-010,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64009-7,T1,0,v100,SA,151227-TH-HVTN100,10.0,22SEP2015,27DEC2015,50,10,10,39,39,1.591064607,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FKKP-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151229;12756;MN;PLATE2.xl,,,0,,20SEP2015,01OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-222,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64018-1,T1,0,v100,SA,151227-TH-HVTN100,10.0,30SEP2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FMJB-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151229;12756;MN;PLATE2.xl,,,0,,26SEP2015,07OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-046,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64022-7,T1,0,v100,SA,151227-TH-HVTN100,10.0,16OCT2015,27DEC2015,50,10,10,103,103,2.0128372247,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FS71-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151229;12755;MN;PLATE1.xl,,,0,,12OCT2015,23OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-037,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64030-7,T1,0,v100,SA,151227-TH-HVTN100,10.0,09OCT2015,27DEC2015,50,10,10,164,164,2.214843848,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FQ9L-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151229;12755;MN;PLATE1.xl,,,0,,01OCT2015,12OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-251,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64033-6,T1,0,v100,SA,160104-TH-HVTN100,10.0,19OCT2015,04JAN2016,50,10,10,21,21,1.3222192947,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FSKN-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20160106;12802;MN;PLATE5.xl,,,0,,12OCT2015,23OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-099,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64034-9,T1,0,v100,SA,151227-TH-HVTN100,10.0,08OCT2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FQ46-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151229;12757;MN;PLATE3.xl,,,0,,03OCT2015,14OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-032,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64038-5,T1,0,v100,SA,151228-TH-HVTN100,10.0,26OCT2015,28DEC2015,50,10,10,125,125,2.096910013,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FWHM-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151230;12774;MN;PLATE4.xl,,,0,,22OCT2015,02NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-245,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64039-8,T1,0,v100,SA,151227-TH-HVTN100,10.0,15OCT2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FRV7-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151229;12756;MN;PLATE2.xl,,,0,,08OCT2015,19OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-057,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64042-6,T1,0,v100,SA,151227-TH-HVTN100,10.0,22OCT2015,27DEC2015,50,10,10,75,75,1.8750612634,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FVNV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151229;12755;MN;PLATE1.xl,,,0,,17OCT2015,28OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-055,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64043-1,T1,0,v100,SA,151227-TH-HVTN100,10.0,14OCT2015,27DEC2015,50,10,10,112,112,2.0492180227,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FRFF-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151229;12756;MN;PLATE2.xl,,,0,,12OCT2015,23OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-021,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64046-7,T1,0,v100,SA,160106-TH-HVTN100,10.0,04NOV2015,06JAN2016,50,10,10,77,77,1.8864907252,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FZ1Z-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,6,,10,3,TH;20160108;12846;MN;PLATE6.xl,,,0,,01NOV2015,12NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-156,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64049-3,T1,0,v100,SA,151227-TH-HVTN100,10.0,14OCT2015,27DEC2015,50,10,10,30,30,1.4771212547,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRCW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151229;12757;MN;PLATE3.xl,,,0,,10OCT2015,21OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-014,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64054-6,T1,0,v100,SA,151227-TH-HVTN100,10.0,23OCT2015,27DEC2015,50,10,10,48,48,1.6812412374,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FW4N-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151229;12758;MN;PLATE4.xl,,,0,,16OCT2015,27OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-240,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64062-9,T1,0,v100,SA,151228-TH-HVTN100,10.0,27OCT2015,28DEC2015,50,10,10,420,420,2.6232492904,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FWTX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20151230;12775;MN;PLATE5.xl,,,0,,23OCT2015,03NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-171,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64063-3,T1,0,v100,SA,151221-TH-HVTN100,10.0,14OCT2015,21DEC2015,50,10,10,115,115,2.0606978404,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRDV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151223;12733;MN;PLATE4-1.,,,0,,10OCT2015,21OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-068,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64064-1,T1,0,v100,SA,160104-TH-HVTN100,10.0,27OCT2015,04JAN2016,50,10,10,260,260,2.414973348,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FWX6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20160106;12798;MN;PLATE3-1.,,,0,,23OCT2015,03NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-062,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64065-7,T1,0,v100,SA,151227-TH-HVTN100,10.0,13OCT2015,27DEC2015,50,10,10,337,337,2.5276299009,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FQWN-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151229;12758;MN;PLATE4.xl,,,0,,12OCT2015,23OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-036,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64066-5,T1,0,v100,SA,151227-TH-HVTN100,10.0,16OCT2015,27DEC2015,50,10,10,172,172,2.2355284469,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FS6F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151229;12756;MN;PLATE2.xl,,,0,,10OCT2015,21OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-095,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64071-4,T1,0,v100,SA,151227-TH-HVTN100,10.0,21OCT2015,27DEC2015,50,10,10,46,46,1.6627578317,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FTPM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151229;12755;MN;PLATE1.xl,,,0,,17OCT2015,28OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-212,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64072-0,T1,0,v100,SA,151229-TH-HVTN100,10.0,02NOV2015,29DEC2015,50,10,10,74,74,1.8692317197,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FY0T-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,6,,10,3,TH;20151231;12790;MN;PLATE6.xl,,,0,,29OCT2015,09NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-072,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64074-5,T1,0,v100,SA,151221-TH-HVTN100,10.0,20OCT2015,21DEC2015,50,10,10,100,100,2,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FSTR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151239;12738;MN;NEWFBS_PL,,,0,,15OCT2015,26OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-229,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64076-1,T1,0,v100,SA,160106-TH-HVTN100,10.0,07NOV2015,06JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20G182-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,24DEC2015,151224,48,Tandile Hermanus,6,,10,3,TH;20160108;12846;MN;PLATE6.xl,,,0,,29OCT2015,09NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-217,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64077-2,T1,0,v100,SA,151228-TH-HVTN100,10.0,29OCT2015,28DEC2015,50,10,10,55,55,1.7403626895,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FXCG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,6,,10,3,TH;20151230;12776;MN;PLATE6.xl,,,0,,25OCT2015,05NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-149,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64078-6,T1,0,v100,SA,151221-TH-HVTN100,10.0,21OCT2015,21DEC2015,50,10,10,36,36,1.5563025008,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FTPZ-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151223;12733;MN;PLATE4-1.,,,0,,16OCT2015,27OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-017,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64085-1,T1,0,v100,SA,151221-TH-HVTN100,10.0,20OCT2015,21DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FSV2-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151223;12733;MN;PLATE4-1.,,,0,,17OCT2015,28OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-074,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64086-4,T1,0,v100,SA,151228-TH-HVTN100,10.0,30OCT2015,28DEC2015,50,10,10,79,79,1.8976270913,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FXJC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20151230;12775;MN;PLATE5.xl,,,0,,26OCT2015,06NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-124,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64089-6,T1,0,v100,SA,151228-TH-HVTN100,10.0,28OCT2015,28DEC2015,50,10,10,26,26,1.414973348,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX1S-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20151230;12775;MN;PLATE5.xl,,,0,,25OCT2015,05NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-004,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64095-6,T1,0,v100,SA,151228-TH-HVTN100,10.0,27OCT2015,28DEC2015,50,10,10,142,142,2.1522883444,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FWWD-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20151230;12775;MN;PLATE5.xl,,,0,,23OCT2015,03NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-182,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64097-5,T1,0,v100,SA,151229-TH-HVTN100,10.0,06NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G0Z4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,6,,10,3,TH;20151231;12790;MN;PLATE6.xl,,,0,,05NOV2015,16NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-034,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64107-1,T1,0,v100,SA,151229,10.0,07NOV2015,29DEC2015,50,10,10,33,33,1.5185139399,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G18P-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,7,,10,3,TH;20151231;12791;MN;PLATE7.xl,,,0,,03NOV2015,14NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-115,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64113-4,T1,0,v100,SA,151228-TH-HVTN100,10.0,30OCT2015,28DEC2015,50,10,10,473,473,2.6748611407,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FXJP-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20151230;12775;MN;PLATE5.xl,,,0,,29OCT2015,09NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-144,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64118-3,T1,0,v100,SA,151229,10.0,10NOV2015,29DEC2015,50,10,10,26,26,1.414973348,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20G20Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,7,,10,3,TH;20151231;12791;MN;PLATE7.xl,,,0,,07NOV2015,18NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-189,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64125-8,T1,0,v100,SA,151229,10.0,12NOV2015,29DEC2015,50,10,10,68,68,1.8325089127,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G3XF-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,7,,10,3,TH;20151231;12791;MN;PLATE7.xl,,,0,,12NOV2015,23NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-141,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64001-8,P2,1,v100,SA,151207-TH-HVTN100,10.0,23JUL2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20DZ2F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151209;12633;MN;PLATE1.xl,,,0,,23JUL2015,03AUG2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-056,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64028-6,P2,1,v100,SA,151207-TH-HVTN100,10.0,04AUG2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20F1PR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151209;12633;MN;PLATE1.xl,,,0,,02AUG2015,13AUG2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-154,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64047-1,P2,1,v100,SA,151207-TH-HVTN100,10.0,17AUG2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20F5F9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151209;12634;MN;PLATE2.xl,,,0,,13AUG2015,24AUG2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-041,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64059-3,P2,1,v100,SA,151207-TH-HVTN100,10.0,19AUG2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20F64B-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151209;12628;MN;PLATE3.xl,,,0,,15AUG2015,26AUG2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-196,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64085-8,P2,1,v100,SA,151207-TH-HVTN100,10.0,07SEP2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FCQJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,5,,10,3,TH;20151209;12630;MN;PLATE5.xl,,,0,,04SEP2015,15SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-200,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64086-6,P2,1,v100,SA,151221-TH-HVTN100,10.0,15SEP2015,21DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FHG1-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151223;12730;MN;PLATE1-1-,,,0,,12SEP2015,23SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-122,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64121-2,P2,1,v100,SA,151221-TH-HVTN100,10.0,29SEP2015,21DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FM29-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151223;12731;MN;PLATE2-1-,,,0,,26SEP2015,07OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-199,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64165-3,P2,1,v100,SA,151229-TH-HVTN100,10.0,09NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20G1N0-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151231;12787;MN;PLATE3-1.,,,0,,05NOV2015,16NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-104,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64052-0,P2,1,v100,SA,151227-TH-HVTN100,10.0,06NOV2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BFW9-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,7,,10,3,TH;20151229;12761;MN;PLATE7.xl,,,0,,02NOV2015,13NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-086,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64077-3,P2,1,v100,SA,160105-TH-HVTN100,10.0,24NOV2015,05JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CA60BGKV-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20160107;12817;MN;PLATE2.xl,,,0,,13NOV2015,24NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-012,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64078-5,P2,1,v100,SA,160104-OK-HVTN100,10.0,19NOV2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BGF7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,5,,10,3,OK;20160106;12809;MN3;PLATE5.x,,,0,,14NOV2015,25NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-214,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64018-8,P2,1,v100,SA,160104-TH-HVTN100,10.0,23SEP2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08APR2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT0552W-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20160106;12800;MN;PLATE2-1.,,,0,0,19SEP2015,30SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-238,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64027-2,P2,1,v100,SA,160104-TH-HVTN100,10.0,27OCT2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT0584P-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20160106;12799;MN;PLATE1.xl,,,0,,23OCT2015,03NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-175,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64030-0,P2,1,v100,SA,151228-TH-HVTN100,10.0,18SEP2015,28DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT054PV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20151230;12772;MN;PLATE2.xl,,,0,,14SEP2015,25SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-045,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64068-9,P2,1,v100,SA,160105-TH-HVTN100,10.0,26NOV2015,05JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05CFM-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20160107;12818;MN;PLATE3.xl,,,0,,22NOV2015,03DEC2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-191,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64024-7,P2,1,v100,SA,151228-TH-HVTN100,10.0,26OCT2015,28DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXHD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,9,,10,3,TH;20151230;12779;MN;PLATE9.xl,,,0,,24OCT2015,04NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-164,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64045-0,P2,1,v100,SA,151229-TH-HVTN100,10.0,16NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J06D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,12,,10,3,TH;20151231;12796;MN;PLATE12.x,,,0,,14NOV2015,25NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-008,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64049-7,P2,1,v100,SA,151229-TH-HVTN100,10.0,02NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HYLY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,12,,10,3,TH;20151231;12796;MN;PLATE12.x,,,0,,29OCT2015,09NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-016,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64051-7,P2,1,v100,SA,160106-OK-HVTN100,10.0,18NOV2015,06JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0N9-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151224,48,Owen Karimanzira,6,,10,3,OK;20160108;12867;MN3;PLATE6.x,,,0,,17NOV2015,28NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-033,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64059-1,P2,1,v100,SA,160104-OK-HVTN100,10.0,12NOV2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HZVY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,2,,10,3,OK;20160106;12807;MN3;PLATE2.x,,,0,,07NOV2015,18NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-241,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64069-9,P2,1,v100,SA,151229-TH-HVTN100,10.0,10NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,10,,10,3,TH;20151231;12794;MN;PLATE10.x,,,0,,05NOV2015,16NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-159,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64073-3,P2,1,v100,SA,151228-TH-HVTN100,10.0,27OCT2015,28DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXSP-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,8,,10,3,TH;20151230;12778;MN;PLATE8.xl,,,0,,26OCT2015,06NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-049,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64083-0,P2,1,v100,SA,151229-TH-HVTN100,10.0,17NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0CK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,10,,10,3,TH;20151231;12794;MN;PLATE10.x,,,0,,14NOV2015,25NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-024,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64008-7,P2,1,v100,SA,151228-TH-HVTN100,10.0,22SEP2015,28DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HTD1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,7,,10,3,TH;20151230;12777;MN;PLATE7.xl,,,0,,18SEP2015,29SEP2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-143,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64021-9,P2,1,v100,SA,151227-TH-HVTN100,10.0,01OCT2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HV6Q-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,6,,10,3,TH;20151229;12760;MN;PLATE6.xl,,,0,,01OCT2015,12OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-009,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64024-0,P2,1,v100,SA,151227-TH-HVTN100,10.0,21OCT2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FTQC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20151229;12757;MN;PLATE3.xl,,,0,,16OCT2015,27OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-094,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64031-2,P2,1,v100,SA,151229-TH-HVTN100,10.0,07NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ68-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,11,,10,3,TH;20151231;12795;MN;PLATE11.x,,,0,,03NOV2015,14NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-026,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64034-7,P2,1,v100,SA,151229-TH-HVTN100,10.0,04NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HYZ4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,9,,10,3,TH;20151231;12793;MN;PLATE9.xl,,,0,,31OCT2015,11NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-166,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64050-7,P2,1,v100,SA,151229-TH-HVTN100,10.0,04NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYV7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,11,,10,3,TH;20151231;12795;MN;PLATE11.x,,,0,,31OCT2015,11NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-005,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64057-3,P2,1,v100,SA,160104-OK-HVTN100,10.0,04NOV2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HYVZ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,2,,10,3,OK;20160106;12807;MN3;PLATE2.x,,,0,,30OCT2015,10NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-133,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64060-1,P2,1,v100,SA,160104-OK-HVTN100,10.0,07NOV2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160106;12805;MN3;PLATE3.x,,,0,,03NOV2015,14NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-195,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64070-6,P2,1,v100,SA,151229-TH-HVTN100,10.0,09NOV2015,29DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20G1M1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,6,,10,3,TH;20151231;12790;MN;PLATE6.xl,,,0,,07NOV2015,18NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-043,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64017-7,P2,1,v100,SA,151118-TH-HVTN100,10.0,13OCT2015,18NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FQTX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151120;12378;MN;PLATE1.xl,,,0,,10OCT2015,21OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-174,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64052-4,P2,1,v100,SA,151227-TH-HVTN100,10.0,23OCT2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FW49-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,4,,10,3,TH;20151229;12758;MN;PLATE4.xl,,,0,,19OCT2015,30OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-067,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64073-7,P2,1,v100,SA,151227-TH-HVTN100,10.0,22OCT2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FVG5-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20151229;12755;MN;PLATE1.xl,,,0,,18OCT2015,29OCT2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-213,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64079-9,P2,1,v100,SA,160104-TH-HVTN100,10.0,28OCT2015,04JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FX13-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,3,,10,3,TH;20160106;12798;MN;PLATE3-1.,,,0,,24OCT2015,04NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-250,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64080-5,P2,1,v100,SA,151228-TH-HVTN100,10.0,28OCT2015,28DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX2K-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,22OCT2015,151022,48,Tandile Hermanus,6,,10,3,TH;20151230;12776;MN;PLATE6.xl,,,0,,24OCT2015,04NOV2015,0,182,0,MN.3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-053,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64003-3,T1,0,v100,SA,151207-TH-HVTN100,10.0,22JUL2015,07DEC2015,50,10,10,216,216,2.3344537512,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20DYKC-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,6,,10,3,TH;20151209;12638;MW965;PLATE6,,,0,,19JUL2015,30JUL2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-111,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64006-5,T1,0,v100,SA,151207-TH-HVTN100,10.0,29JUL2015,07DEC2015,50,10,10,70,70,1.84509804,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20F09P-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,6,,10,3,TH;20151209;12638;MW965;PLATE6,,,0,,26JUL2015,06AUG2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-031,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64009-0,T1,0,v100,SA,151207-TH-HVTN100,10.0,23JUL2015,07DEC2015,50,10,10,144,144,2.1583624921,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20DYTL-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151209;12632;MW965;PLATE1,,,0,,23JUL2015,03AUG2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-209,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64013-9,T1,0,v100,SA,151207-TH-HVTN100,10.0,28JUL2015,07DEC2015,50,10,10,159,159,2.2013971243,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20DZVV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151209;12632;MW965;PLATE1,,,0,,25JUL2015,05AUG2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-158,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64021-4,T1,0,v100,SA,151207-TH-HVTN100,10.0,03AUG2015,07DEC2015,50,10,10,436,436,2.6394864893,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F17D-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151209;12632;MW965;PLATE1,,,0,,01AUG2015,12AUG2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-215,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64029-9,T1,0,v100,SA,151207-TH-HVTN100,10.0,25AUG2015,07DEC2015,50,10,10,1247,1247,3.0958664535,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8HS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,2,,10,3,TH;20151209;12635;MW965;PLATE2,,,0,,14AUG2015,25AUG2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-231,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64031-7,T1,0,v100,SA,151207-TH-HVTN100,10.0,27AUG2015,07DEC2015,50,10,10,169,169,2.2278867046,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8ZN-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,2,,10,3,TH;20151209;12635;MW965;PLATE2,,,0,,21AUG2015,01SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-091,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64033-4,T1,0,v100,SA,151207-TH-HVTN100,10.0,08SEP2015,07DEC2015,50,10,10,1055,1055,3.0232524596,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD4N-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,2,,10,3,TH;20151209;12635;MW965;PLATE2,,,0,,04SEP2015,15SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-077,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64036-9,T1,0,v100,SA,151207-TH-HVTN100,10.0,18AUG2015,07DEC2015,50,10,10,77,77,1.8864907252,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20F5SG-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,6,,10,3,TH;20151209;12638;MW965;PLATE6,,,0,,14AUG2015,25AUG2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-136,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64045-2,T1,0,v100,SA,151207-TH-HVTN100,10.0,13AUG2015,07DEC2015,50,10,10,2400,2400,3.3802112417,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F4C6-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,2,,10,3,TH;20151209;12635;MW965;PLATE2,,,0,,13AUG2015,24AUG2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-227,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64053-1,T1,0,v100,SA,151227-TH-HVTN100,10.0,19AUG2015,27DEC2015,50,10,10,77,77,1.8864907252,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20F676-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151229;12765;MW965;PLATE3,,,0,,16AUG2015,27AUG2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-160,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64054-4,T1,0,v100,SA,151207-TH-HVTN100,10.0,26AUG2015,07DEC2015,50,10,10,2822,2822,3.4505570094,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8R9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151209;12637;MW965;PLATE3,,,0,,21AUG2015,01SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-155,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64055-9,T1,0,v100,SA,151207-TH-HVTN100,10.0,20AUG2015,07DEC2015,50,10,10,471,471,2.6730209071,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F6C4-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151209;12637;MW965;PLATE3,,,0,,14AUG2015,25AUG2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-177,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64057-8,T1,0,v100,SA,151207-TH-HVTN100,10.0,02SEP2015,07DEC2015,50,10,10,364,364,2.5611013836,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FBT0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151209;12637;MW965;PLATE3,,,0,,23AUG2015,03SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-052,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64062-2,T1,0,v100,SA,151207-TH-HVTN100,10.0,03SEP2015,07DEC2015,50,10,10,120,120,2.079181246,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FC68-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151209;12637;MW965;PLATE3,,,0,,28AUG2015,08SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-247,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64063-5,T1,0,v100,SA,151207-TH-HVTN100,10.0,08SEP2015,07DEC2015,50,10,10,1132,1132,3.0538464269,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FD2Q-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,4,,10,3,TH;20151209;12636;MW965;PLATE4,,,0,,04SEP2015,15SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-126,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64066-3,T1,0,v100,SA,151207-TH-HVTN100,10.0,08SEP2015,07DEC2015,50,10,10,852,852,2.9304395948,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD3H-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,4,,10,3,TH;20151209;12636;MW965;PLATE4,,,0,,04SEP2015,15SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-225,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64067-4,T1,0,v100,SA,151207-TH-HVTN100,10.0,08SEP2015,07DEC2015,50,10,10,390,390,2.591064607,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FD43-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,4,,10,3,TH;20151209;12636;MW965;PLATE4,,,0,,04SEP2015,15SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-148,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64069-7,T1,0,v100,SA,151221-TH-HVTN100,10.0,14SEP2015,21DEC2015,50,10,10,94,94,1.9731278536,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FGVK-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151223;12737;MW965;PLATE1,,,0,,12SEP2015,23SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-163,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64077-9,T1,0,v100,SA,151207-TH-HVTN100,10.0,07SEP2015,07DEC2015,50,10,10,487,487,2.6875289612,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FCJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,4,,10,3,TH;20151209;12636;MW965;PLATE4,,,0,,29AUG2015,09SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-073,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64080-3,T1,0,v100,SA,151207-TH-HVTN100,10.0,31AUG2015,07DEC2015,50,10,10,315,315,2.4983105538,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FB33-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,4,,10,3,TH;20151209;12636;MW965;PLATE4,,,0,,28AUG2015,08SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-184,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64087-7,T1,0,v100,SA,151207-TH-HVTN100,10.0,07SEP2015,07DEC2015,50,10,10,1303,1303,3.1149444157,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FCJR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,5,,10,3,TH;20151209;12639;MW965;PLATE5,,,0,,06SEP2015,17SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-170,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64095-4,T1,0,v100,SA,151117-TH-HVTN100,10.0,08OCT2015,17NOV2015,50,10,10,194,194,2.2878017299,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FQ3V-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151119;12353;MW965;PLATE1,,,0,,01OCT2015,12OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-038,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64105-9,T1,0,v100,SA,160122-TH-HVTN100,10.0,17NOV2015,22JAN2016,50,10,10,1954,1954,3.2909245594,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G4TX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,3,,10,3,TH;20160124;13053;MW965;PLATE3,,,0,,14NOV2015,25NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-123,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64117-3,T1,0,v100,SA,151221-TH-HVTN100,10.0,17SEP2015,21DEC2015,50,10,10,248,248,2.3944516808,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FJ00-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,2,,10,3,TH;20151223;12736;MW965;PLATE2,,,0,,13SEP2015,24SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-061,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64119-8,T1,0,v100,SA,151221-TH-HVTN100,10.0,30SEP2015,21DEC2015,50,10,10,54,54,1.7323937598,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FMJ0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,2,,10,3,TH;20151223;12736;MW965;PLATE2,,,0,,26SEP2015,07OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-128,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64129-6,T1,0,v100,SA,151221-TH-HVTN100,10.0,06OCT2015,21DEC2015,50,10,10,601,601,2.778874472,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FPD4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,2,,10,3,TH;20151223;12736;MW965;PLATE2,,,0,,03OCT2015,14OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-108,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64130-3,T1,0,v100,SA,151221-TH-HVTN100,10.0,06OCT2015,21DEC2015,50,10,10,136,136,2.1335389084,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FPDG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151223;12735;MW965;PLATE3,,,0,,02OCT2015,13OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-097,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64135-8,T1,0,v100,SA,151221-TH-HVTN100,10.0,28SEP2015,21DEC2015,50,10,10,96,96,1.982271233,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FLTC-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151223;12735;MW965;PLATE3,,,0,,26SEP2015,07OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-129,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64139-4,T1,0,v100,SA,160115-TH-HVTN100,10.0,26OCT2015,15JAN2016,50,10,10,489,489,2.6893088591,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FWKL-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,4,,10,3,TH;20160118;12953;MW965;PLATE4,,,0,,16OCT2015,27OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-058,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64150-0,T1,0,v100,SA,160118-TH-HVTN100,10.0,11NOV2015,18JAN2016,50,10,10,785,785,2.8948696567,1,Titer>10,,,24JUN2016,,,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20G3JT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,7,,10,3,TH;20160120;12986;MW965;PLATE7,,,0,,07NOV2015,18NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-151,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64154-2,T1,0,v100,SA,160118-TH-HVTN100,10.0,02NOV2015,18JAN2016,50,10,10,110,110,2.0413926852,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FXYX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,8,,10,3,TH;20160120;12987;MW965;PLATE8,,,0,,25OCT2015,05NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-002,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64156-9,T1,0,v100,SA,160118-TH-HVTN100,10.0,02NOV2015,18JAN2016,50,10,10,171,171,2.2329961104,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FXZQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,8,,10,3,TH;20160120;12987;MW965;PLATE8,,,0,,25OCT2015,05NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-194,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64166-1,T1,0,v100,SA,160118-TH-HVTN100,10.0,17NOV2015,18JAN2016,50,10,10,395,395,2.5965970956,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G4VL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,8,,10,3,TH;20160120;12987;MW965;PLATE8,,,0,,14NOV2015,25NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-157,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64167-2,T1,0,v100,SA,160115-TH-HVTN100,10.0,10NOV2015,15JAN2016,50,10,10,782,782,2.8932067531,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G20B-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,4,,10,3,TH;20160118;12953;MW965;PLATE4,,,0,,06NOV2015,17NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-025,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64172-9,T1,0,v100,SA,160115-TH-HVTN100,10.0,12NOV2015,15JAN2016,50,10,10,609,609,2.7846172926,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20G3X4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,5,,10,3,TH;20160118;12955;MW965;PLATE5,,,0,,06NOV2015,17NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-137,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64002-3,T1,0,v100,SA,151207-TH-HVTN100,10.0,28AUG2015,07DEC2015,50,10,10,189,189,2.2764618042,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BCRM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,5,,10,3,TH;20151209;12639;MW965;PLATE5,,,0,,21AUG2015,01SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-064,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64007-0,T1,0,v100,SA,151221-TH-HVTN100,10.0,14SEP2015,21DEC2015,50,10,10,83,83,1.9190780924,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BDHQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151223;12737;MW965;PLATE1,,,0,,10SEP2015,21SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-131,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64008-8,T1,0,v100,SA,151207-TH-HVTN100,10.0,14SEP2015,07DEC2015,50,10,10,441,441,2.6444385895,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BDJC-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,5,,10,3,TH;20151209;12639;MW965;PLATE5,,,0,,07SEP2015,18SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-109,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64028-0,T1,0,v100,SA,151227-TH-HVTN100,10.0,21OCT2015,27DEC2015,50,10,10,58,58,1.7634279936,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BFB3-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,7,,10,3,TH;20151229;12770;MW965;PLATE7,,,0,,17OCT2015,28OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-187,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64029-3,T1,0,v100,SA,160118-TH-HVTN100,10.0,26OCT2015,18JAN2016,50,10,10,106,106,2.0253058653,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFG6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,5,,10,3,TH;20160120;12984;MW965;PLATE5,,,0,,19OCT2015,30OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-090,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64030-6,T1,0,v100,SA,151227-TH-HVTN100,10.0,27OCT2015,27DEC2015,50,10,10,338,338,2.5289167003,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BFGQ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,7,,10,3,TH;20151229;12770;MW965;PLATE7,,,0,,23OCT2015,03NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-130,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64034-8,T1,0,v100,SA,160118-TH-HVTN100,10.0,10NOV2015,18JAN2016,50,10,10,28,28,1.4471580313,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG09-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,5,,10,3,TH;20160120;12984;MW965;PLATE5,,,0,,06NOV2015,17NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-105,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64036-3,T1,0,v100,SA,160118-TH-HVTN100,10.0,13NOV2015,18JAN2016,50,10,10,392,392,2.593286067,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG4G-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,4,,10,3,TH;20160120;12983;MW965;PLATE4,,,0,,09NOV2015,20NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-140,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64037-4,T1,0,v100,SA,160118-TH-HVTN100,10.0,16NOV2015,18JAN2016,50,10,10,129,129,2.1105897103,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG8C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,3,,10,3,TH;20160120;12982;MW965;PLATE3,,,0,,12NOV2015,23NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-138,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64038-9,T1,0,v100,SA,151227-TH-HVTN100,10.0,04NOV2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFT3-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,8,,10,3,TH;20151229;12767;MW965;PLATE8,,,0,,31OCT2015,11NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-084,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64039-7,T1,0,v100,SA,151227-TH-HVTN100,10.0,27OCT2015,27DEC2015,50,10,10,164,164,2.214843848,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFH3-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,8,,10,3,TH;20151229;12767;MW965;PLATE8,,,0,,23OCT2015,03NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-198,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64040-3,T1,0,v100,SA,160118-TH-HVTN100,10.0,17NOV2015,18JAN2016,50,10,10,396,396,2.5976951859,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGC1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,4,,10,3,TH;20160120;12983;MW965;PLATE4,,,0,,07NOV2015,18NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-228,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64044-0,T1,0,v100,SA,160118-OK-HVTN100,10.0,24NOV2015,18JAN2016,50,10,10,483,483,2.6839471308,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BGLK-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,2,,10,3,OK;20160120;12991;MW965;PLATE2,,,0,,14NOV2015,25NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-181,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64050-8,T1,0,v100,SA,151227-TH-HVTN100,10.0,02NOV2015,27DEC2015,50,10,10,261,261,2.4166405073,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFPN-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,6,,10,3,TH;20151229;12769;MW965;PLATE6,,,0,,31OCT2015,11NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-085,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64051-4,T1,0,v100,SA,151227-TH-HVTN100,10.0,06NOV2015,27DEC2015,50,10,10,661,661,2.8202014595,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFVX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,7,,10,3,TH;20151229;12770;MW965;PLATE7,,,0,,02NOV2015,13NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-063,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64053-7,T1,0,v100,SA,160118-TH-HVTN100,10.0,20NOV2015,18JAN2016,50,10,10,13,13,1.1139433523,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGGQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,4,,10,3,TH;20160120;12983;MW965;PLATE4,,,0,,16NOV2015,27NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-235,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64054-5,T1,0,v100,SA,151227-TH-HVTN100,10.0,09NOV2015,27DEC2015,50,10,10,616,616,2.7895807122,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFY7-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,6,,10,3,TH;20151229;12769;MW965;PLATE6,,,0,,05NOV2015,16NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-001,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64061-7,T1,0,v100,SA,151227-TH-HVTN100,10.0,09NOV2015,27DEC2015,50,10,10,76,76,1.8808135923,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFYY-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,7,,10,3,TH;20151229;12770;MW965;PLATE7,,,0,,07NOV2015,18NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-083,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64062-8,T1,0,v100,SA,160118-TH-HVTN100,10.0,13NOV2015,18JAN2016,50,10,10,147,147,2.1673173347,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,5,,10,3,TH;20160120;12984;MW965;PLATE5,,,0,,09NOV2015,20NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-145,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64066-9,T1,0,v100,SA,160118-TH-HVTN100,10.0,11NOV2015,18JAN2016,50,10,10,282,282,2.4502491083,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BG31-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,4,,10,3,TH;20160120;12983;MW965;PLATE4,,,0,,06NOV2015,17NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-127,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64068-3,T1,0,v100,SA,160118-OK-HVTN100,10.0,24NOV2015,18JAN2016,50,10,10,370,370,2.5682017241,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BGMS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,2,,10,3,OK;20160120;12991;MW965;PLATE2,,,0,,19NOV2015,30NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-044,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64069-1,T1,0,v100,SA,160118-TH-HVTN100,10.0,16NOV2015,18JAN2016,50,10,10,460,460,2.6627578317,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GA60BG7M-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,6,,10,3,TH;20160120;12985;MW965;PLATE6,,,0,,12NOV2015,23NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-132,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64070-7,T1,0,v100,SA,160118-TH-HVTN100,10.0,13NOV2015,18JAN2016,50,10,10,296,296,2.4712917111,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BG5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,4,,10,3,TH;20160120;12983;MW965;PLATE4,,,0,,09NOV2015,20NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-048,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64073-6,T1,0,v100,SA,160118-TH-HVTN100,10.0,16NOV2015,18JAN2016,50,10,10,228,228,2.357934847,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG9D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,3,,10,3,TH;20160120;12982;MW965;PLATE3,,,0,,12NOV2015,23NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-092,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64075-4,T1,0,v100,SA,160118-TH-HVTN100,10.0,17NOV2015,18JAN2016,50,10,10,470,470,2.6720978579,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BGCG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,5,,10,3,TH;20160120;12984;MW965;PLATE5,,,0,,13NOV2015,24NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-218,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64076-2,T1,0,v100,SA,160118-TH-HVTN100,10.0,16NOV2015,18JAN2016,50,10,10,369,369,2.5670263662,1,Titer>10,,,24JUN2016,15JUN2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BG9S-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,5,,10,3,TH;20160120;12984;MW965;PLATE5,,,0,0,12NOV2015,23NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-179,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64082-4,T1,0,v100,SA,160122-TH-HVTN100,10.0,10NOV2015,22JAN2016,50,10,10,68,68,1.8325089127,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BG19-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,3,,10,3,TH;20160124;13053;MW965;PLATE3,,,0,,06NOV2015,17NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-040,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64089-5,T1,0,v100,SA,160118-OK-HVTN100,10.0,27NOV2015,18JAN2016,50,10,10,1281,1281,3.1075491297,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BGP5-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,2,,10,3,OK;20160120;12991;MW965;PLATE2,,,0,,21NOV2015,02DEC2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-022,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64001-8,T1,0,v100,SA,151227-TH-HVTN100,10.0,21SEP2015,27DEC2015,50,10,10,351,351,2.5453071165,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,8,,10,3,TH;20151229;12767;MW965;PLATE8,,,0,,20SEP2015,01OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-066,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64002-9,T1,0,v100,SA,151207-TH-HVTN100,10.0,17SEP2015,07DEC2015,50,10,10,635,635,2.8027737253,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GAT054MG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,5,,10,3,TH;20151209;12639;MW965;PLATE5,,,0,,12SEP2015,23SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-142,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64004-1,T1,0,v100,SA,160122-TH-HVTN100,10.0,22OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT057TJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,4,,10,3,TH;20160124;13054;MW965;PLATE4,,,0,,16OCT2015,27OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-236,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64006-5,T1,0,v100,SA,151221-TH-HVTN100,10.0,17SEP2015,21DEC2015,50,10,10,119,119,2.0755469614,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054L4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151223;12737;MW965;PLATE1,,,0,,13SEP2015,24SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-120,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64007-6,T1,0,v100,SA,151221-TH-HVTN100,10.0,17SEP2015,21DEC2015,50,10,10,134,134,2.1271047984,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT054KS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151223;12737;MW965;PLATE1,,,0,,13SEP2015,24SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-029,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64009-0,T1,0,v100,SA,160115-TH-HVTN100,10.0,21SEP2015,15JAN2016,50,10,10,225,225,2.3521825181,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TT-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,1,,10,3,TH;20160118;12950;MW965;PLATE1,,,0,,17SEP2015,28SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-107,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64010-5,T1,0,v100,SA,160115-OK-HVTN100,10.0,22SEP2015,15JAN2016,50,10,10,174,174,2.2405492483,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT0550X-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,7,,10,3,OK;20160118;12964;MW965;PLATE7,,,0,,18SEP2015,29SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-113,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64012-3,T1,0,v100,SA,160115-TH-HVTN100,10.0,21SEP2015,15JAN2016,50,10,10,287,287,2.4578818967,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054V4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,1,,10,3,TH;20160118;12950;MW965;PLATE1,,,0,,20SEP2015,01OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-234,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64016-4,T1,0,v100,SA,160115-TH-HVTN100,10.0,21SEP2015,15JAN2016,50,10,10,1086,1086,3.0358298253,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT054VG-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,1,,10,3,TH;20160118;12950;MW965;PLATE1,,,0,,20SEP2015,01OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-059,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64017-0,T1,0,v100,SA,160115-TH-HVTN100,10.0,28SEP2015,15JAN2016,50,10,10,337,337,2.5276299009,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT05585-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,1,,10,3,TH;20160118;12950;MW965;PLATE1,,,0,,24SEP2015,05OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-023,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64021-4,T1,0,v100,SA,151125-TH-HVTN100,10.0,28SEP2015,25NOV2015,50,10,10,50,50,1.6989700043,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0557V-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151127;12493;MW965;PLATE3,,,0,,24SEP2015,05OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-201,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64029-9,T1,0,v100,SA,160106-TH-HVTN100,10.0,12OCT2015,15JAN2016,50,10,10,109,109,2.0374264979,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT056K1-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,2,,10,3,TH;20160118;12951;MW965;PLATE2,,,0,,08OCT2015,19OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-076,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64031-7,T1,0,v100,SA,160106-TH-HVTN100,10.0,26OCT2015,15JAN2016,50,10,10,470,470,2.6720978579,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT057ZR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,2,,10,3,TH;20160118;12951;MW965;PLATE2,,,0,,22OCT2015,02NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-204,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64035-6,T1,0,v100,SA,151125-TH-HVTN100,10.0,26OCT2015,25NOV2015,50,10,10,1334,1334,3.1251558296,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057X1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151127;12493;MW965;PLATE3,,,0,,22OCT2015,02NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-230,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64036-9,T1,0,v100,SA,160115-TH-HVTN100,10.0,02NOV2015,15JAN2016,50,10,10,318,318,2.50242712,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT058FR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,3,,10,3,TH;20160118;12952;MW965;PLATE3,,,0,,29OCT2015,09NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-011,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64037-5,T1,0,v100,SA,160118-OK-HVTN100,10.0,27OCT2015,18JAN2016,50,10,10,1198,1198,3.0784568181,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0584C-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,4,,10,3,OK;20160120;12993;MW965;PLATE4,,,0,,23OCT2015,03NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-161,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64038-3,T1,0,v100,SA,160118-OK-HVTN100,10.0,19OCT2015,18JAN2016,50,10,10,145,145,2.1613680022,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT05797-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,4,,10,3,OK;20160120;12993;MW965;PLATE4,,,0,,15OCT2015,26OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-180,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64041-3,T1,0,v100,SA,160122-TH-HVTN100,10.0,07NOV2015,22JAN2016,50,10,10,1099,1099,3.0409976924,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05967-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,3,,10,3,TH;20160124;13053;MW965;PLATE3,,,0,,02NOV2015,13NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-116,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64043-8,T1,0,v100,SA,160115-TH-HVTN100,10.0,10NOV2015,15JAN2016,50,10,10,1692,1692,3.2284003587,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT059JJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,3,,10,3,TH;20160118;12952;MW965;PLATE3,,,0,,06NOV2015,17NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-079,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64044-6,T1,0,v100,SA,160115-TH-HVTN100,10.0,23OCT2015,15JAN2016,50,10,10,13,13,1.1139433523,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057VG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,3,,10,3,TH;20160118;12952;MW965;PLATE3,,,0,,19OCT2015,30OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-192,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64045-2,T1,0,v100,SA,160115-TH-HVTN100,10.0,11NOV2015,15JAN2016,50,10,10,212,212,2.3263358609,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT059Q1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,3,,10,3,TH;20160118;12952;MW965;PLATE3,,,0,,09NOV2015,20NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-146,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64050-2,T1,0,v100,SA,160115-TH-HVTN100,10.0,11NOV2015,15JAN2016,50,10,10,286,286,2.4563660331,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT059TS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,4,,10,3,TH;20160118;12953;MW965;PLATE4,,,0,,07NOV2015,18NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-006,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64051-5,T1,0,v100,SA,160115-OK-HVTN100,10.0,09NOV2015,15JAN2016,50,10,10,1599,1599,3.2038484637,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT0598R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,2,,10,3,OK;20160118;12959;MW965;PLATE2,,,0,,05NOV2015,16NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-007,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64053-1,T1,0,v100,SA,160122-TH-HVTN100,10.0,09NOV2015,22JAN2016,50,10,10,24,24,1.3802112417,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT059C4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,4,,10,3,TH;20160124;13054;MW965;PLATE4,,,0,,05NOV2015,16NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-081,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64054-4,T1,0,v100,SA,160122-TH-HVTN100,10.0,10NOV2015,22JAN2016,50,10,10,904,904,2.9561684305,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT059KL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,4,,10,3,TH;20160124;13054;MW965;PLATE4,,,0,,06NOV2015,17NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-172,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64056-7,T1,0,v100,SA,160115-OK-HVTN100,10.0,16NOV2015,15JAN2016,50,10,10,124,124,2.0934216852,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05B6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,3,,10,3,OK;20160118;12960;MW965;PLATE3,,,0,,12NOV2015,23NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-205,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64057-8,T1,0,v100,SA,160115-OK-HVTN100,10.0,11NOV2015,15JAN2016,50,10,10,154,154,2.1875207208,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT059VK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,3,,10,3,OK;20160118;12960;MW965;PLATE3,,,0,,06NOV2015,17NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-202,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64060-6,T1,0,v100,SA,160118-OK-HVTN100,10.0,21NOV2015,18JAN2016,50,10,10,227,227,2.3560258572,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05BWD-05,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,3,,10,3,OK;20160120;12992;MW965;PLATE3,,,0,,17NOV2015,28NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-119,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64062-2,T1,0,v100,SA,160115-OK-HVTN100,10.0,18NOV2015,15JAN2016,50,10,10,363,363,2.559906625,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT05BLC-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,3,,10,3,OK;20160118;12960;MW965;PLATE3,,,0,,14NOV2015,25NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-101,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64072-7,T1,0,v100,SA,160115-OK-HVTN100,10.0,19NOV2015,15JAN2016,50,10,10,202,202,2.3053513694,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05BS4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,2,,10,3,OK;20160118;12959;MW965;PLATE2,,,0,,19NOV2015,30NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-050,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64003-1,T1,0,v100,SA,151227-TH-HVTN100,10.0,02SEP2015,27DEC2015,50,10,10,77,77,1.8864907252,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HRJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,8,,10,3,TH;20151229;12767;MW965;PLATE8,,,0,,29AUG2015,09SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-150,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64005-9,T1,0,v100,SA,160115-TH-HVTN100,10.0,01SEP2015,15JAN2016,50,10,10,184,184,2.264817823,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HR6B-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,7,,10,3,TH;20160118;12954;MW965;PLATE7,,,0,,28AUG2015,08SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-114,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64006-7,T1,0,v100,SA,160115-TH-HVTN100,10.0,18SEP2015,15JAN2016,50,10,10,151,151,2.1789769473,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HT5Y-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,7,,10,3,TH;20160118;12954;MW965;PLATE7,,,0,,14SEP2015,25SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-190,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64007-8,T1,0,v100,SA,151227-TH-HVTN100,10.0,05OCT2015,27DEC2015,50,10,10,687,687,2.8369567371,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HVGX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,5,,10,3,TH;20151229;12768;MW965;PLATE5,,,0,,01OCT2015,12OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-248,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64011-0,T1,0,v100,SA,160115-TH-HVTN100,10.0,23SEP2015,15JAN2016,50,10,10,211,211,2.3242824553,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HTJJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,7,,10,3,TH;20160118;12954;MW965;PLATE7,,,0,,18SEP2015,29SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-042,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64017-3,T1,0,v100,SA,151227-TH-HVTN100,10.0,06OCT2015,27DEC2015,50,10,10,158,158,2.198657087,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HVRV-13,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,4,,10,3,TH;20151229;12766;MW965;PLATE4,,,0,,03OCT2015,14OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-078,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64018-5,T1,0,v100,SA,151227-TH-HVTN100,10.0,02OCT2015,27DEC2015,50,10,10,218,218,2.3384564936,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HVCC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,6,,10,3,TH;20151229;12769;MW965;PLATE6,,,0,,01OCT2015,12OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-242,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64019-8,T1,0,v100,SA,160118-TH-HVTN100,10.0,10NOV2015,18JAN2016,50,10,10,145,145,2.1613680022,1,Titer>10,,,24JUN2016,,,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,7,,10,3,TH;20160120;12986;MW965;PLATE7,,,0,,07NOV2015,18NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-071,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64022-3,T1,0,v100,SA,160118-TH-HVTN100,10.0,23OCT2015,18JAN2016,50,10,10,158,158,2.198657087,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXFC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,1,,10,3,TH;20160120;12980;MW965;PLATE1,,,0,,23OCT2015,03NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-070,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64025-1,T1,0,v100,SA,160118-TH-HVTN100,10.0,26OCT2015,18JAN2016,50,10,10,690,690,2.8388490907,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HXGY-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,1,,10,3,TH;20160120;12980;MW965;PLATE1,,,0,,23OCT2015,03NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-134,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64026-4,T1,0,v100,SA,160118-TH-HVTN100,10.0,09NOV2015,18JAN2016,50,10,10,341,341,2.532754379,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HZB7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,3,,10,3,TH;20160120;12982;MW965;PLATE3,,,0,,05NOV2015,16NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-219,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64028-8,T1,0,v100,SA,160118-TH-HVTN100,10.0,27OCT2015,18JAN2016,50,10,10,343,343,2.53529412,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXTF-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,1,,10,3,TH;20160120;12980;MW965;PLATE1,,,0,,26OCT2015,06NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-176,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64029-6,T1,0,v100,SA,160122-TH-HVTN100,10.0,10NOV2015,22JAN2016,50,10,10,18,18,1.2552725051,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,2,,10,3,TH;20160124;13052;MW965;PLATE2,,,0,,07NOV2015,18NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-135,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64031-9,T1,0,v100,SA,160115-OK-HVTN100,10.0,02NOV2015,15JAN2016,50,10,10,418,418,2.6211762818,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HYLD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,7,,10,3,OK;20160118;12964;MW965;PLATE7,,,0,,24OCT2015,04NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-103,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64036-6,T1,0,v100,SA,160118-TH-HVTN100,10.0,30OCT2015,18JAN2016,50,10,10,287,287,2.4578818967,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYBJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,2,,10,3,TH;20160120;12981;MW965;PLATE2,,,0,,29OCT2015,09NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-169,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64037-7,T1,0,v100,SA,160115-OK-HVTN100,10.0,12NOV2015,15JAN2016,50,10,10,284,284,2.45331834,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZWP-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,6,,10,3,OK;20160118;12963;MW965;PLATE6,,,0,,08NOV2015,19NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-165,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64041-1,T1,0,v100,SA,160118-OK-HVTN100,10.0,01DEC2015,18JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J1Q0-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,1,,10,3,OK;20160120;12990;MW965;PLATE1,,,0,,26NOV2015,07DEC2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-183,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64044-8,T1,0,v100,SA,160118-TH-HVTN100,10.0,30OCT2015,18JAN2016,50,10,10,412,412,2.614897216,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HY9Q-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,1,,10,3,TH;20160120;12980;MW965;PLATE1,,,0,,29OCT2015,09NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-188,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64046-3,T1,0,v100,SA,160122-TH-HVTN100,10.0,17NOV2015,22JAN2016,50,10,10,166,166,2.220108088,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J09C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,2,,10,3,TH;20160124;13052;MW965;PLATE2,,,0,,17NOV2015,28NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-054,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64047-4,T1,0,v100,SA,160122-TH-HVTN100,10.0,03NOV2015,22JAN2016,50,10,10,22,22,1.3424226808,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HYR2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,2,,10,3,TH;20160124;13052;MW965;PLATE2,,,0,,29OCT2015,09NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-239,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64054-2,T1,0,v100,SA,160118-TH-HVTN100,10.0,28OCT2015,18JAN2016,50,10,10,164,164,2.214843848,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HXZP-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,2,,10,3,TH;20160120;12981;MW965;PLATE2,,,0,,26OCT2015,06NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-098,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64062-0,T1,0,v100,SA,160118-OK-HVTN100,10.0,03NOV2015,18JAN2016,50,10,10,292,292,2.4653828514,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HYRQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,6,,10,3,OK;20160120;12989;MW965;PLATE6,,,0,,30OCT2015,10NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-216,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64064-5,T1,0,v100,SA,160115-OK-HVTN100,10.0,12NOV2015,15JAN2016,50,10,10,955,955,2.9800033716,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J015-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,5,,10,3,OK;20160118;12962;MW965;PLATE5,,,0,,09NOV2015,20NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-185,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64065-3,T1,0,v100,SA,160115-OK-HVTN100,10.0,12NOV2015,15JAN2016,50,10,10,251,251,2.3996737215,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZXY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,4,,10,3,OK;20160118;12961;MW965;PLATE4,,,0,,08NOV2015,19NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-102,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64067-2,T1,0,v100,SA,160115-OK-HVTN100,10.0,17NOV2015,15JAN2016,50,10,10,398,398,2.5998830721,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J09F-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,4,,10,3,OK;20160118;12961;MW965;PLATE4,,,0,,13NOV2015,24NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-112,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64070-4,T1,0,v100,SA,160118-TH-HVTN100,10.0,16NOV2015,18JAN2016,50,10,10,426,426,2.6294095991,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J03Q-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,2,,10,3,TH;20160120;12981;MW965;PLATE2,,,0,,05NOV2015,16NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-082,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64074-1,T1,0,v100,SA,160118-TH-HVTN100,10.0,16NOV2015,18JAN2016,50,10,10,717,717,2.8555191557,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J039-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,2,,10,3,TH;20160120;12981;MW965;PLATE2,,,0,,12NOV2015,23NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-197,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64084-3,T1,0,v100,SA,160115-OK-HVTN100,10.0,18NOV2015,15JAN2016,50,10,10,120,120,2.079181246,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J0MY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,5,,10,3,OK;20160118;12962;MW965;PLATE5,,,0,,15NOV2015,26NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-232,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64085-5,T1,0,v100,SA,160118-OK-HVTN100,10.0,01DEC2015,18JAN2016,50,10,10,311,311,2.492760389,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J1QW-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,1,,10,3,OK;20160120;12990;MW965;PLATE1,,,0,,20NOV2015,01DEC2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-003,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64002-4,T1,0,v100,SA,151123-TH-HVTN100,10.0,13OCT2015,23NOV2015,50,10,10,15,15,1.1760912591,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBJ-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151125;12446;MW965;PLATE1,,,0,,08OCT2015,19OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-152,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64006-0,T1,0,v100,SA,160118-TH-HVTN100,10.0,14SEP2015,18JAN2016,50,10,10,56,56,1.748188027,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HSJ4-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,6,,10,3,TH;20160120;12985;MW965;PLATE6,,,0,,06SEP2015,17SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-220,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64009-5,T1,0,v100,SA,151227-TH-HVTN100,10.0,15OCT2015,27DEC2015,50,10,10,229,229,2.3598354823,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWQB-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,6,,10,3,TH;20151229;12769;MW965;PLATE6,,,0,,11OCT2015,22OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-125,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64010-0,T1,0,v100,SA,160115-TH-HVTN100,10.0,14SEP2015,15JAN2016,50,10,10,309,309,2.4899584794,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HSMB-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,7,,10,3,TH;20160118;12954;MW965;PLATE7,,,0,,05SEP2015,16SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-233,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64011-7,T1,0,v100,SA,160115-TH-HVTN100,10.0,22SEP2015,15JAN2016,50,10,10,1296,1296,3.1126050015,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HTGD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,8,,10,3,TH;20160118;12957;MW965;PLATE8,,,0,,18SEP2015,29SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-186,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64016-9,T1,0,v100,SA,160118-TH-HVTN100,10.0,27OCT2015,18JAN2016,50,10,10,108,108,2.0334237555,1,Titer>10,,,24JUN2016,08MAR2016,,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXNV-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,7,,10,3,TH;20160120;12986;MW965;PLATE7,,,0,0,18OCT2015,29OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-039,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64017-5,T1,0,v100,SA,151227-TH-HVTN100,10.0,29SEP2015,27DEC2015,50,10,10,152,152,2.1818435879,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HTWM-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,5,,10,3,TH;20151229;12768;MW965;PLATE5,,,0,,26SEP2015,07OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-013,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64018-3,T1,0,v100,SA,160122-TH-HVTN100,10.0,20NOV2015,22JAN2016,50,10,10,2399,2399,3.380030248,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J0YX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,1,,10,3,TH;20160124;13051;MW965;PLATE1,,,0,,17NOV2015,28NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-121,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64020-3,T1,0,v100,SA,151227-TH-HVTN100,10.0,06OCT2015,27DEC2015,50,10,10,1176,1176,3.0704073217,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HVPF-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,5,,10,3,TH;20151229;12768;MW965;PLATE5,,,0,,01OCT2015,12OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-087,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64023-2,T1,0,v100,SA,160115-TH-HVTN100,10.0,21OCT2015,15JAN2016,50,10,10,79,79,1.8976270913,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HX1W-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,8,,10,3,TH;20160118;12957;MW965;PLATE8,,,0,,16OCT2015,27OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-100,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64025-8,T1,0,v100,SA,151227-TH-HVTN100,10.0,13OCT2015,27DEC2015,50,10,10,149,149,2.1731862684,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBG-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,5,,10,3,TH;20151229;12768;MW965;PLATE5,,,0,,08OCT2015,19OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-069,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64026-6,T1,0,v100,SA,160122-TH-HVTN100,10.0,07NOV2015,22JAN2016,50,10,10,740,740,2.8692317197,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,1,,10,3,TH;20160124;13051;MW965;PLATE1,,,0,,03NOV2015,14NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-206,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64033-9,T1,0,v100,SA,160115-TH-HVTN100,10.0,20OCT2015,15JAN2016,50,10,10,106,106,2.0253058653,1,Titer>10,,,24JUN2016,08DEC2015,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HWYC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,8,,10,3,TH;20160118;12957;MW965;PLATE8,,,0,0,15OCT2015,26OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-047,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64035-1,T1,0,v100,SA,160115-OK-HVTN100,10.0,05NOV2015,15JAN2016,50,10,10,708,708,2.8500332577,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ01-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,4,,10,3,OK;20160118;12961;MW965;PLATE4,,,0,,01NOV2015,12NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-089,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64038-8,T1,0,v100,SA,160122-TH-HVTN100,10.0,25NOV2015,22JAN2016,50,10,10,32,32,1.5051499783,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J17P-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,1,,10,3,TH;20160124;13051;MW965;PLATE1,,,0,,20NOV2015,01DEC2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-139,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64041-8,T1,0,v100,SA,160122-TH-HVTN100,10.0,10NOV2015,22JAN2016,50,10,10,26,26,1.414973348,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFB-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,1,,10,3,TH;20160124;13051;MW965;PLATE1,,,0,,06NOV2015,17NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-080,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64042-9,T1,0,v100,SA,160118-OK-HVTN100,10.0,26OCT2015,18JAN2016,50,10,10,204,204,2.3096301674,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HXGW-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,3,,10,3,OK;20160120;12992;MW965;PLATE3,,,0,,22OCT2015,02NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-210,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64046-5,T1,0,v100,SA,160115-TH-HVTN100,10.0,27OCT2015,15JAN2016,50,10,10,1282,1282,3.1078880252,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXNS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,8,,10,3,TH;20160118;12957;MW965;PLATE8,,,0,,23OCT2015,03NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-162,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64048-2,T1,0,v100,SA,160115-OK-HVTN100,10.0,12NOV2015,15JAN2016,50,10,10,1111,1111,3.0457140589,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J00K-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,3,,10,3,OK;20160118;12960;MW965;PLATE3,,,0,,05NOV2015,16NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-246,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64051-0,T1,0,v100,SA,160118-OK-HVTN100,10.0,11NOV2015,18JAN2016,50,10,10,224,224,2.3502480183,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZP9-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,2,,10,3,OK;20160120;12991;MW965;PLATE2,,,0,,07NOV2015,18NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-223,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64053-6,T1,0,v100,SA,160118-TH-HVTN100,10.0,11NOV2015,18JAN2016,50,10,10,163,163,2.2121876044,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HZQD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,6,,10,3,TH;20160120;12985;MW965;PLATE6,,,0,,07NOV2015,18NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-028,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64055-4,T1,0,v100,SA,160118-TH-HVTN100,10.0,05NOV2015,18JAN2016,50,10,10,1157,1157,3.063333359,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZ03-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,6,,10,3,TH;20160120;12985;MW965;PLATE6,,,0,,01NOV2015,12NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-244,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64059-8,T1,0,v100,SA,160115-OK-HVTN100,10.0,20NOV2015,15JAN2016,50,10,10,306,306,2.4857214265,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J0Y2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,8,,10,3,OK;20160118;12965;MW965;PLATE8,,,0,,17NOV2015,28NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-153,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64061-6,T1,0,v100,SA,160118-OK-HVTN100,10.0,07NOV2015,18JAN2016,50,10,10,936,936,2.9712758487,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,4,,10,3,OK;20160120;12993;MW965;PLATE4,,,0,,03NOV2015,14NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-015,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64063-0,T1,0,v100,SA,160118-OK-HVTN100,10.0,19NOV2015,18JAN2016,50,10,10,59,59,1.7708520116,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J0WN-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,5,,10,3,OK;20160120;12988;MW965;PLATE5,,,1,,14NOV2015,25NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-252,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64064-3,T1,0,v100,SA,160118-OK-HVTN100,10.0,23NOV2015,18JAN2016,50,10,10,302,302,2.480006943,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0ZW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,1,,10,3,OK;20160120;12990;MW965;PLATE1,,,0,,19NOV2015,30NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-211,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64068-4,T1,0,v100,SA,160118-TH-HVTN100,10.0,10NOV2015,18JAN2016,50,10,10,380,380,2.5797835966,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZFD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,7,,10,3,TH;20160120;12986;MW965;PLATE7,,,0,,07NOV2015,18NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-147,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64069-2,T1,0,v100,SA,160115-OK-HVTN100,10.0,16NOV2015,15JAN2016,50,10,10,124,124,2.0934216852,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J02X-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,8,,10,3,OK;20160118;12965;MW965;PLATE8,,,0,,05NOV2015,16NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-168,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64071-1,T1,0,v100,SA,160115-OK-HVTN100,10.0,12NOV2015,15JAN2016,50,10,10,1759,1759,3.2452658395,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZZT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,8,,10,3,OK;20160118;12965;MW965;PLATE8,,,0,,08NOV2015,19NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-203,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64072-2,T1,0,v100,SA,160122-TH-HVTN100,10.0,12NOV2015,22JAN2016,50,10,10,1965,1965,3.2933625547,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZYT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,1,,10,3,TH;20160124;13051;MW965;PLATE1,,,0,,08NOV2015,19NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-167,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64074-8,T1,0,v100,SA,160118-TH-HVTN100,10.0,18NOV2015,18JAN2016,50,10,10,1549,1549,3.1900514178,1,Titer>10,,,24JUN2016,,,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J0LW-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,7,,10,3,TH;20160120;12986;MW965;PLATE7,,,0,,17NOV2015,28NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-224,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64075-0,T1,0,v100,SA,160118-OK-HVTN100,10.0,19NOV2015,18JAN2016,50,10,10,1112,1112,3.0461047872,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J0W8-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,5,,10,3,OK;20160120;12988;MW965;PLATE5,,,0,,13NOV2015,24NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-226,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64077-4,T1,0,v100,SA,160118-OK-HVTN100,10.0,19NOV2015,18JAN2016,50,10,10,343,343,2.53529412,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J0QS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,6,,10,3,OK;20160120;12989;MW965;PLATE6,,,0,,15NOV2015,26NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-020,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64079-7,T1,0,v100,SA,160118-OK-HVTN100,10.0,03DEC2015,18JAN2016,50,10,10,759,759,2.8802417759,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J1WG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,1,,10,3,OK;20160120;12990;MW965;PLATE1,,,0,,27NOV2015,08DEC2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-065,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64001-1,T1,0,v100,SA,151207-TH-HVTN100,10.0,07SEP2015,07DEC2015,50,10,10,149,149,2.1731862684,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FCQ6-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,6,,10,3,TH;20151209;12638;MW965;PLATE6,,,0,,05SEP2015,16SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-018,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64002-2,T1,0,v100,SA,151221-TH-HVTN100,10.0,15SEP2015,21DEC2015,50,10,10,119,119,2.0755469614,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FHFQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151223;12735;MW965;PLATE3,,,0,,14SEP2015,25SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-096,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64004-8,T1,0,v100,SA,151221-TH-HVTN100,10.0,23OCT2015,21DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FW3Z-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151223;12735;MW965;PLATE3,,,0,,22OCT2015,02NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-249,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64006-3,T1,0,v100,SA,151221-TH-HVTN100,10.0,22SEP2015,21DEC2015,50,10,10,184,184,2.264817823,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FK9S-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151223;12735;MW965;PLATE3,,,0,,20SEP2015,01OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-010,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64009-7,T1,0,v100,SA,151227-TH-HVTN100,10.0,22SEP2015,27DEC2015,50,10,10,250,250,2.3979400087,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FKKP-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,2,,10,3,TH;20151229;12764;MW965;PLATE2,,,0,,20SEP2015,01OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-222,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64018-1,T1,0,v100,SA,151227-TH-HVTN100,10.0,30SEP2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FMJB-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,2,,10,3,TH;20151229;12764;MW965;PLATE2,,,0,,26SEP2015,07OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-046,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64022-7,T1,0,v100,SA,151227-TH-HVTN100,10.0,16OCT2015,27DEC2015,50,10,10,368,368,2.5658478187,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FS71-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151229;12736;MW965;PLATE1,,,0,,12OCT2015,23OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-037,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64030-7,T1,0,v100,SA,151227-TH-HVTN100,10.0,09OCT2015,27DEC2015,50,10,10,489,489,2.6893088591,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FQ9L-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151229;12736;MW965;PLATE1,,,0,,01OCT2015,12OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-251,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64033-6,T1,0,v100,SA,151227-TH-HVTN100,10.0,19OCT2015,27DEC2015,50,10,10,161,161,2.206825876,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FSKN-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,4,,10,3,TH;20151229;12766;MW965;PLATE4,,,0,,12OCT2015,23OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-099,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64034-9,T1,0,v100,SA,160122-TH-HVTN100,10.0,08OCT2015,22JAN2016,50,10,10,11,11,1.0413926852,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FQ46-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,2,,10,3,TH;20160124;13052;MW965;PLATE2,,,0,,03OCT2015,14OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-032,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64038-5,T1,0,v100,SA,160118-OK-HVTN100,10.0,26OCT2015,18JAN2016,50,10,10,607,607,2.7831886911,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FWHM-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,3,,10,3,OK;20160120;12992;MW965;PLATE3,,,0,,22OCT2015,02NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-245,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64039-8,T1,0,v100,SA,151227-TH-HVTN100,10.0,15OCT2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FRV7-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,2,,10,3,TH;20151229;12764;MW965;PLATE2,,,0,,08OCT2015,19OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-057,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64042-6,T1,0,v100,SA,151227-TH-HVTN100,10.0,22OCT2015,27DEC2015,50,10,10,116,116,2.0644579892,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FVNV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151229;12736;MW965;PLATE1,,,0,,17OCT2015,28OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-055,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64043-1,T1,0,v100,SA,151227-TH-HVTN100,10.0,14OCT2015,27DEC2015,50,10,10,120,120,2.079181246,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FRFF-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,2,,10,3,TH;20151229;12764;MW965;PLATE2,,,0,,12OCT2015,23OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-021,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64046-7,T1,0,v100,SA,160115-OK-HVTN100,10.0,04NOV2015,15JAN2016,50,10,10,552,552,2.7419390777,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FZ1Z-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,25FEB2010,160106,72,Owen Karimanzira,1,,10,3,OK;20160118;12958;MW965;PLATE1,,,0,,01NOV2015,12NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-156,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64049-3,T1,0,v100,SA,151227-TH-HVTN100,10.0,14OCT2015,27DEC2015,50,10,10,330,330,2.5185139399,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRCW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151229;12765;MW965;PLATE3,,,0,,10OCT2015,21OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-014,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64054-6,T1,0,v100,SA,151227-TH-HVTN100,10.0,23OCT2015,27DEC2015,50,10,10,137,137,2.1367205672,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FW4N-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,4,,10,3,TH;20151229;12766;MW965;PLATE4,,,0,,16OCT2015,27OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-240,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64062-9,T1,0,v100,SA,160122-TH-HVTN100,10.0,27OCT2015,22JAN2016,50,10,10,988,988,2.9947569446,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FWTX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,15JAN2016,160115,48,Tandile Hermanus,2,,10,3,TH;20160124;13052;MW965;PLATE2,,,0,,23OCT2015,03NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-171,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64063-3,T1,0,v100,SA,151221-TH-HVTN100,10.0,14OCT2015,21DEC2015,50,10,10,470,470,2.6720978579,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRDV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,4,,10,3,TH;20151223;12734;MW965;PLATE4,,,0,,10OCT2015,21OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-068,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64064-1,T1,0,v100,SA,160115-TH-HVTN100,10.0,27OCT2015,15JAN2016,50,10,10,982,982,2.9921114878,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FWX6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,5,,10,3,TH;20160118;12955;MW965;PLATE5,,,0,,23OCT2015,03NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-062,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64065-7,T1,0,v100,SA,151227-TH-HVTN100,10.0,13OCT2015,27DEC2015,50,10,10,1139,1139,3.0565237241,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FQWN-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,4,,10,3,TH;20151229;12766;MW965;PLATE4,,,0,,12OCT2015,23OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-036,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64066-5,T1,0,v100,SA,151227-TH-HVTN100,10.0,16OCT2015,27DEC2015,50,10,10,332,332,2.5211380837,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FS6F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,2,,10,3,TH;20151229;12764;MW965;PLATE2,,,0,,10OCT2015,21OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-095,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64071-4,T1,0,v100,SA,151227-TH-HVTN100,10.0,21OCT2015,27DEC2015,50,10,10,232,232,2.3654879849,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FTPM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151229;12736;MW965;PLATE1,,,0,,17OCT2015,28OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-212,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64072-0,T1,0,v100,SA,160115-OK-HVTN100,10.0,02NOV2015,15JAN2016,50,10,10,584,584,2.7664128471,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FY0T-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,25FEB2010,160106,72,Owen Karimanzira,1,,10,3,OK;20160118;12958;MW965;PLATE1,,,0,,29OCT2015,09NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-072,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64074-5,T1,0,v100,SA,151221-TH-HVTN100,10.0,20OCT2015,21DEC2015,50,10,10,334,334,2.5237464668,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FSTR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,4,,10,3,TH;20151223;12734;MW965;PLATE4,,,0,,15OCT2015,26OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-229,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64076-1,T1,0,v100,SA,160115-OK-HVTN100,10.0,07NOV2015,15JAN2016,50,10,10,230,230,2.361727836,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20G182-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,25FEB2010,160106,72,Owen Karimanzira,1,,10,3,OK;20160118;12958;MW965;PLATE1,,,0,,29OCT2015,09NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-217,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64077-2,T1,0,v100,SA,160115-TH-HVTN100,10.0,29OCT2015,15JAN2016,50,10,10,148,148,2.1702617154,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FXCG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,5,,10,3,TH;20160118;12955;MW965;PLATE5,,,0,,25OCT2015,05NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-149,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64078-6,T1,0,v100,SA,151221-TH-HVTN100,10.0,21OCT2015,21DEC2015,50,10,10,160,160,2.2041199827,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FTPZ-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,4,,10,3,TH;20151223;12734;MW965;PLATE4,,,0,,16OCT2015,27OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-017,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64085-1,T1,0,v100,SA,151221-TH-HVTN100,10.0,20OCT2015,21DEC2015,50,10,10,60,60,1.7781512504,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FSV2-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,4,,10,3,TH;20151223;12734;MW965;PLATE4,,,0,,17OCT2015,28OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-074,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64086-4,T1,0,v100,SA,160115-TH-HVTN100,10.0,30OCT2015,15JAN2016,50,10,10,322,322,2.5078558717,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FXJC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,6,,10,3,TH;20160118;12956;MW965;PLATE6,,,0,,26OCT2015,06NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-124,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64089-6,T1,0,v100,SA,160115-TH-HVTN100,10.0,28OCT2015,15JAN2016,50,10,10,181,181,2.2576785749,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX1S-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,6,,10,3,TH;20160118;12956;MW965;PLATE6,,,0,,25OCT2015,05NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-004,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64095-6,T1,0,v100,SA,160115-TH-HVTN100,10.0,27OCT2015,15JAN2016,50,10,10,178,178,2.2504200023,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FWWD-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,6,,10,3,TH;20160118;12956;MW965;PLATE6,,,0,,23OCT2015,03NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-182,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64097-5,T1,0,v100,SA,160115-OK-HVTN100,10.0,06NOV2015,15JAN2016,50,10,10,193,193,2.285557309,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G0Z4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,25FEB2010,160106,72,Owen Karimanzira,1,,10,3,OK;20160118;12958;MW965;PLATE1,,,0,,05NOV2015,16NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-034,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64107-1,T1,0,v100,SA,160115-OK-HVTN100,10.0,07NOV2015,15JAN2016,50,10,10,660,660,2.8195439355,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G18P-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,25FEB2010,160106,72,Owen Karimanzira,1,,10,3,OK;20160118;12958;MW965;PLATE1,,,0,,03NOV2015,14NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-115,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64113-4,T1,0,v100,SA,160115-TH-HVTN100,10.0,30OCT2015,15JAN2016,50,10,10,940,940,2.9731278536,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FXJP-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,5,,10,3,TH;20160118;12955;MW965;PLATE5,,,0,,29OCT2015,09NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-144,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64118-3,T1,0,v100,SA,160115-OK-HVTN100,10.0,10NOV2015,15JAN2016,50,10,10,201,201,2.3031960574,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20G20Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,2,,10,3,OK;20160118;12959;MW965;PLATE2,,,0,,07NOV2015,18NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-189,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64125-8,T1,0,v100,SA,160115-OK-HVTN100,10.0,12NOV2015,15JAN2016,50,10,10,688,688,2.8375884382,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G3XF-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,2,,10,3,OK;20160118;12959;MW965;PLATE2,,,0,,12NOV2015,23NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-141,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64001-8,P2,1,v100,SA,151202-TH-HVTN100,10.0,23JUL2015,02DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20DZ2F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151204;12586;MW965;PLATE1,,,0,,23JUL2015,03AUG2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-056,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64028-6,P2,1,v100,SA,151207-TH-HVTN100,10.0,04AUG2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20F1PR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151209;12632;MW965;PLATE1,,,0,,02AUG2015,13AUG2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-154,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64047-1,P2,1,v100,SA,151207-TH-HVTN100,10.0,17AUG2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20F5F9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,2,,10,3,TH;20151209;12635;MW965;PLATE2,,,0,,13AUG2015,24AUG2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-041,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64059-3,P2,1,v100,SA,151207-TH-HVTN100,10.0,19AUG2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20F64B-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151209;12637;MW965;PLATE3,,,0,,15AUG2015,26AUG2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-196,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64085-8,P2,1,v100,SA,151207-TH-HVTN100,10.0,07SEP2015,07DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FCQJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,5,,10,3,TH;20151209;12639;MW965;PLATE5,,,0,,04SEP2015,15SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-200,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64086-6,P2,1,v100,SA,151221-TH-HVTN100,10.0,15SEP2015,21DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FHG1-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151223;12737;MW965;PLATE1,,,0,,12SEP2015,23SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-122,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64121-2,P2,1,v100,SA,151221-TH-HVTN100,10.0,29SEP2015,21DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FM29-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,2,,10,3,TH;20151223;12736;MW965;PLATE2,,,0,,26SEP2015,07OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-199,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64165-3,P2,1,v100,SA,160118-TH-HVTN100,10.0,09NOV2015,18JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20G1N0-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,8,,10,3,TH;20160120;12987;MW965;PLATE8,,,0,,05NOV2015,16NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-104,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64052-0,P2,1,v100,SA,151227-TH-HVTN100,10.0,06NOV2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BFW9-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,7,,10,3,TH;20151229;12770;MW965;PLATE7,,,0,,02NOV2015,13NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-086,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64077-3,P2,1,v100,SA,160118-OK-HVTN100,10.0,24NOV2015,18JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CA60BGKV-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,3,,10,3,OK;20160120;12992;MW965;PLATE3,,,0,,13NOV2015,24NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-012,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64078-5,P2,1,v100,SA,160118-TH-HVTN100,10.0,19NOV2015,18JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BGF7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,3,,10,3,TH;20160120;12982;MW965;PLATE3,,,0,,14NOV2015,25NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-214,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64018-8,P2,1,v100,SA,160115-TH-HVTN100,10.0,23SEP2015,15JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08APR2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT0552W-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,1,,10,3,TH;20160118;12950;MW965;PLATE1,,,0,0,19SEP2015,30SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-238,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64027-2,P2,1,v100,SA,160106-TH-HVTN100,10.0,27OCT2015,15JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT0584P-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,2,,10,3,TH;20160118;12951;MW965;PLATE2,,,0,,23OCT2015,03NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-175,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64030-0,P2,1,v100,SA,160106-TH-HVTN100,10.0,18SEP2015,15JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT054PV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,2,,10,3,TH;20160118;12951;MW965;PLATE2,,,0,,14SEP2015,25SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-045,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64068-9,P2,1,v100,SA,160118-OK-HVTN100,10.0,26NOV2015,18JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05CFM-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,3,,10,3,OK;20160120;12992;MW965;PLATE3,,,0,,22NOV2015,03DEC2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-191,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64024-7,P2,1,v100,SA,160118-TH-HVTN100,10.0,26OCT2015,18JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXHD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,1,,10,3,TH;20160120;12980;MW965;PLATE1,,,0,,24OCT2015,04NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-164,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64045-0,P2,1,v100,SA,160115-OK-HVTN100,10.0,16NOV2015,15JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J06D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,7,,10,3,OK;20160118;12964;MW965;PLATE7,,,0,,14NOV2015,25NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-008,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64049-7,P2,1,v100,SA,160115-OK-HVTN100,10.0,02NOV2015,15JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HYLY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,7,,10,3,OK;20160118;12964;MW965;PLATE7,,,0,,29OCT2015,09NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-016,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64051-7,P2,1,v100,SA,160115-OK-HVTN100,10.0,18NOV2015,15JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0N9-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,6,,10,3,OK;20160118;12963;MW965;PLATE6,,,0,,17NOV2015,28NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-033,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64059-1,P2,1,v100,SA,160118-OK-HVTN100,10.0,12NOV2015,18JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HZVY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,5,,10,3,OK;20160120;12988;MW965;PLATE5,,,0,,07NOV2015,18NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-241,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64069-9,P2,1,v100,SA,160115-OK-HVTN100,10.0,10NOV2015,15JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,5,,10,3,OK;20160118;12962;MW965;PLATE5,,,0,,05NOV2015,16NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-159,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64073-3,P2,1,v100,SA,160118-TH-HVTN100,10.0,27OCT2015,18JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXSP-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Tandile Hermanus,2,,10,3,TH;20160120;12981;MW965;PLATE2,,,0,,26OCT2015,06NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-049,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64083-0,P2,1,v100,SA,160115-OK-HVTN100,10.0,17NOV2015,15JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0CK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,5,,10,3,OK;20160118;12962;MW965;PLATE5,,,0,,14NOV2015,25NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-024,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64008-7,P2,1,v100,SA,160115-TH-HVTN100,10.0,22SEP2015,15JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HTD1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,7,,10,3,TH;20160118;12954;MW965;PLATE7,,,0,,18SEP2015,29SEP2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-143,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64021-9,P2,1,v100,SA,151227-TH-HVTN100,10.0,01OCT2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HV6Q-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,6,,10,3,TH;20151229;12769;MW965;PLATE6,,,0,,01OCT2015,12OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-009,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64024-0,P2,1,v100,SA,151227-TH-HVTN100,10.0,21OCT2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FTQC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151229;12765;MW965;PLATE3,,,0,,16OCT2015,27OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-094,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64031-2,P2,1,v100,SA,160115-OK-HVTN100,10.0,07NOV2015,15JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ68-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,6,,10,3,OK;20160118;12963;MW965;PLATE6,,,0,,03NOV2015,14NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-026,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64034-7,P2,1,v100,SA,160115-OK-HVTN100,10.0,04NOV2015,15JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HYZ4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,4,,10,3,OK;20160118;12961;MW965;PLATE4,,,0,,31OCT2015,11NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-166,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64050-7,P2,1,v100,SA,160115-OK-HVTN100,10.0,04NOV2015,15JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYV7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Owen Karimanzira,6,,10,3,OK;20160118;12963;MW965;PLATE6,,,0,,31OCT2015,11NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-005,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64057-3,P2,1,v100,SA,160118-OK-HVTN100,10.0,04NOV2015,18JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HYVZ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,5,,10,3,OK;20160120;12988;MW965;PLATE5,,,0,,30OCT2015,10NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-133,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64060-1,P2,1,v100,SA,160118-OK-HVTN100,10.0,07NOV2015,18JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,4,,10,3,OK;20160120;12993;MW965;PLATE4,,,0,,03NOV2015,14NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-195,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64070-6,P2,1,v100,SA,160118-OK-HVTN100,10.0,09NOV2015,18JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20G1M1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,48,Owen Karimanzira,4,,10,3,OK;20160120;12993;MW965;PLATE4,,,0,,07NOV2015,18NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-043,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64017-7,P2,1,v100,SA,151227-TH-HVTN100,10.0,13OCT2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FQTX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,3,,10,3,TH;20151229;12765;MW965;PLATE3,,,0,,10OCT2015,21OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-174,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64052-4,P2,1,v100,SA,151227-TH-HVTN100,10.0,23OCT2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FW49-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,4,,10,3,TH;20151229;12766;MW965;PLATE4,,,0,,19OCT2015,30OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-067,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64073-7,P2,1,v100,SA,151227-TH-HVTN100,10.0,22OCT2015,27DEC2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FVG5-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:1,Dilution,08OCT2015,151008,48,Tandile Hermanus,1,,10,3,TH;20151229;12736;MW965;PLATE1,,,0,,18OCT2015,29OCT2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-213,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64079-9,P2,1,v100,SA,160115-TH-HVTN100,10.0,28OCT2015,15JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FX13-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,6,,10,3,TH;20160118;12956;MW965;PLATE6,,,0,,24OCT2015,04NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-250,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64080-5,P2,1,v100,SA,160115-TH-HVTN100,10.0,28OCT2015,15JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX2K-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:3,Dilution,06JAN2016,160106,72,Tandile Hermanus,6,,10,3,TH;20160118;12956;MW965;PLATE6,,,0,,24OCT2015,04NOV2015,0,182,0,MW965.26,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-053,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64003-3,T1,0,v100,DU,CJ11-49,10.0,22JUL2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BC20DYKC-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,1,,10,3,P20151111;3407.xls,,,0,,19JUL2015,30JUL2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-111,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64006-5,T1,0,v100,DU,CJ11-49,10.0,29JUL2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20F09P-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,1,,10,3,P20151111;3407.xls,,,0,,26JUL2015,06AUG2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-031,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64009-0,T1,0,v100,DU,CJ11-49,10.0,23JUL2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20DYTL-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,1,,10,3,P20151111;3407.xls,,,0,,23JUL2015,03AUG2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-209,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64013-9,T1,0,v100,DU,CJ11-49,10.0,28JUL2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20DZVV-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,1,,10,3,P20151111;3407.xls,,,0,,25JUL2015,05AUG2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-158,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64021-4,T1,0,v100,DU,CJ11-49,10.0,03AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20F17D-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,2,,10,3,P20151111;3408.xls,,,0,,01AUG2015,12AUG2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-215,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64029-9,T1,0,v100,DU,CJ11-49,10.0,25AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20F8HS-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,2,,10,3,P20151111;3408.xls,,,0,,14AUG2015,25AUG2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-231,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64031-7,T1,0,v100,DU,CJ11-49,10.0,27AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20F8ZN-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,2,,10,3,P20151111;3408.xls,,,0,,21AUG2015,01SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-091,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64033-4,T1,0,v100,DU,CJ11-49,10.0,08SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20FD4N-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,2,,10,3,P20151111;3408.xls,,,0,,04SEP2015,15SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-077,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64036-9,T1,0,v100,DU,CJ11-49,10.0,18AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20F5SG-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,3,,10,3,P20151111;3409.xls,,,0,,14AUG2015,25AUG2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-136,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64045-2,T1,0,v100,DU,CJ11-49,10.0,13AUG2015,11NOV2015,50,10,10,30,30,1.4771212547,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20F4C6-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,3,,10,3,P20151111;3409.xls,,,0,,13AUG2015,24AUG2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-227,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64053-1,T1,0,v100,DU,CJ11-49,10.0,19AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CC20F676-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,3,,10,3,P20151111;3409.xls,,,0,,16AUG2015,27AUG2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-160,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64054-4,T1,0,v100,DU,CJ11-49,10.0,26AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20F8R9-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,3,,10,3,P20151111;3409.xls,,,0,,21AUG2015,01SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-155,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64055-9,T1,0,v100,DU,CJ11-49,10.0,20AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20F6C4-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,4,,10,3,P20151111;3410.xls,,,0,,14AUG2015,25AUG2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-177,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64057-8,T1,0,v100,DU,CJ11-49,10.0,02SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FBT0-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,4,,10,3,P20151111;3410.xls,,,0,,23AUG2015,03SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-052,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64062-2,T1,0,v100,DU,CJ11-49,10.0,03SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FC68-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,4,,10,3,P20151111;3410.xls,,,0,,28AUG2015,08SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-247,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64063-5,T1,0,v100,DU,CJ11-49,10.0,08SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20FD2Q-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,4,,10,3,P20151111;3410.xls,,,0,,04SEP2015,15SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-126,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64066-3,T1,0,v100,DU,CJ11-49,10.0,08SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20FD3H-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,5,,10,3,P20151111;3411.xls,,,0,,04SEP2015,15SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-225,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64067-4,T1,0,v100,DU,CJ11-49,10.0,08SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FD43-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,5,,10,3,P20151111;3411.xls,,,0,,04SEP2015,15SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-148,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64069-7,T1,0,v100,DU,CJ11-125,10.0,14SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20FGVK-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,1,,10,3,CJ20160122;1802.xls,,,0,,12SEP2015,23SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-163,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64077-9,T1,0,v100,DU,CJ11-49,10.0,07SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20FCJ1-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,5,,10,3,P20151111;3411.xls,,,0,,29AUG2015,09SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-073,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64080-3,T1,0,v100,DU,CJ11-49,10.0,31AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FB33-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,5,,10,3,P20151111;3411.xls,,,0,,28AUG2015,08SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-184,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64087-7,T1,0,v100,DU,CJ11-49,10.0,07SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20FCJR-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,6,,10,3,P20151111;3412.xls,,,0,,06SEP2015,17SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-170,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64095-4,T1,0,v100,DU,CJ11-125,10.0,08OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20FQ3V-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,1,,10,3,CJ20160122;1802.xls,,,0,,01OCT2015,12OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-038,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64105-9,T1,0,v100,DU,RP-02-27,10.0,17NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20G4TX-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,1,,10,3,RP20160121;4099-1.xls,,,0,,14NOV2015,25NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-123,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64117-3,T1,0,v100,DU,CJ11-125,10.0,17SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20FJ00-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,1,,10,3,CJ20160122;1802.xls,,,0,,13SEP2015,24SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-061,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64119-8,T1,0,v100,DU,CJ11-125,10.0,30SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20FMJ0-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,1,,10,3,CJ20160122;1802.xls,,,0,,26SEP2015,07OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-128,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64129-6,T1,0,v100,DU,CJ11-125,10.0,06OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20FPD4-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,2,,10,3,CJ20160122;1803.xls,,,0,,03OCT2015,14OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-108,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64130-3,T1,0,v100,DU,CJ11-125,10.0,06OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20FPDG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,2,,10,3,CJ20160122;1803.xls,,,0,,02OCT2015,13OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-097,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64135-8,T1,0,v100,DU,CJ11-125,10.0,28SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20FLTC-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,2,,10,3,CJ20160122;1803.xls,,,0,,26SEP2015,07OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-129,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64139-4,T1,0,v100,DU,CJ11-125,10.0,26OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20FWKL-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,2,,10,3,CJ20160122;1803.xls,,,0,,16OCT2015,27OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-058,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64150-0,T1,0,v100,DU,RP-02-27,10.0,11NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20G3JT-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,1,,10,3,RP20160121;4099-1.xls,,,0,,07NOV2015,18NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-151,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64154-2,T1,0,v100,DU,RP-02-27,10.0,02NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20FXYX-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,1,,10,3,RP20160121;4099-1.xls,,,0,,25OCT2015,05NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-002,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64156-9,T1,0,v100,DU,RP-02-27,10.0,02NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20FXZQ-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,1,,10,3,RP20160121;4099-1.xls,,,0,,25OCT2015,05NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-194,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64166-1,T1,0,v100,DU,RP-02-27,10.0,17NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20G4VL-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,2,,10,3,RP20160121;4100.xls,,,0,,14NOV2015,25NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-157,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64167-2,T1,0,v100,DU,RP-02-27,10.0,10NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20G20B-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,2,,10,3,RP20160121;4100.xls,,,0,,06NOV2015,17NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-025,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64172-9,T1,0,v100,DU,RP-02-27,10.0,12NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BC20G3X4-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,2,,10,3,RP20160121;4100.xls,,,0,,06NOV2015,17NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-137,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64002-3,T1,0,v100,DU,CJ11-49,10.0,28AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HA60BCRM-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,6,,10,3,P20151111;3412.xls,,,0,,21AUG2015,01SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-064,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64007-0,T1,0,v100,DU,CJ11-49,10.0,14SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JA60BDHQ-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,6,,10,3,P20151111;3412.xls,,,0,,10SEP2015,21SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-131,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64008-8,T1,0,v100,DU,CJ11-49,10.0,14SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AA60BDJC-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,6,,10,3,P20151111;3412.xls,,,0,,07SEP2015,18SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-109,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64028-0,T1,0,v100,DU,CJ11-125,10.0,21OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BA60BFB3-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,3,,10,3,CJ20160122;1804.xls,,,0,,17OCT2015,28OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-187,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64029-3,T1,0,v100,DU,CJ11-125,10.0,26OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AA60BFG6-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,3,,10,3,CJ20160122;1804.xls,,,0,,19OCT2015,30OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-090,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64030-6,T1,0,v100,DU,CJ11-125,10.0,27OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FA60BFGQ-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,3,,10,3,CJ20160122;1804.xls,,,0,,23OCT2015,03NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-130,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64034-8,T1,0,v100,DU,RP-02-27,10.0,10NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EA60BG09-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,2,,10,3,RP20160121;4100.xls,,,0,,06NOV2015,17NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-105,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64036-3,T1,0,v100,DU,RP-02-27,10.0,13NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EA60BG4G-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,2,,10,3,RP20160121;4100.xls,,,0,,09NOV2015,20NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-140,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64037-4,T1,0,v100,DU,RP-02-27,10.0,16NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EA60BG8C-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,3,,10,3,RP20160121;4101.xls,,,0,,12NOV2015,23NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-138,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64038-9,T1,0,v100,DU,CJ11-125,10.0,04NOV2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HA60BFT3-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,3,,10,3,CJ20160122;1804.xls,,,0,,31OCT2015,11NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-084,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64039-7,T1,0,v100,DU,CJ11-125,10.0,27OCT2015,22JAN2016,50,10,10,16,16,1.2041199827,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DA60BFH3-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,3,,10,3,CJ20160122;1804.xls,,,0,,23OCT2015,03NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-198,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64040-3,T1,0,v100,DU,RP-02-27,10.0,17NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KA60BGC1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,3,,10,3,RP20160121;4101.xls,,,0,,07NOV2015,18NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-228,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64044-0,T1,0,v100,DU,RP-02-27,10.0,24NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BA60BGLK-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,3,,10,3,RP20160121;4101.xls,,,0,,14NOV2015,25NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-181,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64050-8,T1,0,v100,DU,CJ11-125,10.0,02NOV2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HA60BFPN-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,4,,10,3,CJ20160122;1805.xls,,,0,,31OCT2015,11NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-085,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64051-4,T1,0,v100,DU,CJ11-125,10.0,06NOV2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DA60BFVX-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,4,,10,3,CJ20160122;1805.xls,,,0,,02NOV2015,13NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-063,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64053-7,T1,0,v100,DU,RP-02-27,10.0,20NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KA60BGGQ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,3,,10,3,RP20160121;4101.xls,,,0,,16NOV2015,27NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-235,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64054-5,T1,0,v100,DU,CJ11-125,10.0,09NOV2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AA60BFY7-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,4,,10,3,CJ20160122;1805.xls,,,0,,05NOV2015,16NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-001,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64061-7,T1,0,v100,DU,CJ11-125,10.0,09NOV2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DA60BFYY-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,4,,10,3,CJ20160122;1805.xls,,,0,,07NOV2015,18NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-083,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64062-8,T1,0,v100,DU,RP-02-27,10.0,13NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EA60BG5Y-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,3,,10,3,RP20160121;4101.xls,,,0,,09NOV2015,20NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-145,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64066-9,T1,0,v100,DU,RP-02-27,10.0,11NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KA60BG31-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,4,,10,3,RP20160121;4102.xls,,,0,,06NOV2015,17NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-127,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64068-3,T1,0,v100,DU,RP-02-27,10.0,24NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AA60BGMS-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,4,,10,3,RP20160121;4102.xls,,,0,,19NOV2015,30NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-044,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64069-1,T1,0,v100,DU,RP-02-27,10.0,16NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GA60BG7M-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,4,,10,3,RP20160121;4102.xls,,,0,,12NOV2015,23NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-132,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64070-7,T1,0,v100,DU,RP-02-27,10.0,13NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FA60BG5H-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,4,,10,3,RP20160121;4102.xls,,,0,,09NOV2015,20NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-048,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64073-6,T1,0,v100,DU,RP-02-27,10.0,16NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EA60BG9D-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,4,,10,3,RP20160121;4102.xls,,,0,,12NOV2015,23NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-092,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64075-4,T1,0,v100,DU,RP-02-27,10.0,17NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JA60BGCG-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,5,,10,3,RP20160121;4103.xls,,,0,,13NOV2015,24NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-218,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64076-2,T1,0,v100,DU,RP-02-27,10.0,16NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JA60BG9S-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,5,,10,3,RP20160121;4103.xls,,,0,,12NOV2015,23NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-179,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64082-4,T1,0,v100,DU,RP-02-27,10.0,10NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BA60BG19-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,5,,10,3,RP20160121;4103.xls,,,0,,06NOV2015,17NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-040,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64089-5,T1,0,v100,DU,RP-02-27,10.0,27NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FA60BGP5-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,6,,10,3,RP20160121;4104.xls,,,0,,21NOV2015,02DEC2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-022,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64001-8,T1,0,v100,DU,CJ11-125,10.0,21SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HAT054TG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,5,,10,3,CJ20160122;1806.xls,,,0,,20SEP2015,01OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-066,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64002-9,T1,0,v100,DU,CJ11-49,10.0,17SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GAT054MG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,6,,10,3,P20151111;3412.xls,,,0,,12SEP2015,23SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-142,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64004-1,T1,0,v100,DU,CJ11-125,10.0,22OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AAT057TJ-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,5,,10,3,CJ20160122;1806.xls,,,0,,16OCT2015,27OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-236,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64006-5,T1,0,v100,DU,CJ11-49,10.0,17SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BAT054L4-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,7,,10,3,P20151111;3413-1.xls,,,0,,13SEP2015,24SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-120,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64007-6,T1,0,v100,DU,CJ11-49,10.0,17SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DAT054KS-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,7,,10,3,P20151111;3413-1.xls,,,0,,13SEP2015,24SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-029,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64009-0,T1,0,v100,DU,CJ11-125,10.0,21SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HAT054TT-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,5,,10,3,CJ20160122;1806.xls,,,0,,17SEP2015,28SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-107,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64010-5,T1,0,v100,DU,CJ11-125,10.0,22SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JAT0550X-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,5,,10,3,CJ20160122;1806.xls,,,0,,18SEP2015,29SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-113,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64012-3,T1,0,v100,DU,CJ11-125,10.0,21SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BAT054V4-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,5,,10,3,CJ20160122;1806.xls,,,0,,20SEP2015,01OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-234,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64016-4,T1,0,v100,DU,CJ11-125,10.0,21SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CAT054VG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,6,,10,3,CJ20160122;1807.xls,,,0,,20SEP2015,01OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-059,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64017-0,T1,0,v100,DU,CJ11-125,10.0,28SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AAT05585-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,6,,10,3,CJ20160122;1807.xls,,,0,,24SEP2015,05OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-023,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64021-4,T1,0,v100,DU,CJ11-125,10.0,28SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AAT0557V-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,6,,10,3,CJ20160122;1807.xls,,,0,,24SEP2015,05OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-201,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64029-9,T1,0,v100,DU,CJ11-125,10.0,12OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AAT056K1-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,7,,10,3,CJ20160122;1808.xls,,,0,,08OCT2015,19OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-076,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64031-7,T1,0,v100,DU,CJ11-125,10.0,26OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JAT057ZR-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,7,,10,3,CJ20160122;1808.xls,,,0,,22OCT2015,02NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-204,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64035-6,T1,0,v100,DU,CJ11-125,10.0,26OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KAT057X1-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,7,,10,3,CJ20160122;1808.xls,,,0,,22OCT2015,02NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-230,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64036-9,T1,0,v100,DU,CJ11-125,10.0,02NOV2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DAT058FR-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,7,,10,3,CJ20160122;1808.xls,,,0,,29OCT2015,09NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-011,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64037-5,T1,0,v100,DU,CJ11-125,10.0,27OCT2015,22JAN2016,50,10,10,13,13,1.1139433523,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AAT0584C-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,8,,10,3,CJ20160122;1809.xls,,,0,,23OCT2015,03NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-161,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64038-3,T1,0,v100,DU,CJ11-125,10.0,19OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KAT05797-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,8,,10,3,CJ20160122;1809.xls,,,0,,15OCT2015,26OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-180,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64041-3,T1,0,v100,DU,RP-02-27,10.0,07NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BAT05967-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,6,,10,3,RP20160121;4104.xls,,,0,,02NOV2015,13NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-116,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64043-8,T1,0,v100,DU,RP-02-27,10.0,10NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DAT059JJ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,6,,10,3,RP20160121;4104.xls,,,0,,06NOV2015,17NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-079,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64044-6,T1,0,v100,DU,CJ11-125,10.0,23OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KAT057VG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,8,,10,3,CJ20160122;1809.xls,,,0,,19OCT2015,30OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-192,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64045-2,T1,0,v100,DU,RP-02-27,10.0,11NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EAT059Q1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,6,,10,3,RP20160121;4104.xls,,,0,,09NOV2015,20NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-146,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64050-2,T1,0,v100,DU,RP-02-27,10.0,11NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FAT059TS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,6,,10,3,RP20160121;4104.xls,,,0,,07NOV2015,18NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-006,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64051-5,T1,0,v100,DU,RP-02-27,10.0,09NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DAT0598R-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,7,,10,3,RP20160121;4105.xls,,,0,,05NOV2015,16NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-007,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64053-1,T1,0,v100,DU,RP-02-27,10.0,09NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BAT059C4-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,7,,10,3,RP20160121;4105.xls,,,0,,05NOV2015,16NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-081,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64054-4,T1,0,v100,DU,RP-02-27,10.0,10NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JAT059KL-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,7,,10,3,RP20160121;4105.xls,,,0,,06NOV2015,17NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-172,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64056-7,T1,0,v100,DU,RP-02-27,10.0,16NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FAT05B6R-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,7,,10,3,RP20160121;4105.xls,,,0,,12NOV2015,23NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-205,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64057-8,T1,0,v100,DU,RP-02-27,10.0,11NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HAT059VK-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,7,,10,3,RP20160121;4105.xls,,,0,,06NOV2015,17NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-202,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64060-6,T1,0,v100,DU,RP-02-27,10.0,21NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BAT05BWD-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,8,,10,3,RP20160121;4106.xls,,,0,,17NOV2015,28NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-119,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64062-2,T1,0,v100,DU,RP-02-27,10.0,18NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JAT05BLC-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,8,,10,3,RP20160121;4106.xls,,,0,,14NOV2015,25NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-101,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64072-7,T1,0,v100,DU,RP-02-27,10.0,19NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FAT05BS4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,8,,10,3,RP20160121;4106.xls,,,0,,19NOV2015,30NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-050,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64003-1,T1,0,v100,DU,CJ11-125,10.0,02SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,B7Q0HRJ1-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,8,,10,3,CJ20160122;1809.xls,,,0,,29AUG2015,09SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-150,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64005-9,T1,0,v100,DU,CJ11-125,10.0,01SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,G7Q0HR6B-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,9,,10,3,CJ20160122;1810.xls,,,0,,28AUG2015,08SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-114,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64006-7,T1,0,v100,DU,CJ11-125,10.0,18SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,B7Q0HT5Y-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,9,,10,3,CJ20160122;1810.xls,,,0,,14SEP2015,25SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-190,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64007-8,T1,0,v100,DU,CJ11-125,10.0,05OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0HVGX-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,9,,10,3,CJ20160122;1810.xls,,,0,,01OCT2015,12OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-248,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64011-0,T1,0,v100,DU,CJ11-125,10.0,23SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0HTJJ-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,9,,10,3,CJ20160122;1810.xls,,,0,,18SEP2015,29SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-042,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64017-3,T1,0,v100,DU,CJ11-125,10.0,06OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,G7Q0HVRV-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,9,,10,3,CJ20160122;1810.xls,,,0,,03OCT2015,14OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-078,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64018-5,T1,0,v100,DU,CJ11-125,10.0,02OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HVCC-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,10,,10,3,CJ20160122;1811.xls,,,0,,01OCT2015,12OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-242,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64019-8,T1,0,v100,DU,RP-02-27,10.0,10NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0HZFL-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,8,,10,3,RP20160121;4106.xls,,,0,,07NOV2015,18NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-071,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64022-3,T1,0,v100,DU,CJ11-125,10.0,23OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HXFC-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,10,,10,3,CJ20160122;1811.xls,,,0,,23OCT2015,03NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-070,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64025-1,T1,0,v100,DU,CJ11-125,10.0,26OCT2015,22JAN2016,50,10,10,13,13,1.1139433523,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0HXGY-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,10,,10,3,CJ20160122;1811.xls,,,0,,23OCT2015,03NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-134,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64026-4,T1,0,v100,DU,RP-02-27,10.0,09NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,D7Q0HZB7-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,9,,10,3,RP20160121;4107.xls,,,0,,05NOV2015,16NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-219,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64028-8,T1,0,v100,DU,CJ11-125,10.0,27OCT2015,22JAN2016,50,10,10,47,47,1.6720978579,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0HXTF-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,10,,10,3,CJ20160122;1811.xls,,,0,,26OCT2015,06NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-176,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64029-6,T1,0,v100,DU,RP-02-27,10.0,10NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HZFG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,9,,10,3,RP20160121;4107.xls,,,0,,07NOV2015,18NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-135,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64031-9,T1,0,v100,DU,RP-02-27,10.0,02NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HYLD-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,9,,10,3,RP20160121;4107.xls,,,0,,24OCT2015,04NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-103,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64036-6,T1,0,v100,DU,CJ11-125,10.0,30OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,F7Q0HYBJ-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,11,,10,3,CJ20160122;1812.xls,,,0,,29OCT2015,09NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-169,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64037-7,T1,0,v100,DU,RP-02-27,10.0,12NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0HZWP-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,9,,10,3,RP20160121;4107.xls,,,0,,08NOV2015,19NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-165,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64041-1,T1,0,v100,DU,RP-02-27,10.0,01DEC2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0J1Q0-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,9,,10,3,RP20160121;4107.xls,,,0,,26NOV2015,07DEC2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-183,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64044-8,T1,0,v100,DU,CJ11-125,10.0,30OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,F7Q0HY9Q-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,11,,10,3,CJ20160122;1812.xls,,,0,,29OCT2015,09NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-188,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64046-3,T1,0,v100,DU,RP-02-27,10.0,17NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0J09C-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,10,,10,3,RP20160121;4108.xls,,,0,,17NOV2015,28NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-054,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64047-4,T1,0,v100,DU,RP-02-27,10.0,03NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HYR2-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,10,,10,3,RP20160121;4108.xls,,,0,,29OCT2015,09NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-239,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64054-2,T1,0,v100,DU,CJ11-125,10.0,28OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,F7Q0HXZP-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,11,,10,3,CJ20160122;1812.xls,,,0,,26OCT2015,06NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-098,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64062-0,T1,0,v100,DU,RP-02-27,10.0,03NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0HYRQ-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,11,,10,3,RP20160121;4109.xls,,,0,,30OCT2015,10NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-216,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64064-5,T1,0,v100,DU,RP-02-27,10.0,12NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0J015-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,11,,10,3,RP20160121;4109.xls,,,0,,09NOV2015,20NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-185,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64065-3,T1,0,v100,DU,RP-02-27,10.0,12NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0HZXY-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,11,,10,3,RP20160121;4109.xls,,,0,,08NOV2015,19NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-102,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64067-2,T1,0,v100,DU,RP-02-27,10.0,17NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0J09F-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,11,,10,3,RP20160121;4109.xls,,,0,,13NOV2015,24NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-112,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64070-4,T1,0,v100,DU,RP-02-27,10.0,16NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,D7Q0J03Q-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,12,,10,3,RP20160121;4110.xls,,,0,,05NOV2015,16NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-082,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64074-1,T1,0,v100,DU,RP-02-27,10.0,16NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,F7Q0J039-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,12,,10,3,RP20160121;4110.xls,,,0,,12NOV2015,23NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-197,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64084-3,T1,0,v100,DU,RP-02-27,10.0,18NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,B7Q0J0MY-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,12,,10,3,RP20160121;4110.xls,,,0,,15NOV2015,26NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-232,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64085-5,T1,0,v100,DU,RP-02-27,10.0,01DEC2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0J1QW-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,13,,10,3,RP20160121;4111.xls,,,0,,20NOV2015,01DEC2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-003,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64002-4,T1,0,v100,DU,CJ11-125,10.0,13OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HWBJ-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,11,,10,3,CJ20160122;1812.xls,,,0,,08OCT2015,19OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-152,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64006-0,T1,0,v100,DU,CJ11-125,10.0,14SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0HSJ4-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,12,,10,3,CJ20160122;1813.xls,,,0,,06SEP2015,17SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-220,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64009-5,T1,0,v100,DU,CJ11-125,10.0,15OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HWQB-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,12,,10,3,CJ20160122;1813.xls,,,0,,11OCT2015,22OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-125,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64010-0,T1,0,v100,DU,CJ11-125,10.0,14SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HSMB-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,12,,10,3,CJ20160122;1813.xls,,,0,,05SEP2015,16SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-233,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64011-7,T1,0,v100,DU,CJ11-125,10.0,22SEP2015,22JAN2016,50,10,10,109,109,2.0374264979,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,G7Q0HTGD-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,12,,10,3,CJ20160122;1813.xls,,,0,,18SEP2015,29SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-186,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64016-9,T1,0,v100,DU,CJ11-125,10.0,27OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,08MAR2016,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,D7Q0HXNV-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,13,,10,3,CJ20160122;1814.xls,,,0,0,18OCT2015,29OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-039,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64017-5,T1,0,v100,DU,CJ11-125,10.0,29SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0HTWM-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,13,,10,3,CJ20160122;1814.xls,,,0,,26SEP2015,07OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-013,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64018-3,T1,0,v100,DU,RP-02-27,10.0,20NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,F7Q0J0YX-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,13,,10,3,RP20160121;4111.xls,,,0,,17NOV2015,28NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-121,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64020-3,T1,0,v100,DU,CJ11-125,10.0,06OCT2015,22JAN2016,50,10,10,12,12,1.079181246,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0HVPF-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,13,,10,3,CJ20160122;1814.xls,,,0,,01OCT2015,12OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-087,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64023-2,T1,0,v100,DU,CJ11-125,10.0,21OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HX1W-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,13,,10,3,CJ20160122;1814.xls,,,0,,16OCT2015,27OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-100,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64025-8,T1,0,v100,DU,CJ11-125,10.0,13OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HWBG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,14,,10,3,CJ20160122;1815.xls,,,0,,08OCT2015,19OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-069,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64026-6,T1,0,v100,DU,RP-02-27,10.0,07NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HZ6R-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,13,,10,3,RP20160121;4111.xls,,,0,,03NOV2015,14NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-206,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64033-9,T1,0,v100,DU,CJ11-125,10.0,20OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,08DEC2015,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0HWYC-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,14,,10,3,CJ20160122;1815.xls,,,0,0,15OCT2015,26OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-047,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64035-1,T1,0,v100,DU,RP-02-27,10.0,05NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0HZ01-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,14,,10,3,RP20160121;4112.xls,,,0,,01NOV2015,12NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-089,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64038-8,T1,0,v100,DU,RP-02-27,10.0,25NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0J17P-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,14,,10,3,RP20160121;4112.xls,,,0,,20NOV2015,01DEC2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-139,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64041-8,T1,0,v100,DU,RP-02-27,10.0,10NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0HZFB-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,14,,10,3,RP20160121;4112.xls,,,0,,06NOV2015,17NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-080,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64042-9,T1,0,v100,DU,CJ11-125,10.0,26OCT2015,22JAN2016,50,10,10,28,28,1.4471580313,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0HXGW-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,14,,10,3,CJ20160122;1815.xls,,,0,,22OCT2015,02NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-210,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64046-5,T1,0,v100,DU,CJ11-125,10.0,27OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HXNS-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,14,,10,3,CJ20160122;1815.xls,,,0,,23OCT2015,03NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-162,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64048-2,T1,0,v100,DU,RP-02-27,10.0,12NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0J00K-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,14,,10,3,RP20160121;4112.xls,,,0,,05NOV2015,16NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-246,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64051-0,T1,0,v100,DU,RP-02-27,10.0,11NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0HZP9-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,15,,10,3,RP20160121;4113.xls,,,0,,07NOV2015,18NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-223,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64053-6,T1,0,v100,DU,RP-02-27,10.0,11NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,F7Q0HZQD-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,15,,10,3,RP20160121;4113.xls,,,0,,07NOV2015,18NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-028,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64055-4,T1,0,v100,DU,RP-02-27,10.0,05NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0HZ03-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,15,,10,3,RP20160121;4113.xls,,,0,,01NOV2015,12NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-244,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64059-8,T1,0,v100,DU,RP-02-27,10.0,20NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,D7Q0J0Y2-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,15,,10,3,RP20160121;4113.xls,,,0,,17NOV2015,28NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-153,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64061-6,T1,0,v100,DU,RP-02-27,10.0,07NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HZ5Y-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,16,,10,3,RP20160121;4114.xls,,,0,,03NOV2015,14NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-015,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64063-0,T1,0,v100,DU,RP-02-27,10.0,19NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0J0WN-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,16,,10,3,RP20160121;4114.xls,,,0,,14NOV2015,25NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-252,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64064-3,T1,0,v100,DU,RP-02-27,10.0,23NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0J0ZW-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,16,,10,3,RP20160121;4114.xls,,,0,,19NOV2015,30NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-211,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64068-4,T1,0,v100,DU,RP-02-27,10.0,10NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0HZFD-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,16,,10,3,RP20160121;4114.xls,,,0,,07NOV2015,18NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-147,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64069-2,T1,0,v100,DU,RP-02-27,10.0,16NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0J02X-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,17,,10,3,RP20160121;4115.xls,,,0,,05NOV2015,16NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-168,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64071-1,T1,0,v100,DU,RP-02-27,10.0,12NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HZZT-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,17,,10,3,RP20160121;4115.xls,,,0,,08NOV2015,19NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-203,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64072-2,T1,0,v100,DU,RP-02-27,10.0,12NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0HZYT-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,17,,10,3,RP20160121;4115.xls,,,0,,08NOV2015,19NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-167,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64074-8,T1,0,v100,DU,RP-02-27,10.0,18NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0J0LW-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,17,,10,3,RP20160121;4115.xls,,,0,,17NOV2015,28NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-224,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64075-0,T1,0,v100,DU,RP-02-27,10.0,19NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0J0W8-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,18,,10,3,RP20160121;4116.xls,,,0,,13NOV2015,24NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-226,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64077-4,T1,0,v100,DU,RP-02-27,10.0,19NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0J0QS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,18,,10,3,RP20160121;4116.xls,,,0,,15NOV2015,26NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-020,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64079-7,T1,0,v100,DU,RP-02-27,10.0,03DEC2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,B7Q0J1WG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,18,,10,3,RP20160121;4116.xls,,,0,,27NOV2015,08DEC2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-065,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64001-1,T1,0,v100,DU,CJ11-49,10.0,07SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20FCQ6-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,7,,10,3,P20151111;3413-1.xls,,,0,,05SEP2015,16SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-018,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64002-2,T1,0,v100,DU,CJ11-125,10.0,15SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BC20FHFQ-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,15,,10,3,CJ20160122;1816.xls,,,0,,14SEP2015,25SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-096,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64004-8,T1,0,v100,DU,CJ11-125,10.0,23OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20FW3Z-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,15,,10,3,CJ20160122;1816.xls,,,0,,22OCT2015,02NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-249,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64006-3,T1,0,v100,DU,CJ11-125,10.0,22SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FK9S-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,15,,10,3,CJ20160122;1816.xls,,,0,,20SEP2015,01OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-010,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64009-7,T1,0,v100,DU,CJ11-125,10.0,22SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20FKKP-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,15,,10,3,CJ20160122;1816.xls,,,0,,20SEP2015,01OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-222,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64018-1,T1,0,v100,DU,CJ11-125,10.0,30SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FMJB-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,16,,10,3,CJ20160122;1817.xls,,,0,,26SEP2015,07OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-046,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64022-7,T1,0,v100,DU,CJ11-125,10.0,16OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FS71-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,16,,10,3,CJ20160122;1817.xls,,,0,,12OCT2015,23OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-037,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64030-7,T1,0,v100,DU,CJ11-125,10.0,09OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20FQ9L-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,16,,10,3,CJ20160122;1817.xls,,,0,,01OCT2015,12OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-251,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64033-6,T1,0,v100,DU,CJ11-125,10.0,19OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HC20FSKN-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,16,,10,3,CJ20160122;1817.xls,,,0,,12OCT2015,23OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-099,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64034-9,T1,0,v100,DU,CJ11-125,10.0,08OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20FQ46-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,16,,10,3,CJ20160122;1817.xls,,,0,,03OCT2015,14OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-032,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64038-5,T1,0,v100,DU,CJ11-125,10.0,26OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FWHM-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,17,,10,3,CJ20160122;1818.xls,,,0,,22OCT2015,02NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-245,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64039-8,T1,0,v100,DU,CJ11-125,10.0,15OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FRV7-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,17,,10,3,CJ20160122;1818.xls,,,0,,08OCT2015,19OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-057,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64042-6,T1,0,v100,DU,CJ11-125,10.0,22OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FVNV-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,17,,10,3,CJ20160122;1818.xls,,,0,,17OCT2015,28OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-055,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64043-1,T1,0,v100,DU,CJ11-125,10.0,14OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20FRFF-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,17,,10,3,CJ20160122;1818.xls,,,0,,12OCT2015,23OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-021,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64046-7,T1,0,v100,DU,RP-02-27,10.0,04NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20FZ1Z-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,18,,10,3,RP20160121;4116.xls,,,0,,01NOV2015,12NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-156,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64049-3,T1,0,v100,DU,CJ11-125,10.0,14OCT2015,22JAN2016,50,10,10,68,68,1.8325089127,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20FRCW-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,17,,10,3,CJ20160122;1818.xls,,,0,,10OCT2015,21OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-014,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64054-6,T1,0,v100,DU,CJ11-125,10.0,23OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20FW4N-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,18,,10,3,CJ20160122;1819.xls,,,0,,16OCT2015,27OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-240,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64062-9,T1,0,v100,DU,CJ11-125,10.0,27OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CC20FWTX-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,18,,10,3,CJ20160122;1819.xls,,,0,,23OCT2015,03NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-171,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64063-3,T1,0,v100,DU,CJ11-125,10.0,14OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20FRDV-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,18,,10,3,CJ20160122;1819.xls,,,0,,10OCT2015,21OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-068,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64064-1,T1,0,v100,DU,CJ11-125,10.0,27OCT2015,22JAN2016,50,10,10,119,119,2.0755469614,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20FWX6-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,18,,10,3,CJ20160122;1819.xls,,,0,,23OCT2015,03NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-062,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64065-7,T1,0,v100,DU,CJ11-125,10.0,13OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FQWN-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,19,,10,3,CJ20160122;1820.xls,,,0,,12OCT2015,23OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-036,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64066-5,T1,0,v100,DU,CJ11-125,10.0,16OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CC20FS6F-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,19,,10,3,CJ20160122;1820.xls,,,0,,10OCT2015,21OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-095,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64071-4,T1,0,v100,DU,CJ11-125,10.0,21OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20FTPM-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,19,,10,3,CJ20160122;1820.xls,,,0,,17OCT2015,28OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-212,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64072-0,T1,0,v100,DU,RP-02-27,10.0,02NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CC20FY0T-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,18,,10,3,RP20160121;4116.xls,,,0,,29OCT2015,09NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-072,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64074-5,T1,0,v100,DU,CJ11-125,10.0,20OCT2015,22JAN2016,50,10,10,191,191,2.2810333672,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BC20FSTR-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,19,,10,3,CJ20160122;1820.xls,,,0,,15OCT2015,26OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-229,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64076-1,T1,0,v100,DU,RP-02-27,10.0,07NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CC20G182-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,19,,10,3,RP20160121;4117.xls,,,0,,29OCT2015,09NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-217,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64077-2,T1,0,v100,DU,CJ11-125,10.0,29OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20FXCG-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,20,,10,3,CJ20160122;1821.xls,,,0,,25OCT2015,05NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-149,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64078-6,T1,0,v100,DU,CJ11-125,10.0,21OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20FTPZ-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,20,,10,3,CJ20160122;1821.xls,,,0,,16OCT2015,27OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-017,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64085-1,T1,0,v100,DU,CJ11-125,10.0,20OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FSV2-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,20,,10,3,CJ20160122;1821.xls,,,0,,17OCT2015,28OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-074,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64086-4,T1,0,v100,DU,CJ11-125,10.0,30OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CC20FXJC-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,21,,10,3,CJ20160122;1822.xls,,,0,,26OCT2015,06NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-124,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64089-6,T1,0,v100,DU,CJ11-125,10.0,28OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FX1S-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,21,,10,3,CJ20160122;1822.xls,,,0,,25OCT2015,05NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-004,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64095-6,T1,0,v100,DU,CJ11-125,10.0,27OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BC20FWWD-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,21,,10,3,CJ20160122;1822.xls,,,0,,23OCT2015,03NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-182,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64097-5,T1,0,v100,DU,RP-02-27,10.0,06NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20G0Z4-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,19,,10,3,RP20160121;4117.xls,,,0,,05NOV2015,16NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-034,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64107-1,T1,0,v100,DU,RP-02-27,10.0,07NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20G18P-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,19,,10,3,RP20160121;4117.xls,,,0,,03NOV2015,14NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-115,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64113-4,T1,0,v100,DU,CJ11-125,10.0,30OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FXJP-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,21,,10,3,CJ20160122;1822.xls,,,0,,29OCT2015,09NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-144,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64118-3,T1,0,v100,DU,RP-02-27,10.0,10NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20G20Y-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,19,,10,3,RP20160121;4117.xls,,,0,,07NOV2015,18NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-189,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64125-8,T1,0,v100,DU,RP-02-27,10.0,12NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20G3XF-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,19,,10,3,RP20160121;4117.xls,,,0,,12NOV2015,23NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1A"
100-141,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64001-8,P2,1,v100,DU,CJ11-49,10.0,23JUL2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20DZ2F-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,1,,10,3,P20151111;3407.xls,,,0,,23JUL2015,03AUG2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-056,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64028-6,P2,1,v100,DU,CJ11-49,10.0,04AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,BC20F1PR-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,2,,10,3,P20151111;3408.xls,,,0,,02AUG2015,13AUG2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-154,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64047-1,P2,1,v100,DU,CJ11-49,10.0,17AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20F5F9-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,3,,10,3,P20151111;3409.xls,,,0,,13AUG2015,24AUG2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-041,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64059-3,P2,1,v100,DU,CJ11-49,10.0,19AUG2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20F64B-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,4,,10,3,P20151111;3410.xls,,,0,,15AUG2015,26AUG2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-196,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64085-8,P2,1,v100,DU,CJ11-49,10.0,07SEP2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20FCQJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:15,Dilution,09JUL2015,6735,48,Jennifer Martin,5,,10,3,P20151111;3411.xls,,,0,,04SEP2015,15SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-200,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64086-6,P2,1,v100,DU,CJ11-125,10.0,15SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20FHG1-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,1,,10,3,CJ20160122;1802.xls,,,0,,12SEP2015,23SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-122,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64121-2,P2,1,v100,DU,CJ11-125,10.0,29SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CC20FM29-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,2,,10,3,CJ20160122;1803.xls,,,0,,26SEP2015,07OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-199,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64165-3,P2,1,v100,DU,RP-02-27,10.0,09NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,KC20G1N0-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,1,,10,3,RP20160121;4099-1.xls,,,0,,05NOV2015,16NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-104,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64052-0,P2,1,v100,DU,CJ11-125,10.0,06NOV2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EA60BFW9-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,4,,10,3,CJ20160122;1805.xls,,,0,,02NOV2015,13NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-086,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64077-3,P2,1,v100,DU,RP-02-27,10.0,24NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CA60BGKV-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,5,,10,3,RP20160121;4103.xls,,,0,,13NOV2015,24NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-012,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64078-5,P2,1,v100,DU,RP-02-27,10.0,19NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HA60BGF7-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,5,,10,3,RP20160121;4103.xls,,,0,,14NOV2015,25NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-214,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64018-8,P2,1,v100,DU,CJ11-125,10.0,23SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,08APR2016,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,CAT0552W-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,6,,10,3,CJ20160122;1807.xls,,,0,0,19SEP2015,30SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-238,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64027-2,P2,1,v100,DU,CJ11-125,10.0,27OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,HAT0584P-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,6,,10,3,CJ20160122;1807.xls,,,0,,23OCT2015,03NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-175,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64030-0,P2,1,v100,DU,CJ11-125,10.0,18SEP2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EAT054PV-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,7,,10,3,CJ20160122;1808.xls,,,0,,14SEP2015,25SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-045,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64068-9,P2,1,v100,DU,RP-02-27,10.0,26NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FAT05CFM-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,8,,10,3,RP20160121;4106.xls,,,0,,22NOV2015,03DEC2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-191,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64024-7,P2,1,v100,DU,CJ11-125,10.0,26OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0HXHD-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,10,,10,3,CJ20160122;1811.xls,,,0,,24OCT2015,04NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-164,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64045-0,P2,1,v100,DU,RP-02-27,10.0,16NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,B7Q0J06D-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,10,,10,3,RP20160121;4108.xls,,,0,,14NOV2015,25NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-008,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64049-7,P2,1,v100,DU,RP-02-27,10.0,02NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,J7Q0HYLY-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,10,,10,3,RP20160121;4108.xls,,,0,,29OCT2015,09NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-016,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64051-7,P2,1,v100,DU,RP-02-27,10.0,18NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0J0N9-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,10,,10,3,RP20160121;4108.xls,,,0,,17NOV2015,28NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-033,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64059-1,P2,1,v100,DU,RP-02-27,10.0,12NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,B7Q0HZVY-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,11,,10,3,RP20160121;4109.xls,,,0,,07NOV2015,18NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-241,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64069-9,P2,1,v100,DU,RP-02-27,10.0,10NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,K7Q0HZFJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,12,,10,3,RP20160121;4110.xls,,,0,,05NOV2015,16NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-159,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64073-3,P2,1,v100,DU,CJ11-125,10.0,27OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,D7Q0HXSP-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,11,,10,3,CJ20160122;1812.xls,,,0,,26OCT2015,06NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-049,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64083-0,P2,1,v100,DU,RP-02-27,10.0,17NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,E7Q0J0CK-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,12,,10,3,RP20160121;4110.xls,,,0,,14NOV2015,25NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-024,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64008-7,P2,1,v100,DU,CJ11-125,10.0,22SEP2015,22JAN2016,50,10,10,25,25,1.3979400087,1,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HTD1-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,12,,10,3,CJ20160122;1813.xls,,,0,,18SEP2015,29SEP2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-143,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64021-9,P2,1,v100,DU,CJ11-125,10.0,01OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,G7Q0HV6Q-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,13,,10,3,CJ20160122;1814.xls,,,0,,01OCT2015,12OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-009,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64024-0,P2,1,v100,DU,CJ11-125,10.0,21OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FTQC-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,14,,10,3,CJ20160122;1815.xls,,,0,,16OCT2015,27OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-094,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64031-2,P2,1,v100,DU,RP-02-27,10.0,07NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,C7Q0HZ68-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,13,,10,3,RP20160121;4111.xls,,,0,,03NOV2015,14NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-026,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64034-7,P2,1,v100,DU,RP-02-27,10.0,04NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,B7Q0HYZ4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,13,,10,3,RP20160121;4111.xls,,,0,,31OCT2015,11NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-166,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64050-7,P2,1,v100,DU,RP-02-27,10.0,04NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,F7Q0HYV7-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,14,,10,3,RP20160121;4112.xls,,,0,,31OCT2015,11NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-005,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64057-3,P2,1,v100,DU,RP-02-27,10.0,04NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,A7Q0HYVZ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,15,,10,3,RP20160121;4113.xls,,,0,,30OCT2015,10NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-133,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64060-1,P2,1,v100,DU,RP-02-27,10.0,07NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,H7Q0HZ5H-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,16,,10,3,RP20160121;4114.xls,,,0,,03NOV2015,14NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-195,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64070-6,P2,1,v100,DU,RP-02-27,10.0,09NOV2015,21JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,EC20G1M1-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,46,Renia Passie,17,,10,3,RP20160121;4115.xls,,,0,,07NOV2015,18NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-043,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64017-7,P2,1,v100,DU,CJ11-125,10.0,13OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,GC20FQTX-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,15,,10,3,CJ20160122;1816.xls,,,0,,10OCT2015,21OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-174,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64052-4,P2,1,v100,DU,CJ11-125,10.0,23OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,DC20FW49-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,18,,10,3,CJ20160122;1819.xls,,,0,,19OCT2015,30OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-067,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64073-7,P2,1,v100,DU,CJ11-125,10.0,22OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,JC20FVG5-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,19,,10,3,CJ20160122;1820.xls,,,0,,18OCT2015,29OCT2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-213,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64079-9,P2,1,v100,DU,CJ11-125,10.0,28OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,AC20FX13-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,20,,10,3,CJ20160122;1821.xls,,,0,,24OCT2015,04NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-250,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64080-5,P2,1,v100,DU,CJ11-125,10.0,28OCT2015,22JAN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24MAY2016,,,VTN_NAB04DU20151122E001_B.TXT,100,NAB,04,FC20FX2K-02,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,05FEB2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:7,Dilution,07JAN2016,6977,47,Jennifer Martin,20,,10,3,CJ20160122;1821.xls,,,0,,24OCT2015,04NOV2015,0,182,0,SO032_A2.8-1,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1A"
100-053,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64003-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,22JUL2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20DYKC-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,4,,10,3,VB;20160307;1107;13517;PLATE4.,,,0,,19JUL2015,30JUL2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-111,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64006-5,T1,0,v100,SA,160307-VB-HVTN100,10.0,29JUL2015,04MAR2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20F09P-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,5,,10,3,VB;20160307;1107;13518;PLATE5.,,,0,,26JUL2015,06AUG2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-031,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64009-0,T1,0,v100,SA,160304-OK-HVTN100,10.0,23JUL2015,04MAR2016,50,10,10,72,72,1.8573324964,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20DYTL-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,5,,10,3,OK;20160307;13554;1107;PLATE5-,,,0,,23JUL2015,03AUG2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-209,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64013-9,T1,0,v100,SA,160308-VB-HVTN100,10.0,28JUL2015,08MAR2016,50,10,10,10,10,1,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20DZVV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160310;1107;13574;PLATE2.,,,0,,25JUL2015,05AUG2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-158,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64021-4,T1,0,v100,SA,160304-OK-HVTN100,10.0,03AUG2015,04MAR2016,50,10,10,62,62,1.7923916895,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F17D-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,5,,10,3,OK;20160307;13554;1107;PLATE5-,,,0,,01AUG2015,12AUG2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-215,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64029-9,T1,0,v100,SA,160308-VB-HVTN100,10.0,25AUG2015,08MAR2016,50,10,10,32,32,1.5051499783,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8HS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160310;1107;13574;PLATE2.,,,0,,14AUG2015,25AUG2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-231,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64031-7,T1,0,v100,SA,160422-TH-HVTN100,10.0,27AUG2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8ZN-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,1,,10,3,TH;20160425;14062;1107;PLATE1-,,,0,,21AUG2015,01SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-091,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64033-4,T1,0,v100,SA,160422-TH-HVTN100,10.0,08SEP2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD4N-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,1,,10,3,TH;20160425;14062;1107;PLATE1-,,,0,,04SEP2015,15SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-077,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64036-9,T1,0,v100,SA,160307-VB-HVTN100,10.0,18AUG2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20F5SG-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,4,,10,3,VB;20160307;1107;13517;PLATE4.,,,0,,14AUG2015,25AUG2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-136,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64045-2,T1,0,v100,SA,160308-VB-HVTN100,10.0,13AUG2015,08MAR2016,50,10,10,62,62,1.7923916895,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F4C6-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160310;1107;13574;PLATE2.,,,0,,13AUG2015,24AUG2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-227,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64053-1,T1,0,v100,SA,160422-TH-HVTN100,10.0,19AUG2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20F676-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,1,,10,3,TH;20160425;14062;1107;PLATE1-,,,0,,16AUG2015,27AUG2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-160,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64054-4,T1,0,v100,SA,160308-VB-HVTN100,10.0,26AUG2015,08MAR2016,50,10,10,15,15,1.1760912591,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8R9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160310;1107;13574;PLATE2.,,,0,,21AUG2015,01SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-155,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64055-9,T1,0,v100,SA,160308-VB-HVTN100,10.0,20AUG2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F6C4-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160310;1107;13575;PLATE3-,,,0,,14AUG2015,25AUG2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-177,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64057-8,T1,0,v100,SA,160308-VB-HVTN100,10.0,02SEP2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FBT0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160310;1107;13573;PLATE1.,,,0,,23AUG2015,03SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-052,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64062-2,T1,0,v100,SA,160308-VB-HVTN100,10.0,03SEP2015,08MAR2016,50,10,10,17,17,1.2304489214,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FC68-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160310;1107;13575;PLATE3-,,,0,,28AUG2015,08SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-247,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64063-5,T1,0,v100,SA,160304-OK-HVTN100,10.0,08SEP2015,04MAR2016,50,10,10,13,13,1.1139433523,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FD2Q-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,5,,10,3,OK;20160307;13554;1107;PLATE5-,,,0,,04SEP2015,15SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-126,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64066-3,T1,0,v100,SA,160318-VB-HVTN100,10.0,08SEP2015,18MAR2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD3H-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160320;1107;13846;PLATE1.,,,0,,04SEP2015,15SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-225,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64067-4,T1,0,v100,SA,160422-TH-HVTN100,10.0,08SEP2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FD43-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,1,,10,3,TH;20160425;14062;1107;PLATE1-,,,0,,04SEP2015,15SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-148,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64069-7,T1,0,v100,SA,160302-VB-HVTN100,10.0,14SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FGVK-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160303;1107;13469;PLATE3.,,,0,,12SEP2015,23SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-163,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64077-9,T1,0,v100,SA,160304-OK-HVTN100,10.0,07SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FCJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,2,,10,3,OK;20160307;13551;1107;PLATE2-,,,0,,29AUG2015,09SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-073,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64080-3,T1,0,v100,SA,160308-VB-HVTN100,10.0,31AUG2015,08MAR2016,50,10,10,17,17,1.2304489214,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FB33-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160310;1107;13573;PLATE1.,,,0,,28AUG2015,08SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-184,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64087-7,T1,0,v100,SA,160304-OK-HVTN100,10.0,07SEP2015,04MAR2016,50,10,10,17,17,1.2304489214,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FCJR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,2,,10,3,OK;20160307;13551;1107;PLATE2-,,,0,,06SEP2015,17SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-170,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64095-4,T1,0,v100,SA,160301-OK-HVTN100,10.0,08OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FQ3V-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,4,,10,3,OK;20160303;13442;1107;PLATE4.,,,0,,01OCT2015,12OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-038,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64105-9,T1,0,v100,SA,160307-VB-HVTN100,10.0,17NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G4TX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,5,,10,3,VB;20160307;1107;13518;PLATE5.,,,0,,14NOV2015,25NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-123,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64117-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,17SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FJ00-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,3,,10,3,VB;20160307;1107;13516;PLATE3.,,,0,,13SEP2015,24SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-061,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64119-8,T1,0,v100,SA,160307-VB-HVTN100,10.0,30SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FMJ0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,5,,10,3,VB;20160307;1107;13518;PLATE5.,,,0,,26SEP2015,07OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-128,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64129-6,T1,0,v100,SA,160302-VB-HVTN100,10.0,06OCT2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FPD4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160303;1107;13469;PLATE3.,,,0,,03OCT2015,14OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-108,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64130-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,06OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FPDG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,4,,10,3,VB;20160307;1107;13517;PLATE4.,,,0,,02OCT2015,13OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-097,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64135-8,T1,0,v100,SA,160302-VB-HVTN100,10.0,28SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FLTC-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160303;1107;13469;PLATE3.,,,0,,26SEP2015,07OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-129,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64139-4,T1,0,v100,SA,160301-OK-HVTN100,10.0,26OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FWKL-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,2,,10,3,OK;20160303;13440;1107;PLATE2.,,,0,,16OCT2015,27OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-058,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64150-0,T1,0,v100,SA,160301-OK-HVTN100,10.0,11NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20G3JT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,2,,10,3,OK;20160303;13440;1107;PLATE2.,,,0,,07NOV2015,18NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-151,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64154-2,T1,0,v100,SA,160304-OK-HVTN100,10.0,02NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FXYX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,1,,10,3,OK;20160307;13550;1107;PLATE1-,,,0,,25OCT2015,05NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-002,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64156-9,T1,0,v100,SA,160301-OK-HVTN100,10.0,02NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FXZQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,3,,10,3,OK;20160303;13441;1107;PLATE3.,,,0,,25OCT2015,05NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-194,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64166-1,T1,0,v100,SA,160304-OK-HVTN100,10.0,17NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G4VL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,2,,10,3,OK;20160307;13551;1107;PLATE2-,,,0,,14NOV2015,25NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-157,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64167-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,10NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G20B-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160303;1107;13468;PLATE2-,,,0,,06NOV2015,17NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-025,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64172-9,T1,0,v100,SA,160301-OK-HVTN100,10.0,12NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20G3X4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,2,,10,3,OK;20160303;13440;1107;PLATE2.,,,0,,06NOV2015,17NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-137,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64002-3,T1,0,v100,SA,160316-OK-HVTN100,10.0,28AUG2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BCRM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,2,,10,3,OK;20160318;13813;1107;PLATE2.,,,0,,21AUG2015,01SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-064,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64007-0,T1,0,v100,SA,160316-OK-HVTN100,10.0,14SEP2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BDHQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,2,,10,3,OK;20160318;13813;1107;PLATE2.,,,0,,10SEP2015,21SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-131,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64008-8,T1,0,v100,SA,160302-OK-HVTN100,10.0,14SEP2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BDJC-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160304;13510;1107;PLATE3.,,,0,,07SEP2015,18SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-109,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64028-0,T1,0,v100,SA,160422-TH-HVTN100,10.0,21OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BFB3-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,2,,10,3,TH;20160425;14063;11073;PLATE2,,,0,,17OCT2015,28OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-187,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64029-3,T1,0,v100,SA,160308-VB-HVTN100,10.0,26OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFG6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160310;1107;13575;PLATE3-,,,0,,19OCT2015,30OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-090,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64030-6,T1,0,v100,SA,160224-VB-HVTN100,10.0,27OCT2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BFGQ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160226;1107;13374;PLATE1.,,,0,,23OCT2015,03NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-130,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64034-8,T1,0,v100,SA,160223-VB-HVTN100,10.0,10NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG09-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160225;1107;13359;PLATE5.,,,0,,06NOV2015,17NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-105,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64036-3,T1,0,v100,SA,160224-VB-HVTN100,10.0,13NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG4G-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160226;1107;13375;PLATE2.,,,0,,09NOV2015,20NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-140,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64037-4,T1,0,v100,SA,160223-VB-HVTN100,10.0,16NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG8C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160225;1107;13358;PLATE4.,,,0,,12NOV2015,23NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-138,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64038-9,T1,0,v100,SA,160224-VB-HVTN100,10.0,04NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFT3-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160226;1107;13374;PLATE1.,,,0,,31OCT2015,11NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-084,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64039-7,T1,0,v100,SA,160422-TH-HVTN100,10.0,27OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFH3-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,2,,10,3,TH;20160425;14063;11073;PLATE2,,,0,,23OCT2015,03NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-198,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64040-3,T1,0,v100,SA,160224-VB-HVTN100,10.0,17NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGC1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160226;1107;13375;PLATE2.,,,0,,07NOV2015,18NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-228,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64044-0,T1,0,v100,SA,160224-VB-HVTN100,10.0,24NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BGLK-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160226;1107;13377;PLATE4.,,,0,,14NOV2015,25NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-181,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64050-8,T1,0,v100,SA,160224-VB-HVTN100,10.0,02NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFPN-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160226;1107;13374;PLATE1.,,,0,,31OCT2015,11NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-085,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64051-4,T1,0,v100,SA,160422-TH-HVTN100,10.0,06NOV2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFVX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,2,,10,3,TH;20160425;14063;11073;PLATE2,,,0,,02NOV2015,13NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-063,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64053-7,T1,0,v100,SA,160224-VB-HVTN100,10.0,20NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGGQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160226;1107;13377;PLATE4.,,,0,,16NOV2015,27NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-235,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64054-5,T1,0,v100,SA,160422-TH-HVTN100,10.0,09NOV2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFY7-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,4,,10,3,TH;20160425;14065;11073;PLATE4,,,0,,05NOV2015,16NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-001,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64061-7,T1,0,v100,SA,160304-OK-HVTN100,10.0,09NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFYY-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,4,,10,3,OK;20160307;13553;1107;PLATE4-,,,0,,07NOV2015,18NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-083,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64062-8,T1,0,v100,SA,160304-OK-HVTN100,10.0,13NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,4,,10,3,OK;20160307;13553;1107;PLATE4-,,,0,,09NOV2015,20NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-145,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64066-9,T1,0,v100,SA,160224-VB-HVTN100,10.0,11NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BG31-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160226;1107;13375;PLATE2.,,,0,,06NOV2015,17NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-127,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64068-3,T1,0,v100,SA,160224-VB-HVTN100,10.0,24NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BGMS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160226;1107;13377;PLATE4.,,,0,,19NOV2015,30NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-044,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64069-1,T1,0,v100,SA,160304-OK-HVTN100,10.0,16NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GA60BG7M-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,4,,10,3,OK;20160307;13553;1107;PLATE4-,,,0,,12NOV2015,23NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-132,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64070-7,T1,0,v100,SA,160224-VB-HVTN100,10.0,13NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BG5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160226;1107;13375;PLATE2.,,,0,,09NOV2015,20NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-048,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64073-6,T1,0,v100,SA,160224-VB-HVTN100,10.0,16NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG9D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160226;1107;13375;PLATE2.,,,0,,12NOV2015,23NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-092,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64075-4,T1,0,v100,SA,160223-VB-HVTN100,10.0,17NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BGCG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160225;1107;13357;PLATE3.,,,0,,13NOV2015,24NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-218,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64076-2,T1,0,v100,SA,160223-VB-HVTN100,10.0,16NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,15JUN2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BG9S-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160225;1107;13359;PLATE5.,,,0,0,12NOV2015,23NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-179,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64082-4,T1,0,v100,SA,160224-VB-HVTN100,10.0,10NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BG19-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160226;1107;13378;PLATE5.,,,0,,06NOV2015,17NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-040,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64089-5,T1,0,v100,SA,160224-VB-HVTN100,10.0,27NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BGP5-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160226;1107;13377;PLATE4.,,,0,,21NOV2015,02DEC2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-022,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64001-8,T1,0,v100,SA,160304-OK-HVTN100,10.0,21SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,1,,10,3,OK;20160307;13550;1107;PLATE1-,,,0,,20SEP2015,01OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-066,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64002-9,T1,0,v100,SA,160302-VB-HVTN100,10.0,17SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GAT054MG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160303;1107;13468;PLATE2-,,,0,,12SEP2015,23SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-142,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64004-1,T1,0,v100,SA,160302-VB-HVTN100,10.0,22OCT2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT057TJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160303;1107;13467;PLATE1-,,,0,,16OCT2015,27OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-236,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64006-5,T1,0,v100,SA,160302-VB-HVTN100,10.0,17SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054L4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160303;1107;13468;PLATE2-,,,0,,13SEP2015,24SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-120,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64007-6,T1,0,v100,SA,160304-OK-HVTN100,10.0,17SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT054KS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,1,,10,3,OK;20160307;13550;1107;PLATE1-,,,0,,13SEP2015,24SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-029,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64009-0,T1,0,v100,SA,160226-VB-HVTN100,10.0,21SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TT-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,2,,10,3,VB;20160229;1107;13397;PLATE2-,,,0,,17SEP2015,28SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-107,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64010-5,T1,0,v100,SA,160226-VB-HVTN100,10.0,22SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT0550X-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,5,,10,3,VB;20160229;1107;13400;PLATE5.,,,0,,18SEP2015,29SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-113,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64012-3,T1,0,v100,SA,160226-VB-HVTN100,10.0,21SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054V4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,2,,10,3,VB;20160229;1107;13397;PLATE2-,,,0,,20SEP2015,01OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-234,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64016-4,T1,0,v100,SA,160226-VB-HVTN100,10.0,21SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT054VG-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,1,,10,3,VB;20160229;1107;13396;PLATE1-,,,0,,20SEP2015,01OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-059,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64017-0,T1,0,v100,SA,160226-VB-HVTN100,10.0,28SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT05585-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,1,,10,3,VB;20160229;1107;13396;PLATE1-,,,0,,24SEP2015,05OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-023,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64021-4,T1,0,v100,SA,160302-VB-HVTN100,10.0,28SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0557V-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160303;1107;13468;PLATE2-,,,0,,24SEP2015,05OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-201,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64029-9,T1,0,v100,SA,160226-VB-HVTN100,10.0,12OCT2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT056K1-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,1,,10,3,VB;20160229;1107;13396;PLATE1-,,,0,,08OCT2015,19OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-076,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64031-7,T1,0,v100,SA,160226-VB-HVTN100,10.0,26OCT2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT057ZR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,1,,10,3,VB;20160229;1107;13396;PLATE1-,,,0,,22OCT2015,02NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-204,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64035-6,T1,0,v100,SA,160302-VB-HVTN100,10.0,26OCT2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057X1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160303;1107;13467;PLATE1-,,,0,,22OCT2015,02NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-230,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64036-9,T1,0,v100,SA,160226-VB-HVTN100,10.0,02NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT058FR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,2,,10,3,VB;20160229;1107;13397;PLATE2-,,,0,,29OCT2015,09NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-011,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64037-5,T1,0,v100,SA,160226-VB-HVTN100,10.0,27OCT2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0584C-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,5,,10,3,VB;20160229;1107;13400;PLATE5.,,,0,,23OCT2015,03NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-161,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64038-3,T1,0,v100,SA,160226-VB-HVTN100,10.0,19OCT2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT05797-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,4,,10,3,VB;20160229;1107;13399;PLATE4-,,,0,,15OCT2015,26OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-180,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64041-3,T1,0,v100,SA,160226-VB-HVTN100,10.0,07NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05967-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,5,,10,3,VB;20160229;1107;13400;PLATE5.,,,0,,02NOV2015,13NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-116,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64043-8,T1,0,v100,SA,160226-VB-HVTN100,10.0,10NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT059JJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,2,,10,3,VB;20160229;1107;13397;PLATE2-,,,0,,06NOV2015,17NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-079,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64044-6,T1,0,v100,SA,160302-VB-HVTN100,10.0,23OCT2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057VG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160303;1107;13467;PLATE1-,,,0,,19OCT2015,30OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-192,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64045-2,T1,0,v100,SA,160226-VB-HVTN100,10.0,11NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT059Q1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,3,,10,3,VB;20160229;1107;13398;PLATE3-,,,0,,09NOV2015,20NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-146,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64050-2,T1,0,v100,SA,160226-VB-HVTN100,10.0,11NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT059TS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,2,,10,3,VB;20160229;1107;13397;PLATE2-,,,0,,07NOV2015,18NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-006,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64051-5,T1,0,v100,SA,160226-VB-HVTN100,10.0,09NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT0598R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,3,,10,3,VB;20160229;1107;13398;PLATE3-,,,0,,05NOV2015,16NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-007,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64053-1,T1,0,v100,SA,160302-VB-HVTN100,10.0,09NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT059C4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160303;1107;13468;PLATE2-,,,0,,05NOV2015,16NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-081,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64054-4,T1,0,v100,SA,160226-VB-HVTN100,10.0,10NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT059KL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,5,,10,3,VB;20160229;1107;13400;PLATE5.,,,0,,06NOV2015,17NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-172,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64056-7,T1,0,v100,SA,160226-VB-HVTN100,10.0,16NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05B6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,4,,10,3,VB;20160229;1107;13399;PLATE4-,,,0,,12NOV2015,23NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-205,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64057-8,T1,0,v100,SA,160302-VB-HVTN100,10.0,11NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT059VK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160303;1107;13467;PLATE1-,,,0,,06NOV2015,17NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-202,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64060-6,T1,0,v100,SA,160226-VB-HVTN100,10.0,21NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05BWD-05,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,4,,10,3,VB;20160229;1107;13399;PLATE4-,,,0,,17NOV2015,28NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-119,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64062-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,18NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT05BLC-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160303;1107;13467;PLATE1-,,,0,,14NOV2015,25NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-101,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64072-7,T1,0,v100,SA,160226-VB-HVTN100,10.0,19NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05BS4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,4,,10,3,VB;20160229;1107;13399;PLATE4-,,,0,,19NOV2015,30NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-050,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64003-1,T1,0,v100,SA,160422-TH-HVTN100,10.0,02SEP2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HRJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,3,,10,3,TH;20160425;14064;11073;PLATE3,,,0,,29AUG2015,09SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-150,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64005-9,T1,0,v100,SA,160223-VB-HVTN100,10.0,01SEP2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HR6B-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160225;1107;13355;PLATE1.,,,0,,28AUG2015,08SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-114,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64006-7,T1,0,v100,SA,160304-OK-HVTN100,10.0,18SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HT5Y-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,3,,10,3,OK;20160307;13552;1107;PLATE3-,,,0,,14SEP2015,25SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-190,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64007-8,T1,0,v100,SA,160422-TH-HVTN100,10.0,05OCT2015,22APR2016,50,10,10,12,12,1.079181246,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HVGX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,3,,10,3,TH;20160425;14064;11073;PLATE3,,,0,,01OCT2015,12OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-248,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64011-0,T1,0,v100,SA,160223-VB-HVTN100,10.0,23SEP2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HTJJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160225;1107;13355;PLATE1.,,,0,,18SEP2015,29SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-042,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64017-3,T1,0,v100,SA,160422-TH-HVTN100,10.0,06OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HVRV-13,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,3,,10,3,TH;20160425;14064;11073;PLATE3,,,0,,03OCT2015,14OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-078,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64018-5,T1,0,v100,SA,160316-OK-HVTN100,10.0,02OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HVCC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,1,,10,3,OK;20160318;13810;1107;PLATE1.,,,0,,01OCT2015,12OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-242,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64019-8,T1,0,v100,SA,160224-VB-HVTN100,10.0,10NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160226;1107;13378;PLATE5.,,,0,,07NOV2015,18NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-071,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64022-3,T1,0,v100,SA,160223-VB-HVTN100,10.0,23OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXFC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160225;1107;13357;PLATE3.,,,0,,23OCT2015,03NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-070,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64025-1,T1,0,v100,SA,160223-VB-HVTN100,10.0,26OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HXGY-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160225;1107;13356;PLATE2.,,,0,,23OCT2015,03NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-134,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64026-4,T1,0,v100,SA,160304-OK-HVTN100,10.0,09NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HZB7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,3,,10,3,OK;20160307;13552;1107;PLATE3-,,,0,,05NOV2015,16NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-219,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64028-8,T1,0,v100,SA,160223-VB-HVTN100,10.0,27OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXTF-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160225;1107;13356;PLATE2.,,,0,,26OCT2015,06NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-176,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64029-6,T1,0,v100,SA,160302-VB-HVTN100,10.0,10NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160303;1107;13470;PLATE4.,,,0,,07NOV2015,18NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-135,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64031-9,T1,0,v100,SA,160304-VB-HVTN100,10.0,02NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HYLD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160304;1107;13483;PLATE2.,,,0,,24OCT2015,04NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-103,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64036-6,T1,0,v100,SA,160223-VB-HVTN100,10.0,30OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYBJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160225;1107;13359;PLATE5.,,,0,,29OCT2015,09NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-169,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64037-7,T1,0,v100,SA,160304-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZWP-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160304;1107;13482;PLATE1.,,,0,,08NOV2015,19NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-165,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64041-1,T1,0,v100,SA,160302-OK-HVTN100,10.0,01DEC2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J1Q0-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160304;13510;1107;PLATE3.,,,0,,26NOV2015,07DEC2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-183,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64044-8,T1,0,v100,SA,160318-VB-HVTN100,10.0,30OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HY9Q-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160320;1107;13846;PLATE1.,,,0,,29OCT2015,09NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-188,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64046-3,T1,0,v100,SA,160224-VB-HVTN100,10.0,17NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J09C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160226;1107;13376;PLATE3.,,,0,,17NOV2015,28NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-054,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64047-4,T1,0,v100,SA,160224-VB-HVTN100,10.0,03NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HYR2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160226;1107;13378;PLATE5.,,,0,,29OCT2015,09NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-239,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64054-2,T1,0,v100,SA,160223-VB-HVTN100,10.0,28OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HXZP-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160225;1107;13358;PLATE4.,,,0,,26OCT2015,06NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-098,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64062-0,T1,0,v100,SA,160304-VB-HVTN100,10.0,03NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HYRQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160304;1107;13486;PLATE5.,,,0,,30OCT2015,10NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-216,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64064-5,T1,0,v100,SA,160302-OK-HVTN100,10.0,12NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J015-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,4,,10,3,OK;20160304;13512;1107;PLATE4.,,,0,,09NOV2015,20NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-185,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64065-3,T1,0,v100,SA,160302-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZXY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160303;1107;13470;PLATE4.,,,0,,08NOV2015,19NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-102,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64067-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,17NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J09F-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160303;1107;13471;PLATE5.,,,0,,13NOV2015,24NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-112,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64070-4,T1,0,v100,SA,160304-OK-HVTN100,10.0,16NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J03Q-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,3,,10,3,OK;20160307;13552;1107;PLATE3-,,,0,,05NOV2015,16NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-082,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64074-1,T1,0,v100,SA,160223-VB-HVTN100,10.0,16NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J039-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160225;1107;13358;PLATE4.,,,0,,12NOV2015,23NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-197,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64084-3,T1,0,v100,SA,160304-VB-HVTN100,10.0,18NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J0MY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160304;1107;13482;PLATE1.,,,0,,15NOV2015,26NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-232,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64085-5,T1,0,v100,SA,160316-OK-HVTN100,10.0,01DEC2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J1QW-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,3,,10,3,OK;20160318;13815;1107;PLATE3.,,,0,,20NOV2015,01DEC2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-003,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64002-4,T1,0,v100,SA,160316-OK-HVTN100,10.0,13OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBJ-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,2,,10,3,OK;20160318;13813;1107;PLATE2.,,,0,,08OCT2015,19OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-152,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64006-0,T1,0,v100,SA,160224-VB-HVTN100,10.0,14SEP2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HSJ4-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160226;1107;13376;PLATE3.,,,0,,06SEP2015,17SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-220,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64009-5,T1,0,v100,SA,160316-OK-HVTN100,10.0,15OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWQB-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,1,,10,3,OK;20160318;13810;1107;PLATE1.,,,0,,11OCT2015,22OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-125,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64010-0,T1,0,v100,SA,160223-VB-HVTN100,10.0,14SEP2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HSMB-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160225;1107;13355;PLATE1.,,,0,,05SEP2015,16SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-233,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64011-7,T1,0,v100,SA,160223-VB-HVTN100,10.0,22SEP2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HTGD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160225;1107;13355;PLATE1.,,,0,,18SEP2015,29SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-186,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64016-9,T1,0,v100,SA,160224-VB-HVTN100,10.0,27OCT2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08MAR2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXNV-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160226;1107;13376;PLATE3.,,,0,0,18OCT2015,29OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-039,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64017-5,T1,0,v100,SA,160422-TH-HVTN100,10.0,29SEP2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HTWM-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,3,,10,3,TH;20160425;14064;11073;PLATE3,,,0,,26SEP2015,07OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-013,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64018-3,T1,0,v100,SA,160304-VB-HVTN100,10.0,20NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J0YX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160304;1107;13484;PLATE3.,,,0,,17NOV2015,28NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-121,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64020-3,T1,0,v100,SA,160422-TH-HVTN100,10.0,06OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HVPF-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,3,,10,3,TH;20160425;14064;11073;PLATE3,,,0,,01OCT2015,12OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-087,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64023-2,T1,0,v100,SA,160223-VB-HVTN100,10.0,21OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HX1W-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160225;1107;13356;PLATE2.,,,0,,16OCT2015,27OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-100,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64025-8,T1,0,v100,SA,160316-OK-HVTN100,10.0,13OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBG-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,1,,10,3,OK;20160318;13810;1107;PLATE1.,,,0,,08OCT2015,19OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-069,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64026-6,T1,0,v100,SA,160316-OK-HVTN100,10.0,07NOV2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,3,,10,3,OK;20160318;13815;1107;PLATE3.,,,0,,03NOV2015,14NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-206,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64033-9,T1,0,v100,SA,160223-VB-HVTN100,10.0,20OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08DEC2015,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HWYC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160225;1107;13356;PLATE2.,,,0,0,15OCT2015,26OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-047,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64035-1,T1,0,v100,SA,160304-VB-HVTN100,10.0,05NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ01-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160304;1107;13484;PLATE3.,,,0,,01NOV2015,12NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-089,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64038-8,T1,0,v100,SA,160304-VB-HVTN100,10.0,25NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J17P-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160304;1107;13486;PLATE5.,,,0,,20NOV2015,01DEC2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-139,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64041-8,T1,0,v100,SA,160304-VB-HVTN100,10.0,10NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFB-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160304;1107;13486;PLATE5.,,,0,,06NOV2015,17NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-080,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64042-9,T1,0,v100,SA,160304-VB-HVTN100,10.0,26OCT2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HXGW-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160304;1107;13482;PLATE1.,,,0,,22OCT2015,02NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-210,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64046-5,T1,0,v100,SA,160223-VB-HVTN100,10.0,27OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXNS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160225;1107;13356;PLATE2.,,,0,,23OCT2015,03NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-162,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64048-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J00K-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160303;1107;13471;PLATE5.,,,0,,05NOV2015,16NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-246,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64051-0,T1,0,v100,SA,160304-VB-HVTN100,10.0,11NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZP9-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160304;1107;13482;PLATE1.,,,0,,07NOV2015,18NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-223,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64053-6,T1,0,v100,SA,160223-VB-HVTN100,10.0,11NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HZQD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160225;1107;13359;PLATE5.,,,0,,07NOV2015,18NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-028,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64055-4,T1,0,v100,SA,160223-VB-HVTN100,10.0,05NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZ03-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160225;1107;13357;PLATE3.,,,0,,01NOV2015,12NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-244,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64059-8,T1,0,v100,SA,160302-VB-HVTN100,10.0,20NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J0Y2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160303;1107;13470;PLATE4.,,,0,,17NOV2015,28NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-153,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64061-6,T1,0,v100,SA,160304-VB-HVTN100,10.0,07NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160304;1107;13485;PLATE4.,,,0,,03NOV2015,14NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-015,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64063-0,T1,0,v100,SA,160304-VB-HVTN100,10.0,19NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J0WN-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160304;1107;13485;PLATE4.,,,1,,14NOV2015,25NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-252,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64064-3,T1,0,v100,SA,160302-VB-HVTN100,10.0,23NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0ZW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160303;1107;13471;PLATE5.,,,0,,19NOV2015,30NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-211,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64068-4,T1,0,v100,SA,160224-VB-HVTN100,10.0,10NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZFD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160226;1107;13376;PLATE3.,,,0,,07NOV2015,18NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-147,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64069-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,16NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J02X-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160303;1107;13469;PLATE3.,,,0,,05NOV2015,16NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-168,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64071-1,T1,0,v100,SA,160302-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZZT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160303;1107;13470;PLATE4.,,,0,,08NOV2015,19NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-203,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64072-2,T1,0,v100,SA,160304-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZYT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160304;1107;13486;PLATE5.,,,0,,08NOV2015,19NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-167,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64074-8,T1,0,v100,SA,160224-VB-HVTN100,10.0,18NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J0LW-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160226;1107;13376;PLATE3.,,,0,,17NOV2015,28NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-224,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64075-0,T1,0,v100,SA,160304-VB-HVTN100,10.0,19NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J0W8-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160304;1107;13485;PLATE4.,,,0,,13NOV2015,24NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-226,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64077-4,T1,0,v100,SA,160304-VB-HVTN100,10.0,19NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J0QS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160304;1107;13484;PLATE3.,,,0,,15NOV2015,26NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-020,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64079-7,T1,0,v100,SA,160304-VB-HVTN100,10.0,03DEC2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J1WG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160304;1107;13482;PLATE1.,,,0,,27NOV2015,08DEC2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-065,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64001-1,T1,0,v100,SA,160307-VB-HVTN100,10.0,07SEP2015,04MAR2016,50,10,10,13,13,1.1139433523,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FCQ6-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,4,,10,3,VB;20160307;1107;13517;PLATE4.,,,0,,05SEP2015,16SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-018,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64002-2,T1,0,v100,SA,160307-VB-HVTN100,10.0,15SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FHFQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,3,,10,3,VB;20160307;1107;13516;PLATE3.,,,0,,14SEP2015,25SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-096,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64004-8,T1,0,v100,SA,160307-VB-HVTN100,10.0,23OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FW3Z-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,3,,10,3,VB;20160307;1107;13516;PLATE3.,,,0,,22OCT2015,02NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-249,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64006-3,T1,0,v100,SA,160302-VB-HVTN100,10.0,22SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FK9S-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160303;1107;13469;PLATE3.,,,0,,20SEP2015,01OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-010,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64009-7,T1,0,v100,SA,160307-VB-HVTN100,10.0,22SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FKKP-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,1,,10,3,VB;20160307;1107;13514;PLATE1.,,,0,,20SEP2015,01OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-222,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64018-1,T1,0,v100,SA,160307-VB-HVTN100,10.0,30SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FMJB-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,1,,10,3,VB;20160307;1107;13514;PLATE1.,,,0,,26SEP2015,07OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-046,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64022-7,T1,0,v100,SA,160307-VB-HVTN100,10.0,16OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FS71-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,3,,10,3,VB;20160307;1107;13516;PLATE3.,,,0,,12OCT2015,23OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-037,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64030-7,T1,0,v100,SA,160422-TH-HVTN100,10.0,09OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FQ9L-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,4,,10,3,TH;20160425;14065;11073;PLATE4,,,0,,01OCT2015,12OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-251,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64033-6,T1,0,v100,SA,160318-VB-HVTN100,10.0,19OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FSKN-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160320;1107;13846;PLATE1.,,,0,,12OCT2015,23OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-099,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64034-9,T1,0,v100,SA,160301-OK-HVTN100,10.0,08OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FQ46-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,4,,10,3,OK;20160303;13442;1107;PLATE4.,,,0,,03OCT2015,14OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-032,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64038-5,T1,0,v100,SA,160301-OK-HVTN100,10.0,26OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FWHM-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,4,,10,3,OK;20160303;13442;1107;PLATE4.,,,0,,22OCT2015,02NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-245,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64039-8,T1,0,v100,SA,160422-TH-HVTN100,10.0,15OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FRV7-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,5,,10,3,TH;20160425;14066;11073;PLATE5,,,0,,08OCT2015,19OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-057,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64042-6,T1,0,v100,SA,160307-VB-HVTN100,10.0,22OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FVNV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,1,,10,3,VB;20160307;1107;13514;PLATE1.,,,0,,17OCT2015,28OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-055,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64043-1,T1,0,v100,SA,160316-OK-HVTN100,10.0,14OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FRFF-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,5,,10,3,OK;20160318;13819;1107;PLATE5.,,,0,,12OCT2015,23OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-021,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64046-7,T1,0,v100,SA,160301-OK-HVTN100,10.0,04NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FZ1Z-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,5,,10,3,OK;20160303;13443;1107;PLATE5.,,,0,,01NOV2015,12NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-156,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64049-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,14OCT2015,04MAR2016,50,10,10,41,41,1.6127838567,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRCW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,1,,10,3,VB;20160307;1107;13514;PLATE1.,,,0,,10OCT2015,21OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-014,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64054-6,T1,0,v100,SA,160422-TH-HVTN100,10.0,23OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FW4N-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,5,,10,3,TH;20160425;14066;11073;PLATE5,,,0,,16OCT2015,27OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-240,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64062-9,T1,0,v100,SA,160301-OK-HVTN100,10.0,27OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FWTX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,4,,10,3,OK;20160303;13442;1107;PLATE4.,,,0,,23OCT2015,03NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-171,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64063-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,14OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRDV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,2,,10,3,VB;20160307;1107;13515;PLATE2.,,,0,,10OCT2015,21OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-068,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64064-1,T1,0,v100,SA,160301-OK-HVTN100,10.0,27OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FWX6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,3,,10,3,OK;20160303;13441;1107;PLATE3.,,,0,,23OCT2015,03NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-062,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64065-7,T1,0,v100,SA,160422-TH-HVTN100,10.0,13OCT2015,22APR2016,50,10,10,25,25,1.3979400087,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FQWN-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,4,,10,3,TH;20160425;14065;11073;PLATE4,,,0,,12OCT2015,23OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-036,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64066-5,T1,0,v100,SA,160316-OK-HVTN100,10.0,16OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FS6F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,5,,10,3,OK;20160318;13819;1107;PLATE5.,,,0,,10OCT2015,21OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-095,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64071-4,T1,0,v100,SA,160307-VB-HVTN100,10.0,21OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FTPM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,2,,10,3,VB;20160307;1107;13515;PLATE2.,,,0,,17OCT2015,28OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-212,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64072-0,T1,0,v100,SA,160301-OK-HVTN100,10.0,02NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FY0T-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,1,,10,3,OK;20160303;13439;1107;PLATE1.,,,0,,29OCT2015,09NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-072,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64074-5,T1,0,v100,SA,160307-VB-HVTN100,10.0,20OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FSTR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,2,,10,3,VB;20160307;1107;13515;PLATE2.,,,0,,15OCT2015,26OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-229,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64076-1,T1,0,v100,SA,160301-OK-HVTN100,10.0,07NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20G182-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,1,,10,3,OK;20160303;13439;1107;PLATE1.,,,0,,29OCT2015,09NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-217,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64077-2,T1,0,v100,SA,160301-OK-HVTN100,10.0,29OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FXCG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,3,,10,3,OK;20160303;13441;1107;PLATE3.,,,0,,25OCT2015,05NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-149,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64078-6,T1,0,v100,SA,160307-VB-HVTN100,10.0,21OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FTPZ-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,2,,10,3,VB;20160307;1107;13515;PLATE2.,,,0,,16OCT2015,27OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-017,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64085-1,T1,0,v100,SA,160307-VB-HVTN100,10.0,20OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FSV2-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,2,,10,3,VB;20160307;1107;13515;PLATE2.,,,0,,17OCT2015,28OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-074,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64086-4,T1,0,v100,SA,160301-OK-HVTN100,10.0,30OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FXJC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,2,,10,3,OK;20160303;13440;1107;PLATE2.,,,0,,26OCT2015,06NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-124,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64089-6,T1,0,v100,SA,160301-OK-HVTN100,10.0,28OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX1S-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,2,,10,3,OK;20160303;13440;1107;PLATE2.,,,0,,25OCT2015,05NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-004,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64095-6,T1,0,v100,SA,160301-OK-HVTN100,10.0,27OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FWWD-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,3,,10,3,OK;20160303;13441;1107;PLATE3.,,,0,,23OCT2015,03NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-182,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64097-5,T1,0,v100,SA,160301-OK-HVTN100,10.0,06NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G0Z4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,1,,10,3,OK;20160303;13439;1107;PLATE1.,,,0,,05NOV2015,16NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-034,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64107-1,T1,0,v100,SA,160304-OK-HVTN100,10.0,07NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G18P-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,1,,10,3,OK;20160307;13550;1107;PLATE1-,,,0,,03NOV2015,14NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-115,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64113-4,T1,0,v100,SA,160301-OK-HVTN100,10.0,30OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FXJP-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,3,,10,3,OK;20160303;13441;1107;PLATE3.,,,0,,29OCT2015,09NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-144,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64118-3,T1,0,v100,SA,160301-OK-HVTN100,10.0,10NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20G20Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,5,,10,3,OK;20160303;13443;1107;PLATE5.,,,0,,07NOV2015,18NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-189,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64125-8,T1,0,v100,SA,160301-OK-HVTN100,10.0,12NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G3XF-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,5,,10,3,OK;20160303;13443;1107;PLATE5.,,,0,,12NOV2015,23NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-141,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64001-8,P2,1,v100,SA,160422-TH-HVTN100,10.0,23JUL2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20DZ2F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,1,,10,3,TH;20160425;14062;1107;PLATE1-,,,0,,23JUL2015,03AUG2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-056,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64028-6,P2,1,v100,SA,160308-VB-HVTN100,10.0,04AUG2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20F1PR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160310;1107;13574;PLATE2.,,,0,,02AUG2015,13AUG2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-154,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64047-1,P2,1,v100,SA,160308-VB-HVTN100,10.0,17AUG2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20F5F9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160310;1107;13573;PLATE1.,,,0,,13AUG2015,24AUG2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-041,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64059-3,P2,1,v100,SA,160308-VB-HVTN100,10.0,19AUG2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20F64B-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160310;1107;13573;PLATE1.,,,0,,15AUG2015,26AUG2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-196,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64085-8,P2,1,v100,SA,160304-OK-HVTN100,10.0,07SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FCQJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,2,,10,3,OK;20160307;13551;1107;PLATE2-,,,0,,04SEP2015,15SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-200,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64086-6,P2,1,v100,SA,160307-VB-HVTN100,10.0,15SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FHG1-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,5,,10,3,VB;20160307;1107;13518;PLATE5.,,,0,,12SEP2015,23SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-122,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64121-2,P2,1,v100,SA,160304-OK-HVTN100,10.0,29SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FM29-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,1,,10,3,OK;20160307;13550;1107;PLATE1-,,,0,,26SEP2015,07OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-199,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64165-3,P2,1,v100,SA,160304-OK-HVTN100,10.0,09NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20G1N0-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,2,,10,3,OK;20160307;13551;1107;PLATE2-,,,0,,05NOV2015,16NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-104,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64052-0,P2,1,v100,SA,160422-TH-HVTN100,10.0,06NOV2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BFW9-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,2,,10,3,TH;20160425;14063;11073;PLATE2,,,0,,02NOV2015,13NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-086,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64077-3,P2,1,v100,SA,160224-VB-HVTN100,10.0,24NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CA60BGKV-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160226;1107;13377;PLATE4.,,,0,,13NOV2015,24NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-012,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64078-5,P2,1,v100,SA,160223-VB-HVTN100,10.0,19NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BGF7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160225;1107;13358;PLATE4.,,,0,,14NOV2015,25NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-214,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64018-8,P2,1,v100,SA,160226-VB-HVTN100,10.0,23SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08APR2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT0552W-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,3,,10,3,VB;20160229;1107;13398;PLATE3-,,,0,0,19SEP2015,30SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-238,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64027-2,P2,1,v100,SA,160226-VB-HVTN100,10.0,27OCT2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT0584P-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,1,,10,3,VB;20160229;1107;13396;PLATE1-,,,0,,23OCT2015,03NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-175,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64030-0,P2,1,v100,SA,160226-VB-HVTN100,10.0,18SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT054PV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,3,,10,3,VB;20160229;1107;13398;PLATE3-,,,0,,14SEP2015,25SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-045,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64068-9,P2,1,v100,SA,160226-VB-HVTN100,10.0,26NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05CFM-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Valerie Bekker,4,,10,3,VB;20160229;1107;13399;PLATE4-,,,0,,22NOV2015,03DEC2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-191,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64024-7,P2,1,v100,SA,160223-VB-HVTN100,10.0,26OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXHD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160225;1107;13357;PLATE3.,,,0,,24OCT2015,04NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-164,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64045-0,P2,1,v100,SA,160304-VB-HVTN100,10.0,16NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J06D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160304;1107;13483;PLATE2.,,,0,,14NOV2015,25NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-008,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64049-7,P2,1,v100,SA,160304-VB-HVTN100,10.0,02NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HYLY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160304;1107;13483;PLATE2.,,,0,,29OCT2015,09NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-016,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64051-7,P2,1,v100,SA,160304-VB-HVTN100,10.0,18NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0N9-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160304;1107;13483;PLATE2.,,,0,,17NOV2015,28NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-033,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64059-1,P2,1,v100,SA,160304-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HZVY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160304;1107;13485;PLATE4.,,,0,,07NOV2015,18NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-241,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64069-9,P2,1,v100,SA,160302-VB-HVTN100,10.0,10NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160303;1107;13470;PLATE4.,,,0,,05NOV2015,16NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-159,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64073-3,P2,1,v100,SA,160223-VB-HVTN100,10.0,27OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXSP-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160225;1107;13358;PLATE4.,,,0,,26OCT2015,06NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-049,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64083-0,P2,1,v100,SA,160304-OK-HVTN100,10.0,17NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0CK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Owen Karimanzira,3,,10,3,OK;20160307;13552;1107;PLATE3-,,,0,,14NOV2015,25NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-024,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64008-7,P2,1,v100,SA,160223-VB-HVTN100,10.0,22SEP2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HTD1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,1,,10,3,VB;20160225;1107;13355;PLATE1.,,,0,,18SEP2015,29SEP2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-143,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64021-9,P2,1,v100,SA,160316-OK-HVTN100,10.0,01OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HV6Q-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,1,,10,3,OK;20160318;13810;1107;PLATE1.,,,0,,01OCT2015,12OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-009,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64024-0,P2,1,v100,SA,160316-OK-HVTN100,10.0,21OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FTQC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,5,,10,3,OK;20160318;13819;1107;PLATE5.,,,0,,16OCT2015,27OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-094,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64031-2,P2,1,v100,SA,160302-VB-HVTN100,10.0,07NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ68-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,5,,10,3,VB;20160303;1107;13471;PLATE5.,,,0,,03NOV2015,14NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-026,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64034-7,P2,1,v100,SA,160304-VB-HVTN100,10.0,04NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HYZ4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160304;1107;13484;PLATE3.,,,0,,31OCT2015,11NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-166,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64050-7,P2,1,v100,SA,160304-VB-HVTN100,10.0,04NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYV7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,2,,10,3,VB;20160304;1107;13483;PLATE2.,,,0,,31OCT2015,11NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-005,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64057-3,P2,1,v100,SA,160304-VB-HVTN100,10.0,04NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HYVZ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,4,,10,3,VB;20160304;1107;13485;PLATE4.,,,0,,30OCT2015,10NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-133,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64060-1,P2,1,v100,SA,160304-VB-HVTN100,10.0,07NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Valerie Bekker,3,,10,3,VB;20160304;1107;13484;PLATE3.,,,0,,03NOV2015,14NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-195,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64070-6,P2,1,v100,SA,160301-OK-HVTN100,10.0,09NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20G1M1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,4,,10,3,OK;20160303;13442;1107;PLATE4.,,,0,,07NOV2015,18NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-043,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64017-7,P2,1,v100,SA,160422-TH-HVTN100,10.0,13OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FQTX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,4,,10,3,TH;20160425;14065;11073;PLATE4,,,0,,10OCT2015,21OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-174,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64052-4,P2,1,v100,SA,160316-OK-HVTN100,10.0,23OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FW49-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,4,,10,3,OK;20160318;13818;1107;PLATE4.,,,0,,19OCT2015,30OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-067,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64073-7,P2,1,v100,SA,160422-TH-HVTN100,10.0,22OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FVG5-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,72,Tandile Hermanus,4,,10,3,TH;20160425;14065;11073;PLATE4,,,0,,18OCT2015,29OCT2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-213,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64079-9,P2,1,v100,SA,160301-OK-HVTN100,10.0,28OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FX13-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,1,,10,3,OK;20160303;13439;1107;PLATE1.,,,0,,24OCT2015,04NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-250,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64080-5,P2,1,v100,SA,160301-OK-HVTN100,10.0,28OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX2K-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:40,Dilution,06NOV2015,151106,48,Owen Karimanzira,1,,10,3,OK;20160303;13439;1107;PLATE1.,,,0,,24OCT2015,04NOV2015,0,182,0,1107356.07,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-053,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64003-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,22JUL2015,04MAR2016,50,10,10,34,34,1.531478917,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20DYKC-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,4,,10,3,VB;20160307;6644;13527;PLATE4.,,,0,,19JUL2015,30JUL2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-111,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64006-5,T1,0,v100,SA,160307-VB-HVTN100,10.0,29JUL2015,04MAR2016,50,10,10,22,22,1.3424226808,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20F09P-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,5,,10,3,VB;20160307;6644;13528;PLATE5.,,,0,,26JUL2015,06AUG2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-031,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64009-0,T1,0,v100,SA,160304-OK-HVTN100,10.0,23JUL2015,04MAR2016,50,10,10,24,24,1.3802112417,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20DYTL-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,5,,10,3,OK;20160307;13541;6644;PLATE5-,,,0,,23JUL2015,03AUG2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-209,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64013-9,T1,0,v100,SA,160308-VB-HVTN100,10.0,28JUL2015,08MAR2016,50,10,10,30,30,1.4771212547,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20DZVV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160310;6644;13580;PLATE2.,,,0,,25JUL2015,05AUG2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-158,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64021-4,T1,0,v100,SA,160304-OK-HVTN100,10.0,03AUG2015,04MAR2016,50,10,10,16,16,1.2041199827,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F17D-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,5,,10,3,OK;20160307;13541;6644;PLATE5-,,,0,,01AUG2015,12AUG2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-215,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64029-9,T1,0,v100,SA,160308-VB-HVTN100,10.0,25AUG2015,08MAR2016,50,10,10,82,82,1.9138138524,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8HS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160310;6644;13580;PLATE2.,,,0,,14AUG2015,25AUG2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-231,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64031-7,T1,0,v100,SA,160418-TH-HVTN100,10.0,27AUG2015,18APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8ZN-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20160420;14040;6644;PLATE1.,,,0,,21AUG2015,01SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-091,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64033-4,T1,0,v100,SA,160418-TH-HVTN100,10.0,08SEP2015,18APR2016,50,10,10,41,41,1.6127838567,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD4N-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20160420;14040;6644;PLATE1.,,,0,,04SEP2015,15SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-077,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64036-9,T1,0,v100,SA,160307-VB-HVTN100,10.0,18AUG2015,04MAR2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20F5SG-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,4,,10,3,VB;20160307;6644;13527;PLATE4.,,,0,,14AUG2015,25AUG2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-136,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64045-2,T1,0,v100,SA,160308-VB-HVTN100,10.0,13AUG2015,08MAR2016,50,10,10,85,85,1.9294189257,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F4C6-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160310;6644;13580;PLATE2.,,,0,,13AUG2015,24AUG2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-227,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64053-1,T1,0,v100,SA,160418-TH-HVTN100,10.0,19AUG2015,18APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20F676-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20160420;14040;6644;PLATE1.,,,0,,16AUG2015,27AUG2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-160,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64054-4,T1,0,v100,SA,160308-VB-HVTN100,10.0,26AUG2015,08MAR2016,50,10,10,208,208,2.318063335,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8R9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160310;6644;13580;PLATE2.,,,0,,21AUG2015,01SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-155,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64055-9,T1,0,v100,SA,160308-VB-HVTN100,10.0,20AUG2015,08MAR2016,50,10,10,20,20,1.3010299957,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F6C4-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160310;6644;13581;PLATE3.,,,0,,14AUG2015,25AUG2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-177,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64057-8,T1,0,v100,SA,160308-VB-HVTN100,10.0,02SEP2015,08MAR2016,50,10,10,15,15,1.1760912591,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FBT0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160310;6644;13579;PLATE1.,,,0,,23AUG2015,03SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-052,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64062-2,T1,0,v100,SA,160308-VB-HVTN100,10.0,03SEP2015,08MAR2016,50,10,10,39,39,1.591064607,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FC68-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160310;6644;13581;PLATE3.,,,0,,28AUG2015,08SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-247,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64063-5,T1,0,v100,SA,160304-OK-HVTN100,10.0,08SEP2015,04MAR2016,50,10,10,30,30,1.4771212547,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FD2Q-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,5,,10,3,OK;20160307;13541;6644;PLATE5-,,,0,,04SEP2015,15SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-126,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64066-3,T1,0,v100,SA,160304-OK-HVTN100,10.0,08SEP2015,04MAR2016,50,10,10,82,82,1.9138138524,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD3H-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,5,,10,3,OK;20160307;13541;6644;PLATE5-,,,0,,04SEP2015,15SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-225,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64067-4,T1,0,v100,SA,160418-TH-HVTN100,10.0,08SEP2015,18APR2016,50,10,10,28,28,1.4471580313,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FD43-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20160420;14040;6644;PLATE1.,,,0,,04SEP2015,15SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-148,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64069-7,T1,0,v100,SA,160302-VB-HVTN100,10.0,14SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FGVK-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160302;6644;13479;PLATE3.,,,0,,12SEP2015,23SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-163,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64077-9,T1,0,v100,SA,160304-OK-HVTN100,10.0,07SEP2015,04MAR2016,50,10,10,26,26,1.414973348,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FCJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,2,,10,3,OK;20160307;13544;6644;PLATE2-,,,0,,29AUG2015,09SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-073,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64080-3,T1,0,v100,SA,160308-VB-HVTN100,10.0,31AUG2015,08MAR2016,50,10,10,103,103,2.0128372247,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FB33-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160310;6644;13579;PLATE1.,,,0,,28AUG2015,08SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-184,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64087-7,T1,0,v100,SA,160304-OK-HVTN100,10.0,07SEP2015,04MAR2016,50,10,10,57,57,1.7558748557,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FCJR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,2,,10,3,OK;20160307;13544;6644;PLATE2-,,,0,,06SEP2015,17SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-170,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64095-4,T1,0,v100,SA,160301-OK-HVTN100,10.0,08OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FQ3V-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,4,,10,3,OK;20160303;13447;6644;PLATE4.,,,0,,01OCT2015,12OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-038,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64105-9,T1,0,v100,SA,160307-VB-HVTN100,10.0,17NOV2015,04MAR2016,50,10,10,188,188,2.2741578493,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G4TX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,5,,10,3,VB;20160307;6644;13528;PLATE5.,,,0,,14NOV2015,25NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-123,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64117-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,17SEP2015,04MAR2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FJ00-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,3,,10,3,VB;20160307;6644;13526;PLATE3.,,,0,,13SEP2015,24SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-061,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64119-8,T1,0,v100,SA,160307-VB-HVTN100,10.0,30SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FMJ0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,5,,10,3,VB;20160307;6644;13528;PLATE5.,,,0,,26SEP2015,07OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-128,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64129-6,T1,0,v100,SA,160318-VB-HVTN100,10.0,06OCT2015,18MAR2016,50,10,10,16,16,1.2041199827,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FPD4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160320;6644;13843;PLATE2.,,,0,,03OCT2015,14OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-108,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64130-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,06OCT2015,04MAR2016,50,10,10,15,15,1.1760912591,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FPDG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,4,,10,3,VB;20160307;6644;13527;PLATE4.,,,0,,02OCT2015,13OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-097,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64135-8,T1,0,v100,SA,160302-VB-HVTN100,10.0,28SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FLTC-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160302;6644;13479;PLATE3.,,,0,,26SEP2015,07OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-129,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64139-4,T1,0,v100,SA,160301-OK-HVTN100,10.0,26OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FWKL-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,2,,10,3,OK;20160303;13445;6644;PLATE2.,,,0,,16OCT2015,27OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-058,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64150-0,T1,0,v100,SA,160301-OK-HVTN100,10.0,11NOV2015,01MAR2016,50,10,10,38,38,1.5797835966,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20G3JT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,2,,10,3,OK;20160303;13445;6644;PLATE2.,,,0,,07NOV2015,18NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-151,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64154-2,T1,0,v100,SA,160304-OK-HVTN,10.0,02NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FXYX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,1,,10,3,OK;20160307;13555;6644;PLATE1-,,,0,,25OCT2015,05NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-002,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64156-9,T1,0,v100,SA,160301-OK-HVTN100,10.0,02NOV2015,01MAR2016,50,10,10,14,14,1.1461280357,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FXZQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160303;13446;6644;PLATE3.,,,0,,25OCT2015,05NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-194,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64166-1,T1,0,v100,SA,160304-OK-HVTN100,10.0,17NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G4VL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,2,,10,3,OK;20160307;13544;6644;PLATE2-,,,0,,14NOV2015,25NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-157,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64167-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,10NOV2015,02MAR2016,50,10,10,20,20,1.3010299957,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G20B-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160302;6644;13478;PLATE2.,,,0,,06NOV2015,17NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-025,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64172-9,T1,0,v100,SA,160318-VB-HVTN100,10.0,12NOV2015,18MAR2016,50,10,10,20,20,1.3010299957,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20G3X4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160320;6644;13844;PLATE3.,,,0,,06NOV2015,17NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-137,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64002-3,T1,0,v100,SA,160316-OK-HVTN100,10.0,28AUG2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BCRM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,2,,10,3,OK;20160318;13814;6644;PLATE2.,,,0,,21AUG2015,01SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-064,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64007-0,T1,0,v100,SA,160302-OK-HVTN100,10.0,14SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BDHQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,2,,10,3,OK;20160304;13506;6644;PLATE2.,,,0,,10SEP2015,21SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-131,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64008-8,T1,0,v100,SA,160316-OK-HVTN100,10.0,14SEP2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BDJC-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160318;13816;6644;PLATE3.,,,0,,07SEP2015,18SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-109,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64028-0,T1,0,v100,SA,160418-TH-HVTN100,10.0,21OCT2015,18APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BFB3-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20160420;14039;6644;PLATE2.,,,0,,17OCT2015,28OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-187,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64029-3,T1,0,v100,SA,160308-VB-HVTN100,10.0,26OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFG6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160310;6644;13581;PLATE3.,,,0,,19OCT2015,30OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-090,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64030-6,T1,0,v100,SA,160224-VB-HVTN100,10.0,27OCT2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BFGQ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160226;6644;13369;PLATE1.,,,0,,23OCT2015,03NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-130,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64034-8,T1,0,v100,SA,160223-VB-HVTN100,10.0,10NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG09-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160225;6644;13364;PLATE5.,,,0,,06NOV2015,17NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-105,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64036-3,T1,0,v100,SA,160224-VB-HVTN100,10.0,13NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG4G-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160226;6644;13370;PLATE2.,,,0,,09NOV2015,20NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-140,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64037-4,T1,0,v100,SA,160223-VB-HVTN100,10.0,16NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG8C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160225;6644;13363;PLATE4.,,,0,,12NOV2015,23NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-138,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64038-9,T1,0,v100,SA,160224-VB-HVTN100,10.0,04NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFT3-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160226;6644;13369;PLATE1.,,,0,,31OCT2015,11NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-084,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64039-7,T1,0,v100,SA,160418-TH-HVTN100,10.0,27OCT2015,18APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFH3-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20160420;14039;6644;PLATE2.,,,0,,23OCT2015,03NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-198,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64040-3,T1,0,v100,SA,160224-VB-HVTN100,10.0,17NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGC1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160226;6644;13370;PLATE2.,,,0,,07NOV2015,18NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-228,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64044-0,T1,0,v100,SA,160224-VB-HVTN100,10.0,24NOV2015,24FEB2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BGLK-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160226;6644;13372;PLATE4.,,,0,,14NOV2015,25NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-181,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64050-8,T1,0,v100,SA,160224-VB-HVTN100,10.0,02NOV2015,24FEB2016,50,10,10,44,44,1.6434526765,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFPN-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160226;6644;13369;PLATE1.,,,0,,31OCT2015,11NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-085,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64051-4,T1,0,v100,SA,160418-TH-HVTN100,10.0,06NOV2015,18APR2016,50,10,10,93,93,1.9684829486,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFVX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20160420;14039;6644;PLATE2.,,,0,,02NOV2015,13NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-063,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64053-7,T1,0,v100,SA,160224-VB-HVTN100,10.0,20NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGGQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160226;6644;13372;PLATE4.,,,0,,16NOV2015,27NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-235,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64054-5,T1,0,v100,SA,160422-TH-HVTN100,10.0,09NOV2015,22APR2016,50,10,10,81,81,1.9084850189,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFY7-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Tandile Hermanus,2,,10,3,TH;20160425;14068;6644;PLATE2.,,,0,,05NOV2015,16NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-001,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64061-7,T1,0,v100,SA,160304-OK-HVTN100,10.0,09NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFYY-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,4,,10,3,OK;20160307;13546;6644;PLATE4-,,,0,,07NOV2015,18NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-083,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64062-8,T1,0,v100,SA,160304-OK-HVTN100,10.0,13NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,4,,10,3,OK;20160307;13546;6644;PLATE4-,,,0,,09NOV2015,20NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-145,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64066-9,T1,0,v100,SA,160224-VB-HVTN100,10.0,11NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BG31-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160226;6644;13370;PLATE2.,,,0,,06NOV2015,17NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-127,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64068-3,T1,0,v100,SA,160224-VB-HVTN100,10.0,24NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BGMS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160226;6644;13372;PLATE4.,,,0,,19NOV2015,30NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-044,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64069-1,T1,0,v100,SA,160304-OK-HVTN100,10.0,16NOV2015,04MAR2016,50,10,10,27,27,1.4313637642,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GA60BG7M-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,4,,10,3,OK;20160307;13546;6644;PLATE4-,,,0,,12NOV2015,23NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-132,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64070-7,T1,0,v100,SA,160224-VB-HVTN100,10.0,13NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BG5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160226;6644;13370;PLATE2.,,,0,,09NOV2015,20NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-048,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64073-6,T1,0,v100,SA,160224-VB-HVTN100,10.0,16NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG9D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160226;6644;13370;PLATE2.,,,0,,12NOV2015,23NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-092,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64075-4,T1,0,v100,SA,160223-VB-HVTN100,10.0,17NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BGCG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160225;6644;13362;PLATE3-,,,0,,13NOV2015,24NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-218,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64076-2,T1,0,v100,SA,160223-VB-HVTN100,10.0,16NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,15JUN2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BG9S-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160225;6644;13364;PLATE5.,,,0,0,12NOV2015,23NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-179,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64082-4,T1,0,v100,SA,160224-VB-HVTN100,10.0,10NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BG19-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160226;6644;13373;PLATE5.,,,0,,06NOV2015,17NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-040,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64089-5,T1,0,v100,SA,160224-VB-HVTN100,10.0,27NOV2015,24FEB2016,50,10,10,65,65,1.8129133566,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BGP5-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160226;6644;13372;PLATE4.,,,0,,21NOV2015,02DEC2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-022,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64001-8,T1,0,v100,SA,160318-VB-HVTN100,10.0,21SEP2015,18MAR2016,50,10,10,24,24,1.3802112417,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160320;6644;13844;PLATE3.,,,0,,20SEP2015,01OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-066,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64002-9,T1,0,v100,SA,160302-VB-HVTN100,10.0,17SEP2015,02MAR2016,50,10,10,40,40,1.6020599913,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GAT054MG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160302;6644;13478;PLATE2.,,,0,,12SEP2015,23SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-142,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64004-1,T1,0,v100,SA,160302-VB-HVTN100,10.0,22OCT2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT057TJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160302;6644;13477;PLATE1-,,,0,,16OCT2015,27OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-236,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64006-5,T1,0,v100,SA,160302-VB-HVTN100,10.0,17SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054L4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160302;6644;13478;PLATE2.,,,0,,13SEP2015,24SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-120,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64007-6,T1,0,v100,SA,160304-OK-HVTN,10.0,17SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT054KS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,1,,10,3,OK;20160307;13555;6644;PLATE1-,,,0,,13SEP2015,24SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-029,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64009-0,T1,0,v100,SA,160226-VB-HVTN100,10.0,21SEP2015,26FEB2016,50,10,10,15,15,1.1760912591,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TT-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,2,,10,3,VB;20160229;6644;13407;PLATE2.,,,0,,17SEP2015,28SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-107,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64010-5,T1,0,v100,SA,160226-VB-HVTN100,10.0,22SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT0550X-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,5,,10,3,VB;20160229;6644;13410;PLATE5.,,,0,,18SEP2015,29SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-113,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64012-3,T1,0,v100,SA,160226-VB-HVTN100,10.0,21SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054V4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,2,,10,3,VB;20160229;6644;13407;PLATE2.,,,0,,20SEP2015,01OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-234,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64016-4,T1,0,v100,SA,160226-VB-HVTN100,10.0,21SEP2015,26FEB2016,50,10,10,68,68,1.8325089127,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT054VG-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,1,,10,3,VB;20160229;6644;13406;PLATE1.,,,0,,20SEP2015,01OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-059,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64017-0,T1,0,v100,SA,160226-VB-HVTN100,10.0,28SEP2015,26FEB2016,50,10,10,10,10,1,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT05585-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,1,,10,3,VB;20160229;6644;13406;PLATE1.,,,0,,24SEP2015,05OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-023,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64021-4,T1,0,v100,SA,160302-VB-HVTN100,10.0,28SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0557V-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160302;6644;13478;PLATE2.,,,0,,24SEP2015,05OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-201,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64029-9,T1,0,v100,SA,160226-VB-HVTN100,10.0,12OCT2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT056K1-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,1,,10,3,VB;20160229;6644;13406;PLATE1.,,,0,,08OCT2015,19OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-076,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64031-7,T1,0,v100,SA,160226-VB-HVTN100,10.0,26OCT2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT057ZR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,1,,10,3,VB;20160229;6644;13406;PLATE1.,,,0,,22OCT2015,02NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-204,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64035-6,T1,0,v100,SA,160302-VB-HVTN100,10.0,26OCT2015,02MAR2016,50,10,10,82,82,1.9138138524,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057X1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160302;6644;13477;PLATE1-,,,0,,22OCT2015,02NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-230,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64036-9,T1,0,v100,SA,160226-VB-HVTN100,10.0,02NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT058FR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,2,,10,3,VB;20160229;6644;13407;PLATE2.,,,0,,29OCT2015,09NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-011,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64037-5,T1,0,v100,SA,160226-VB-HVTN100,10.0,27OCT2015,26FEB2016,50,10,10,69,69,1.8388490907,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0584C-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,5,,10,3,VB;20160229;6644;13410;PLATE5.,,,0,,23OCT2015,03NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-161,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64038-3,T1,0,v100,SA,160226-VB-HVTN100,10.0,19OCT2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT05797-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,4,,10,3,VB;20160229;6644;13409;PLATE4.,,,0,,15OCT2015,26OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-180,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64041-3,T1,0,v100,SA,160226-VB-HVTN100,10.0,07NOV2015,26FEB2016,50,10,10,217,217,2.3364597338,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05967-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,5,,10,3,VB;20160229;6644;13410;PLATE5.,,,0,,02NOV2015,13NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-116,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64043-8,T1,0,v100,SA,160226-VB-HVTN100,10.0,10NOV2015,26FEB2016,50,10,10,137,137,2.1367205672,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT059JJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,2,,10,3,VB;20160229;6644;13407;PLATE2.,,,0,,06NOV2015,17NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-079,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64044-6,T1,0,v100,SA,160302-VB-HVTN100,10.0,23OCT2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057VG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160302;6644;13477;PLATE1-,,,0,,19OCT2015,30OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-192,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64045-2,T1,0,v100,SA,160226-VB-HVTN100,10.0,11NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT059Q1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,3,,10,3,VB;20160229;6644;13408;PLATE3-,,,0,,09NOV2015,20NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-146,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64050-2,T1,0,v100,SA,160226-VB-HVTN100,10.0,11NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT059TS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,2,,10,3,VB;20160229;6644;13407;PLATE2.,,,0,,07NOV2015,18NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-006,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64051-5,T1,0,v100,SA,160226-VB-HVTN100,10.0,09NOV2015,26FEB2016,50,10,10,98,98,1.9912260757,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT0598R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,3,,10,3,VB;20160229;6644;13408;PLATE3-,,,0,,05NOV2015,16NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-007,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64053-1,T1,0,v100,SA,160302-VB-HVTN100,10.0,09NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT059C4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160302;6644;13478;PLATE2.,,,0,,05NOV2015,16NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-081,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64054-4,T1,0,v100,SA,160226-VB-HVTN100,10.0,10NOV2015,26FEB2016,50,10,10,217,217,2.3364597338,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT059KL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,5,,10,3,VB;20160229;6644;13410;PLATE5.,,,0,,06NOV2015,17NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-172,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64056-7,T1,0,v100,SA,160226-VB-HVTN100,10.0,16NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05B6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,4,,10,3,VB;20160229;6644;13409;PLATE4.,,,0,,12NOV2015,23NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-205,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64057-8,T1,0,v100,SA,160302-VB-HVTN100,10.0,11NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT059VK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160302;6644;13477;PLATE1-,,,0,,06NOV2015,17NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-202,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64060-6,T1,0,v100,SA,160226-VB-HVTN100,10.0,21NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05BWD-05,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,4,,10,3,VB;20160229;6644;13409;PLATE4.,,,0,,17NOV2015,28NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-119,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64062-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,18NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT05BLC-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160302;6644;13477;PLATE1-,,,0,,14NOV2015,25NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-101,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64072-7,T1,0,v100,SA,160226-VB-HVTN100,10.0,19NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05BS4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,4,,10,3,VB;20160229;6644;13409;PLATE4.,,,0,,19NOV2015,30NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-050,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64003-1,T1,0,v100,SA,160422-TH-HVTN100,10.0,02SEP2015,22APR2016,50,10,10,11,11,1.0413926852,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HRJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Tandile Hermanus,1,,10,3,TH;20160425;14067;6644;PLATE1.,,,0,,29AUG2015,09SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-150,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64005-9,T1,0,v100,SA,160223-VB-HVTN100,10.0,01SEP2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HR6B-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160225;6644;13360;PLATE1.,,,0,,28AUG2015,08SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-114,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64006-7,T1,0,v100,SA,160304-OK-HVTN100,10.0,18SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HT5Y-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,3,,10,3,OK;20160307;13545;6644;PLATE3-,,,0,,14SEP2015,25SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-190,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64007-8,T1,0,v100,SA,160422-TH-HVTN100,10.0,05OCT2015,22APR2016,50,10,10,168,168,2.2253092817,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HVGX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Tandile Hermanus,1,,10,3,TH;20160425;14067;6644;PLATE1.,,,0,,01OCT2015,12OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-248,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64011-0,T1,0,v100,SA,160223-VB-HVTN100,10.0,23SEP2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HTJJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160225;6644;13360;PLATE1.,,,0,,18SEP2015,29SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-042,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64017-3,T1,0,v100,SA,160422-TH-HVTN100,10.0,06OCT2015,22APR2016,50,10,10,49,49,1.69019608,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HVRV-13,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Tandile Hermanus,1,,10,3,TH;20160425;14067;6644;PLATE1.,,,0,,03OCT2015,14OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-078,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64018-5,T1,0,v100,SA,160316-OK-HVTN100,10.0,02OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HVCC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,1,,10,3,OK;20160318;13809;6644;PLATE1.,,,0,,01OCT2015,12OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-242,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64019-8,T1,0,v100,SA,160224-VB-HVTN100,10.0,10NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160226;6644;13373;PLATE5.,,,0,,07NOV2015,18NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-071,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64022-3,T1,0,v100,SA,160223-VB-HVTN100,10.0,23OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXFC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160225;6644;13362;PLATE3-,,,0,,23OCT2015,03NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-070,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64025-1,T1,0,v100,SA,160223-VB-HVTN100,10.0,26OCT2015,23FEB2016,50,10,10,12,12,1.079181246,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HXGY-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160225;6644;13361;PLATE2.,,,0,,23OCT2015,03NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-134,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64026-4,T1,0,v100,SA,160304-OK-HVTN100,10.0,09NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HZB7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,3,,10,3,OK;20160307;13545;6644;PLATE3-,,,0,,05NOV2015,16NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-219,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64028-8,T1,0,v100,SA,160223-VB-HVTN100,10.0,27OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXTF-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160225;6644;13361;PLATE2.,,,0,,26OCT2015,06NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-176,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64029-6,T1,0,v100,SA,160302-VB-HVTN100,10.0,10NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160302;6644;13480;PLATE4.,,,0,,07NOV2015,18NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-135,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64031-9,T1,0,v100,SA,160304-VB-HVTN100,10.0,02NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HYLD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160304;6644;13493;PLATE2.,,,0,,24OCT2015,04NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-103,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64036-6,T1,0,v100,SA,160223-VB-HVTN100,10.0,30OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYBJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160225;6644;13364;PLATE5.,,,0,,29OCT2015,09NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-169,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64037-7,T1,0,v100,SA,160318-VB-HVTN100,10.0,12NOV2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZWP-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160320;6644;13842;PLATE1.,,,0,,08NOV2015,19NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-165,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64041-1,T1,0,v100,SA,160316-OK-HVTN100,10.0,01DEC2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J1Q0-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160318;13816;6644;PLATE3.,,,0,,26NOV2015,07DEC2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-183,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64044-8,T1,0,v100,SA,160223-VB-HVTN100,10.0,30OCT2015,23FEB2016,50,10,10,14,14,1.1461280357,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HY9Q-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160225;6644;13362;PLATE3-,,,0,,29OCT2015,09NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-188,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64046-3,T1,0,v100,SA,160224-VB-HVTN100,10.0,17NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J09C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160226;6644;13371;PLATE3.,,,0,,17NOV2015,28NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-054,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64047-4,T1,0,v100,SA,160224-VB-HVTN100,10.0,03NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HYR2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160226;6644;13373;PLATE5.,,,0,,29OCT2015,09NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-239,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64054-2,T1,0,v100,SA,160223-VB-HVTN100,10.0,28OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HXZP-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160225;6644;13363;PLATE4.,,,0,,26OCT2015,06NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-098,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64062-0,T1,0,v100,SA,160304-VB-HVTN100,10.0,03NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HYRQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160304;6644;13496;PLATE5.,,,0,,30OCT2015,10NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-216,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64064-5,T1,0,v100,SA,160316-OK-HVTN100,10.0,12NOV2015,18MAR2016,50,10,10,17,17,1.2304489214,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J015-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,4,,10,3,OK;20160318;13807;6644;PLATE4.,,,0,,09NOV2015,20NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-185,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64065-3,T1,0,v100,SA,160302-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZXY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160302;6644;13480;PLATE4.,,,0,,08NOV2015,19NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-102,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64067-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,17NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J09F-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160302;6644;13481;PLATE5.,,,0,,13NOV2015,24NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-112,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64070-4,T1,0,v100,SA,160304-OK-HVTN100,10.0,16NOV2015,04MAR2016,50,10,10,39,39,1.591064607,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J03Q-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,3,,10,3,OK;20160307;13545;6644;PLATE3-,,,0,,05NOV2015,16NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-082,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64074-1,T1,0,v100,SA,160223-VB-HVTN100,10.0,16NOV2015,23FEB2016,50,10,10,27,27,1.4313637642,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J039-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160225;6644;13363;PLATE4.,,,0,,12NOV2015,23NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-197,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64084-3,T1,0,v100,SA,160304-VB-HVTN100,10.0,18NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J0MY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160304;6644;13492;PLATE1.,,,0,,15NOV2015,26NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-232,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64085-5,T1,0,v100,SA,160316-OK-HVTN100,10.0,01DEC2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J1QW-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160318;13816;6644;PLATE3.,,,0,,20NOV2015,01DEC2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-003,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64002-4,T1,0,v100,SA,160316-OK-HVTN100,10.0,13OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBJ-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,2,,10,3,OK;20160318;13814;6644;PLATE2.,,,0,,08OCT2015,19OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-152,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64006-0,T1,0,v100,SA,160224-VB-HVTN100,10.0,14SEP2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HSJ4-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160226;6644;13371;PLATE3.,,,0,,06SEP2015,17SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-220,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64009-5,T1,0,v100,SA,160316-OK-HVTN100,10.0,15OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWQB-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,1,,10,3,OK;20160318;13809;6644;PLATE1.,,,0,,11OCT2015,22OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-125,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64010-0,T1,0,v100,SA,160223-VB-HVTN100,10.0,14SEP2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HSMB-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160225;6644;13360;PLATE1.,,,0,,05SEP2015,16SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-233,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64011-7,T1,0,v100,SA,160223-VB-HVTN100,10.0,22SEP2015,23FEB2016,50,10,10,20,20,1.3010299957,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HTGD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160225;6644;13360;PLATE1.,,,0,,18SEP2015,29SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-186,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64016-9,T1,0,v100,SA,160224-VB-HVTN100,10.0,27OCT2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08MAR2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXNV-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160226;6644;13371;PLATE3.,,,0,0,18OCT2015,29OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-039,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64017-5,T1,0,v100,SA,160422-TH-HVTN100,10.0,29SEP2015,22APR2016,50,10,10,53,53,1.7242758696,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HTWM-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Tandile Hermanus,1,,10,3,TH;20160425;14067;6644;PLATE1.,,,0,,26SEP2015,07OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-013,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64018-3,T1,0,v100,SA,160318-VB-HVTN100,10.0,20NOV2015,18MAR2016,50,10,10,225,225,2.3521825181,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J0YX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160320;6644;13845;PLATE4.,,,0,,17NOV2015,28NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-121,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64020-3,T1,0,v100,SA,160422-TH-HVTN100,10.0,06OCT2015,22APR2016,50,10,10,239,239,2.3783979009,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HVPF-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Tandile Hermanus,1,,10,3,TH;20160425;14067;6644;PLATE1.,,,0,,01OCT2015,12OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-087,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64023-2,T1,0,v100,SA,160223-VB-HVTN100,10.0,21OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HX1W-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160225;6644;13361;PLATE2.,,,0,,16OCT2015,27OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-100,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64025-8,T1,0,v100,SA,160316-OK-HVTN100,10.0,13OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBG-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,1,,10,3,OK;20160318;13809;6644;PLATE1.,,,0,,08OCT2015,19OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-069,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64026-6,T1,0,v100,SA,160316-OK-HVTN100,10.0,07NOV2015,18MAR2016,50,10,10,38,38,1.5797835966,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160318;13816;6644;PLATE3.,,,0,,03NOV2015,14NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-206,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64033-9,T1,0,v100,SA,160223-VB-HVTN100,10.0,20OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08DEC2015,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HWYC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160225;6644;13361;PLATE2.,,,0,0,15OCT2015,26OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-047,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64035-1,T1,0,v100,SA,160304-VB-HVTN100,10.0,05NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ01-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160304;6644;13494;PLATE3.,,,0,,01NOV2015,12NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-089,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64038-8,T1,0,v100,SA,160304-VB-HVTN100,10.0,25NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J17P-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160304;6644;13496;PLATE5.,,,0,,20NOV2015,01DEC2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-139,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64041-8,T1,0,v100,SA,160304-VB-HVTN100,10.0,10NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFB-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160304;6644;13496;PLATE5.,,,0,,06NOV2015,17NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-080,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64042-9,T1,0,v100,SA,160318-VB-HVTN100,10.0,26OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HXGW-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160320;6644;13842;PLATE1.,,,0,,22OCT2015,02NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-210,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64046-5,T1,0,v100,SA,160223-VB-HVTN100,10.0,27OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXNS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160225;6644;13361;PLATE2.,,,0,,23OCT2015,03NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-162,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64048-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,30,30,1.4771212547,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J00K-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160302;6644;13481;PLATE5.,,,0,,05NOV2015,16NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-246,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64051-0,T1,0,v100,SA,160304-VB-HVTN100,10.0,11NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZP9-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160304;6644;13492;PLATE1.,,,0,,07NOV2015,18NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-223,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64053-6,T1,0,v100,SA,160223-VB-HVTN100,10.0,11NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HZQD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160225;6644;13364;PLATE5.,,,0,,07NOV2015,18NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-028,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64055-4,T1,0,v100,SA,160223-VB-HVTN100,10.0,05NOV2015,23FEB2016,50,10,10,23,23,1.361727836,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZ03-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160225;6644;13362;PLATE3-,,,0,,01NOV2015,12NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-244,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64059-8,T1,0,v100,SA,160302-VB-HVTN100,10.0,20NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J0Y2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160302;6644;13480;PLATE4.,,,0,,17NOV2015,28NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-153,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64061-6,T1,0,v100,SA,160304-VB-HVTN100,10.0,07NOV2015,02MAR2016,50,10,10,12,12,1.079181246,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160304;6644;13495;PLATE4.,,,0,,03NOV2015,14NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-015,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64063-0,T1,0,v100,SA,160304-VB-HVTN100,10.0,19NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J0WN-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160304;6644;13495;PLATE4.,,,1,,14NOV2015,25NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-252,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64064-3,T1,0,v100,SA,160302-VB-HVTN100,10.0,23NOV2015,02MAR2016,50,10,10,17,17,1.2304489214,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0ZW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160302;6644;13481;PLATE5.,,,0,,19NOV2015,30NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-211,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64068-4,T1,0,v100,SA,160224-VB-HVTN100,10.0,10NOV2015,24FEB2016,50,10,10,11,11,1.0413926852,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZFD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160226;6644;13371;PLATE3.,,,0,,07NOV2015,18NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-147,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64069-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,16NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J02X-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160302;6644;13479;PLATE3.,,,0,,05NOV2015,16NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-168,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64071-1,T1,0,v100,SA,160302-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,42,42,1.6232492904,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZZT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160302;6644;13480;PLATE4.,,,0,,08NOV2015,19NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-203,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64072-2,T1,0,v100,SA,160304-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,133,133,2.123851641,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZYT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160304;6644;13496;PLATE5.,,,0,,08NOV2015,19NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-167,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64074-8,T1,0,v100,SA,160224-VB-HVTN100,10.0,18NOV2015,24FEB2016,50,10,10,48,48,1.6812412374,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J0LW-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160226;6644;13371;PLATE3.,,,0,,17NOV2015,28NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-224,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64075-0,T1,0,v100,SA,160304-VB-HVTN100,10.0,19NOV2015,02MAR2016,50,10,10,38,38,1.5797835966,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J0W8-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160304;6644;13495;PLATE4.,,,0,,13NOV2015,24NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-226,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64077-4,T1,0,v100,SA,160304-VB-HVTN100,10.0,19NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J0QS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160304;6644;13494;PLATE3.,,,0,,15NOV2015,26NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-020,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64079-7,T1,0,v100,SA,160304-VB-HVTN100,10.0,03DEC2015,02MAR2016,50,10,10,36,36,1.5563025008,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J1WG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160304;6644;13492;PLATE1.,,,0,,27NOV2015,08DEC2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-065,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64001-1,T1,0,v100,SA,160307-VB-HVTN100,10.0,07SEP2015,04MAR2016,50,10,10,32,32,1.5051499783,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FCQ6-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,4,,10,3,VB;20160307;6644;13527;PLATE4.,,,0,,05SEP2015,16SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-018,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64002-2,T1,0,v100,SA,160307-VB-HVTN100,10.0,15SEP2015,04MAR2016,50,10,10,22,22,1.3424226808,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FHFQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,3,,10,3,VB;20160307;6644;13526;PLATE3.,,,0,,14SEP2015,25SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-096,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64004-8,T1,0,v100,SA,160307-VB-HVTN100,10.0,23OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FW3Z-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,3,,10,3,VB;20160307;6644;13526;PLATE3.,,,0,,22OCT2015,02NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-249,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64006-3,T1,0,v100,SA,160302-VB-HVTN100,10.0,22SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FK9S-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160302;6644;13479;PLATE3.,,,0,,20SEP2015,01OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-010,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64009-7,T1,0,v100,SA,160307-VB-HVTN100,10.0,22SEP2015,04MAR2016,50,10,10,24,24,1.3802112417,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FKKP-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,1,,10,3,VB;20160307;6644;13524;PLATE1.,,,0,,20SEP2015,01OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-222,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64018-1,T1,0,v100,SA,160307-VB-HVTN100,10.0,30SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FMJB-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,1,,10,3,VB;20160307;6644;13524;PLATE1.,,,0,,26SEP2015,07OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-046,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64022-7,T1,0,v100,SA,160307-VB-HVTN100,10.0,16OCT2015,04MAR2016,50,10,10,26,26,1.414973348,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FS71-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,3,,10,3,VB;20160307;6644;13526;PLATE3.,,,0,,12OCT2015,23OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-037,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64030-7,T1,0,v100,SA,160422-TH-HVTN100,10.0,09OCT2015,22APR2016,50,10,10,89,89,1.9493900066,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FQ9L-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Tandile Hermanus,2,,10,3,TH;20160425;14068;6644;PLATE2.,,,0,,01OCT2015,12OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-251,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64033-6,T1,0,v100,SA,160301-OK-HVTN100,10.0,19OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FSKN-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,5,,10,3,OK;20160303;13448;6644;PLATE5.,,,0,,12OCT2015,23OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-099,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64034-9,T1,0,v100,SA,160301-OK-HVTN100,10.0,08OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FQ46-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,4,,10,3,OK;20160303;13447;6644;PLATE4.,,,0,,03OCT2015,14OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-032,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64038-5,T1,0,v100,SA,160301-OK-HVTN100,10.0,26OCT2015,01MAR2016,50,10,10,13,13,1.1139433523,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FWHM-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,4,,10,3,OK;20160303;13447;6644;PLATE4.,,,0,,22OCT2015,02NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-245,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64039-8,T1,0,v100,SA,160422-TH-HVTN100,10.0,15OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FRV7-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Tandile Hermanus,3,,10,3,TH;20160425;14069;6644;PLATE3.,,,0,,08OCT2015,19OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-057,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64042-6,T1,0,v100,SA,160307-VB-HVTN100,10.0,22OCT2015,04MAR2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FVNV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,1,,10,3,VB;20160307;6644;13524;PLATE1.,,,0,,17OCT2015,28OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-055,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64043-1,T1,0,v100,SA,160316-OK-HVTN100,10.0,14OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FRFF-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,5,,10,3,OK;20160318;13808;6644;PLATE5.,,,0,,12OCT2015,23OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-021,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64046-7,T1,0,v100,SA,160318-VB-HVTN100,10.0,04NOV2015,18MAR2016,50,10,10,15,15,1.1760912591,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FZ1Z-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160320;6644;13843;PLATE2.,,,0,,01NOV2015,12NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-156,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64049-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,14OCT2015,04MAR2016,50,10,10,38,38,1.5797835966,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRCW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,1,,10,3,VB;20160307;6644;13524;PLATE1.,,,0,,10OCT2015,21OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-014,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64054-6,T1,0,v100,SA,160422-TH-HVTN100,10.0,23OCT2015,22APR2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FW4N-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Tandile Hermanus,3,,10,3,TH;20160425;14069;6644;PLATE3.,,,0,,16OCT2015,27OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-240,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64062-9,T1,0,v100,SA,160301-OK-HVTN100,10.0,27OCT2015,01MAR2016,50,10,10,53,53,1.7242758696,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FWTX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,4,,10,3,OK;20160303;13447;6644;PLATE4.,,,0,,23OCT2015,03NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-171,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64063-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,14OCT2015,04MAR2016,50,10,10,36,36,1.5563025008,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRDV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,2,,10,3,VB;20160307;6644;13525;PLATE2.,,,0,,10OCT2015,21OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-068,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64064-1,T1,0,v100,SA,160301-OK-HVTN100,10.0,27OCT2015,01MAR2016,50,10,10,13,13,1.1139433523,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FWX6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160303;13446;6644;PLATE3.,,,0,,23OCT2015,03NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-062,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64065-7,T1,0,v100,SA,160422-TH-HVTN100,10.0,13OCT2015,22APR2016,50,10,10,217,217,2.3364597338,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FQWN-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Tandile Hermanus,2,,10,3,TH;20160425;14068;6644;PLATE2.,,,0,,12OCT2015,23OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-036,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64066-5,T1,0,v100,SA,160316-OK-HVTN100,10.0,16OCT2015,18MAR2016,50,10,10,15,15,1.1760912591,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FS6F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,5,,10,3,OK;20160318;13808;6644;PLATE5.,,,0,,10OCT2015,21OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-095,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64071-4,T1,0,v100,SA,160307-VB-HVTN100,10.0,21OCT2015,04MAR2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FTPM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,2,,10,3,VB;20160307;6644;13525;PLATE2.,,,0,,17OCT2015,28OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-212,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64072-0,T1,0,v100,SA,160301-OK-HVTN100,10.0,02NOV2015,01MAR2016,50,10,10,12,12,1.079181246,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FY0T-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,1,,10,3,OK;20160303;13444;6644;PLATE1.,,,0,,29OCT2015,09NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-072,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64074-5,T1,0,v100,SA,160307-VB-HVTN100,10.0,20OCT2015,04MAR2016,50,10,10,26,26,1.414973348,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FSTR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,2,,10,3,VB;20160307;6644;13525;PLATE2.,,,0,,15OCT2015,26OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-229,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64076-1,T1,0,v100,SA,160301-OK-HVTN100,10.0,07NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20G182-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,1,,10,3,OK;20160303;13444;6644;PLATE1.,,,0,,29OCT2015,09NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-217,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64077-2,T1,0,v100,SA,160301-OK-HVTN100,10.0,29OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FXCG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160303;13446;6644;PLATE3.,,,0,,25OCT2015,05NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-149,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64078-6,T1,0,v100,SA,160318-VB-HVTN100,10.0,21OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FTPZ-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160320;6644;13844;PLATE3.,,,0,,16OCT2015,27OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-017,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64085-1,T1,0,v100,SA,160307-VB-HVTN100,10.0,20OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FSV2-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,2,,10,3,VB;20160307;6644;13525;PLATE2.,,,0,,17OCT2015,28OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-074,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64086-4,T1,0,v100,SA,160301-OK-HVTN100,10.0,30OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FXJC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,2,,10,3,OK;20160303;13445;6644;PLATE2.,,,0,,26OCT2015,06NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-124,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64089-6,T1,0,v100,SA,160301-OK-HVTN100,10.0,28OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX1S-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,2,,10,3,OK;20160303;13445;6644;PLATE2.,,,0,,25OCT2015,05NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-004,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64095-6,T1,0,v100,SA,160301-OK-HVTN100,10.0,27OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FWWD-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160303;13446;6644;PLATE3.,,,0,,23OCT2015,03NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-182,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64097-5,T1,0,v100,SA,160301-OK-HVTN100,10.0,06NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G0Z4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,1,,10,3,OK;20160303;13444;6644;PLATE1.,,,0,,05NOV2015,16NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-034,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64107-1,T1,0,v100,SA,160304-OK-HVTN,10.0,07NOV2015,04MAR2016,50,10,10,12,12,1.079181246,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G18P-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,1,,10,3,OK;20160307;13555;6644;PLATE1-,,,0,,03NOV2015,14NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-115,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64113-4,T1,0,v100,SA,160301-OK-HVTN100,10.0,30OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FXJP-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,3,,10,3,OK;20160303;13446;6644;PLATE3.,,,0,,29OCT2015,09NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-144,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64118-3,T1,0,v100,SA,160301-OK-HVTN100,10.0,10NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20G20Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,5,,10,3,OK;20160303;13448;6644;PLATE5.,,,0,,07NOV2015,18NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-189,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64125-8,T1,0,v100,SA,160301-OK-HVTN100,10.0,12NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G3XF-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,5,,10,3,OK;20160303;13448;6644;PLATE5.,,,0,,12NOV2015,23NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-141,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64001-8,P2,1,v100,SA,160418-TH-HVTN100,10.0,23JUL2015,18APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20DZ2F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Tandile Hermanus,1,,10,3,TH;20160420;14040;6644;PLATE1.,,,0,,23JUL2015,03AUG2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-056,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64028-6,P2,1,v100,SA,160308-VB-HVTN100,10.0,04AUG2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20F1PR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160310;6644;13580;PLATE2.,,,0,,02AUG2015,13AUG2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-154,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64047-1,P2,1,v100,SA,160308-VB-HVTN100,10.0,17AUG2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20F5F9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160310;6644;13579;PLATE1.,,,0,,13AUG2015,24AUG2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-041,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64059-3,P2,1,v100,SA,160308-VB-HVTN100,10.0,19AUG2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20F64B-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160310;6644;13579;PLATE1.,,,0,,15AUG2015,26AUG2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-196,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64085-8,P2,1,v100,SA,160304-OK-HVTN100,10.0,07SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FCQJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,2,,10,3,OK;20160307;13544;6644;PLATE2-,,,0,,04SEP2015,15SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-200,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64086-6,P2,1,v100,SA,160307-VB-HVTN100,10.0,15SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FHG1-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,5,,10,3,VB;20160307;6644;13528;PLATE5.,,,0,,12SEP2015,23SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-122,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64121-2,P2,1,v100,SA,160304-OK-HVTN,10.0,29SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FM29-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,1,,10,3,OK;20160307;13555;6644;PLATE1-,,,0,,26SEP2015,07OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-199,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64165-3,P2,1,v100,SA,160304-OK-HVTN100,10.0,09NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20G1N0-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,2,,10,3,OK;20160307;13544;6644;PLATE2-,,,0,,05NOV2015,16NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-104,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64052-0,P2,1,v100,SA,160418-TH-HVTN100,10.0,06NOV2015,18APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BFW9-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Tandile Hermanus,2,,10,3,TH;20160420;14039;6644;PLATE2.,,,0,,02NOV2015,13NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-086,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64077-3,P2,1,v100,SA,160224-VB-HVTN100,10.0,24NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CA60BGKV-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160226;6644;13372;PLATE4.,,,0,,13NOV2015,24NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-012,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64078-5,P2,1,v100,SA,160223-VB-HVTN100,10.0,19NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BGF7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160225;6644;13363;PLATE4.,,,0,,14NOV2015,25NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-214,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64018-8,P2,1,v100,SA,160226-VB-HVTN100,10.0,23SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08APR2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT0552W-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,3,,10,3,VB;20160229;6644;13408;PLATE3-,,,0,0,19SEP2015,30SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-238,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64027-2,P2,1,v100,SA,160226-VB-HVTN100,10.0,27OCT2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT0584P-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,1,,10,3,VB;20160229;6644;13406;PLATE1.,,,0,,23OCT2015,03NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-175,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64030-0,P2,1,v100,SA,160226-VB-HVTN100,10.0,18SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT054PV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,3,,10,3,VB;20160229;6644;13408;PLATE3-,,,0,,14SEP2015,25SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-045,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64068-9,P2,1,v100,SA,160226-VB-HVTN100,10.0,26NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05CFM-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Valerie Bekker,4,,10,3,VB;20160229;6644;13409;PLATE4.,,,0,,22NOV2015,03DEC2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-191,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64024-7,P2,1,v100,SA,160223-VB-HVTN100,10.0,26OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXHD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160225;6644;13362;PLATE3-,,,0,,24OCT2015,04NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-164,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64045-0,P2,1,v100,SA,160304-VB-HVTN100,10.0,16NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J06D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160304;6644;13493;PLATE2.,,,0,,14NOV2015,25NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-008,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64049-7,P2,1,v100,SA,160304-VB-HVTN100,10.0,02NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HYLY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160304;6644;13493;PLATE2.,,,0,,29OCT2015,09NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-016,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64051-7,P2,1,v100,SA,160304-VB-HVTN100,10.0,18NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0N9-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160304;6644;13493;PLATE2.,,,0,,17NOV2015,28NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-033,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64059-1,P2,1,v100,SA,160304-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HZVY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160304;6644;13495;PLATE4.,,,0,,07NOV2015,18NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-241,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64069-9,P2,1,v100,SA,160302-VB-HVTN100,10.0,10NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160302;6644;13480;PLATE4.,,,0,,05NOV2015,16NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-159,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64073-3,P2,1,v100,SA,160223-VB-HVTN100,10.0,27OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXSP-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160225;6644;13363;PLATE4.,,,0,,26OCT2015,06NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-049,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64083-0,P2,1,v100,SA,160304-OK-HVTN100,10.0,17NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0CK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Owen Karimanzira,3,,10,3,OK;20160307;13545;6644;PLATE3-,,,0,,14NOV2015,25NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-024,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64008-7,P2,1,v100,SA,160223-VB-HVTN100,10.0,22SEP2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HTD1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,1,,10,3,VB;20160225;6644;13360;PLATE1.,,,0,,18SEP2015,29SEP2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-143,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64021-9,P2,1,v100,SA,160316-OK-HVTN100,10.0,01OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HV6Q-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,1,,10,3,OK;20160318;13809;6644;PLATE1.,,,0,,01OCT2015,12OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-009,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64024-0,P2,1,v100,SA,160316-OK-HVTN100,10.0,21OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FTQC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,5,,10,3,OK;20160318;13808;6644;PLATE5.,,,0,,16OCT2015,27OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-094,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64031-2,P2,1,v100,SA,160302-VB-HVTN100,10.0,07NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ68-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,5,,10,3,VB;20160302;6644;13481;PLATE5.,,,0,,03NOV2015,14NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-026,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64034-7,P2,1,v100,SA,160304-VB-HVTN100,10.0,04NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HYZ4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160304;6644;13494;PLATE3.,,,0,,31OCT2015,11NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-166,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64050-7,P2,1,v100,SA,160304-VB-HVTN100,10.0,04NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYV7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,2,,10,3,VB;20160304;6644;13493;PLATE2.,,,0,,31OCT2015,11NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-005,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64057-3,P2,1,v100,SA,160304-VB-HVTN100,10.0,04NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HYVZ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,4,,10,3,VB;20160304;6644;13495;PLATE4.,,,0,,30OCT2015,10NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-133,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64060-1,P2,1,v100,SA,160304-VB-HVTN100,10.0,07NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Valerie Bekker,3,,10,3,VB;20160304;6644;13494;PLATE3.,,,0,,03NOV2015,14NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-195,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64070-6,P2,1,v100,SA,160301-OK-HVTN100,10.0,09NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20G1M1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,4,,10,3,OK;20160303;13447;6644;PLATE4.,,,0,,07NOV2015,18NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-043,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64017-7,P2,1,v100,SA,160422-TH-HVTN100,10.0,13OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FQTX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Tandile Hermanus,2,,10,3,TH;20160425;14068;6644;PLATE2.,,,0,,10OCT2015,21OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-174,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64052-4,P2,1,v100,SA,160316-OK-HVTN100,10.0,23OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FW49-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,4,,10,3,OK;20160318;13807;6644;PLATE4.,,,0,,19OCT2015,30OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-067,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64073-7,P2,1,v100,SA,160422-TH-HVTN100,10.0,22OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FVG5-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,72,Tandile Hermanus,2,,10,3,TH;20160425;14068;6644;PLATE2.,,,0,,18OCT2015,29OCT2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-213,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64079-9,P2,1,v100,SA,160301-OK-HVTN100,10.0,28OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FX13-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,1,,10,3,OK;20160303;13444;6644;PLATE1.,,,0,,24OCT2015,04NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-250,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64080-5,P2,1,v100,SA,160301-OK-HVTN100,10.0,28OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX2K-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,22OCT2015,151022,48,Owen Karimanzira,1,,10,3,OK;20160303;13444;6644;PLATE1.,,,0,,24OCT2015,04NOV2015,0,182,0,6644.v2.c33,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-053,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64003-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,22JUL2015,04MAR2016,50,10,10,25,25,1.3979400087,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20DYKC-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,4,,10,3,VB;20160307;CA146;13522;PLATE4,,,0,,19JUL2015,30JUL2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-111,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64006-5,T1,0,v100,SA,160307-VB-HVTN100,10.0,29JUL2015,04MAR2016,50,10,10,46,46,1.6627578317,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20F09P-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,5,,10,3,VB;20160307;CA146;13523;PLATE5,,,0,,26JUL2015,06AUG2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-031,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64009-0,T1,0,v100,SA,160304-OK-HVTN100,10.0,23JUL2015,04MAR2016,50,10,10,47,47,1.6720978579,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20DYTL-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,5,,10,3,OK;20160307;13549;CA146;PLATE5,,,0,,23JUL2015,03AUG2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-209,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64013-9,T1,0,v100,SA,160308-VB-HVTN100,10.0,28JUL2015,08MAR2016,50,10,10,20,20,1.3010299957,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20DZVV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160310;CA146;13577;PLATE2,,,0,,25JUL2015,05AUG2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-158,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64021-4,T1,0,v100,SA,160304-OK-HVTN100,10.0,03AUG2015,04MAR2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F17D-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,5,,10,3,OK;20160307;13549;CA146;PLATE5,,,0,,01AUG2015,12AUG2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-215,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64029-9,T1,0,v100,SA,160308-VB-HVTN100,10.0,25AUG2015,08MAR2016,50,10,10,42,42,1.6232492904,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8HS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160310;CA146;13577;PLATE2,,,0,,14AUG2015,25AUG2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-231,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64031-7,T1,0,v100,SA,160422-TH-HVTN100,10.0,27AUG2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8ZN-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,1,,10,3,TH;20160425;14057;CA146;PLATE1,,,0,,21AUG2015,01SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-091,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64033-4,T1,0,v100,SA,160422-TH-HVTN100,10.0,08SEP2015,22APR2016,50,10,10,22,22,1.3424226808,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD4N-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,1,,10,3,TH;20160425;14057;CA146;PLATE1,,,0,,04SEP2015,15SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-077,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64036-9,T1,0,v100,SA,160307-VB-HVTN100,10.0,18AUG2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20F5SG-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,4,,10,3,VB;20160307;CA146;13522;PLATE4,,,0,,14AUG2015,25AUG2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-136,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64045-2,T1,0,v100,SA,160308-VB-HVTN100,10.0,13AUG2015,08MAR2016,50,10,10,16,16,1.2041199827,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F4C6-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160310;CA146;13577;PLATE2,,,0,,13AUG2015,24AUG2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-227,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64053-1,T1,0,v100,SA,160422-TH-HVTN100,10.0,19AUG2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20F676-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,1,,10,3,TH;20160425;14057;CA146;PLATE1,,,0,,16AUG2015,27AUG2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-160,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64054-4,T1,0,v100,SA,160308-VB-HVTN100,10.0,26AUG2015,08MAR2016,50,10,10,53,53,1.7242758696,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8R9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160310;CA146;13577;PLATE2,,,0,,21AUG2015,01SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-155,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64055-9,T1,0,v100,SA,160308-VB-HVTN100,10.0,20AUG2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F6C4-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160310;CA146;13578;PLATE3,,,0,,14AUG2015,25AUG2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-177,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64057-8,T1,0,v100,SA,160308-VB-HVTN100,10.0,02SEP2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FBT0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160310;CA146;13576;PLATE1,,,0,,23AUG2015,03SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-052,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64062-2,T1,0,v100,SA,160308-VB-HVTN100,10.0,03SEP2015,08MAR2016,50,10,10,30,30,1.4771212547,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FC68-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160310;CA146;13578;PLATE3,,,0,,28AUG2015,08SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-247,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64063-5,T1,0,v100,SA,160304-OK-HVTN100,10.0,08SEP2015,04MAR2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FD2Q-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,5,,10,3,OK;20160307;13549;CA146;PLATE5,,,0,,04SEP2015,15SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-126,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64066-3,T1,0,v100,SA,160304-OK-HVTN100,10.0,08SEP2015,04MAR2016,50,10,10,20,20,1.3010299957,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD3H-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,5,,10,3,OK;20160307;13549;CA146;PLATE5,,,0,,04SEP2015,15SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-225,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64067-4,T1,0,v100,SA,160422-TH-HVTN100,10.0,08SEP2015,22APR2016,50,10,10,27,27,1.4313637642,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FD43-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,1,,10,3,TH;20160425;14057;CA146;PLATE1,,,0,,04SEP2015,15SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-148,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64069-7,T1,0,v100,SA,160302-VB-HVTN100,10.0,14SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FGVK-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160302;CA146;13474;PLATE3,,,0,,12SEP2015,23SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-163,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64077-9,T1,0,v100,SA,160304-OK-HVTN100,10.0,07SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FCJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,2,,10,3,OK;20160307;13543;CA146;PLATE2,,,0,,29AUG2015,09SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-073,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64080-3,T1,0,v100,SA,160308-VB-HVTN100,10.0,31AUG2015,08MAR2016,50,10,10,122,122,2.0863598307,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FB33-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160310;CA146;13576;PLATE1,,,0,,28AUG2015,08SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-184,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64087-7,T1,0,v100,SA,160304-OK-HVTN100,10.0,07SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FCJR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,2,,10,3,OK;20160307;13543;CA146;PLATE2,,,0,,06SEP2015,17SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-170,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64095-4,T1,0,v100,SA,160301-OK-HVTN100,10.0,08OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FQ3V-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,4,,10,3,OK;20160303;13452;CA146;PLATE4,,,0,,01OCT2015,12OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-038,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64105-9,T1,0,v100,SA,160318-VB-HVTN100,10.0,17NOV2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G4TX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160320;CA146;13849;PLATE2,,,0,,14NOV2015,25NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-123,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64117-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,17SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FJ00-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,3,,10,3,VB;20160307;CA146;13521;PLATE3,,,0,,13SEP2015,24SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-061,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64119-8,T1,0,v100,SA,160307-VB-HVTN100,10.0,30SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FMJ0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,5,,10,3,VB;20160307;CA146;13523;PLATE5,,,0,,26SEP2015,07OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-128,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64129-6,T1,0,v100,SA,160302-VB-HVTN100,10.0,06OCT2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FPD4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160302;CA146;13474;PLATE3,,,0,,03OCT2015,14OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-108,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64130-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,06OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FPDG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,4,,10,3,VB;20160307;CA146;13522;PLATE4,,,0,,02OCT2015,13OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-097,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64135-8,T1,0,v100,SA,160302-VB-HVTN100,10.0,28SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FLTC-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160302;CA146;13474;PLATE3,,,0,,26SEP2015,07OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-129,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64139-4,T1,0,v100,SA,160301-OK-HVTN100,10.0,26OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FWKL-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,2,,10,3,OK;20160303;13450;CA146;PLATE2,,,0,,16OCT2015,27OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-058,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64150-0,T1,0,v100,SA,160301-OK-HVTN100,10.0,11NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20G3JT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,2,,10,3,OK;20160303;13450;CA146;PLATE2,,,0,,07NOV2015,18NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-151,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64154-2,T1,0,v100,SA,160304-OK-HVTN100,10.0,02NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FXYX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,1,,10,3,OK;20160307;13542;CA146;PLATE1,,,0,,25OCT2015,05NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-002,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64156-9,T1,0,v100,SA,160301-OK-HVTN100,10.0,02NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FXZQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,3,,10,3,OK;20160303;13451;CA146;PLATE3,,,0,,25OCT2015,05NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-194,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64166-1,T1,0,v100,SA,160304-OK-HVTN100,10.0,17NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G4VL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,2,,10,3,OK;20160307;13543;CA146;PLATE2,,,0,,14NOV2015,25NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-157,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64167-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,10NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G20B-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160302;CA146;13473;PLATE2,,,0,,06NOV2015,17NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-025,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64172-9,T1,0,v100,SA,160301-OK-HVTN100,10.0,12NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20G3X4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,2,,10,3,OK;20160303;13450;CA146;PLATE2,,,0,,06NOV2015,17NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-137,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64002-3,T1,0,v100,SA,160316-OK-HVTN100,10.0,28AUG2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BCRM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,2,,10,3,OK;20160318;13821;CA146;PLATE2,,,0,,21AUG2015,01SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-064,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64007-0,T1,0,v100,SA,160316-OK-HVTN100,10.0,14SEP2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BDHQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,2,,10,3,OK;20160318;13821;CA146;PLATE2,,,0,,10SEP2015,21SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-131,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64008-8,T1,0,v100,SA,160316-OK-HVTN100,10.0,14SEP2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BDJC-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,3,,10,3,OK;20160318;13811;CA146;PLATE3,,,0,,07SEP2015,18SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-109,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64028-0,T1,0,v100,SA,160422-TH-HVTN100,10.0,21OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BFB3-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,2,,10,3,TH;20160425;14058;CA146;PLATE2,,,0,,17OCT2015,28OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-187,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64029-3,T1,0,v100,SA,160308-VB-HVTN100,10.0,26OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFG6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160310;CA146;13578;PLATE3,,,0,,19OCT2015,30OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-090,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64030-6,T1,0,v100,SA,160224-VB-HVTN100,10.0,27OCT2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BFGQ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160226;CA146;13379;PLATE1,,,0,,23OCT2015,03NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-130,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64034-8,T1,0,v100,SA,160223-VB-HVTN100,10.0,10NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG09-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160225;CA146;13354;PLATE5,,,0,,06NOV2015,17NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-105,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64036-3,T1,0,v100,SA,160224-VB-HVTN100,10.0,13NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG4G-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160226;CA146;13380;PLATE2,,,0,,09NOV2015,20NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-140,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64037-4,T1,0,v100,SA,160223-VB-HVTN100,10.0,16NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG8C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160225;CA146;13353;PLATE4,,,0,,12NOV2015,23NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-138,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64038-9,T1,0,v100,SA,160224-VB-HVTN100,10.0,04NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFT3-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160226;CA146;13379;PLATE1,,,0,,31OCT2015,11NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-084,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64039-7,T1,0,v100,SA,160422-TH-HVTN100,10.0,27OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFH3-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,2,,10,3,TH;20160425;14058;CA146;PLATE2,,,0,,23OCT2015,03NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-198,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64040-3,T1,0,v100,SA,160224-VB-HVTN100,10.0,17NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGC1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160226;CA146;13380;PLATE2,,,0,,07NOV2015,18NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-228,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64044-0,T1,0,v100,SA,160224-VB-HVTN100,10.0,24NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BGLK-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160226;CA146;13382;PLATE4,,,0,,14NOV2015,25NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-181,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64050-8,T1,0,v100,SA,160224-VB-HVTN100,10.0,02NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFPN-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160226;CA146;13379;PLATE1,,,0,,31OCT2015,11NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-085,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64051-4,T1,0,v100,SA,160422-TH-HVTN100,10.0,06NOV2015,22APR2016,50,10,10,40,40,1.6020599913,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFVX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,2,,10,3,TH;20160425;14058;CA146;PLATE2,,,0,,02NOV2015,13NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-063,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64053-7,T1,0,v100,SA,160224-VB-HVTN100,10.0,20NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGGQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160226;CA146;13382;PLATE4,,,0,,16NOV2015,27NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-235,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64054-5,T1,0,v100,SA,160422-TH-HVTN100,10.0,09NOV2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFY7-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,4,,10,3,TH;20160425;14060;CA146;PLATE4,,,0,,05NOV2015,16NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-001,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64061-7,T1,0,v100,SA,160304-OK-HVTN100,10.0,09NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFYY-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,4,,10,3,OK;20160307;13548;CA146;PLATE4,,,0,,07NOV2015,18NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-083,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64062-8,T1,0,v100,SA,160304-OK-HVTN100,10.0,13NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,4,,10,3,OK;20160307;13548;CA146;PLATE4,,,0,,09NOV2015,20NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-145,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64066-9,T1,0,v100,SA,160224-VB-HVTN100,10.0,11NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BG31-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160226;CA146;13380;PLATE2,,,0,,06NOV2015,17NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-127,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64068-3,T1,0,v100,SA,160224-VB-HVTN100,10.0,24NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BGMS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160226;CA146;13382;PLATE4,,,0,,19NOV2015,30NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-044,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64069-1,T1,0,v100,SA,160304-OK-HVTN100,10.0,16NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GA60BG7M-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,4,,10,3,OK;20160307;13548;CA146;PLATE4,,,0,,12NOV2015,23NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-132,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64070-7,T1,0,v100,SA,160224-VB-HVTN100,10.0,13NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BG5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160226;CA146;13380;PLATE2,,,0,,09NOV2015,20NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-048,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64073-6,T1,0,v100,SA,160224-VB-HVTN100,10.0,16NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG9D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160226;CA146;13380;PLATE2,,,0,,12NOV2015,23NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-092,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64075-4,T1,0,v100,SA,160223-VB-HVTN100,10.0,17NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BGCG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160225;CA146;13352;PLATE3,,,0,,13NOV2015,24NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-218,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64076-2,T1,0,v100,SA,160223-VB-HVTN100,10.0,16NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,15JUN2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BG9S-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160225;CA146;13354;PLATE5,,,0,0,12NOV2015,23NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-179,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64082-4,T1,0,v100,SA,160224-VB-HVTN100,10.0,10NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BG19-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160226;CA146;13383;PLATE5,,,0,,06NOV2015,17NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-040,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64089-5,T1,0,v100,SA,160224-VB-HVTN100,10.0,27NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BGP5-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160226;CA146;13382;PLATE4,,,0,,21NOV2015,02DEC2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-022,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64001-8,T1,0,v100,SA,160304-OK-HVTN100,10.0,21SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,1,,10,3,OK;20160307;13542;CA146;PLATE1,,,0,,20SEP2015,01OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-066,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64002-9,T1,0,v100,SA,160302-VB-HVTN100,10.0,17SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GAT054MG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160302;CA146;13473;PLATE2,,,0,,12SEP2015,23SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-142,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64004-1,T1,0,v100,SA,160302-VB-HVTN100,10.0,22OCT2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT057TJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160302;CA146;13472;PLATE1,,,0,,16OCT2015,27OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-236,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64006-5,T1,0,v100,SA,160302-VB-HVTN100,10.0,17SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054L4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160302;CA146;13473;PLATE2,,,0,,13SEP2015,24SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-120,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64007-6,T1,0,v100,SA,160304-OK-HVTN100,10.0,17SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT054KS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,1,,10,3,OK;20160307;13542;CA146;PLATE1,,,0,,13SEP2015,24SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-029,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64009-0,T1,0,v100,SA,160226-VB-HVTN100,10.0,21SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TT-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,2,,10,3,VB;20160229;CA146;13402;PLATE2,,,0,,17SEP2015,28SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-107,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64010-5,T1,0,v100,SA,160226-VB-HVTN100,10.0,22SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT0550X-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,5,,10,3,VB;20160229;CA146;13405;PLATE5,,,0,,18SEP2015,29SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-113,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64012-3,T1,0,v100,SA,160226-VB-HVTN100,10.0,21SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054V4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,2,,10,3,VB;20160229;CA146;13402;PLATE2,,,0,,20SEP2015,01OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-234,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64016-4,T1,0,v100,SA,160226-VB-HVTN100,10.0,21SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT054VG-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,1,,10,3,VB;20160229;CA146;13401;PLATE1,,,0,,20SEP2015,01OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-059,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64017-0,T1,0,v100,SA,160226-VB-HVTN100,10.0,28SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT05585-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,1,,10,3,VB;20160229;CA146;13401;PLATE1,,,0,,24SEP2015,05OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-023,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64021-4,T1,0,v100,SA,160302-VB-HVTN100,10.0,28SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0557V-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160302;CA146;13473;PLATE2,,,0,,24SEP2015,05OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-201,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64029-9,T1,0,v100,SA,160226-VB-HVTN100,10.0,12OCT2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT056K1-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,1,,10,3,VB;20160229;CA146;13401;PLATE1,,,0,,08OCT2015,19OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-076,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64031-7,T1,0,v100,SA,160226-VB-HVTN100,10.0,26OCT2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT057ZR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,1,,10,3,VB;20160229;CA146;13401;PLATE1,,,0,,22OCT2015,02NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-204,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64035-6,T1,0,v100,SA,160302-VB-HVTN100,10.0,26OCT2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057X1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160302;CA146;13472;PLATE1,,,0,,22OCT2015,02NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-230,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64036-9,T1,0,v100,SA,160226-VB-HVTN100,10.0,02NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT058FR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,2,,10,3,VB;20160229;CA146;13402;PLATE2,,,0,,29OCT2015,09NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-011,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64037-5,T1,0,v100,SA,160226-VB-HVTN100,10.0,27OCT2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0584C-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,5,,10,3,VB;20160229;CA146;13405;PLATE5,,,0,,23OCT2015,03NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-161,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64038-3,T1,0,v100,SA,160226-VB-HVTN100,10.0,19OCT2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT05797-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,4,,10,3,VB;20160229;CA146;13404;PLATE4,,,0,,15OCT2015,26OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-180,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64041-3,T1,0,v100,SA,160226-VB-HVTN100,10.0,07NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05967-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,5,,10,3,VB;20160229;CA146;13405;PLATE5,,,0,,02NOV2015,13NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-116,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64043-8,T1,0,v100,SA,160226-VB-HVTN100,10.0,10NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT059JJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,2,,10,3,VB;20160229;CA146;13402;PLATE2,,,0,,06NOV2015,17NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-079,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64044-6,T1,0,v100,SA,160302-VB-HVTN100,10.0,23OCT2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057VG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160302;CA146;13472;PLATE1,,,0,,19OCT2015,30OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-192,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64045-2,T1,0,v100,SA,160226-VB-HVTN100,10.0,11NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT059Q1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,3,,10,3,VB;20160229;CA146;13403;PLATE3,,,0,,09NOV2015,20NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-146,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64050-2,T1,0,v100,SA,160226-VB-HVTN100,10.0,11NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT059TS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,2,,10,3,VB;20160229;CA146;13402;PLATE2,,,0,,07NOV2015,18NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-006,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64051-5,T1,0,v100,SA,160226-VB-HVTN100,10.0,09NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT0598R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,3,,10,3,VB;20160229;CA146;13403;PLATE3,,,0,,05NOV2015,16NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-007,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64053-1,T1,0,v100,SA,160302-VB-HVTN100,10.0,09NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT059C4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160302;CA146;13473;PLATE2,,,0,,05NOV2015,16NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-081,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64054-4,T1,0,v100,SA,160226-VB-HVTN100,10.0,10NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT059KL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,5,,10,3,VB;20160229;CA146;13405;PLATE5,,,0,,06NOV2015,17NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-172,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64056-7,T1,0,v100,SA,160226-VB-HVTN100,10.0,16NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05B6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,4,,10,3,VB;20160229;CA146;13404;PLATE4,,,0,,12NOV2015,23NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-205,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64057-8,T1,0,v100,SA,160302-VB-HVTN100,10.0,11NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT059VK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160302;CA146;13472;PLATE1,,,0,,06NOV2015,17NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-202,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64060-6,T1,0,v100,SA,160226-VB-HVTN100,10.0,21NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05BWD-05,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,4,,10,3,VB;20160229;CA146;13404;PLATE4,,,0,,17NOV2015,28NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-119,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64062-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,18NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT05BLC-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160302;CA146;13472;PLATE1,,,0,,14NOV2015,25NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-101,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64072-7,T1,0,v100,SA,160226-VB-HVTN100,10.0,19NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05BS4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,4,,10,3,VB;20160229;CA146;13404;PLATE4,,,0,,19NOV2015,30NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-050,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64003-1,T1,0,v100,SA,160422-TH-HVTN100,10.0,02SEP2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HRJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,3,,10,3,TH;20160425;14059;CA146;PLATE3,,,0,,29AUG2015,09SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-150,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64005-9,T1,0,v100,SA,160223-VB-HVTN100,10.0,01SEP2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HR6B-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160225;CA146;13350;PLATE1,,,0,,28AUG2015,08SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-114,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64006-7,T1,0,v100,SA,160304-OK-HVTN100,10.0,18SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HT5Y-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,3,,10,3,OK;20160307;13547;CA146;PLATE3,,,0,,14SEP2015,25SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-190,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64007-8,T1,0,v100,SA,160422-TH-HVTN100,10.0,05OCT2015,22APR2016,50,10,10,15,15,1.1760912591,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HVGX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,3,,10,3,TH;20160425;14059;CA146;PLATE3,,,0,,01OCT2015,12OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-248,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64011-0,T1,0,v100,SA,160223-VB-HVTN100,10.0,23SEP2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HTJJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160225;CA146;13350;PLATE1,,,0,,18SEP2015,29SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-042,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64017-3,T1,0,v100,SA,160422-TH-HVTN100,10.0,06OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HVRV-13,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,3,,10,3,TH;20160425;14059;CA146;PLATE3,,,0,,03OCT2015,14OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-078,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64018-5,T1,0,v100,SA,160316-OK-HVTN100,10.0,02OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HVCC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,1,,10,3,OK;20160318;13820;CA146;PLATE1,,,0,,01OCT2015,12OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-242,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64019-8,T1,0,v100,SA,160224-VB-HVTN100,10.0,10NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160226;CA146;13383;PLATE5,,,0,,07NOV2015,18NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-071,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64022-3,T1,0,v100,SA,160223-VB-HVTN100,10.0,23OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXFC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160225;CA146;13352;PLATE3,,,0,,23OCT2015,03NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-070,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64025-1,T1,0,v100,SA,160223-VB-HVTN100,10.0,26OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HXGY-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160225;CA146;13351;PLATE2,,,0,,23OCT2015,03NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-134,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64026-4,T1,0,v100,SA,160304-OK-HVTN100,10.0,09NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HZB7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,3,,10,3,OK;20160307;13547;CA146;PLATE3,,,0,,05NOV2015,16NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-219,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64028-8,T1,0,v100,SA,160223-VB-HVTN100,10.0,27OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXTF-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160225;CA146;13351;PLATE2,,,0,,26OCT2015,06NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-176,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64029-6,T1,0,v100,SA,160302-VB-HVTN100,10.0,10NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160302;CA146;13475;PLATE4,,,0,,07NOV2015,18NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-135,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64031-9,T1,0,v100,SA,160304-VB-HVTN100,10.0,02NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HYLD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160304;CA146;13488;PLATE2,,,0,,24OCT2015,04NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-103,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64036-6,T1,0,v100,SA,160223-VB-HVTN100,10.0,30OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYBJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160225;CA146;13354;PLATE5,,,0,,29OCT2015,09NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-169,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64037-7,T1,0,v100,SA,160304-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZWP-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160304;CA146;13487;PLATE1,,,0,,08NOV2015,19NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-165,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64041-1,T1,0,v100,SA,160316-OK-HVTN100,10.0,01DEC2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J1Q0-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,3,,10,3,OK;20160318;13811;CA146;PLATE3,,,0,,26NOV2015,07DEC2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-183,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64044-8,T1,0,v100,SA,160223-VB-HVTN100,10.0,30OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HY9Q-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160225;CA146;13352;PLATE3,,,0,,29OCT2015,09NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-188,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64046-3,T1,0,v100,SA,160224-VB-HVTN100,10.0,17NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J09C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160226;CA146;13381;PLATE3,,,0,,17NOV2015,28NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-054,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64047-4,T1,0,v100,SA,160224-VB-HVTN100,10.0,03NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HYR2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160226;CA146;13383;PLATE5,,,0,,29OCT2015,09NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-239,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64054-2,T1,0,v100,SA,160223-VB-HVTN100,10.0,28OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HXZP-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160225;CA146;13353;PLATE4,,,0,,26OCT2015,06NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-098,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64062-0,T1,0,v100,SA,160304-VB-HVTN100,10.0,03NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HYRQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160304;CA146;13491;PLATE5,,,0,,30OCT2015,10NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-216,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64064-5,T1,0,v100,SA,160316-OK-HVTN100,10.0,12NOV2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J015-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,4,,10,3,OK;20160318;13812;CA146;PLATE4,,,0,,09NOV2015,20NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-185,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64065-3,T1,0,v100,SA,160302-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZXY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160302;CA146;13475;PLATE4,,,0,,08NOV2015,19NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-102,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64067-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,17NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J09F-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160302;CA146;13476;PLATE5,,,0,,13NOV2015,24NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-112,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64070-4,T1,0,v100,SA,160304-OK-HVTN100,10.0,16NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J03Q-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,3,,10,3,OK;20160307;13547;CA146;PLATE3,,,0,,05NOV2015,16NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-082,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64074-1,T1,0,v100,SA,160223-VB-HVTN100,10.0,16NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J039-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160225;CA146;13353;PLATE4,,,0,,12NOV2015,23NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-197,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64084-3,T1,0,v100,SA,160304-VB-HVTN100,10.0,18NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J0MY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160304;CA146;13487;PLATE1,,,0,,15NOV2015,26NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-232,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64085-5,T1,0,v100,SA,160316-OK-HVTN100,10.0,01DEC2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J1QW-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,3,,10,3,OK;20160318;13811;CA146;PLATE3,,,0,,20NOV2015,01DEC2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-003,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64002-4,T1,0,v100,SA,160316-OK-HVTN100,10.0,13OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBJ-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,2,,10,3,OK;20160318;13821;CA146;PLATE2,,,0,,08OCT2015,19OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-152,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64006-0,T1,0,v100,SA,160224-VB-HVTN100,10.0,14SEP2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HSJ4-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160226;CA146;13381;PLATE3,,,0,,06SEP2015,17SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-220,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64009-5,T1,0,v100,SA,160316-OK-HVTN100,10.0,15OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWQB-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,1,,10,3,OK;20160318;13820;CA146;PLATE1,,,0,,11OCT2015,22OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-125,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64010-0,T1,0,v100,SA,160223-VB-HVTN100,10.0,14SEP2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HSMB-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160225;CA146;13350;PLATE1,,,0,,05SEP2015,16SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-233,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64011-7,T1,0,v100,SA,160223-VB-HVTN100,10.0,22SEP2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HTGD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160225;CA146;13350;PLATE1,,,0,,18SEP2015,29SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-186,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64016-9,T1,0,v100,SA,160224-VB-HVTN100,10.0,27OCT2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08MAR2016,,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXNV-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160226;CA146;13381;PLATE3,,,0,0,18OCT2015,29OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-039,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64017-5,T1,0,v100,SA,160422-TH-HVTN100,10.0,29SEP2015,22APR2016,50,10,10,11,11,1.0413926852,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HTWM-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,3,,10,3,TH;20160425;14059;CA146;PLATE3,,,0,,26SEP2015,07OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-013,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64018-3,T1,0,v100,SA,160304-VB-HVTN100,10.0,20NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J0YX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160304;CA146;13489;PLATE3,,,0,,17NOV2015,28NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-121,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64020-3,T1,0,v100,SA,160422-TH-HVTN100,10.0,06OCT2015,22APR2016,50,10,10,36,36,1.5563025008,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HVPF-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,3,,10,3,TH;20160425;14059;CA146;PLATE3,,,0,,01OCT2015,12OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-087,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64023-2,T1,0,v100,SA,160223-VB-HVTN100,10.0,21OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HX1W-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160225;CA146;13351;PLATE2,,,0,,16OCT2015,27OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-100,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64025-8,T1,0,v100,SA,160316-OK-HVTN100,10.0,13OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBG-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,1,,10,3,OK;20160318;13820;CA146;PLATE1,,,0,,08OCT2015,19OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-069,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64026-6,T1,0,v100,SA,160316-OK-HVTN100,10.0,07NOV2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,3,,10,3,OK;20160318;13811;CA146;PLATE3,,,0,,03NOV2015,14NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-206,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64033-9,T1,0,v100,SA,160223-VB-HVTN100,10.0,20OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08DEC2015,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HWYC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160225;CA146;13351;PLATE2,,,0,0,15OCT2015,26OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-047,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64035-1,T1,0,v100,SA,160506-TH-HVTN100,10.0,05NOV2015,06MAY2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ01-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,1,,10,3,TH;20160509;14131;CA146;PLATE1,,,0,,01NOV2015,12NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-089,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64038-8,T1,0,v100,SA,160304-VB-HVTN100,10.0,25NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J17P-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160304;CA146;13491;PLATE5,,,0,,20NOV2015,01DEC2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-139,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64041-8,T1,0,v100,SA,160304-VB-HVTN100,10.0,10NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFB-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160304;CA146;13491;PLATE5,,,0,,06NOV2015,17NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-080,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64042-9,T1,0,v100,SA,160304-VB-HVTN100,10.0,26OCT2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HXGW-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160304;CA146;13487;PLATE1,,,0,,22OCT2015,02NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-210,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64046-5,T1,0,v100,SA,160223-VB-HVTN100,10.0,27OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXNS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160225;CA146;13351;PLATE2,,,0,,23OCT2015,03NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-162,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64048-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J00K-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160302;CA146;13476;PLATE5,,,0,,05NOV2015,16NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-246,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64051-0,T1,0,v100,SA,160304-VB-HVTN100,10.0,11NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZP9-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160304;CA146;13487;PLATE1,,,0,,07NOV2015,18NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-223,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64053-6,T1,0,v100,SA,160223-VB-HVTN100,10.0,11NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HZQD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160225;CA146;13354;PLATE5,,,0,,07NOV2015,18NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-028,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64055-4,T1,0,v100,SA,160223-VB-HVTN100,10.0,05NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZ03-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160225;CA146;13352;PLATE3,,,0,,01NOV2015,12NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-244,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64059-8,T1,0,v100,SA,160302-VB-HVTN100,10.0,20NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J0Y2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160302;CA146;13475;PLATE4,,,0,,17NOV2015,28NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-153,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64061-6,T1,0,v100,SA,160304-VB-HVTN100,10.0,07NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160304;CA146;13490;PLATE4,,,0,,03NOV2015,14NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-015,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64063-0,T1,0,v100,SA,160304-VB-HVTN100,10.0,19NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J0WN-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160304;CA146;13490;PLATE4,,,1,,14NOV2015,25NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-252,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64064-3,T1,0,v100,SA,160302-VB-HVTN100,10.0,23NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0ZW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160302;CA146;13476;PLATE5,,,0,,19NOV2015,30NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-211,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64068-4,T1,0,v100,SA,160224-VB-HVTN100,10.0,10NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZFD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160226;CA146;13381;PLATE3,,,0,,07NOV2015,18NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-147,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64069-2,T1,0,v100,SA,160302-VB-HVTN100,10.0,16NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J02X-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160302;CA146;13474;PLATE3,,,0,,05NOV2015,16NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-168,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64071-1,T1,0,v100,SA,160302-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZZT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160302;CA146;13475;PLATE4,,,0,,08NOV2015,19NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-203,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64072-2,T1,0,v100,SA,160304-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZYT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160304;CA146;13491;PLATE5,,,0,,08NOV2015,19NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-167,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64074-8,T1,0,v100,SA,160224-VB-HVTN100,10.0,18NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J0LW-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160226;CA146;13381;PLATE3,,,0,,17NOV2015,28NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-224,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64075-0,T1,0,v100,SA,160304-VB-HVTN100,10.0,19NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J0W8-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160304;CA146;13490;PLATE4,,,0,,13NOV2015,24NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-226,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64077-4,T1,0,v100,SA,160304-VB-HVTN100,10.0,19NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J0QS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160304;CA146;13489;PLATE3,,,0,,15NOV2015,26NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-020,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64079-7,T1,0,v100,SA,160304-VB-HVTN100,10.0,03DEC2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J1WG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160304;CA146;13487;PLATE1,,,0,,27NOV2015,08DEC2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-065,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64001-1,T1,0,v100,SA,160307-VB-HVTN100,10.0,07SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FCQ6-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,4,,10,3,VB;20160307;CA146;13522;PLATE4,,,0,,05SEP2015,16SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-018,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64002-2,T1,0,v100,SA,160307-VB-HVTN100,10.0,15SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FHFQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,3,,10,3,VB;20160307;CA146;13521;PLATE3,,,0,,14SEP2015,25SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-096,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64004-8,T1,0,v100,SA,160307-VB-HVTN100,10.0,23OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FW3Z-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,3,,10,3,VB;20160307;CA146;13521;PLATE3,,,0,,22OCT2015,02NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-249,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64006-3,T1,0,v100,SA,160302-VB-HVTN100,10.0,22SEP2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FK9S-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160302;CA146;13474;PLATE3,,,0,,20SEP2015,01OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-010,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64009-7,T1,0,v100,SA,160307-VB-HVTN100,10.0,22SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FKKP-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,1,,10,3,VB;20160307;CA146;13519;PLATE1,,,0,,20SEP2015,01OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-222,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64018-1,T1,0,v100,SA,160307-VB-HVTN100,10.0,30SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FMJB-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,1,,10,3,VB;20160307;CA146;13519;PLATE1,,,0,,26SEP2015,07OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-046,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64022-7,T1,0,v100,SA,160307-VB-HVTN100,10.0,16OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FS71-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,3,,10,3,VB;20160307;CA146;13521;PLATE3,,,0,,12OCT2015,23OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-037,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64030-7,T1,0,v100,SA,160422-TH-HVTN100,10.0,09OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FQ9L-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,4,,10,3,TH;20160425;14060;CA146;PLATE4,,,0,,01OCT2015,12OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-251,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64033-6,T1,0,v100,SA,160301-OK-HVTN100,10.0,19OCT2015,01MAR2016,50,10,10,19,19,1.278753601,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FSKN-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,5,,10,3,OK;20160303;13453;CA146;PLATE5,,,0,,12OCT2015,23OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-099,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64034-9,T1,0,v100,SA,160301-OK-HVTN100,10.0,08OCT2015,01MAR2016,50,10,10,23,23,1.361727836,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FQ46-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,4,,10,3,OK;20160303;13452;CA146;PLATE4,,,0,,03OCT2015,14OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-032,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64038-5,T1,0,v100,SA,160301-OK-HVTN100,10.0,26OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FWHM-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,4,,10,3,OK;20160303;13452;CA146;PLATE4,,,0,,22OCT2015,02NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-245,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64039-8,T1,0,v100,SA,160422-TH-HVTN100,10.0,15OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FRV7-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,5,,10,3,TH;20160425;14061;CA146;PLATE5,,,0,,08OCT2015,19OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-057,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64042-6,T1,0,v100,SA,160307-VB-HVTN100,10.0,22OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FVNV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,1,,10,3,VB;20160307;CA146;13519;PLATE1,,,0,,17OCT2015,28OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-055,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64043-1,T1,0,v100,SA,160316-OK-HVTN100,10.0,14OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FRFF-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,5,,10,3,OK;20160318;13817;CA146;PLATE5,,,0,,12OCT2015,23OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-021,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64046-7,T1,0,v100,SA,160301-OK-HVTN100,10.0,04NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FZ1Z-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,5,,10,3,OK;20160303;13453;CA146;PLATE5,,,0,,01NOV2015,12NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-156,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64049-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,14OCT2015,04MAR2016,50,10,10,22,22,1.3424226808,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRCW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,1,,10,3,VB;20160307;CA146;13519;PLATE1,,,0,,10OCT2015,21OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-014,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64054-6,T1,0,v100,SA,160422-TH-HVTN100,10.0,23OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FW4N-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,5,,10,3,TH;20160425;14061;CA146;PLATE5,,,0,,16OCT2015,27OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-240,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64062-9,T1,0,v100,SA,160301-OK-HVTN100,10.0,27OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FWTX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,4,,10,3,OK;20160303;13452;CA146;PLATE4,,,0,,23OCT2015,03NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-171,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64063-3,T1,0,v100,SA,160307-VB-HVTN100,10.0,14OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRDV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,2,,10,3,VB;20160307;CA146;13520;PLATE2,,,0,,10OCT2015,21OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-068,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64064-1,T1,0,v100,SA,160301-OK-HVTN100,10.0,27OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FWX6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,3,,10,3,OK;20160303;13451;CA146;PLATE3,,,0,,23OCT2015,03NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-062,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64065-7,T1,0,v100,SA,160422-TH-HVTN100,10.0,13OCT2015,22APR2016,50,10,10,37,37,1.5682017241,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FQWN-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,4,,10,3,TH;20160425;14060;CA146;PLATE4,,,0,,12OCT2015,23OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-036,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64066-5,T1,0,v100,SA,160316-OK-HVTN100,10.0,16OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FS6F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,5,,10,3,OK;20160318;13817;CA146;PLATE5,,,0,,10OCT2015,21OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-095,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64071-4,T1,0,v100,SA,160307-VB-HVTN100,10.0,21OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FTPM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,2,,10,3,VB;20160307;CA146;13520;PLATE2,,,0,,17OCT2015,28OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-212,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64072-0,T1,0,v100,SA,160301-OK-HVTN100,10.0,02NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FY0T-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,1,,10,3,OK;20160303;13449;CA146;PLATE1,,,0,,29OCT2015,09NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-072,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64074-5,T1,0,v100,SA,160307-VB-HVTN100,10.0,20OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FSTR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,2,,10,3,VB;20160307;CA146;13520;PLATE2,,,0,,15OCT2015,26OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-229,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64076-1,T1,0,v100,SA,160301-OK-HVTN100,10.0,07NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20G182-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,1,,10,3,OK;20160303;13449;CA146;PLATE1,,,0,,29OCT2015,09NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-217,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64077-2,T1,0,v100,SA,160301-OK-HVTN100,10.0,29OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FXCG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,3,,10,3,OK;20160303;13451;CA146;PLATE3,,,0,,25OCT2015,05NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-149,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64078-6,T1,0,v100,SA,160307-VB-HVTN100,10.0,21OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FTPZ-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,2,,10,3,VB;20160307;CA146;13520;PLATE2,,,0,,16OCT2015,27OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-017,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64085-1,T1,0,v100,SA,160307-VB-HVTN100,10.0,20OCT2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FSV2-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,2,,10,3,VB;20160307;CA146;13520;PLATE2,,,0,,17OCT2015,28OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-074,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64086-4,T1,0,v100,SA,160301-OK-HVTN100,10.0,30OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FXJC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,2,,10,3,OK;20160303;13450;CA146;PLATE2,,,0,,26OCT2015,06NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-124,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64089-6,T1,0,v100,SA,160301-OK-HVTN100,10.0,28OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX1S-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,2,,10,3,OK;20160303;13450;CA146;PLATE2,,,0,,25OCT2015,05NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-004,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64095-6,T1,0,v100,SA,160301-OK-HVTN100,10.0,27OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FWWD-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,3,,10,3,OK;20160303;13451;CA146;PLATE3,,,0,,23OCT2015,03NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-182,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64097-5,T1,0,v100,SA,160301-OK-HVTN100,10.0,06NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G0Z4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,1,,10,3,OK;20160303;13449;CA146;PLATE1,,,0,,05NOV2015,16NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-034,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64107-1,T1,0,v100,SA,160304-OK-HVTN100,10.0,07NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G18P-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,1,,10,3,OK;20160307;13542;CA146;PLATE1,,,0,,03NOV2015,14NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-115,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64113-4,T1,0,v100,SA,160301-OK-HVTN100,10.0,30OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FXJP-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,3,,10,3,OK;20160303;13451;CA146;PLATE3,,,0,,29OCT2015,09NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-144,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64118-3,T1,0,v100,SA,160301-OK-HVTN100,10.0,10NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20G20Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,5,,10,3,OK;20160303;13453;CA146;PLATE5,,,0,,07NOV2015,18NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-189,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64125-8,T1,0,v100,SA,160301-OK-HVTN100,10.0,12NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G3XF-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,5,,10,3,OK;20160303;13453;CA146;PLATE5,,,0,,12NOV2015,23NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,T1,"TZM-bl, Tier 1B"
100-141,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64001-8,P2,1,v100,SA,160422-TH-HVTN100,10.0,23JUL2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20DZ2F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,1,,10,3,TH;20160425;14057;CA146;PLATE1,,,0,,23JUL2015,03AUG2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-056,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64028-6,P2,1,v100,SA,160308-VB-HVTN100,10.0,04AUG2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20F1PR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160310;CA146;13577;PLATE2,,,0,,02AUG2015,13AUG2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-154,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64047-1,P2,1,v100,SA,160308-VB-HVTN100,10.0,17AUG2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20F5F9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160310;CA146;13576;PLATE1,,,0,,13AUG2015,24AUG2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-041,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64059-3,P2,1,v100,SA,160308-VB-HVTN100,10.0,19AUG2015,08MAR2016,50,10,10,59,59,1.7708520116,1,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20F64B-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160310;CA146;13576;PLATE1,,,0,,15AUG2015,26AUG2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-196,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64085-8,P2,1,v100,SA,160304-OK-HVTN100,10.0,07SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FCQJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,2,,10,3,OK;20160307;13543;CA146;PLATE2,,,0,,04SEP2015,15SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-200,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64086-6,P2,1,v100,SA,160307-VB-HVTN100,10.0,15SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FHG1-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,5,,10,3,VB;20160307;CA146;13523;PLATE5,,,0,,12SEP2015,23SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-122,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64121-2,P2,1,v100,SA,160304-OK-HVTN100,10.0,29SEP2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FM29-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,1,,10,3,OK;20160307;13542;CA146;PLATE1,,,0,,26SEP2015,07OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-199,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64165-3,P2,1,v100,SA,160304-OK-HVTN100,10.0,09NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20G1N0-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,2,,10,3,OK;20160307;13543;CA146;PLATE2,,,0,,05NOV2015,16NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-104,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64052-0,P2,1,v100,SA,160422-TH-HVTN100,10.0,06NOV2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BFW9-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,2,,10,3,TH;20160425;14058;CA146;PLATE2,,,0,,02NOV2015,13NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-086,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64077-3,P2,1,v100,SA,160224-VB-HVTN100,10.0,24NOV2015,24FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CA60BGKV-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160226;CA146;13382;PLATE4,,,0,,13NOV2015,24NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-012,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64078-5,P2,1,v100,SA,160223-VB-HVTN100,10.0,19NOV2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BGF7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160225;CA146;13353;PLATE4,,,0,,14NOV2015,25NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-214,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64018-8,P2,1,v100,SA,160226-VB-HVTN100,10.0,23SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08APR2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT0552W-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,3,,10,3,VB;20160229;CA146;13403;PLATE3,,,0,0,19SEP2015,30SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-238,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64027-2,P2,1,v100,SA,160226-VB-HVTN100,10.0,27OCT2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT0584P-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,1,,10,3,VB;20160229;CA146;13401;PLATE1,,,0,,23OCT2015,03NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-175,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64030-0,P2,1,v100,SA,160226-VB-HVTN100,10.0,18SEP2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT054PV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,3,,10,3,VB;20160229;CA146;13403;PLATE3,,,0,,14SEP2015,25SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-045,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64068-9,P2,1,v100,SA,160226-VB-HVTN100,10.0,26NOV2015,26FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05CFM-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Valerie Bekker,4,,10,3,VB;20160229;CA146;13404;PLATE4,,,0,,22NOV2015,03DEC2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-191,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64024-7,P2,1,v100,SA,160223-VB-HVTN100,10.0,26OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXHD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160225;CA146;13352;PLATE3,,,0,,24OCT2015,04NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-164,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64045-0,P2,1,v100,SA,160304-VB-HVTN100,10.0,16NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J06D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160304;CA146;13488;PLATE2,,,0,,14NOV2015,25NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-008,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64049-7,P2,1,v100,SA,160304-VB-HVTN100,10.0,02NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HYLY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160304;CA146;13488;PLATE2,,,0,,29OCT2015,09NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-016,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64051-7,P2,1,v100,SA,160304-VB-HVTN100,10.0,18NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0N9-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160304;CA146;13488;PLATE2,,,0,,17NOV2015,28NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-033,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64059-1,P2,1,v100,SA,160304-VB-HVTN100,10.0,12NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HZVY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160304;CA146;13490;PLATE4,,,0,,07NOV2015,18NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-241,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64069-9,P2,1,v100,SA,160302-VB-HVTN100,10.0,10NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160302;CA146;13475;PLATE4,,,0,,05NOV2015,16NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-159,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64073-3,P2,1,v100,SA,160223-VB-HVTN100,10.0,27OCT2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXSP-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,4,,10,3,VB;20160225;CA146;13353;PLATE4,,,0,,26OCT2015,06NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-049,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64083-0,P2,1,v100,SA,160304-OK-HVTN100,10.0,17NOV2015,04MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0CK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Owen Karimanzira,3,,10,3,OK;20160307;13547;CA146;PLATE3,,,0,,14NOV2015,25NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-024,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64008-7,P2,1,v100,SA,160223-VB-HVTN100,10.0,22SEP2015,23FEB2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HTD1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,1,,10,3,VB;20160225;CA146;13350;PLATE1,,,0,,18SEP2015,29SEP2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-143,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64021-9,P2,1,v100,SA,160316-OK-HVTN100,10.0,01OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HV6Q-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,1,,10,3,OK;20160318;13820;CA146;PLATE1,,,0,,01OCT2015,12OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-009,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64024-0,P2,1,v100,SA,160316-OK-HVTN100,10.0,21OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FTQC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,5,,10,3,OK;20160318;13817;CA146;PLATE5,,,0,,16OCT2015,27OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-094,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64031-2,P2,1,v100,SA,160302-VB-HVTN100,10.0,07NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ68-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,5,,10,3,VB;20160302;CA146;13476;PLATE5,,,0,,03NOV2015,14NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-026,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64034-7,P2,1,v100,SA,160304-VB-HVTN100,10.0,04NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HYZ4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160304;CA146;13489;PLATE3,,,0,,31OCT2015,11NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-166,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64050-7,P2,1,v100,SA,160304-VB-HVTN100,10.0,04NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYV7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,2,,10,3,VB;20160304;CA146;13488;PLATE2,,,0,,31OCT2015,11NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-005,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64057-3,P2,1,v100,SA,160304-VB-HVTN100,10.0,04NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HYVZ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160304;CA146;13489;PLATE3,,,0,,30OCT2015,10NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-133,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64060-1,P2,1,v100,SA,160304-VB-HVTN100,10.0,07NOV2015,02MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Valerie Bekker,3,,10,3,VB;20160304;CA146;13489;PLATE3,,,0,,03NOV2015,14NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-195,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64070-6,P2,1,v100,SA,160301-OK-HVTN100,10.0,09NOV2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20G1M1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,4,,10,3,OK;20160303;13452;CA146;PLATE4,,,0,,07NOV2015,18NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-043,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64017-7,P2,1,v100,SA,160422-TH-HVTN100,10.0,13OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FQTX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,4,,10,3,TH;20160425;14060;CA146;PLATE4,,,0,,10OCT2015,21OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-174,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64052-4,P2,1,v100,SA,160316-OK-HVTN100,10.0,23OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FW49-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,4,,10,3,OK;20160318;13812;CA146;PLATE4,,,0,,19OCT2015,30OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-067,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64073-7,P2,1,v100,SA,160422-TH-HVTN100,10.0,22OCT2015,22APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FVG5-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,72,Tandile Hermanus,4,,10,3,TH;20160425;14060;CA146;PLATE4,,,0,,18OCT2015,29OCT2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-213,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64079-9,P2,1,v100,SA,160301-OK-HVTN100,10.0,28OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FX13-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,1,,10,3,OK;20160303;13449;CA146;PLATE1,,,0,,24OCT2015,04NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-250,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64080-5,P2,1,v100,SA,160301-OK-HVTN100,10.0,28OCT2015,01MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX2K-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:2,Dilution,12NOV2015,151112,48,Owen Karimanzira,1,,10,3,OK;20160303;13449;CA146;PLATE1,,,0,,24OCT2015,04NOV2015,0,182,0,CA146_H3_3,,,,,,,,,,,,,,,,,P2,"TZM-bl, Tier 1B"
100-053,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64003-3,T1,0,v100,SA,160315-VB-HVTN100,10.0,22JUL2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20DYKC-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,2,,10,3,VB;20160317;96ZM;13746;PLATE2.,,,0,,19JUL2015,30JUL2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-111,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64006-5,T1,0,v100,SA,160315-VB-HVTN100,10.0,29JUL2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20F09P-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,2,,10,3,VB;20160317;96ZM;13746;PLATE2.,,,0,,26JUL2015,06AUG2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-031,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64009-0,T1,0,v100,SA,160314-OK-HVTN100,10.0,23JUL2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20DYTL-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,3,,10,3,OK;20160316;13727;96ZM651;PLAT,,,0,,23JUL2015,03AUG2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-209,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64013-9,T1,0,v100,SA,160316-TH-HVTN100,10.0,28JUL2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20DZVV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,2,,10,3,TH;20160318;13802;96ZM651;Plat,,,0,,25JUL2015,05AUG2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-158,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64021-4,T1,0,v100,SA,160314-OK-HVTN100,10.0,03AUG2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F17D-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,2,,10,3,OK;20160316;13728;96ZM651;PLAT,,,0,,01AUG2015,12AUG2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-215,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64029-9,T1,0,v100,SA,160316-TH-HVTN100,10.0,25AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8HS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,2,,10,3,TH;20160318;13802;96ZM651;Plat,,,0,,14AUG2015,25AUG2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-231,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64031-7,T1,0,v100,SA,160428-TH-HVTN100,10.0,27AUG2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8ZN-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,1,,10,3,TH;20160501;14103;96ZM651;PLAT,,,0,,21AUG2015,01SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-091,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64033-4,T1,0,v100,SA,160428-TH-HVTN100,10.0,08SEP2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD4N-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,1,,10,3,TH;20160501;14103;96ZM651;PLAT,,,0,,04SEP2015,15SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-077,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64036-9,T1,0,v100,SA,160315-VB-HVTN100,10.0,18AUG2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20F5SG-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,5,,10,3,VB;20160317;96ZM;13750;PLATE5.,,,0,,14AUG2015,25AUG2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-136,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64045-2,T1,0,v100,SA,160316-TH-HVTN100,10.0,13AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F4C6-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,20NOV2015,151120,48,Tandile Hermanus,1,,10,3,TH;20160318;13803;96ZM651;Plat,,,0,,13AUG2015,24AUG2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-227,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64053-1,T1,0,v100,SA,160428-TH-HVTN100,10.0,19AUG2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20F676-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,1,,10,3,TH;20160501;14103;96ZM651;PLAT,,,0,,16AUG2015,27AUG2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-160,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64054-4,T1,0,v100,SA,160316-TH-HVTN100,10.0,26AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8R9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,20NOV2015,151120,48,Tandile Hermanus,1,,10,3,TH;20160318;13803;96ZM651;Plat,,,0,,21AUG2015,01SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-155,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64055-9,T1,0,v100,SA,160316-TH-HVTN100,10.0,20AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F6C4-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,2,,10,3,TH;20160318;13802;96ZM651;Plat,,,0,,14AUG2015,25AUG2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-177,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64057-8,T1,0,v100,SA,160316-TH-HVTN100,10.0,02SEP2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FBT0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,3,,10,3,TH;20160318;13806;96ZM651;Plat,,,0,,23AUG2015,03SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-052,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64062-2,T1,0,v100,SA,160316-TH-HVTN100,10.0,03SEP2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FC68-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,20NOV2015,151120,48,Tandile Hermanus,1,,10,3,TH;20160318;13803;96ZM651;Plat,,,0,,28AUG2015,08SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-247,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64063-5,T1,0,v100,SA,160314-OK-HVTN100,10.0,08SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FD2Q-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,2,,10,3,OK;20160316;13728;96ZM651;PLAT,,,0,,04SEP2015,15SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-126,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64066-3,T1,0,v100,SA,160314-OK-HVTN100,10.0,08SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD3H-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,2,,10,3,OK;20160316;13728;96ZM651;PLAT,,,0,,04SEP2015,15SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-225,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64067-4,T1,0,v100,SA,160428-TH-HVTN100,10.0,08SEP2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FD43-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,1,,10,3,TH;20160501;14103;96ZM651;PLAT,,,0,,04SEP2015,15SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-148,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64069-7,T1,0,v100,SA,160314-OK-HVTN100,10.0,14SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FGVK-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,1,,10,3,OK;20160316;13737;96ZM651;PLAT,,,0,,12SEP2015,23SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-163,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64077-9,T1,0,v100,SA,160608-TH-HVTN100,10.0,07SEP2015,08JUN2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FCJ1-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,48,Tandile Hermanus,1,,10,3,TH;20160610;14520;96ZM651.xls,,,0,,29AUG2015,09SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-073,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64080-3,T1,0,v100,SA,160316-TH-HVTN100,10.0,31AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FB33-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,20NOV2015,151120,48,Tandile Hermanus,1,,10,3,TH;20160318;13803;96ZM651;Plat,,,0,,28AUG2015,08SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-184,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64087-7,T1,0,v100,SA,160314-OK-HVTN100,10.0,07SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FCJR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,1,,10,3,OK;20160316;13737;96ZM651;PLAT,,,0,,06SEP2015,17SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-170,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64095-4,T1,0,v100,SA,160314-OK-HVTN100,10.0,08OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FQ3V-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,1,,10,3,OK;20160316;13737;96ZM651;PLAT,,,0,,01OCT2015,12OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-038,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64105-9,T1,0,v100,SA,160316-TH-HVTN100,10.0,17NOV2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G4TX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,2,,10,3,TH;20160318;13802;96ZM651;Plat,,,0,,14NOV2015,25NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-123,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64117-3,T1,0,v100,SA,160315-VB-HVTN100,10.0,17SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FJ00-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,3,,10,3,VB;20160317;96ZM;13748;PLATE3.,,,0,,13SEP2015,24SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-061,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64119-8,T1,0,v100,SA,160315-VB-HVTN100,10.0,30SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FMJ0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,2,,10,3,VB;20160317;96ZM;13746;PLATE2.,,,0,,26SEP2015,07OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-128,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64129-6,T1,0,v100,SA,160314-OK-HVTN100,10.0,06OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FPD4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,1,,10,3,OK;20160316;13737;96ZM651;PLAT,,,0,,03OCT2015,14OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-108,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64130-3,T1,0,v100,SA,160315-VB-HVTN100,10.0,06OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FPDG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,3,,10,3,VB;20160317;96ZM;13748;PLATE3.,,,0,,02OCT2015,13OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-097,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64135-8,T1,0,v100,SA,160314-OK-HVTN100,10.0,28SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FLTC-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,1,,10,3,OK;20160316;13737;96ZM651;PLAT,,,0,,26SEP2015,07OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-129,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64139-4,T1,0,v100,SA,160316-TH-HVTN100,10.0,26OCT2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FWKL-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,3,,10,3,TH;20160318;13806;96ZM651;Plat,,,0,,16OCT2015,27OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-058,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64150-0,T1,0,v100,SA,160315-VB-HVTN100,10.0,11NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20G3JT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,4,,10,3,VB;20160317;96ZM;13749;PLATE4.,,,0,,07NOV2015,18NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-151,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64154-2,T1,0,v100,SA,160315-VB-HVTN100,10.0,02NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FXYX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,7,,10,3,VB;20160317;96ZM;13752;PLATE7.,,,0,,25OCT2015,05NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-002,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64156-9,T1,0,v100,SA,160315-VB-HVTN100,10.0,02NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FXZQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,4,,10,3,VB;20160317;96ZM;13749;PLATE4.,,,0,,25OCT2015,05NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-194,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64166-1,T1,0,v100,SA,160316-TH-HVTN100,10.0,17NOV2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G4VL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,4,,10,3,TH;20160318;13805;96ZM651;Plat,,,0,,14NOV2015,25NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-157,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64167-2,T1,0,v100,SA,160315-VB-HVTN100,10.0,10NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G20B-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,2,,10,3,VB;20160317;96ZM;13746;PLATE2.,,,0,,06NOV2015,17NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-025,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64172-9,T1,0,v100,SA,160315-VB-HVTN100,10.0,12NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20G3X4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,2,,10,3,VB;20160317;96ZM;13746;PLATE2.,,,0,,06NOV2015,17NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-137,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64002-3,T1,0,v100,SA,160314-TH-HVTN100,10.0,28AUG2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BCRM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,1,,10,3,TH;20160316;13713;96ZM651;PLAT,,,0,,21AUG2015,01SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-064,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64007-0,T1,0,v100,SA,160315-TH-HVTN100,10.0,14SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BDHQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,3,,10,3,TH;20160317;13772;96ZM651;Plat,,,0,,10SEP2015,21SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-131,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64008-8,T1,0,v100,SA,160314-TH-HVTN100,10.0,14SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BDJC-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,1,,10,3,TH;20160316;13713;96ZM651;PLAT,,,0,,07SEP2015,18SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-109,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64028-0,T1,0,v100,SA,160428-TH-HVTN100,10.0,21OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BFB3-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,2,,10,3,TH;20160501;14106;96ZM651;PLAT,,,0,,17OCT2015,28OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-187,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64029-3,T1,0,v100,SA,160314-VB-HVTN100,10.0,26OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFG6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,7,,10,3,VB;20160316;96ZM;13699;PLATE7x,,,0,,19OCT2015,30OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-090,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64030-6,T1,0,v100,SA,160315-TH-HVTN100,10.0,27OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BFGQ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,2,,10,3,TH;20160317;13769;96ZM651;Plat,,,0,,23OCT2015,03NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-130,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64034-8,T1,0,v100,SA,160315-TH-HVTN100,10.0,10NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG09-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,2,,10,3,TH;20160317;13769;96ZM651;Plat,,,0,,06NOV2015,17NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-105,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64036-3,T1,0,v100,SA,160315-TH-HVTN100,10.0,13NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG4G-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,1,,10,3,TH;20160317;13771;96ZM651;Plat,,,0,,09NOV2015,20NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-140,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64037-4,T1,0,v100,SA,160315-TH-HVTN100,10.0,16NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG8C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,1,,10,3,TH;20160317;13771;96ZM651;Plat,,,0,,12NOV2015,23NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-138,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64038-9,T1,0,v100,SA,160315-TH-HVTN100,10.0,04NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFT3-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,1,,10,3,TH;20160317;13771;96ZM651;Plat,,,0,,31OCT2015,11NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-084,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64039-7,T1,0,v100,SA,160428-TH-HVTN100,10.0,27OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFH3-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,2,,10,3,TH;20160501;14106;96ZM651;PLAT,,,0,,23OCT2015,03NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-198,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64040-3,T1,0,v100,SA,160315-TH-HVTN100,10.0,17NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGC1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,1,,10,3,TH;20160317;13771;96ZM651;Plat,,,0,,07NOV2015,18NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-228,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64044-0,T1,0,v100,SA,160314-TH-HVTN100,10.0,24NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BGLK-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,1,,10,3,TH;20160316;13713;96ZM651;PLAT,,,0,,14NOV2015,25NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-181,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64050-8,T1,0,v100,SA,160314-TH-HVTN100,10.0,02NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFPN-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,1,,10,3,TH;20160316;13713;96ZM651;PLAT,,,0,,31OCT2015,11NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-085,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64051-4,T1,0,v100,SA,160428-TH-HVTN100,10.0,06NOV2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFVX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,2,,10,3,TH;20160501;14106;96ZM651;PLAT,,,0,,02NOV2015,13NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-063,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64053-7,T1,0,v100,SA,160316-TH-HVTN100,10.0,20NOV2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGGQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,5,,10,3,TH;20160318;13798;96ZM651;Plat,,,0,,16NOV2015,27NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-235,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64054-5,T1,0,v100,SA,160428-TH-HVTN100,10.0,09NOV2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFY7-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,3,,10,3,TH;20160501;14105;96ZM651;PLAT,,,0,,05NOV2015,16NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-001,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64061-7,T1,0,v100,SA,160316-TH-HVTN100,10.0,09NOV2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFYY-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,5,,10,3,TH;20160318;13798;96ZM651;Plat,,,0,,07NOV2015,18NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-083,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64062-8,T1,0,v100,SA,160315-TH-HVTN100,10.0,13NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,3,,10,3,TH;20160317;13772;96ZM651;Plat,,,0,,09NOV2015,20NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-145,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64066-9,T1,0,v100,SA,160315-TH-HVTN100,10.0,11NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BG31-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,2,,10,3,TH;20160317;13769;96ZM651;Plat,,,0,,06NOV2015,17NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-127,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64068-3,T1,0,v100,SA,160315-TH-HVTN100,10.0,24NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BGMS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,3,,10,3,TH;20160317;13772;96ZM651;Plat,,,0,,19NOV2015,30NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-044,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64069-1,T1,0,v100,SA,160315-OK-HVTN100,10.0,16NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GA60BG7M-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,7,,10,3,OK;20160317;13788;96ZM651;PLAT,,,0,,12NOV2015,23NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-132,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64070-7,T1,0,v100,SA,160314-TH-HVTN100,10.0,13NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BG5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,2,,10,3,TH;20160316;13719;96ZM651;PLAT,,,0,,09NOV2015,20NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-048,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64073-6,T1,0,v100,SA,160314-TH-HVTN100,10.0,16NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG9D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,2,,10,3,TH;20160316;13719;96ZM651;PLAT,,,0,,12NOV2015,23NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-092,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64075-4,T1,0,v100,SA,160314-VB-HVTN100,10.0,17NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BGCG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,7,,10,3,VB;20160316;96ZM;13699;PLATE7x,,,0,,13NOV2015,24NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-218,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64076-2,T1,0,v100,SA,160314-TH-HVTN100,10.0,16NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,15JUN2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BG9S-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,2,,10,3,TH;20160316;13719;96ZM651;PLAT,,,0,0,12NOV2015,23NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-179,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64082-4,T1,0,v100,SA,160315-TH-HVTN100,10.0,10NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BG19-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,2,,10,3,TH;20160317;13769;96ZM651;Plat,,,0,,06NOV2015,17NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-040,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64089-5,T1,0,v100,SA,160315-TH-HVTN100,10.0,27NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BGP5-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,1,,10,3,TH;20160317;13771;96ZM651;Plat,,,0,,21NOV2015,02DEC2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-022,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64001-8,T1,0,v100,SA,160315-OK-HVTN100,10.0,21SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,6,,10,3,OK;20160317;13789;96ZM651;PLAT,,,0,,20SEP2015,01OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-066,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64002-9,T1,0,v100,SA,160316-TH-HVTN100,10.0,17SEP2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GAT054MG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,5,,10,3,TH;20160318;13798;96ZM651;Plat,,,0,,12SEP2015,23SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-142,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64004-1,T1,0,v100,SA,160315-OK-HVTN100,10.0,22OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT057TJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,1,,10,3,OK;20160317;13779;96ZM651;PLAT,,,0,,16OCT2015,27OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-236,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64006-5,T1,0,v100,SA,160315-OK-HVTN100,10.0,17SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054L4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,1,,10,3,OK;20160317;13779;96ZM651;PLAT,,,0,,13SEP2015,24SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-120,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64007-6,T1,0,v100,SA,160315-OK-HVTN100,10.0,17SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT054KS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,6,,10,3,OK;20160317;13789;96ZM651;PLAT,,,0,,13SEP2015,24SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-029,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64009-0,T1,0,v100,SA,160315-OK-HVTN100,10.0,21SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TT-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,1,,10,3,OK;20160317;13779;96ZM651;PLAT,,,0,,17SEP2015,28SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-107,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64010-5,T1,0,v100,SA,160315-OK-HVTN100,10.0,22SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT0550X-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,2,,10,3,OK;20160317;13776;96ZM651;PLAT,,,0,,18SEP2015,29SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-113,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64012-3,T1,0,v100,SA,160315-OK-HVTN100,10.0,21SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054V4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,2,,10,3,OK;20160317;13776;96ZM651;PLAT,,,0,,20SEP2015,01OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-234,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64016-4,T1,0,v100,SA,160315-OK-HVTN100,10.0,21SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT054VG-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,6,,10,3,OK;20160317;13789;96ZM651;PLAT,,,0,,20SEP2015,01OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-059,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64017-0,T1,0,v100,SA,160314-OK-HVTN100,10.0,28SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT05585-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,7,,10,3,OK;20160316;13731;96ZM651;PLAT,,,0,,24SEP2015,05OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-023,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64021-4,T1,0,v100,SA,160315-OK-HVTN100,10.0,28SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0557V-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,1,,10,3,OK;20160317;13779;96ZM651;PLAT,,,0,,24SEP2015,05OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-201,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64029-9,T1,0,v100,SA,160314-OK-HVTN100,10.0,12OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT056K1-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,7,,10,3,OK;20160316;13731;96ZM651;PLAT,,,0,,08OCT2015,19OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-076,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64031-7,T1,0,v100,SA,160314-OK-HVTN100,10.0,26OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT057ZR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,7,,10,3,OK;20160316;13731;96ZM651;PLAT,,,0,,22OCT2015,02NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-204,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64035-6,T1,0,v100,SA,160315-OK-HVTN100,10.0,26OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057X1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,1,,10,3,OK;20160317;13779;96ZM651;PLAT,,,0,,22OCT2015,02NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-230,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64036-9,T1,0,v100,SA,160315-OK-HVTN100,10.0,02NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT058FR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,2,,10,3,OK;20160317;13776;96ZM651;PLAT,,,0,,29OCT2015,09NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-011,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64037-5,T1,0,v100,SA,160315-OK-HVTN100,10.0,27OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0584C-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,3,,10,3,OK;20160317;13787;96ZM651;PLAT,,,0,,23OCT2015,03NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-161,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64038-3,T1,0,v100,SA,160315-OK-HVTN100,10.0,19OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT05797-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,5,,10,3,OK;20160317;13777;96ZM651;PLAT,,,0,,15OCT2015,26OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-180,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64041-3,T1,0,v100,SA,160315-OK-HVTN100,10.0,07NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05967-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,5,,10,3,OK;20160317;13777;96ZM651;PLAT,,,0,,02NOV2015,13NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-116,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64043-8,T1,0,v100,SA,160315-OK-HVTN100,10.0,10NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT059JJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,2,,10,3,OK;20160317;13776;96ZM651;PLAT,,,0,,06NOV2015,17NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-079,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64044-6,T1,0,v100,SA,160315-OK-HVTN100,10.0,23OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057VG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,3,,10,3,OK;20160317;13787;96ZM651;PLAT,,,0,,19OCT2015,30OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-192,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64045-2,T1,0,v100,SA,160315-OK-HVTN100,10.0,11NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT059Q1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,5,,10,3,OK;20160317;13777;96ZM651;PLAT,,,0,,09NOV2015,20NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-146,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64050-2,T1,0,v100,SA,160315-OK-HVTN100,10.0,11NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT059TS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,6,,10,3,OK;20160317;13789;96ZM651;PLAT,,,0,,07NOV2015,18NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-006,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64051-5,T1,0,v100,SA,160315-OK-HVTN100,10.0,09NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT0598R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,6,,10,3,OK;20160317;13789;96ZM651;PLAT,,,0,,05NOV2015,16NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-007,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64053-1,T1,0,v100,SA,160315-OK-HVTN100,10.0,09NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT059C4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,3,,10,3,OK;20160317;13787;96ZM651;PLAT,,,0,,05NOV2015,16NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-081,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64054-4,T1,0,v100,SA,160315-OK-HVTN100,10.0,10NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT059KL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,4,,10,3,OK;20160317;13778;96ZM651;PLAT,,,0,,06NOV2015,17NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-172,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64056-7,T1,0,v100,SA,160315-OK-HVTN100,10.0,16NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05B6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,5,,10,3,OK;20160317;13777;96ZM651;PLAT,,,0,,12NOV2015,23NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-205,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64057-8,T1,0,v100,SA,160315-OK-HVTN100,10.0,11NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT059VK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,3,,10,3,OK;20160317;13787;96ZM651;PLAT,,,0,,06NOV2015,17NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-202,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64060-6,T1,0,v100,SA,160315-OK-HVTN100,10.0,21NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05BWD-05,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,4,,10,3,OK;20160317;13778;96ZM651;PLAT,,,0,,17NOV2015,28NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-119,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64062-2,T1,0,v100,SA,160315-OK-HVTN100,10.0,18NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT05BLC-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,3,,10,3,OK;20160317;13787;96ZM651;PLAT,,,0,,14NOV2015,25NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-101,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64072-7,T1,0,v100,SA,160314-OK-HVTN100,10.0,19NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05BS4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,7,,10,3,OK;20160316;13731;96ZM651;PLAT,,,0,,19NOV2015,30NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-050,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64003-1,T1,0,v100,SA,160428-TH-HVTN100,10.0,02SEP2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HRJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,3,,10,3,TH;20160501;14105;96ZM651;PLAT,,,0,,29AUG2015,09SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-150,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64005-9,T1,0,v100,SA,160315-TH-HVTN100,10.0,01SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HR6B-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,7,,10,3,TH;20160317;13774;96ZM651;Plat,,,0,,28AUG2015,08SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-114,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64006-7,T1,0,v100,SA,160315-OK-HVTN100,10.0,18SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HT5Y-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,7,,10,3,OK;20160317;13788;96ZM651;PLAT,,,0,,14SEP2015,25SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-190,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64007-8,T1,0,v100,SA,160428-TH-HVTN100,10.0,05OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HVGX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,3,,10,3,TH;20160501;14105;96ZM651;PLAT,,,0,,01OCT2015,12OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-248,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64011-0,T1,0,v100,SA,160315-TH-HVTN100,10.0,23SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HTJJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,6,,10,3,TH;20160317;13770;96ZM651;Plat,,,0,,18SEP2015,29SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-042,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64017-3,T1,0,v100,SA,160428-TH-HVTN100,10.0,06OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HVRV-13,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,3,,10,3,TH;20160501;14105;96ZM651;PLAT,,,0,,03OCT2015,14OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-078,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64018-5,T1,0,v100,SA,160314-TH-HVTN100,10.0,02OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HVCC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,7,,10,3,TH;20160316;13714;96ZM651;PLAT,,,0,,01OCT2015,12OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-242,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64019-8,T1,0,v100,SA,160315-TH-HVTN100,10.0,10NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,6,,10,3,TH;20160317;13770;96ZM651;Plat,,,0,,07NOV2015,18NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-071,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64022-3,T1,0,v100,SA,160314-TH-HVTN100,10.0,23OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXFC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,7,,10,3,TH;20160316;13714;96ZM651;PLAT,,,0,,23OCT2015,03NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-070,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64025-1,T1,0,v100,SA,160315-TH-HVTN100,10.0,26OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HXGY-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,6,,10,3,TH;20160317;13770;96ZM651;Plat,,,0,,23OCT2015,03NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-134,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64026-4,T1,0,v100,SA,160315-OK-HVTN100,10.0,09NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HZB7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,7,,10,3,OK;20160317;13788;96ZM651;PLAT,,,0,,05NOV2015,16NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-219,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64028-8,T1,0,v100,SA,160314-TH-HVTN100,10.0,27OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXTF-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,6,,10,3,TH;20160316;13721;96ZM651;PLAT,,,0,,26OCT2015,06NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-176,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64029-6,T1,0,v100,SA,160314-TH-HVTN100,10.0,10NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,5,,10,3,TH;20160316;13716;96ZM651;PLAT,,,0,,07NOV2015,18NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-135,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64031-9,T1,0,v100,SA,160314-VB-HVTN100,10.0,02NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HYLD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,5,,10,3,VB;20160316;96ZM;13697;PLATE5.,,,0,,24OCT2015,04NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-103,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64036-6,T1,0,v100,SA,160314-TH-HVTN100,10.0,30OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYBJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,5,,10,3,TH;20160316;13716;96ZM651;PLAT,,,0,,29OCT2015,09NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-169,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64037-7,T1,0,v100,SA,160314-VB-HVTN100,10.0,12NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZWP-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,6,,10,3,VB;20160316;96ZM;13698;PLATE6x,,,0,,08NOV2015,19NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-165,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64041-1,T1,0,v100,SA,160314-TH-HVTN100,10.0,01DEC2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J1Q0-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,7,,10,3,TH;20160316;13714;96ZM651;PLAT,,,0,,26NOV2015,07DEC2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-183,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64044-8,T1,0,v100,SA,160314-VB-HVTN100,10.0,30OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HY9Q-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,7,,10,3,VB;20160316;96ZM;13699;PLATE7x,,,0,,29OCT2015,09NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-188,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64046-3,T1,0,v100,SA,160314-TH-HVTN100,10.0,17NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J09C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,6,,10,3,TH;20160316;13721;96ZM651;PLAT,,,0,,17NOV2015,28NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-054,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64047-4,T1,0,v100,SA,160314-TH-HVTN100,10.0,03NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HYR2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,6,,10,3,TH;20160316;13721;96ZM651;PLAT,,,0,,29OCT2015,09NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-239,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64054-2,T1,0,v100,SA,160314-TH-HVTN100,10.0,28OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HXZP-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,5,,10,3,TH;20160316;13716;96ZM651;PLAT,,,0,,26OCT2015,06NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-098,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64062-0,T1,0,v100,SA,160314-VB-HVTN100,10.0,03NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HYRQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,5,,10,3,VB;20160316;96ZM;13697;PLATE5.,,,0,,30OCT2015,10NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-216,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64064-5,T1,0,v100,SA,160315-TH-HVTN100,10.0,12NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J015-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,7,,10,3,TH;20160317;13774;96ZM651;Plat,,,0,,09NOV2015,20NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-185,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64065-3,T1,0,v100,SA,160314-VB-HVTN100,10.0,12NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZXY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,4,,10,3,VB;20160316;96ZM;13696;PLATE4.,,,0,,08NOV2015,19NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-102,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64067-2,T1,0,v100,SA,160314-VB-HVTN100,10.0,17NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J09F-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,6,,10,3,VB;20160316;96ZM;13698;PLATE6x,,,0,,13NOV2015,24NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-112,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64070-4,T1,0,v100,SA,160316-TH-HVTN100,10.0,16NOV2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J03Q-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,6,,10,3,TH;20160318;13801;96ZM651;Plat,,,0,,05NOV2015,16NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-082,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64074-1,T1,0,v100,SA,160314-TH-HVTN100,10.0,16NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J039-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,6,,10,3,TH;20160316;13721;96ZM651;PLAT,,,0,,12NOV2015,23NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-197,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64084-3,T1,0,v100,SA,160314-VB-HVTN100,10.0,18NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J0MY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,6,,10,3,VB;20160316;96ZM;13698;PLATE6x,,,0,,15NOV2015,26NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-232,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64085-5,T1,0,v100,SA,160315-TH-HVTN100,10.0,01DEC2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J1QW-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,7,,10,3,TH;20160317;13774;96ZM651;Plat,,,0,,20NOV2015,01DEC2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-003,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64002-4,T1,0,v100,SA,160315-TH-HVTN100,10.0,13OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBJ-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,4,,10,3,TH;20160317;13773;96ZM651;Plat,,,0,,08OCT2015,19OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-152,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64006-0,T1,0,v100,SA,160314-TH-HVTN100,10.0,14SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HSJ4-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,4,,10,3,TH;20160316;13720;96ZM651;PLAT,,,0,,06SEP2015,17SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-220,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64009-5,T1,0,v100,SA,160314-TH-HVTN100,10.0,15OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWQB-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,4,,10,3,TH;20160316;13720;96ZM651;PLAT,,,0,,11OCT2015,22OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-125,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64010-0,T1,0,v100,SA,160315-TH-HVTN100,10.0,14SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HSMB-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,5,,10,3,TH;20160317;13775;96ZM651;Plat,,,0,,05SEP2015,16SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-233,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64011-7,T1,0,v100,SA,160315-TH-HVTN100,10.0,22SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HTGD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,6,,10,3,TH;20160317;13770;96ZM651;Plat,,,0,,18SEP2015,29SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-186,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64016-9,T1,0,v100,SA,160314-TH-HVTN100,10.0,27OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08MAR2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXNV-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,3,,10,3,TH;20160316;13715;96ZM651;PLAT,,,0,0,18OCT2015,29OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-039,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64017-5,T1,0,v100,SA,160428-TH-HVTN100,10.0,29SEP2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HTWM-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,3,,10,3,TH;20160501;14105;96ZM651;PLAT,,,0,,26SEP2015,07OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-013,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64018-3,T1,0,v100,SA,160314-VB-HVTN100,10.0,20NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J0YX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,2,,10,3,VB;20160316;96ZM;13694;PLATE2.,,,0,,17NOV2015,28NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-121,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64020-3,T1,0,v100,SA,160428-TH-HVTN100,10.0,06OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HVPF-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,2,,10,3,TH;20160501;14106;96ZM651;PLAT,,,0,,01OCT2015,12OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-087,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64023-2,T1,0,v100,SA,160315-TH-HVTN100,10.0,21OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HX1W-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,4,,10,3,TH;20160317;13773;96ZM651;Plat,,,0,,16OCT2015,27OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-100,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64025-8,T1,0,v100,SA,160314-TH-HVTN100,10.0,13OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBG-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,3,,10,3,TH;20160316;13715;96ZM651;PLAT,,,0,,08OCT2015,19OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-069,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64026-6,T1,0,v100,SA,160314-TH-HVTN100,10.0,07NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,3,,10,3,TH;20160316;13715;96ZM651;PLAT,,,0,,03NOV2015,14NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-206,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64033-9,T1,0,v100,SA,160315-TH-HVTN100,10.0,20OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08DEC2015,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HWYC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,4,,10,3,TH;20160317;13773;96ZM651;Plat,,,0,0,15OCT2015,26OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-047,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64035-1,T1,0,v100,SA,160314-VB-HVTN100,10.0,05NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ01-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,2,,10,3,VB;20160316;96ZM;13694;PLATE2.,,,0,,01NOV2015,12NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-089,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64038-8,T1,0,v100,SA,160314-VB-HVTN100,10.0,25NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J17P-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,4,,10,3,VB;20160316;96ZM;13696;PLATE4.,,,0,,20NOV2015,01DEC2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-139,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64041-8,T1,0,v100,SA,160314-VB-HVTN100,10.0,10NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFB-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,4,,10,3,VB;20160316;96ZM;13696;PLATE4.,,,0,,06NOV2015,17NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-080,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64042-9,T1,0,v100,SA,160314-VB-HVTN100,10.0,26OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HXGW-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,2,,10,3,VB;20160316;96ZM;13694;PLATE2.,,,0,,22OCT2015,02NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-210,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64046-5,T1,0,v100,SA,160315-TH-HVTN100,10.0,27OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXNS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,4,,10,3,TH;20160317;13773;96ZM651;Plat,,,0,,23OCT2015,03NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-162,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64048-2,T1,0,v100,SA,160314-VB-HVTN100,10.0,12NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J00K-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,6,,10,3,VB;20160316;96ZM;13698;PLATE6x,,,0,,05NOV2015,16NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-246,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64051-0,T1,0,v100,SA,160314-VB-HVTN100,10.0,11NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZP9-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,3,,10,3,VB;20160316;96ZM;13695;PLATE3.,,,0,,07NOV2015,18NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-223,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64053-6,T1,0,v100,SA,160314-TH-HVTN100,10.0,11NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HZQD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,4,,10,3,TH;20160316;13720;96ZM651;PLAT,,,0,,07NOV2015,18NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-028,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64055-4,T1,0,v100,SA,160315-TH-HVTN100,10.0,05NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZ03-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,3,,10,3,TH;20160317;13772;96ZM651;Plat,,,0,,01NOV2015,12NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-244,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64059-8,T1,0,v100,SA,160315-TH-HVTN100,10.0,20NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J0Y2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,5,,10,3,TH;20160317;13775;96ZM651;Plat,,,0,,17NOV2015,28NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-153,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64061-6,T1,0,v100,SA,160314-VB-HVTN100,10.0,07NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,1,,10,3,VB;20160316;96ZM;13693;PLATE1.,,,0,,03NOV2015,14NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-015,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64063-0,T1,0,v100,SA,160314-VB-HVTN100,10.0,19NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J0WN-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,1,,10,3,VB;20160316;96ZM;13693;PLATE1.,,,1,,14NOV2015,25NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-252,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64064-3,T1,0,v100,SA,160314-VB-HVTN100,10.0,23NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0ZW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,4,,10,3,VB;20160316;96ZM;13696;PLATE4.,,,0,,19NOV2015,30NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-211,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64068-4,T1,0,v100,SA,160315-TH-HVTN100,10.0,10NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZFD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,5,,10,3,TH;20160317;13775;96ZM651;Plat,,,0,,07NOV2015,18NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-147,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64069-2,T1,0,v100,SA,160315-TH-HVTN100,10.0,16NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J02X-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,5,,10,3,TH;20160317;13775;96ZM651;Plat,,,0,,05NOV2015,16NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-168,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64071-1,T1,0,v100,SA,160314-TH-HVTN100,10.0,12NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZZT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,3,,10,3,TH;20160316;13715;96ZM651;PLAT,,,0,,08NOV2015,19NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-203,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64072-2,T1,0,v100,SA,160314-VB-HVTN100,10.0,12NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZYT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,4,,10,3,VB;20160316;96ZM;13696;PLATE4.,,,0,,08NOV2015,19NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-167,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64074-8,T1,0,v100,SA,160314-TH-HVTN100,10.0,18NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J0LW-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,3,,10,3,TH;20160316;13715;96ZM651;PLAT,,,0,,17NOV2015,28NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-224,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64075-0,T1,0,v100,SA,160314-VB-HVTN100,10.0,19NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J0W8-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,1,,10,3,VB;20160316;96ZM;13693;PLATE1.,,,0,,13NOV2015,24NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-226,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64077-4,T1,0,v100,SA,160314-VB-HVTN100,10.0,19NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J0QS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,2,,10,3,VB;20160316;96ZM;13694;PLATE2.,,,0,,15NOV2015,26NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-020,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64079-7,T1,0,v100,SA,160314-VB-HVTN100,10.0,03DEC2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J1WG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,3,,10,3,VB;20160316;96ZM;13695;PLATE3.,,,0,,27NOV2015,08DEC2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-065,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64001-1,T1,0,v100,SA,160315-VB-HVTN100,10.0,07SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FCQ6-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,3,,10,3,VB;20160317;96ZM;13748;PLATE3.,,,0,,05SEP2015,16SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-018,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64002-2,T1,0,v100,SA,160315-VB-HVTN100,10.0,15SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FHFQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,6,,10,3,VB;20160317;96ZM;13751;PLATE6.,,,0,,14SEP2015,25SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-096,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64004-8,T1,0,v100,SA,160315-VB-HVTN100,10.0,23OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FW3Z-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,1,,10,3,VB;20160317;96ZM;13745;PLATE1.,,,0,,22OCT2015,02NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-249,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64006-3,T1,0,v100,SA,160314-OK-HVTN100,10.0,22SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FK9S-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,6,,10,3,OK;20160316;13732;96ZM651;PLAT,,,0,,20SEP2015,01OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-010,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64009-7,T1,0,v100,SA,160315-VB-HVTN100,10.0,22SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FKKP-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,5,,10,3,VB;20160317;96ZM;13750;PLATE5.,,,0,,20SEP2015,01OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-222,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64018-1,T1,0,v100,SA,160315-VB-HVTN100,10.0,30SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FMJB-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,7,,10,3,VB;20160317;96ZM;13752;PLATE7.,,,0,,26SEP2015,07OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-046,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64022-7,T1,0,v100,SA,160315-VB-HVTN100,10.0,16OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FS71-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,5,,10,3,VB;20160317;96ZM;13750;PLATE5.,,,0,,12OCT2015,23OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-037,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64030-7,T1,0,v100,SA,160428-TH-HVTN100,10.0,09OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FQ9L-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,4,,10,3,TH;20160501;14104;96ZM651;PLAT,,,0,,01OCT2015,12OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-251,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64033-6,T1,0,v100,SA,160314-OK-HVTN100,10.0,19OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FSKN-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,6,,10,3,OK;20160316;13732;96ZM651;PLAT,,,0,,12OCT2015,23OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-099,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64034-9,T1,0,v100,SA,160314-OK-HVTN100,10.0,08OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FQ46-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,5,,10,3,OK;20160316;13733;96ZM651;PLAT,,,0,,03OCT2015,14OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-032,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64038-5,T1,0,v100,SA,160314-OK-HVTN100,10.0,26OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FWHM-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,5,,10,3,OK;20160316;13733;96ZM651;PLAT,,,0,,22OCT2015,02NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-245,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64039-8,T1,0,v100,SA,160428-TH-HVTN100,10.0,15OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FRV7-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,4,,10,3,TH;20160501;14104;96ZM651;PLAT,,,0,,08OCT2015,19OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-057,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64042-6,T1,0,v100,SA,160315-VB-HVTN100,10.0,22OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FVNV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,4,,10,3,VB;20160317;96ZM;13749;PLATE4.,,,0,,17OCT2015,28OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-055,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64043-1,T1,0,v100,SA,160316-TH-HVTN100,10.0,14OCT2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FRFF-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,5,,10,3,TH;20160318;13798;96ZM651;Plat,,,0,,12OCT2015,23OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-021,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64046-7,T1,0,v100,SA,160314-OK-HVTN100,10.0,04NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FZ1Z-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,6,,10,3,OK;20160316;13732;96ZM651;PLAT,,,0,,01NOV2015,12NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-156,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64049-3,T1,0,v100,SA,160315-VB-HVTN100,10.0,14OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRCW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,5,,10,3,VB;20160317;96ZM;13750;PLATE5.,,,0,,10OCT2015,21OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-014,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64054-6,T1,0,v100,SA,160428-TH-HVTN100,10.0,23OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FW4N-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,5,,10,3,TH;20160501;14107;96ZM651;PLAT,,,0,,16OCT2015,27OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-240,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64062-9,T1,0,v100,SA,160314-OK-HVTN100,10.0,27OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FWTX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,5,,10,3,OK;20160316;13733;96ZM651;PLAT,,,0,,23OCT2015,03NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-171,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64063-3,T1,0,v100,SA,160315-VB-HVTN100,10.0,14OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRDV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,4,,10,3,VB;20160317;96ZM;13749;PLATE4.,,,0,,10OCT2015,21OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-068,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64064-1,T1,0,v100,SA,16031-OK-HVTN100,10.0,27OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FWX6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,4,,10,3,OK;20160316;13734;96ZM651;PLAT,,,0,,23OCT2015,03NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-062,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64065-7,T1,0,v100,SA,160428-TH-HVTN100,10.0,13OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FQWN-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,4,,10,3,TH;20160501;14104;96ZM651;PLAT,,,0,,12OCT2015,23OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-036,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64066-5,T1,0,v100,SA,160315-VB-HVTN100,10.0,16OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FS6F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,7,,10,3,VB;20160317;96ZM;13752;PLATE7.,,,0,,10OCT2015,21OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-095,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64071-4,T1,0,v100,SA,160315-VB-HVTN100,10.0,21OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FTPM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,6,,10,3,VB;20160317;96ZM;13751;PLATE6.,,,0,,17OCT2015,28OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-212,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64072-0,T1,0,v100,SA,160314-OK-HVTN100,10.0,02NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FY0T-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,3,,10,3,OK;20160316;13727;96ZM651;PLAT,,,0,,29OCT2015,09NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-072,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64074-5,T1,0,v100,SA,160315-VB-HVTN100,10.0,20OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FSTR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,1,,10,3,VB;20160317;96ZM;13745;PLATE1.,,,0,,15OCT2015,26OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-229,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64076-1,T1,0,v100,SA,160314-OK-HVTN100,10.0,07NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20G182-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,3,,10,3,OK;20160316;13727;96ZM651;PLAT,,,0,,29OCT2015,09NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-217,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64077-2,T1,0,v100,SA,160314-OK-HVTN100,10.0,29OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FXCG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,5,,10,3,OK;20160316;13733;96ZM651;PLAT,,,0,,25OCT2015,05NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-149,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64078-6,T1,0,v100,SA,160315-VB-HVTN100,10.0,21OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FTPZ-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,7,,10,3,VB;20160317;96ZM;13752;PLATE7.,,,0,,16OCT2015,27OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-017,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64085-1,T1,0,v100,SA,160315-VB-HVTN100,10.0,20OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FSV2-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,1,,10,3,VB;20160317;96ZM;13745;PLATE1.,,,0,,17OCT2015,28OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-074,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64086-4,T1,0,v100,SA,16031-OK-HVTN100,10.0,30OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FXJC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,4,,10,3,OK;20160316;13734;96ZM651;PLAT,,,0,,26OCT2015,06NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-124,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64089-6,T1,0,v100,SA,16031-OK-HVTN100,10.0,28OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX1S-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,4,,10,3,OK;20160316;13734;96ZM651;PLAT,,,0,,25OCT2015,05NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-004,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64095-6,T1,0,v100,SA,160314-OK-HVTN100,10.0,27OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FWWD-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,5,,10,3,OK;20160316;13733;96ZM651;PLAT,,,0,,23OCT2015,03NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-182,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64097-5,T1,0,v100,SA,16031-OK-HVTN100,10.0,06NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G0Z4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,4,,10,3,OK;20160316;13734;96ZM651;PLAT,,,0,,05NOV2015,16NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-034,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64107-1,T1,0,v100,SA,160316-TH-HVTN100,10.0,07NOV2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G18P-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,4,,10,3,TH;20160318;13805;96ZM651;Plat,,,0,,03NOV2015,14NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-115,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64113-4,T1,0,v100,SA,16031-OK-HVTN100,10.0,30OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FXJP-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,4,,10,3,OK;20160316;13734;96ZM651;PLAT,,,0,,29OCT2015,09NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-144,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64118-3,T1,0,v100,SA,160314-OK-HVTN100,10.0,10NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20G20Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,6,,10,3,OK;20160316;13732;96ZM651;PLAT,,,0,,07NOV2015,18NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-189,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64125-8,T1,0,v100,SA,160314-OK-HVTN100,10.0,12NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G3XF-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,6,,10,3,OK;20160316;13732;96ZM651;PLAT,,,0,,12NOV2015,23NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-141,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64001-8,P2,1,v100,SA,160428-TH-HVTN100,10.0,23JUL2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20DZ2F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,1,,10,3,TH;20160501;14103;96ZM651;PLAT,,,0,,23JUL2015,03AUG2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-056,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64028-6,P2,1,v100,SA,160316-TH-HVTN100,10.0,04AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20F1PR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,2,,10,3,TH;20160318;13802;96ZM651;Plat,,,0,,02AUG2015,13AUG2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-154,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64047-1,P2,1,v100,SA,160316-TH-HVTN100,10.0,17AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20F5F9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,20NOV2015,151120,48,Tandile Hermanus,1,,10,3,TH;20160318;13803;96ZM651;Plat,,,0,,13AUG2015,24AUG2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-041,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64059-3,P2,1,v100,SA,160316-TH-HVTN100,10.0,19AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20F64B-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,3,,10,3,TH;20160318;13806;96ZM651;Plat,,,0,,15AUG2015,26AUG2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-196,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64085-8,P2,1,v100,SA,160314-OK-HVTN100,10.0,07SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FCQJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,2,,10,3,OK;20160316;13728;96ZM651;PLAT,,,0,,04SEP2015,15SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-200,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64086-6,P2,1,v100,SA,160315-VB-HVTN100,10.0,15SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FHG1-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,6,,10,3,VB;20160317;96ZM;13751;PLATE6.,,,0,,12SEP2015,23SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-122,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64121-2,P2,1,v100,SA,160316-TH-HVTN100,10.0,29SEP2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FM29-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,3,,10,3,TH;20160318;13806;96ZM651;Plat,,,0,,26SEP2015,07OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-199,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64165-3,P2,1,v100,SA,160315-VB-HVTN100,10.0,09NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20G1N0-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,3,,10,3,VB;20160317;96ZM;13748;PLATE3.,,,0,,05NOV2015,16NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-104,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64052-0,P2,1,v100,SA,160428-TH-HVTN100,10.0,06NOV2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BFW9-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,2,,10,3,TH;20160501;14106;96ZM651;PLAT,,,0,,02NOV2015,13NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-086,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64077-3,P2,1,v100,SA,160315-TH-HVTN100,10.0,24NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CA60BGKV-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,2,,10,3,TH;20160317;13769;96ZM651;Plat,,,0,,13NOV2015,24NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-012,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64078-5,P2,1,v100,SA,160315-TH-HVTN100,10.0,19NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BGF7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,3,,10,3,TH;20160317;13772;96ZM651;Plat,,,0,,14NOV2015,25NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-214,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64018-8,P2,1,v100,SA,160315-OK-HVTN100,10.0,23SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08APR2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT0552W-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,4,,10,3,OK;20160317;13778;96ZM651;PLAT,,,0,0,19SEP2015,30SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-238,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64027-2,P2,1,v100,SA,160315-OK-HVTN100,10.0,27OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT0584P-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,2,,10,3,OK;20160317;13776;96ZM651;PLAT,,,0,,23OCT2015,03NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-175,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64030-0,P2,1,v100,SA,160315-OK-HVTN100,10.0,18SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT054PV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,4,,10,3,OK;20160317;13778;96ZM651;PLAT,,,0,,14SEP2015,25SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-045,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64068-9,P2,1,v100,SA,160315-OK-HVTN100,10.0,26NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05CFM-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,5,,10,3,OK;20160317;13777;96ZM651;PLAT,,,0,,22NOV2015,03DEC2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-191,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64024-7,P2,1,v100,SA,160314-VB-HVTN100,10.0,26OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXHD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,7,,10,3,VB;20160316;96ZM;13699;PLATE7x,,,0,,24OCT2015,04NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-164,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64045-0,P2,1,v100,SA,160314-VB-HVTN100,10.0,16NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J06D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,5,,10,3,VB;20160316;96ZM;13697;PLATE5.,,,0,,14NOV2015,25NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-008,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64049-7,P2,1,v100,SA,160314-VB-HVTN100,10.0,02NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HYLY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,5,,10,3,VB;20160316;96ZM;13697;PLATE5.,,,0,,29OCT2015,09NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-016,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64051-7,P2,1,v100,SA,160314-VB-HVTN100,10.0,18NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0N9-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,6,,10,3,VB;20160316;96ZM;13698;PLATE6x,,,0,,17NOV2015,28NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-033,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64059-1,P2,1,v100,SA,160314-VB-HVTN100,10.0,12NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HZVY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,5,,10,3,VB;20160316;96ZM;13697;PLATE5.,,,0,,07NOV2015,18NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-241,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64069-9,P2,1,v100,SA,160314-TH-HVTN100,10.0,10NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,5,,10,3,TH;20160316;13716;96ZM651;PLAT,,,0,,05NOV2015,16NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-159,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64073-3,P2,1,v100,SA,160314-TH-HVTN100,10.0,27OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXSP-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,7,,10,3,TH;20160316;13714;96ZM651;PLAT,,,0,,26OCT2015,06NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-049,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64083-0,P2,1,v100,SA,160315-TH-HVTN100,10.0,17NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0CK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,7,,10,3,TH;20160317;13774;96ZM651;Plat,,,0,,14NOV2015,25NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-024,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64008-7,P2,1,v100,SA,160315-TH-HVTN100,10.0,22SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HTD1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,4,,10,3,TH;20160317;13773;96ZM651;Plat,,,0,,18SEP2015,29SEP2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-143,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64021-9,P2,1,v100,SA,160314-TH-HVTN100,10.0,01OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HV6Q-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,4,,10,3,TH;20160316;13720;96ZM651;PLAT,,,0,,01OCT2015,12OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-009,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64024-0,P2,1,v100,SA,160316-TH-HVTN100,10.0,21OCT2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FTQC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Tandile Hermanus,4,,10,3,TH;20160318;13805;96ZM651;Plat,,,0,,16OCT2015,27OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-094,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64031-2,P2,1,v100,SA,160314-VB-HVTN100,10.0,07NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ68-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,3,,10,3,VB;20160316;96ZM;13695;PLATE3.,,,0,,03NOV2015,14NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-026,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64034-7,P2,1,v100,SA,160314-VB-HVTN100,10.0,04NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HYZ4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,3,,10,3,VB;20160316;96ZM;13695;PLATE3.,,,0,,31OCT2015,11NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-166,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64050-7,P2,1,v100,SA,160314-VB-HVTN100,10.0,04NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYV7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,2,,10,3,VB;20160316;96ZM;13694;PLATE2.,,,0,,31OCT2015,11NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-005,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64057-3,P2,1,v100,SA,160314-VB-HVTN100,10.0,04NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HYVZ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,1,,10,3,VB;20160316;96ZM;13693;PLATE1.,,,0,,30OCT2015,10NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-133,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64060-1,P2,1,v100,SA,160314-VB-HVTN100,10.0,07NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,3,,10,3,VB;20160316;96ZM;13695;PLATE3.,,,0,,03NOV2015,14NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-195,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64070-6,P2,1,v100,SA,160315-VB-HVTN100,10.0,09NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20G1M1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,5,,10,3,VB;20160317;96ZM;13750;PLATE5.,,,0,,07NOV2015,18NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-043,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64017-7,P2,1,v100,SA,160428-TH-HVTN100,10.0,13OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FQTX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,4,,10,3,TH;20160501;14104;96ZM651;PLAT,,,0,,10OCT2015,21OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-174,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64052-4,P2,1,v100,SA,160315-VB-HVTN100,10.0,23OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FW49-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:60,Dilution,20NOV2015,151120,48,Valerie Bekker,1,,10,3,VB;20160317;96ZM;13745;PLATE1.,,,0,,19OCT2015,30OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-067,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64073-7,P2,1,v100,SA,160428-TH-HVTN100,10.0,22OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FVG5-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,04DEC2015,151204,72,Tandile Hermanus,4,,10,3,TH;20160501;14104;96ZM651;PLAT,,,0,,18OCT2015,29OCT2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-213,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64079-9,P2,1,v100,SA,160314-OK-HVTN100,10.0,28OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FX13-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,3,,10,3,OK;20160316;13727;96ZM651;PLAT,,,0,,24OCT2015,04NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-250,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64080-5,P2,1,v100,SA,160314-OK-HVTN100,10.0,28OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX2K-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:64,Dilution,20NOV2015,151120,48,Owen Karimanzira,3,,10,3,OK;20160316;13727;96ZM651;PLAT,,,0,,24OCT2015,04NOV2015,0,182,0,96ZM651.2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-053,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64003-3,T1,0,v100,SA,160315-VB-HVTN100,10.0,22JUL2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20DYKC-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,2,,10,3,VB;20160317;CE1086;13754;PLATE,,,0,,19JUL2015,30JUL2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-111,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64006-5,T1,0,v100,SA,160315-VB-HVTN100,10.0,29JUL2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20F09P-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,2,,10,3,VB;20160317;CE1086;13754;PLATE,,,0,,26JUL2015,06AUG2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-031,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64009-0,T1,0,v100,SA,160314-OK-VTN100,10.0,23JUL2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20DYTL-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,3,,10,3,OK;20160316;13730;Ce1086;PLATE,,,0,,23JUL2015,03AUG2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-209,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64013-9,T1,0,v100,SA,160316-TH-HVTN100,10.0,28JUL2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20DZVV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,2,,10,3,TH;20160318;13796;Ce1086;Plate,,,0,,25JUL2015,05AUG2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-158,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64021-4,T1,0,v100,SA,160314-OK-HVTN100,10.0,03AUG2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F17D-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,2,,10,3,OK;20160316;13739;Ce1086;PLATE,,,0,,01AUG2015,12AUG2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-215,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64029-9,T1,0,v100,SA,160316-TH-HVTN100,10.0,25AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8HS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,2,,10,3,TH;20160318;13796;Ce1086;Plate,,,0,,14AUG2015,25AUG2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-231,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64031-7,T1,0,v100,SA,160428-TH-HVTN100,10.0,27AUG2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8ZN-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,1,,10,3,TH;20160501;14100;CE1086;PLATE,,,0,,21AUG2015,01SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-091,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64033-4,T1,0,v100,SA,160428-TH-HVTN100,10.0,08SEP2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD4N-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,1,,10,3,TH;20160501;14100;CE1086;PLATE,,,0,,04SEP2015,15SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-077,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64036-9,T1,0,v100,SA,160315-VB-HVTN100,10.0,18AUG2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20F5SG-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,5,,10,3,VB;20160317;CE1086;13757;PLATE,,,0,,14AUG2015,25AUG2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-136,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64045-2,T1,0,v100,SA,160316-TH-HVTN100,10.0,13AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F4C6-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,1,,10,3,TH;20160318;13795;Ce1086;Plate,,,0,,13AUG2015,24AUG2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-227,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64053-1,T1,0,v100,SA,160428-TH-HVTN100,10.0,19AUG2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20F676-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,1,,10,3,TH;20160501;14100;CE1086;PLATE,,,0,,16AUG2015,27AUG2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-160,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64054-4,T1,0,v100,SA,160316-TH-HVTN100,10.0,26AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8R9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,1,,10,3,TH;20160318;13795;Ce1086;Plate,,,0,,21AUG2015,01SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-155,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64055-9,T1,0,v100,SA,160316-TH-HVTN100,10.0,20AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F6C4-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,2,,10,3,TH;20160318;13796;Ce1086;Plate,,,0,,14AUG2015,25AUG2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-177,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64057-8,T1,0,v100,SA,160316-TH-HVTN100,10.0,02SEP2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FBT0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,3,,10,3,TH;20160318;13804;Ce1086;Plate,,,0,,23AUG2015,03SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-052,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64062-2,T1,0,v100,SA,160316-TH-HVTN100,10.0,03SEP2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FC68-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,1,,10,3,TH;20160318;13795;Ce1086;Plate,,,0,,28AUG2015,08SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-247,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64063-5,T1,0,v100,SA,160314-OK-HVTN100,10.0,08SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FD2Q-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,2,,10,3,OK;20160316;13739;Ce1086;PLATE,,,0,,04SEP2015,15SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-126,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64066-3,T1,0,v100,SA,160314-OK-HVTN100,10.0,08SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD3H-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,2,,10,3,OK;20160316;13739;Ce1086;PLATE,,,0,,04SEP2015,15SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-225,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64067-4,T1,0,v100,SA,160428-TH-HVTN100,10.0,08SEP2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FD43-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,1,,10,3,TH;20160501;14100;CE1086;PLATE,,,0,,04SEP2015,15SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-148,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64069-7,T1,0,v100,SA,160314-OK-HVTN100,10.0,14SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FGVK-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,1,,10,3,OK;20160316;13740;Ce1086;PLATE,,,0,,12SEP2015,23SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-163,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64077-9,T1,0,v100,SA,160314-OK-HVTN100,10.0,07SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FCJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,2,,10,3,OK;20160316;13739;Ce1086;PLATE,,,0,,29AUG2015,09SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-073,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64080-3,T1,0,v100,SA,160316-TH-HVTN100,10.0,31AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FB33-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,1,,10,3,TH;20160318;13795;Ce1086;Plate,,,0,,28AUG2015,08SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-184,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64087-7,T1,0,v100,SA,160314-OK-HVTN100,10.0,07SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FCJR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,1,,10,3,OK;20160316;13740;Ce1086;PLATE,,,0,,06SEP2015,17SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-170,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64095-4,T1,0,v100,SA,160314-OK-HVTN100,10.0,08OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FQ3V-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,1,,10,3,OK;20160316;13740;Ce1086;PLATE,,,0,,01OCT2015,12OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-038,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64105-9,T1,0,v100,SA,160316-TH-HVTN100,10.0,17NOV2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G4TX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,2,,10,3,TH;20160318;13796;Ce1086;Plate,,,0,,14NOV2015,25NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-123,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64117-3,T1,0,v100,SA,160315-VB-HVTN100,10.0,17SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FJ00-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,3,,10,3,VB;20160317;CE1086;13755;PLATE,,,0,,13SEP2015,24SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-061,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64119-8,T1,0,v100,SA,160315-VB-HVTN100,10.0,30SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FMJ0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,2,,10,3,VB;20160317;CE1086;13754;PLATE,,,0,,26SEP2015,07OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-128,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64129-6,T1,0,v100,SA,160314-OK-HVTN100,10.0,06OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FPD4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,1,,10,3,OK;20160316;13740;Ce1086;PLATE,,,0,,03OCT2015,14OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-108,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64130-3,T1,0,v100,SA,160315-VB-HVTN100,10.0,06OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FPDG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,3,,10,3,VB;20160317;CE1086;13755;PLATE,,,0,,02OCT2015,13OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-097,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64135-8,T1,0,v100,SA,160314-OK-HVTN100,10.0,28SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FLTC-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,1,,10,3,OK;20160316;13740;Ce1086;PLATE,,,0,,26SEP2015,07OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-129,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64139-4,T1,0,v100,SA,160316-TH-HVTN100,10.0,26OCT2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FWKL-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,3,,10,3,TH;20160318;13804;Ce1086;Plate,,,0,,16OCT2015,27OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-058,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64150-0,T1,0,v100,SA,160315-VB-HVTN100,10.0,11NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20G3JT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,4,,10,3,VB;20160317;CE1086;13756;PLATE,,,0,,07NOV2015,18NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-151,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64154-2,T1,0,v100,SA,160315-VB-HVTN100,10.0,02NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FXYX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,7,,10,3,VB;20160317;CE1086;13759;PLATE,,,0,,25OCT2015,05NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-002,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64156-9,T1,0,v100,SA,160315-VB-HVTN100,10.0,02NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FXZQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,4,,10,3,VB;20160317;CE1086;13756;PLATE,,,0,,25OCT2015,05NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-194,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64166-1,T1,0,v100,SA,160316-TH-HVTN100,10.0,17NOV2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G4VL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,4,,10,3,TH;20160318;13799;Ce1086;Plate,,,0,,14NOV2015,25NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-157,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64167-2,T1,0,v100,SA,160315-VB-HVTN100,10.0,10NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G20B-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,2,,10,3,VB;20160317;CE1086;13754;PLATE,,,0,,06NOV2015,17NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-025,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64172-9,T1,0,v100,SA,160315-VB-HVTN100,10.0,12NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20G3X4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,2,,10,3,VB;20160317;CE1086;13754;PLATE,,,0,,06NOV2015,17NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-137,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64002-3,T1,0,v100,SA,160314-TH-HVTN100,10.0,28AUG2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BCRM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,1,,10,3,TH;20160316;13722;Ce1086;PLATE,,,0,,21AUG2015,01SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-064,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64007-0,T1,0,v100,SA,160315-TH-HVTN100,10.0,14SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BDHQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,3,,10,3,TH;20160317;13768;Ce1086;Plate,,,0,,10SEP2015,21SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-131,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64008-8,T1,0,v100,SA,160314-TH-HVTN100,10.0,14SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BDJC-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,1,,10,3,TH;20160316;13722;Ce1086;PLATE,,,0,,07SEP2015,18SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-109,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64028-0,T1,0,v100,SA,160428-TH-HVTN100,10.0,21OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BFB3-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,2,,10,3,TH;20160501;14099;CE1086;PLATE,,,0,,17OCT2015,28OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-187,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64029-3,T1,0,v100,SA,160314-VB-HVTN100,10.0,26OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFG6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,7,,10,3,VB;20160316;CE1086;13706;PLATE,,,0,,19OCT2015,30OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-090,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64030-6,T1,0,v100,SA,160315-TH-HVTN100,10.0,27OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BFGQ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,2,,10,3,TH;20160317;13764;Ce1086;Plate,,,0,,23OCT2015,03NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-130,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64034-8,T1,0,v100,SA,160315-TH-HVTN100,10.0,10NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG09-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,2,,10,3,TH;20160317;13764;Ce1086;Plate,,,0,,06NOV2015,17NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-105,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64036-3,T1,0,v100,SA,160315-TH-HVTN100,10.0,13NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG4G-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,1,,10,3,TH;20160317;13763;Ce1086;Plate,,,0,,09NOV2015,20NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-140,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64037-4,T1,0,v100,SA,160315-TH-HVTN100,10.0,16NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG8C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,1,,10,3,TH;20160317;13763;Ce1086;Plate,,,0,,12NOV2015,23NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-138,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64038-9,T1,0,v100,SA,160315-TH-HVTN100,10.0,04NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFT3-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,1,,10,3,TH;20160317;13763;Ce1086;Plate,,,0,,31OCT2015,11NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-084,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64039-7,T1,0,v100,SA,160428-TH-HVTN100,10.0,27OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFH3-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,2,,10,3,TH;20160501;14099;CE1086;PLATE,,,0,,23OCT2015,03NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-198,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64040-3,T1,0,v100,SA,160315-TH-HVTN100,10.0,17NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGC1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,1,,10,3,TH;20160317;13763;Ce1086;Plate,,,0,,07NOV2015,18NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-228,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64044-0,T1,0,v100,SA,160314-TH-HVTN100,10.0,24NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BGLK-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,1,,10,3,TH;20160316;13722;Ce1086;PLATE,,,0,,14NOV2015,25NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-181,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64050-8,T1,0,v100,SA,160314-TH-HVTN100,10.0,02NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFPN-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,1,,10,3,TH;20160316;13722;Ce1086;PLATE,,,0,,31OCT2015,11NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-085,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64051-4,T1,0,v100,SA,160428-TH-HVTN100,10.0,06NOV2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFVX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,2,,10,3,TH;20160501;14099;CE1086;PLATE,,,0,,02NOV2015,13NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-063,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64053-7,T1,0,v100,SA,160316-TH-HVTN100,10.0,20NOV2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGGQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,5,,10,3,TH;20160318;13797;Ce1086;Plate,,,0,,16NOV2015,27NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-235,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64054-5,T1,0,v100,SA,160428-TH-HVTN100,10.0,09NOV2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFY7-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,3,,10,3,TH;20160501;14098;CE1086;PLATE,,,0,,05NOV2015,16NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-001,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64061-7,T1,0,v100,SA,160316-TH-HVTN100,10.0,09NOV2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFYY-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,5,,10,3,TH;20160318;13797;Ce1086;Plate,,,0,,07NOV2015,18NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-083,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64062-8,T1,0,v100,SA,160315-TH-HVTN100,10.0,13NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,3,,10,3,TH;20160317;13768;Ce1086;Plate,,,0,,09NOV2015,20NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-145,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64066-9,T1,0,v100,SA,160315-TH-HVTN100,10.0,11NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BG31-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,2,,10,3,TH;20160317;13764;Ce1086;Plate,,,0,,06NOV2015,17NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-127,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64068-3,T1,0,v100,SA,160315-TH-HVTN100,10.0,24NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BGMS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,3,,10,3,TH;20160317;13768;Ce1086;Plate,,,0,,19NOV2015,30NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-044,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64069-1,T1,0,v100,SA,160315-OK-HVTN100,10.0,16NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GA60BG7M-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,7,,10,3,OK;20160317;13780;Ce1086;PLATE,,,0,,12NOV2015,23NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-132,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64070-7,T1,0,v100,SA,160314-TH-HVTN100,10.0,13NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BG5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,2,,10,3,TH;20160316;13718;Ce1086;PLATE,,,0,,09NOV2015,20NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-048,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64073-6,T1,0,v100,SA,160314-TH-HVTN100,10.0,16NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG9D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,2,,10,3,TH;20160316;13718;Ce1086;PLATE,,,0,,12NOV2015,23NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-092,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64075-4,T1,0,v100,SA,160314-VB-HVTN100,10.0,17NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BGCG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,7,,10,3,VB;20160316;CE1086;13706;PLATE,,,0,,13NOV2015,24NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-218,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64076-2,T1,0,v100,SA,160314-TH-HVTN100,10.0,16NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,15JUN2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BG9S-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,2,,10,3,TH;20160316;13718;Ce1086;PLATE,,,0,0,12NOV2015,23NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-179,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64082-4,T1,0,v100,SA,160315-TH-HVTN100,10.0,10NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BG19-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,2,,10,3,TH;20160317;13764;Ce1086;Plate,,,0,,06NOV2015,17NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-040,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64089-5,T1,0,v100,SA,160315-TH-HVTN100,10.0,27NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BGP5-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,1,,10,3,TH;20160317;13763;Ce1086;Plate,,,0,,21NOV2015,02DEC2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-022,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64001-8,T1,0,v100,SA,160315-OK-HVTN100,10.0,21SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,6,,10,3,OK;20160317;13781;Ce1086;PLATE,,,0,,20SEP2015,01OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-066,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64002-9,T1,0,v100,SA,160316-TH-HVTN100,10.0,17SEP2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GAT054MG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,5,,10,3,TH;20160318;13797;Ce1086;Plate,,,0,,12SEP2015,23SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-142,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64004-1,T1,0,v100,SA,160315-OK-HVTN100,10.0,22OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT057TJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,1,,10,3,OK;20160317;13784;Ce1086;PLATE,,,0,,16OCT2015,27OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-236,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64006-5,T1,0,v100,SA,160315-OK-HVTN100,10.0,17SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054L4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,1,,10,3,OK;20160317;13784;Ce1086;PLATE,,,0,,13SEP2015,24SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-120,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64007-6,T1,0,v100,SA,160315-OK-HVTN100,10.0,17SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT054KS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,6,,10,3,OK;20160317;13781;Ce1086;PLATE,,,0,,13SEP2015,24SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-029,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64009-0,T1,0,v100,SA,160315-OK-HVTN100,10.0,21SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TT-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,1,,10,3,OK;20160317;13784;Ce1086;PLATE,,,0,,17SEP2015,28SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-107,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64010-5,T1,0,v100,SA,160315-OK-HVTN100,10.0,22SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT0550X-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,2,,10,3,OK;20160317;13783;Ce1086;PLATE,,,0,,18SEP2015,29SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-113,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64012-3,T1,0,v100,SA,160315-OK-HVTN100,10.0,21SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054V4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,2,,10,3,OK;20160317;13783;Ce1086;PLATE,,,0,,20SEP2015,01OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-234,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64016-4,T1,0,v100,SA,160315-OK-HVTN100,10.0,21SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT054VG-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,6,,10,3,OK;20160317;13781;Ce1086;PLATE,,,0,,20SEP2015,01OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-059,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64017-0,T1,0,v100,SA,160314-OK-HVTN100,10.0,28SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT05585-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,7,,10,3,OK;20160316;13738;Ce1086;PLATE,,,0,,24SEP2015,05OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-023,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64021-4,T1,0,v100,SA,160315-OK-HVTN100,10.0,28SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0557V-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,1,,10,3,OK;20160317;13784;Ce1086;PLATE,,,0,,24SEP2015,05OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-201,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64029-9,T1,0,v100,SA,160314-OK-HVTN100,10.0,12OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT056K1-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,7,,10,3,OK;20160316;13738;Ce1086;PLATE,,,0,,08OCT2015,19OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-076,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64031-7,T1,0,v100,SA,160314-OK-HVTN100,10.0,26OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT057ZR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,7,,10,3,OK;20160316;13738;Ce1086;PLATE,,,0,,22OCT2015,02NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-204,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64035-6,T1,0,v100,SA,160315-OK-HVTN100,10.0,26OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057X1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,1,,10,3,OK;20160317;13784;Ce1086;PLATE,,,0,,22OCT2015,02NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-230,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64036-9,T1,0,v100,SA,160315-OK-HVTN100,10.0,02NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT058FR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,2,,10,3,OK;20160317;13783;Ce1086;PLATE,,,0,,29OCT2015,09NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-011,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64037-5,T1,0,v100,SA,160315-OK-HVTN100,10.0,27OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0584C-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,3,,10,3,OK;20160317;13786;Ce1086;PLATE,,,0,,23OCT2015,03NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-161,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64038-3,T1,0,v100,SA,160315-OK-HVTN100,10.0,19OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT05797-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,5,,10,3,OK;20160317;13782;Ce1086;PLATE,,,0,,15OCT2015,26OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-180,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64041-3,T1,0,v100,SA,160315-OK-HVTN100,10.0,07NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05967-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,5,,10,3,OK;20160317;13782;Ce1086;PLATE,,,0,,02NOV2015,13NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-116,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64043-8,T1,0,v100,SA,160315-OK-HVTN100,10.0,10NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT059JJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,2,,10,3,OK;20160317;13783;Ce1086;PLATE,,,0,,06NOV2015,17NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-079,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64044-6,T1,0,v100,SA,160315-OK-HVTN100,10.0,23OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057VG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,3,,10,3,OK;20160317;13786;Ce1086;PLATE,,,0,,19OCT2015,30OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-192,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64045-2,T1,0,v100,SA,160315-OK-HVTN100,10.0,11NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT059Q1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,5,,10,3,OK;20160317;13782;Ce1086;PLATE,,,0,,09NOV2015,20NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-146,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64050-2,T1,0,v100,SA,160315-OK-HVTN100,10.0,11NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT059TS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,6,,10,3,OK;20160317;13781;Ce1086;PLATE,,,0,,07NOV2015,18NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-006,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64051-5,T1,0,v100,SA,160315-OK-HVTN100,10.0,09NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT0598R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,6,,10,3,OK;20160317;13781;Ce1086;PLATE,,,0,,05NOV2015,16NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-007,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64053-1,T1,0,v100,SA,160315-OK-HVTN100,10.0,09NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT059C4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,3,,10,3,OK;20160317;13786;Ce1086;PLATE,,,0,,05NOV2015,16NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-081,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64054-4,T1,0,v100,SA,160315-OK-HVTN100,10.0,10NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT059KL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,4,,10,3,OK;20160317;13785;Ce1086;PLATE,,,0,,06NOV2015,17NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-172,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64056-7,T1,0,v100,SA,160315-OK-HVTN100,10.0,16NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05B6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,5,,10,3,OK;20160317;13782;Ce1086;PLATE,,,0,,12NOV2015,23NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-205,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64057-8,T1,0,v100,SA,160315-OK-HVTN100,10.0,11NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT059VK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,3,,10,3,OK;20160317;13786;Ce1086;PLATE,,,0,,06NOV2015,17NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-202,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64060-6,T1,0,v100,SA,160315-OK-HVTN100,10.0,21NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05BWD-05,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,4,,10,3,OK;20160317;13785;Ce1086;PLATE,,,0,,17NOV2015,28NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-119,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64062-2,T1,0,v100,SA,160315-OK-HVTN100,10.0,18NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT05BLC-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,3,,10,3,OK;20160317;13786;Ce1086;PLATE,,,0,,14NOV2015,25NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-101,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64072-7,T1,0,v100,SA,160314-OK-HVTN100,10.0,19NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05BS4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,7,,10,3,OK;20160316;13738;Ce1086;PLATE,,,0,,19NOV2015,30NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-050,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64003-1,T1,0,v100,SA,160428-TH-HVTN100,10.0,02SEP2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HRJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,3,,10,3,TH;20160501;14098;CE1086;PLATE,,,0,,29AUG2015,09SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-150,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64005-9,T1,0,v100,SA,160315-TH-HVTN100,10.0,01SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HR6B-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,7,,10,3,TH;20160317;13767;Ce1086;Plate,,,0,,28AUG2015,08SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-114,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64006-7,T1,0,v100,SA,160315-OK-HVTN100,10.0,18SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HT5Y-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,7,,10,3,OK;20160317;13780;Ce1086;PLATE,,,0,,14SEP2015,25SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-190,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64007-8,T1,0,v100,SA,160428-TH-HVTN100,10.0,05OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HVGX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,3,,10,3,TH;20160501;14098;CE1086;PLATE,,,0,,01OCT2015,12OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-248,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64011-0,T1,0,v100,SA,160315-TH-HVTN100,10.0,23SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HTJJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,6,,10,3,TH;20160317;13762;Ce1086;Plate,,,0,,18SEP2015,29SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-042,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64017-3,T1,0,v100,SA,160428-TH-HVTN100,10.0,06OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HVRV-13,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,3,,10,3,TH;20160501;14098;CE1086;PLATE,,,0,,03OCT2015,14OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-078,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64018-5,T1,0,v100,SA,160314-TH-HVTN100,10.0,02OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HVCC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,7,,10,3,TH;20160316;13724;Ce1086;PLATE,,,0,,01OCT2015,12OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-242,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64019-8,T1,0,v100,SA,160315-TH-HVTN100,10.0,10NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,6,,10,3,TH;20160317;13762;Ce1086;Plate,,,0,,07NOV2015,18NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-071,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64022-3,T1,0,v100,SA,160314-TH-HVTN100,10.0,23OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXFC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,7,,10,3,TH;20160316;13724;Ce1086;PLATE,,,0,,23OCT2015,03NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-070,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64025-1,T1,0,v100,SA,160315-TH-HVTN100,10.0,26OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HXGY-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,6,,10,3,TH;20160317;13762;Ce1086;Plate,,,0,,23OCT2015,03NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-134,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64026-4,T1,0,v100,SA,160315-OK-HVTN100,10.0,09NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HZB7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,7,,10,3,OK;20160317;13780;Ce1086;PLATE,,,0,,05NOV2015,16NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-219,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64028-8,T1,0,v100,SA,160314-TH-HVTN100,10.0,27OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXTF-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,6,,10,3,TH;20160316;13726;Ce1086;PLATE,,,0,,26OCT2015,06NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-176,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64029-6,T1,0,v100,SA,160314-TH-HVTN100,10.0,10NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,5,,10,3,TH;20160316;13725;Ce1086;PLATE,,,0,,07NOV2015,18NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-135,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64031-9,T1,0,v100,SA,160314-VB-HVTN100,10.0,02NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HYLD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,5,,10,3,VB;20160316;CE1086;13704;PLATE,,,0,,24OCT2015,04NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-103,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64036-6,T1,0,v100,SA,160314-TH-HVTN100,10.0,30OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYBJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,5,,10,3,TH;20160316;13725;Ce1086;PLATE,,,0,,29OCT2015,09NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-169,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64037-7,T1,0,v100,SA,160314-VB-HVTN100,10.0,12NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZWP-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,6,,10,3,VB;20160316;CE1086;13705;PLATE,,,0,,08NOV2015,19NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-165,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64041-1,T1,0,v100,SA,160314-TH-HVTN100,10.0,01DEC2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J1Q0-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,7,,10,3,TH;20160316;13724;Ce1086;PLATE,,,0,,26NOV2015,07DEC2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-183,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64044-8,T1,0,v100,SA,160314-VB-HVTN100,10.0,30OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HY9Q-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,7,,10,3,VB;20160316;CE1086;13706;PLATE,,,0,,29OCT2015,09NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-188,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64046-3,T1,0,v100,SA,160314-TH-HVTN100,10.0,17NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J09C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,6,,10,3,TH;20160316;13726;Ce1086;PLATE,,,0,,17NOV2015,28NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-054,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64047-4,T1,0,v100,SA,160314-TH-HVTN100,10.0,03NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HYR2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,6,,10,3,TH;20160316;13726;Ce1086;PLATE,,,0,,29OCT2015,09NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-239,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64054-2,T1,0,v100,SA,160314-TH-HVTN100,10.0,28OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HXZP-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,5,,10,3,TH;20160316;13725;Ce1086;PLATE,,,0,,26OCT2015,06NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-098,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64062-0,T1,0,v100,SA,160314-VB-HVTN100,10.0,03NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HYRQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,5,,10,3,VB;20160316;CE1086;13704;PLATE,,,0,,30OCT2015,10NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-216,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64064-5,T1,0,v100,SA,160315-TH-HVTN100,10.0,12NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J015-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,7,,10,3,TH;20160317;13767;Ce1086;Plate,,,0,,09NOV2015,20NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-185,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64065-3,T1,0,v100,SA,160314-VB-HVTN100,10.0,12NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZXY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,4,,10,3,VB;20160316;CE1086;13703;PLATE,,,0,,08NOV2015,19NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-102,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64067-2,T1,0,v100,SA,160314-VB-HVTN100,10.0,17NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J09F-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,6,,10,3,VB;20160316;CE1086;13705;PLATE,,,0,,13NOV2015,24NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-112,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64070-4,T1,0,v100,SA,160316-TH-HVTN,10.0,16NOV2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J03Q-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,6,,10,3,TH;20160318;13800;Ce1086;Plate,,,0,,05NOV2015,16NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-082,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64074-1,T1,0,v100,SA,160314-TH-HVTN100,10.0,16NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J039-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,6,,10,3,TH;20160316;13726;Ce1086;PLATE,,,0,,12NOV2015,23NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-197,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64084-3,T1,0,v100,SA,160314-VB-HVTN100,10.0,18NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J0MY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,6,,10,3,VB;20160316;CE1086;13705;PLATE,,,0,,15NOV2015,26NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-232,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64085-5,T1,0,v100,SA,160315-TH-HVTN100,10.0,01DEC2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J1QW-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,7,,10,3,TH;20160317;13767;Ce1086;Plate,,,0,,20NOV2015,01DEC2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-003,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64002-4,T1,0,v100,SA,160315-TH-HVTN100,10.0,13OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBJ-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,4,,10,3,TH;20160317;13765;Ce1086;Plate,,,0,,08OCT2015,19OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-152,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64006-0,T1,0,v100,SA,160314-TH-HVTN100,10.0,14SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HSJ4-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,4,,10,3,TH;20160316;13717;Ce1086;PLATE,,,0,,06SEP2015,17SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-220,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64009-5,T1,0,v100,SA,160314-TH-HVTN100,10.0,15OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWQB-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,4,,10,3,TH;20160316;13717;Ce1086;PLATE,,,0,,11OCT2015,22OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-125,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64010-0,T1,0,v100,SA,160315-TH-HVTN100,10.0,14SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HSMB-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,5,,10,3,TH;20160317;13766;Ce1086;Plate,,,0,,05SEP2015,16SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-233,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64011-7,T1,0,v100,SA,160315-TH-HVTN100,10.0,22SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HTGD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,6,,10,3,TH;20160317;13762;Ce1086;Plate,,,0,,18SEP2015,29SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-186,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64016-9,T1,0,v100,SA,160314-TH-HVTN100,10.0,27OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08MAR2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXNV-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,3,,10,3,TH;20160316;13723;Ce1086;PLATE,,,0,0,18OCT2015,29OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-039,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64017-5,T1,0,v100,SA,160428-TH-HVTN100,10.0,29SEP2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HTWM-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,3,,10,3,TH;20160501;14098;CE1086;PLATE,,,0,,26SEP2015,07OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-013,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64018-3,T1,0,v100,SA,160314-VB-HVTN100,10.0,20NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J0YX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,2,,10,3,VB;20160316;CE1086;13701;PLATE,,,0,,17NOV2015,28NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-121,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64020-3,T1,0,v100,SA,160428-TH-HVTN100,10.0,06OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HVPF-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,2,,10,3,TH;20160501;14099;CE1086;PLATE,,,0,,01OCT2015,12OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-087,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64023-2,T1,0,v100,SA,160315-TH-HVTN100,10.0,21OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HX1W-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,4,,10,3,TH;20160317;13765;Ce1086;Plate,,,0,,16OCT2015,27OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-100,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64025-8,T1,0,v100,SA,160314-TH-HVTN100,10.0,13OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBG-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,3,,10,3,TH;20160316;13723;Ce1086;PLATE,,,0,,08OCT2015,19OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-069,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64026-6,T1,0,v100,SA,160314-TH-HVTN100,10.0,07NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,3,,10,3,TH;20160316;13723;Ce1086;PLATE,,,0,,03NOV2015,14NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-206,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64033-9,T1,0,v100,SA,160315-TH-HVTN100,10.0,20OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08DEC2015,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HWYC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,4,,10,3,TH;20160317;13765;Ce1086;Plate,,,0,0,15OCT2015,26OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-047,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64035-1,T1,0,v100,SA,160314-VB-HVTN100,10.0,05NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ01-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,2,,10,3,VB;20160316;CE1086;13701;PLATE,,,0,,01NOV2015,12NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-089,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64038-8,T1,0,v100,SA,160314-VB-HVTN100,10.0,25NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J17P-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,4,,10,3,VB;20160316;CE1086;13703;PLATE,,,0,,20NOV2015,01DEC2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-139,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64041-8,T1,0,v100,SA,160314-VB-HVTN100,10.0,10NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFB-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,4,,10,3,VB;20160316;CE1086;13703;PLATE,,,0,,06NOV2015,17NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-080,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64042-9,T1,0,v100,SA,160314-VB-HVTN100,10.0,26OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HXGW-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,2,,10,3,VB;20160316;CE1086;13701;PLATE,,,0,,22OCT2015,02NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-210,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64046-5,T1,0,v100,SA,160315-TH-HVTN100,10.0,27OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXNS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,4,,10,3,TH;20160317;13765;Ce1086;Plate,,,0,,23OCT2015,03NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-162,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64048-2,T1,0,v100,SA,160314-VB-HVTN100,10.0,12NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J00K-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,6,,10,3,VB;20160316;CE1086;13705;PLATE,,,0,,05NOV2015,16NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-246,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64051-0,T1,0,v100,SA,160314-VB-HVTN100,10.0,11NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZP9-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,3,,10,3,VB;20160316;CE1086;13702;PLATE,,,0,,07NOV2015,18NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-223,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64053-6,T1,0,v100,SA,160314-TH-HVTN100,10.0,11NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HZQD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,4,,10,3,TH;20160316;13717;Ce1086;PLATE,,,0,,07NOV2015,18NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-028,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64055-4,T1,0,v100,SA,160315-TH-HVTN100,10.0,05NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZ03-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,3,,10,3,TH;20160317;13768;Ce1086;Plate,,,0,,01NOV2015,12NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-244,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64059-8,T1,0,v100,SA,160315-TH-HVTN100,10.0,20NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J0Y2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,5,,10,3,TH;20160317;13766;Ce1086;Plate,,,0,,17NOV2015,28NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-153,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64061-6,T1,0,v100,SA,160314-VB-HVTN100,10.0,07NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,1,,10,3,VB;20160316;CE1086;13700;PLATE,,,0,,03NOV2015,14NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-015,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64063-0,T1,0,v100,SA,160314-VB-HVTN100,10.0,19NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J0WN-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,1,,10,3,VB;20160316;CE1086;13700;PLATE,,,1,,14NOV2015,25NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-252,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64064-3,T1,0,v100,SA,160314-VB-HVTN100,10.0,23NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0ZW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,4,,10,3,VB;20160316;CE1086;13703;PLATE,,,0,,19NOV2015,30NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-211,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64068-4,T1,0,v100,SA,160315-TH-HVTN100,10.0,10NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZFD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,5,,10,3,TH;20160317;13766;Ce1086;Plate,,,0,,07NOV2015,18NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-147,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64069-2,T1,0,v100,SA,160315-TH-HVTN100,10.0,16NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J02X-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,5,,10,3,TH;20160317;13766;Ce1086;Plate,,,0,,05NOV2015,16NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-168,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64071-1,T1,0,v100,SA,160314-TH-HVTN100,10.0,12NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZZT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,3,,10,3,TH;20160316;13723;Ce1086;PLATE,,,0,,08NOV2015,19NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-203,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64072-2,T1,0,v100,SA,160314-VB-HVTN100,10.0,12NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZYT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,4,,10,3,VB;20160316;CE1086;13703;PLATE,,,0,,08NOV2015,19NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-167,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64074-8,T1,0,v100,SA,160314-TH-HVTN100,10.0,18NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J0LW-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,3,,10,3,TH;20160316;13723;Ce1086;PLATE,,,0,,17NOV2015,28NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-224,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64075-0,T1,0,v100,SA,160314-VB-HVTN100,10.0,19NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J0W8-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,1,,10,3,VB;20160316;CE1086;13700;PLATE,,,0,,13NOV2015,24NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-226,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64077-4,T1,0,v100,SA,160314-VB-HVTN100,10.0,19NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J0QS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,2,,10,3,VB;20160316;CE1086;13701;PLATE,,,0,,15NOV2015,26NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-020,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64079-7,T1,0,v100,SA,160314-VB-HVTN100,10.0,03DEC2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J1WG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,3,,10,3,VB;20160316;CE1086;13702;PLATE,,,0,,27NOV2015,08DEC2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-065,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64001-1,T1,0,v100,SA,160315-VB-HVTN100,10.0,07SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FCQ6-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,3,,10,3,VB;20160317;CE1086;13755;PLATE,,,0,,05SEP2015,16SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-018,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64002-2,T1,0,v100,SA,160315-VB-HVTN100,10.0,15SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FHFQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,6,,10,3,VB;20160317;CE1086;13758;PLATE,,,0,,14SEP2015,25SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-096,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64004-8,T1,0,v100,SA,160315-VB-HVTN100,10.0,23OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FW3Z-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,1,,10,3,VB;20160317;CE1086;13753;PLATE,,,0,,22OCT2015,02NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-249,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64006-3,T1,0,v100,SA,160314-OK-HVTN100,10.0,22SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FK9S-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,6,,10,3,OK;20160316;13735;Ce1086;PLATE,,,0,,20SEP2015,01OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-010,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64009-7,T1,0,v100,SA,160315-VB-HVTN100,10.0,22SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FKKP-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,5,,10,3,VB;20160317;CE1086;13757;PLATE,,,0,,20SEP2015,01OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-222,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64018-1,T1,0,v100,SA,160315-VB-HVTN100,10.0,30SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FMJB-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,7,,10,3,VB;20160317;CE1086;13759;PLATE,,,0,,26SEP2015,07OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-046,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64022-7,T1,0,v100,SA,160315-VB-HVTN100,10.0,16OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FS71-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,5,,10,3,VB;20160317;CE1086;13757;PLATE,,,0,,12OCT2015,23OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-037,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64030-7,T1,0,v100,SA,160428-TH-HVTN100,10.0,09OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FQ9L-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,4,,10,3,TH;20160501;14101;CE1086;PLATE,,,0,,01OCT2015,12OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-251,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64033-6,T1,0,v100,SA,160314-OK-HVTN100,10.0,19OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FSKN-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,6,,10,3,OK;20160316;13735;Ce1086;PLATE,,,0,,12OCT2015,23OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-099,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64034-9,T1,0,v100,SA,160314-OK-HVTN100,10.0,08OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FQ46-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,5,,10,3,OK;20160316;13736;Ce1086;PLATE,,,0,,03OCT2015,14OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-032,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64038-5,T1,0,v100,SA,160314-OK-HVTN100,10.0,26OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FWHM-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,5,,10,3,OK;20160316;13736;Ce1086;PLATE,,,0,,22OCT2015,02NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-245,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64039-8,T1,0,v100,SA,160428-TH-HVTN100,10.0,15OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FRV7-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,4,,10,3,TH;20160501;14101;CE1086;PLATE,,,0,,08OCT2015,19OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-057,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64042-6,T1,0,v100,SA,160315-VB-HVTN100,10.0,22OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FVNV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,4,,10,3,VB;20160317;CE1086;13756;PLATE,,,0,,17OCT2015,28OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-055,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64043-1,T1,0,v100,SA,160316-TH-HVTN100,10.0,14OCT2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FRFF-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,5,,10,3,TH;20160318;13797;Ce1086;Plate,,,0,,12OCT2015,23OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-021,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64046-7,T1,0,v100,SA,160314-OK-HVTN100,10.0,04NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FZ1Z-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,6,,10,3,OK;20160316;13735;Ce1086;PLATE,,,0,,01NOV2015,12NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-156,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64049-3,T1,0,v100,SA,160315-VB-HVTN100,10.0,14OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRCW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,5,,10,3,VB;20160317;CE1086;13757;PLATE,,,0,,10OCT2015,21OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-014,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64054-6,T1,0,v100,SA,160428-TH-HVTN100,10.0,23OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FW4N-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,5,,10,3,TH;20160501;14102;CE1086;PLATE,,,0,,16OCT2015,27OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-240,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64062-9,T1,0,v100,SA,160314-OK-HVTN100,10.0,27OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FWTX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,5,,10,3,OK;20160316;13736;Ce1086;PLATE,,,0,,23OCT2015,03NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-171,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64063-3,T1,0,v100,SA,160315-VB-HVTN100,10.0,14OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRDV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,4,,10,3,VB;20160317;CE1086;13756;PLATE,,,0,,10OCT2015,21OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-068,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64064-1,T1,0,v100,SA,160314-OK-HVTN100,10.0,27OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FWX6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,4,,10,3,OK;20160316;13729;Ce1086;PLATE,,,0,,23OCT2015,03NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-062,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64065-7,T1,0,v100,SA,160428-TH-HVTN100,10.0,13OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FQWN-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,4,,10,3,TH;20160501;14101;CE1086;PLATE,,,0,,12OCT2015,23OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-036,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64066-5,T1,0,v100,SA,160315-VB-HVTN100,10.0,16OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FS6F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,7,,10,3,VB;20160317;CE1086;13759;PLATE,,,0,,10OCT2015,21OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-095,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64071-4,T1,0,v100,SA,160315-VB-HVTN100,10.0,21OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FTPM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,6,,10,3,VB;20160317;CE1086;13758;PLATE,,,0,,17OCT2015,28OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-212,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64072-0,T1,0,v100,SA,160314-OK-VTN100,10.0,02NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FY0T-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,3,,10,3,OK;20160316;13730;Ce1086;PLATE,,,0,,29OCT2015,09NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-072,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64074-5,T1,0,v100,SA,160315-VB-HVTN100,10.0,20OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FSTR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,1,,10,3,VB;20160317;CE1086;13753;PLATE,,,0,,15OCT2015,26OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-229,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64076-1,T1,0,v100,SA,160314-OK-VTN100,10.0,07NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20G182-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,3,,10,3,OK;20160316;13730;Ce1086;PLATE,,,0,,29OCT2015,09NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-217,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64077-2,T1,0,v100,SA,160314-OK-HVTN100,10.0,29OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FXCG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,5,,10,3,OK;20160316;13736;Ce1086;PLATE,,,0,,25OCT2015,05NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-149,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64078-6,T1,0,v100,SA,160315-VB-HVTN100,10.0,21OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FTPZ-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,7,,10,3,VB;20160317;CE1086;13759;PLATE,,,0,,16OCT2015,27OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-017,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64085-1,T1,0,v100,SA,160315-VB-HVTN100,10.0,20OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FSV2-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,1,,10,3,VB;20160317;CE1086;13753;PLATE,,,0,,17OCT2015,28OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-074,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64086-4,T1,0,v100,SA,160314-OK-HVTN100,10.0,30OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FXJC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,4,,10,3,OK;20160316;13729;Ce1086;PLATE,,,0,,26OCT2015,06NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-124,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64089-6,T1,0,v100,SA,160314-OK-HVTN100,10.0,28OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX1S-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,4,,10,3,OK;20160316;13729;Ce1086;PLATE,,,0,,25OCT2015,05NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-004,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64095-6,T1,0,v100,SA,160314-OK-HVTN100,10.0,27OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FWWD-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,5,,10,3,OK;20160316;13736;Ce1086;PLATE,,,0,,23OCT2015,03NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-182,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64097-5,T1,0,v100,SA,160314-OK-HVTN100,10.0,06NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G0Z4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,4,,10,3,OK;20160316;13729;Ce1086;PLATE,,,0,,05NOV2015,16NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-034,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64107-1,T1,0,v100,SA,160316-TH-HVTN100,10.0,07NOV2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G18P-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,4,,10,3,TH;20160318;13799;Ce1086;Plate,,,0,,03NOV2015,14NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-115,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64113-4,T1,0,v100,SA,160314-OK-HVTN100,10.0,30OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FXJP-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,4,,10,3,OK;20160316;13729;Ce1086;PLATE,,,0,,29OCT2015,09NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-144,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64118-3,T1,0,v100,SA,160314-OK-HVTN100,10.0,10NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20G20Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,6,,10,3,OK;20160316;13735;Ce1086;PLATE,,,0,,07NOV2015,18NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-189,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64125-8,T1,0,v100,SA,160314-OK-HVTN100,10.0,12NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G3XF-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,6,,10,3,OK;20160316;13735;Ce1086;PLATE,,,0,,12NOV2015,23NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-141,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64001-8,P2,1,v100,SA,160428-TH-HVTN100,10.0,23JUL2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20DZ2F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,1,,10,3,TH;20160501;14100;CE1086;PLATE,,,0,,23JUL2015,03AUG2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-056,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64028-6,P2,1,v100,SA,160316-TH-HVTN100,10.0,04AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20F1PR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,2,,10,3,TH;20160318;13796;Ce1086;Plate,,,0,,02AUG2015,13AUG2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-154,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64047-1,P2,1,v100,SA,160316-TH-HVTN100,10.0,17AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20F5F9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,1,,10,3,TH;20160318;13795;Ce1086;Plate,,,0,,13AUG2015,24AUG2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-041,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64059-3,P2,1,v100,SA,160316-TH-HVTN100,10.0,19AUG2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20F64B-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,3,,10,3,TH;20160318;13804;Ce1086;Plate,,,0,,15AUG2015,26AUG2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-196,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64085-8,P2,1,v100,SA,160314-OK-HVTN100,10.0,07SEP2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FCQJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,2,,10,3,OK;20160316;13739;Ce1086;PLATE,,,0,,04SEP2015,15SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-200,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64086-6,P2,1,v100,SA,160315-VB-HVTN100,10.0,15SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FHG1-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,6,,10,3,VB;20160317;CE1086;13758;PLATE,,,0,,12SEP2015,23SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-122,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64121-2,P2,1,v100,SA,160316-TH-HVTN100,10.0,29SEP2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FM29-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,3,,10,3,TH;20160318;13804;Ce1086;Plate,,,0,,26SEP2015,07OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-199,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64165-3,P2,1,v100,SA,160315-VB-HVTN100,10.0,09NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20G1N0-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,3,,10,3,VB;20160317;CE1086;13755;PLATE,,,0,,05NOV2015,16NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-104,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64052-0,P2,1,v100,SA,160428-TH-HVTN100,10.0,06NOV2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BFW9-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,2,,10,3,TH;20160501;14099;CE1086;PLATE,,,0,,02NOV2015,13NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-086,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64077-3,P2,1,v100,SA,160315-TH-HVTN100,10.0,24NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CA60BGKV-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,2,,10,3,TH;20160317;13764;Ce1086;Plate,,,0,,13NOV2015,24NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-012,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64078-5,P2,1,v100,SA,160315-TH-HVTN100,10.0,19NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BGF7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,3,,10,3,TH;20160317;13768;Ce1086;Plate,,,0,,14NOV2015,25NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-214,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64018-8,P2,1,v100,SA,160315-OK-HVTN100,10.0,23SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08APR2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT0552W-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,4,,10,3,OK;20160317;13785;Ce1086;PLATE,,,0,0,19SEP2015,30SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-238,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64027-2,P2,1,v100,SA,160315-OK-HVTN100,10.0,27OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT0584P-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,2,,10,3,OK;20160317;13783;Ce1086;PLATE,,,0,,23OCT2015,03NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-175,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64030-0,P2,1,v100,SA,160315-OK-HVTN100,10.0,18SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT054PV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,4,,10,3,OK;20160317;13785;Ce1086;PLATE,,,0,,14SEP2015,25SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-045,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64068-9,P2,1,v100,SA,160315-OK-HVTN100,10.0,26NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05CFM-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,5,,10,3,OK;20160317;13782;Ce1086;PLATE,,,0,,22NOV2015,03DEC2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-191,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64024-7,P2,1,v100,SA,160314-VB-HVTN100,10.0,26OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXHD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,7,,10,3,VB;20160316;CE1086;13706;PLATE,,,0,,24OCT2015,04NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-164,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64045-0,P2,1,v100,SA,160314-VB-HVTN100,10.0,16NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J06D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,5,,10,3,VB;20160316;CE1086;13704;PLATE,,,0,,14NOV2015,25NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-008,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64049-7,P2,1,v100,SA,160314-VB-HVTN100,10.0,02NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HYLY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,5,,10,3,VB;20160316;CE1086;13704;PLATE,,,0,,29OCT2015,09NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-016,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64051-7,P2,1,v100,SA,160314-VB-HVTN100,10.0,18NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0N9-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,6,,10,3,VB;20160316;CE1086;13705;PLATE,,,0,,17NOV2015,28NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-033,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64059-1,P2,1,v100,SA,160314-VB-HVTN100,10.0,12NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HZVY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,5,,10,3,VB;20160316;CE1086;13704;PLATE,,,0,,07NOV2015,18NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-241,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64069-9,P2,1,v100,SA,160314-TH-HVTN100,10.0,10NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,5,,10,3,TH;20160316;13725;Ce1086;PLATE,,,0,,05NOV2015,16NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-159,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64073-3,P2,1,v100,SA,160314-TH-HVTN100,10.0,27OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXSP-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,7,,10,3,TH;20160316;13724;Ce1086;PLATE,,,0,,26OCT2015,06NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-049,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64083-0,P2,1,v100,SA,160315-TH-HVTN100,10.0,17NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0CK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,7,,10,3,TH;20160317;13767;Ce1086;Plate,,,0,,14NOV2015,25NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-024,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64008-7,P2,1,v100,SA,160315-TH-HVTN100,10.0,22SEP2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HTD1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,4,,10,3,TH;20160317;13765;Ce1086;Plate,,,0,,18SEP2015,29SEP2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-143,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64021-9,P2,1,v100,SA,160314-TH-HVTN100,10.0,01OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HV6Q-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,4,,10,3,TH;20160316;13717;Ce1086;PLATE,,,0,,01OCT2015,12OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-009,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64024-0,P2,1,v100,SA,160316-TH-HVTN100,10.0,21OCT2015,16MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FTQC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Tandile Hermanus,4,,10,3,TH;20160318;13799;Ce1086;Plate,,,0,,16OCT2015,27OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-094,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64031-2,P2,1,v100,SA,160314-VB-HVTN100,10.0,07NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ68-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,3,,10,3,VB;20160316;CE1086;13702;PLATE,,,0,,03NOV2015,14NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-026,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64034-7,P2,1,v100,SA,160314-VB-HVTN100,10.0,04NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HYZ4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,3,,10,3,VB;20160316;CE1086;13702;PLATE,,,0,,31OCT2015,11NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-166,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64050-7,P2,1,v100,SA,160314-VB-HVTN100,10.0,04NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYV7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,2,,10,3,VB;20160316;CE1086;13701;PLATE,,,0,,31OCT2015,11NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-005,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64057-3,P2,1,v100,SA,160314-VB-HVTN100,10.0,04NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HYVZ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,1,,10,3,VB;20160316;CE1086;13700;PLATE,,,0,,30OCT2015,10NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-133,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64060-1,P2,1,v100,SA,160314-VB-HVTN100,10.0,07NOV2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,3,,10,3,VB;20160316;CE1086;13702;PLATE,,,0,,03NOV2015,14NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-195,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64070-6,P2,1,v100,SA,160315-VB-HVTN100,10.0,09NOV2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20G1M1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,5,,10,3,VB;20160317;CE1086;13757;PLATE,,,0,,07NOV2015,18NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-043,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64017-7,P2,1,v100,SA,160428-TH-HVTN100,10.0,13OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FQTX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,4,,10,3,TH;20160501;14101;CE1086;PLATE,,,0,,10OCT2015,21OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-174,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64052-4,P2,1,v100,SA,160315-VB-HVTN100,10.0,23OCT2015,15MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FW49-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Valerie Bekker,1,,10,3,VB;20160317;CE1086;13753;PLATE,,,0,,19OCT2015,30OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-067,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64073-7,P2,1,v100,SA,160428-TH-HVTN100,10.0,22OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FVG5-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:5,Dilution,04APR2016,160404,72,Tandile Hermanus,4,,10,3,TH;20160501;14101;CE1086;PLATE,,,0,,18OCT2015,29OCT2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-213,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64079-9,P2,1,v100,SA,160314-OK-VTN100,10.0,28OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FX13-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,3,,10,3,OK;20160316;13730;Ce1086;PLATE,,,0,,24OCT2015,04NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-250,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64080-5,P2,1,v100,SA,160314-OK-VTN100,10.0,28OCT2015,14MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX2K-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:4,Dilution,26FEB2016,160226,48,Owen Karimanzira,3,,10,3,OK;20160316;13730;Ce1086;PLATE,,,0,,24OCT2015,04NOV2015,0,182,0,Ce1086_B2,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-053,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64003-3,T1,0,v100,SA,151028-TH-HVTN100,10.0,22JUL2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20DYKC-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151030;12046;TV1;PLATE4.x,,,0,,19JUL2015,30JUL2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-111,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64006-5,T1,0,v100,SA,151028-TH-HVTN100,10.0,29JUL2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20F09P-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151030;12046;TV1;PLATE4.x,,,0,,26JUL2015,06AUG2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-031,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64009-0,T1,0,v100,SA,151028-TH-HVTN100,10.0,23JUL2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20DYTL-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151030;12046;TV1;PLATE4.x,,,0,,23JUL2015,03AUG2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-209,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64013-9,T1,0,v100,SA,151028-TH-HVTN100,10.0,28JUL2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20DZVV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151030;12046;TV1;PLATE4.x,,,0,,25JUL2015,05AUG2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-158,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64021-4,T1,0,v100,SA,151028-TH-HVTN100,10.0,03AUG2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F17D-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151030;12046;TV1;PLATE4.x,,,0,,01AUG2015,12AUG2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-215,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64029-9,T1,0,v100,SA,151028-TH-HVTN100,10.0,25AUG2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8HS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20151030;12047;TV1;PLATE5.x,,,0,,14AUG2015,25AUG2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-231,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64031-7,T1,0,v100,SA,151028-TH-HVTN100,10.0,27AUG2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8ZN-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20151030;12047;TV1;PLATE5.x,,,0,,21AUG2015,01SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-091,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64033-4,T1,0,v100,SA,151028-TH-HVTN100,10.0,08SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD4N-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20151030;12047;TV1;PLATE5.x,,,0,,04SEP2015,15SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-077,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64036-9,T1,0,v100,SA,151028-TH-HVTN100,10.0,18AUG2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20F5SG-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20151030;12048;TV1;PLATE6.x,,,0,,14AUG2015,25AUG2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-136,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64045-2,T1,0,v100,SA,151028-TH-HVTN100,10.0,13AUG2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F4C6-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20151030;12048;TV1;PLATE6.x,,,0,,13AUG2015,24AUG2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-227,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64053-1,T1,0,v100,SA,151028-TH-HVTN100,10.0,19AUG2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20F676-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20151030;12044;TV1;PLATE3.x,,,0,,16AUG2015,27AUG2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-160,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64054-4,T1,0,v100,SA,151028-TH-HVTN100,10.0,26AUG2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20F8R9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151030;12043;TV1;PLATE2.x,,,0,,21AUG2015,01SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-155,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64055-9,T1,0,v100,SA,151028-TH-HVTN,10.0,20AUG2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20F6C4-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151030;12042;TV1;PLATE1.x,,,0,,14AUG2015,25AUG2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-177,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64057-8,T1,0,v100,SA,151028-TH-HVTN100,10.0,02SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FBT0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20151030;12044;TV1;PLATE3.x,,,0,,23AUG2015,03SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-052,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64062-2,T1,0,v100,SA,151028-TH-HVTN100,10.0,03SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FC68-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151030;12043;TV1;PLATE2.x,,,0,,28AUG2015,08SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-247,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64063-5,T1,0,v100,SA,151028-TH-HVTN100,10.0,08SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FD2Q-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151030;12043;TV1;PLATE2.x,,,0,,04SEP2015,15SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-126,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64066-3,T1,0,v100,SA,151028-TH-HVTN100,10.0,08SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FD3H-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151030;12043;TV1;PLATE2.x,,,0,,04SEP2015,15SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-225,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64067-4,T1,0,v100,SA,151028-TH-HVTN100,10.0,08SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FD43-06,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20151030;12044;TV1;PLATE3.x,,,0,,04SEP2015,15SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-148,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64069-7,T1,0,v100,SA,151110-TH-HVTN100,10.0,14SEP2015,10NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FGVK-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151112;12209;TV1;PLATE1.x,,,0,,12SEP2015,23SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-163,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64077-9,T1,0,v100,SA,151028-TH-HVTN,10.0,07SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FCJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151030;12042;TV1;PLATE1.x,,,0,,29AUG2015,09SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-073,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64080-3,T1,0,v100,SA,151028-TH-HVTN,10.0,31AUG2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FB33-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151030;12042;TV1;PLATE1.x,,,0,,28AUG2015,08SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-184,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64087-7,T1,0,v100,SA,151028-TH-HVTN,10.0,07SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FCJR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151030;12042;TV1;PLATE1.x,,,0,,06SEP2015,17SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-170,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64095-4,T1,0,v100,SA,151110-TH-HVTN100,10.0,08OCT2015,10NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FQ3V-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151112;12209;TV1;PLATE1.x,,,0,,01OCT2015,12OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-038,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64105-9,T1,0,v100,SA,160309-OK-HVTN100,10.0,17NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G4TX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,2,,10,3,OK;20160310;13628;TV1;PLATE2.x,,,0,,14NOV2015,25NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-123,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64117-3,T1,0,v100,SA,151118-TH-HVTN100,10.0,17SEP2015,18NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FJ00-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151120;12383;TV1;PLATE2.x,,,0,,13SEP2015,24SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-061,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64119-8,T1,0,v100,SA,151110-TH-HVTN100,10.0,30SEP2015,10NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FMJ0-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151112;12209;TV1;PLATE1.x,,,0,,26SEP2015,07OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-128,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64129-6,T1,0,v100,SA,151110-TH-HVTN100,10.0,06OCT2015,10NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FPD4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151112;12208;TV1;PLATE2.x,,,0,,03OCT2015,14OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-108,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64130-3,T1,0,v100,SA,151110-TH-HVTN100,10.0,06OCT2015,10NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FPDG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151112;12208;TV1;PLATE2.x,,,0,,02OCT2015,13OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-097,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64135-8,T1,0,v100,SA,151110-TH-HVTN100,10.0,28SEP2015,10NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FLTC-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151112;12208;TV1;PLATE2.x,,,0,,26SEP2015,07OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-129,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64139-4,T1,0,v100,SA,160308-VB-HVTN100,10.0,26OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FWKL-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,5,,10,3,VB;20160310;TV1;13592;PLATE5.x,,,0,,16OCT2015,27OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-058,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64150-0,T1,0,v100,SA,160308-VB-HVTN100,10.0,11NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20G3JT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,5,,10,3,VB;20160310;TV1;13592;PLATE5.x,,,0,,07NOV2015,18NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-151,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64154-2,T1,0,v100,SA,160309-VB-HVTN100,10.0,02NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FXYX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,1,,10,3,VB;20160311;TV1;13636;PLATE1.x,,,0,,25OCT2015,05NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-002,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64156-9,T1,0,v100,SA,160308-VB-HVTN100,10.0,02NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FXZQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,5,,10,3,VB;20160310;TV1;13592;PLATE5.x,,,0,,25OCT2015,05NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-194,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64166-1,T1,0,v100,SA,160309-VB-HVTN100,10.0,17NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G4VL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,1,,10,3,VB;20160311;TV1;13636;PLATE1.x,,,0,,14NOV2015,25NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-157,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64167-2,T1,0,v100,SA,160308-VB-HVTN100,10.0,10NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20G20B-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,5,,10,3,VB;20160310;TV1;13592;PLATE5.x,,,0,,06NOV2015,17NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-025,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,138-64172-9,T1,0,v100,SA,160308-VB-HVTN100,10.0,12NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20G3X4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,6,,10,3,VB;20160310;TV1;13593;PLATE6.x,,,0,,06NOV2015,17NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-137,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64002-3,T1,0,v100,SA,151028-TH-HVTN100,10.0,28AUG2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BCRM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20151030;12048;TV1;PLATE6.x,,,0,,21AUG2015,01SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-064,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64007-0,T1,0,v100,SA,151028-TH-HVTN100,10.0,14SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BDHQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20151030;12048;TV1;PLATE6.x,,,0,,10SEP2015,21SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-131,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64008-8,T1,0,v100,SA,151028-TH-HVTN100,10.0,14SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BDJC-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20151030;12048;TV1;PLATE6.x,,,0,,07SEP2015,18SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-109,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64028-0,T1,0,v100,SA,151125-TH-HVTN100,10.0,21OCT2015,25NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BFB3-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151127;12498;TV1;PLATE2.x,,,0,,17OCT2015,28OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-187,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64029-3,T1,0,v100,SA,160309-TH-HVTN100,10.0,26OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFG6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20160311;13624;TV1;PLATE6.x,,,0,,19OCT2015,30OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-090,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64030-6,T1,0,v100,SA,151125-TH-HVTN100,10.0,27OCT2015,25NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BFGQ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151127;12498;TV1;PLATE2.x,,,0,,23OCT2015,03NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-130,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64034-8,T1,0,v100,SA,160308-TH-HVTN100,10.0,10NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG09-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20160310;13586;TV1;PLATE5.x,,,0,,06NOV2015,17NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-105,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64036-3,T1,0,v100,SA,160308-TH-HVTN100,10.0,13NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG4G-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20160310;13587;TV1;PLATE6.x,,,0,,09NOV2015,20NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-140,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64037-4,T1,0,v100,SA,160308-TH-HVTN100,10.0,16NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG8C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20160310;13587;TV1;PLATE6.x,,,0,,12NOV2015,23NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-138,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64038-9,T1,0,v100,SA,151125-TH-HVTN100,10.0,04NOV2015,25NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFT3-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151127;12498;TV1;PLATE2.x,,,0,,31OCT2015,11NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-084,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64039-7,T1,0,v100,SA,151125-TH-HVTN100,10.0,27OCT2015,25NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFH3-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151127;12498;TV1;PLATE2.x,,,0,,23OCT2015,03NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-198,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64040-3,T1,0,v100,SA,160308-TH-HVTN100,10.0,17NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGC1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20160310;13587;TV1;PLATE6.x,,,0,,07NOV2015,18NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-228,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64044-0,T1,0,v100,SA,160308-TH-HVTN100,10.0,24NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BGLK-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160310;13585;TV1;PLATE4.x,,,0,,14NOV2015,25NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-181,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64050-8,T1,0,v100,SA,151125-TH-HVTN100,10.0,02NOV2015,25NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BFPN-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151127;12497;TV1;PLATE1.x,,,0,,31OCT2015,11NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-085,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64051-4,T1,0,v100,SA,151125-TH-HVTN100,10.0,06NOV2015,25NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFVX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151127;12497;TV1;PLATE1.x,,,0,,02NOV2015,13NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-063,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64053-7,T1,0,v100,SA,160309-OK-HVTN100,10.0,20NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BGGQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,5,,10,3,OK;20160310;13631;TV1;PLATE5.x,,,0,,16NOV2015,27NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-235,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64054-5,T1,0,v100,SA,151125-TH-HVTN100,10.0,09NOV2015,25NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BFY7-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151127;12497;TV1;PLATE1.x,,,0,,05NOV2015,16NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-001,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64061-7,T1,0,v100,SA,151125-TH-HVTN100,10.0,09NOV2015,25NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DA60BFYY-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151127;12497;TV1;PLATE1.x,,,0,,07NOV2015,18NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-083,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64062-8,T1,0,v100,SA,160309-OK-HVTN100,10.0,13NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,4,,10,3,OK;20160310;13630;TV1;PLATE4.x,,,0,,09NOV2015,20NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-145,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64066-9,T1,0,v100,SA,160308-TH-HVTN100,10.0,11NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KA60BG31-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20160310;13586;TV1;PLATE5.x,,,0,,06NOV2015,17NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-127,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64068-3,T1,0,v100,SA,160308-TH-HVTN100,10.0,24NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AA60BGMS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20160310;13586;TV1;PLATE5.x,,,0,,19NOV2015,30NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-044,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64069-1,T1,0,v100,SA,160309-VB-HVTN100,10.0,16NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GA60BG7M-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,4,,10,3,VB;20160311;TV1;13639;PLATE4.x,,,0,,12NOV2015,23NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-132,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64070-7,T1,0,v100,SA,160308-TH-HVTN100,10.0,13NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BG5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160310;13585;TV1;PLATE4.x,,,0,,09NOV2015,20NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-048,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64073-6,T1,0,v100,SA,160308-TH-HVTN100,10.0,16NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BG9D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20160310;13586;TV1;PLATE5.x,,,0,,12NOV2015,23NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-092,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64075-4,T1,0,v100,SA,160309-TH-HVTN100,10.0,17NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BGCG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20160311;13624;TV1;PLATE6.x,,,0,,13NOV2015,24NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-218,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64076-2,T1,0,v100,SA,160308-TH-HVTN100,10.0,16NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,15JUN2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JA60BG9S-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160310;13585;TV1;PLATE4.x,,,0,0,12NOV2015,23NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-179,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64082-4,T1,0,v100,SA,160308-TH-HVTN100,10.0,10NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BA60BG19-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160310;13585;TV1;PLATE4.x,,,0,,06NOV2015,17NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-040,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,156-64089-5,T1,0,v100,SA,160308-TH-HVTN100,10.0,27NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FA60BGP5-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20160310;13587;TV1;PLATE6.x,,,0,,21NOV2015,02DEC2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-022,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64001-8,T1,0,v100,SA,151125-TH-HVTN100,10.0,21SEP2015,25NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20151127;12499;TV1;PLATE3-1,,,0,,20SEP2015,01OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-066,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64002-9,T1,0,v100,SA,151028-TH-HVTN100,10.0,17SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GAT054MG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,7,,10,3,TH;20151030;12049;TV1;PLATE7.x,,,0,,12SEP2015,23SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-142,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64004-1,T1,0,v100,SA,160308-VB-HVTN100,10.0,22OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT057TJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,6,,10,3,VB;20160310;TV1;13593;PLATE6.x,,,0,,16OCT2015,27OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-236,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64006-5,T1,0,v100,SA,151028-TH-HVTN100,10.0,17SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054L4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,7,,10,3,TH;20151030;12049;TV1;PLATE7.x,,,0,,13SEP2015,24SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-120,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64007-6,T1,0,v100,SA,151028-TH-HVTN100,10.0,17SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT054KS-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,7,,10,3,TH;20151030;12049;TV1;PLATE7.x,,,0,,13SEP2015,24SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-029,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64009-0,T1,0,v100,SA,160309-TH-HVTN100,10.0,21SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT054TT-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,7,,10,3,TH;20160311;13625;TV1;PLATE7.x,,,0,,17SEP2015,28SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-107,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64010-5,T1,0,v100,SA,160309-TH-HVTN100,10.0,22SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT0550X-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,8,,10,3,TH;20160311;13626;TV1;PLATE8.x,,,0,,18SEP2015,29SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-113,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64012-3,T1,0,v100,SA,160309-TH-HVTN100,10.0,21SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT054V4-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,7,,10,3,TH;20160311;13625;TV1;PLATE7.x,,,0,,20SEP2015,01OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-234,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64016-4,T1,0,v100,SA,160309-VB-HVTN100,10.0,21SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT054VG-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,5,,10,3,VB;20160311;TV1;13640;PLATE5.x,,,0,,20SEP2015,01OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-059,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64017-0,T1,0,v100,SA,160309-TH-HVTN100,10.0,28SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT05585-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,7,,10,3,TH;20160311;13625;TV1;PLATE7.x,,,0,,24SEP2015,05OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-023,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64021-4,T1,0,v100,SA,151125-TH-HVTN100,10.0,28SEP2015,25NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0557V-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20151127;12499;TV1;PLATE3-1,,,0,,24SEP2015,05OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-201,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64029-9,T1,0,v100,SA,160309-TH-HVTN100,10.0,12OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT056K1-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20160311;13624;TV1;PLATE6.x,,,0,,08OCT2015,19OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-076,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64031-7,T1,0,v100,SA,160309-TH-HVTN100,10.0,26OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT057ZR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,7,,10,3,TH;20160311;13625;TV1;PLATE7.x,,,0,,22OCT2015,02NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-204,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64035-6,T1,0,v100,SA,151125-TH-HVTN100,10.0,26OCT2015,25NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057X1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20151127;12499;TV1;PLATE3-1,,,0,,22OCT2015,02NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-230,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64036-9,T1,0,v100,SA,160309-OK-HVTN100,10.0,02NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT058FR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,3,,10,3,OK;20160310;13629;TV1;PLATE3.x,,,0,,29OCT2015,09NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-011,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64037-5,T1,0,v100,SA,160309-TH-HVTN100,10.0,27OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AAT0584C-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,8,,10,3,TH;20160311;13626;TV1;PLATE8.x,,,0,,23OCT2015,03NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-161,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64038-3,T1,0,v100,SA,160309-VB-HVTN100,10.0,19OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT05797-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,6,,10,3,VB;20160311;TV1;13641;PLATE6.x,,,0,,15OCT2015,26OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-180,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64041-3,T1,0,v100,SA,160309-OK-HVTN100,10.0,07NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05967-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,6,,10,3,OK;20160310;13632;TV1;PLATE6.x,,,0,,02NOV2015,13NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-116,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64043-8,T1,0,v100,SA,160309-TH-HVTN100,10.0,10NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT059JJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,7,,10,3,TH;20160311;13625;TV1;PLATE7.x,,,0,,06NOV2015,17NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-079,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64044-6,T1,0,v100,SA,160308-VB-HVTN100,10.0,23OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KAT057VG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,6,,10,3,VB;20160310;TV1;13593;PLATE6.x,,,0,,19OCT2015,30OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-192,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64045-2,T1,0,v100,SA,160309-VB-HVTN100,10.0,11NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT059Q1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,5,,10,3,VB;20160311;TV1;13640;PLATE5.x,,,0,,09NOV2015,20NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-146,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64050-2,T1,0,v100,SA,160309-OK-HVTN100,10.0,11NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT059TS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,5,,10,3,OK;20160310;13631;TV1;PLATE5.x,,,0,,07NOV2015,18NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-006,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64051-5,T1,0,v100,SA,160309-VB-HVTN100,10.0,09NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DAT0598R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,5,,10,3,VB;20160311;TV1;13640;PLATE5.x,,,0,,05NOV2015,16NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-007,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64053-1,T1,0,v100,SA,160308-VB-HVTN100,10.0,09NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT059C4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,6,,10,3,VB;20160310;TV1;13593;PLATE6.x,,,0,,05NOV2015,16NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-081,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64054-4,T1,0,v100,SA,160309-OK-HVTN100,10.0,10NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT059KL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,3,,10,3,OK;20160310;13629;TV1;PLATE3.x,,,0,,06NOV2015,17NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-172,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64056-7,T1,0,v100,SA,160309-VB-HVTN100,10.0,16NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05B6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,5,,10,3,VB;20160311;TV1;13640;PLATE5.x,,,0,,12NOV2015,23NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-205,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64057-8,T1,0,v100,SA,160309-VB-HVTN100,10.0,11NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT059VK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,4,,10,3,VB;20160311;TV1;13639;PLATE4.x,,,0,,06NOV2015,17NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-202,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64060-6,T1,0,v100,SA,160309-OK-HVTN100,10.0,21NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BAT05BWD-05,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,3,,10,3,OK;20160310;13629;TV1;PLATE3.x,,,0,,17NOV2015,28NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-119,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64062-2,T1,0,v100,SA,160309-VB-HVTN100,10.0,18NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JAT05BLC-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,4,,10,3,VB;20160311;TV1;13639;PLATE4.x,,,0,,14NOV2015,25NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-101,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,157-64072-7,T1,0,v100,SA,160309-TH-HVTN100,10.0,19NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05BS4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,8,,10,3,TH;20160311;13626;TV1;PLATE8.x,,,0,,19NOV2015,30NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-050,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64003-1,T1,0,v100,SA,151125-TH-HVTN100,10.0,02SEP2015,25NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HRJ1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151127;12498;TV1;PLATE2.x,,,0,,29AUG2015,09SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-150,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64005-9,T1,0,v100,SA,160309-TH-HVTN100,10.0,01SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HR6B-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20160311;13624;TV1;PLATE6.x,,,0,,28AUG2015,08SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-114,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64006-7,T1,0,v100,SA,160309-OK-HVTN100,10.0,18SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HT5Y-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,4,,10,3,OK;20160310;13630;TV1;PLATE4.x,,,0,,14SEP2015,25SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-190,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64007-8,T1,0,v100,SA,151118-TH-HVTN100,10.0,05OCT2015,18NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HVGX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151120;12383;TV1;PLATE2.x,,,0,,01OCT2015,12OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-248,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64011-0,T1,0,v100,SA,160309-TH-HVTN100,10.0,23SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HTJJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160311;13622;TV1;PLATE4.x,,,0,,18SEP2015,29SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-042,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64017-3,T1,0,v100,SA,160428-TH-HVTN100,10.0,06OCT2015,28APR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HVRV-13,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,72,Tandile Hermanus,1,,10,3,TH;20160501;14108;TV1;PLATE1.x,,,0,,03OCT2015,14OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-078,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64018-5,T1,0,v100,SA,151123-TH-HVTN100,10.0,02OCT2015,23NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HVCC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151125;12443;TV1;PLATE2.x,,,0,,01OCT2015,12OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-242,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64019-8,T1,0,v100,SA,160309-OK-HVTN100,10.0,10NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFL-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,5,,10,3,OK;20160310;13631;TV1;PLATE5.x,,,0,,07NOV2015,18NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-071,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64022-3,T1,0,v100,SA,160309-TH-HVTN100,10.0,23OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXFC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20160311;13623;TV1;PLATE5.x,,,0,,23OCT2015,03NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-070,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64025-1,T1,0,v100,SA,160309-TH-HVTN100,10.0,26OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HXGY-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160311;13622;TV1;PLATE4.x,,,0,,23OCT2015,03NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-134,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64026-4,T1,0,v100,SA,160309-OK-HVTN100,10.0,09NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HZB7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,4,,10,3,OK;20160310;13630;TV1;PLATE4.x,,,0,,05NOV2015,16NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-219,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64028-8,T1,0,v100,SA,160309-TH-HVTN100,10.0,27OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXTF-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20160311;13623;TV1;PLATE5.x,,,0,,26OCT2015,06NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-176,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64029-6,T1,0,v100,SA,160308-TH-HVTN100,10.0,10NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFG-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160310;13583;TV1;PLATE2.x,,,0,,07NOV2015,18NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-135,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64031-9,T1,0,v100,SA,160307-TH-HVTN100,10.0,02NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HYLD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20160309;13568;TV1;PLATE5.x,,,0,,24OCT2015,04NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-103,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64036-6,T1,0,v100,SA,160308-TH-HVTN100,10.0,30OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYBJ-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160310;13585;TV1;PLATE4.x,,,0,,29OCT2015,09NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-169,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64037-7,T1,0,v100,SA,160307-TH-HVTN100,10.0,12NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZWP-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160309;13565;TV1;PLATE4.x,,,0,,08NOV2015,19NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-165,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64041-1,T1,0,v100,SA,160309-TH-HVTN100,10.0,01DEC2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J1Q0-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160311;13622;TV1;PLATE4.x,,,0,,26NOV2015,07DEC2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-183,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64044-8,T1,0,v100,SA,160309-TH-HVTN100,10.0,30OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HY9Q-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20160311;13623;TV1;PLATE5.x,,,0,,29OCT2015,09NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-188,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64046-3,T1,0,v100,SA,160308-TH-HVTN100,10.0,17NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J09C-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20160310;13584;TV1;PLATE3.x,,,0,,17NOV2015,28NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-054,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64047-4,T1,0,v100,SA,160308-TH-HVTN100,10.0,03NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HYR2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20160310;13584;TV1;PLATE3.x,,,0,,29OCT2015,09NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-239,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64054-2,T1,0,v100,SA,160308-TH-HVTN100,10.0,28OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HXZP-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20160310;13584;TV1;PLATE3.x,,,0,,26OCT2015,06NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-098,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64062-0,T1,0,v100,SA,160307-TH-HVTN100,10.0,03NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HYRQ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20160309;13568;TV1;PLATE5.x,,,0,,30OCT2015,10NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-216,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64064-5,T1,0,v100,SA,160309-TH-HVTN100,10.0,12NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J015-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160311;13622;TV1;PLATE4.x,,,0,,09NOV2015,20NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-185,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64065-3,T1,0,v100,SA,160307-TH-HVTN100,10.0,12NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZXY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20160309;13567;TV1;PLATE6.x,,,0,,08NOV2015,19NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-102,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64067-2,T1,0,v100,SA,160307-TH-HVTN100,10.0,17NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J09F-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20160309;13567;TV1;PLATE6.x,,,0,,13NOV2015,24NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-112,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64070-4,T1,0,v100,SA,160309-OK-HVTN100,10.0,16NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J03Q-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,4,,10,3,OK;20160310;13630;TV1;PLATE4.x,,,0,,05NOV2015,16NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-082,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64074-1,T1,0,v100,SA,160308-TH-HVTN100,10.0,16NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J039-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20160310;13584;TV1;PLATE3.x,,,0,,12NOV2015,23NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-197,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64084-3,T1,0,v100,SA,160307-TH-HVTN100,10.0,18NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J0MY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20160309;13568;TV1;PLATE5.x,,,0,,15NOV2015,26NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-232,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,175-64085-5,T1,0,v100,SA,160309-TH-HVTN100,10.0,01DEC2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J1QW-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160311;13622;TV1;PLATE4.x,,,0,,20NOV2015,01DEC2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-003,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64002-4,T1,0,v100,SA,151123-TH-HVTN100,10.0,13OCT2015,23NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBJ-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151125;12444;TV1;PLATE1.x,,,0,,08OCT2015,19OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-152,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64006-0,T1,0,v100,SA,160308-TH-HVTN100,10.0,14SEP2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HSJ4-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160310;13583;TV1;PLATE2.x,,,0,,06SEP2015,17SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-220,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64009-5,T1,0,v100,SA,160309-TH-HVTN100,10.0,15OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWQB-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160311;13620;TV1;PLATE2.x,,,0,,11OCT2015,22OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-125,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64010-0,T1,0,v100,SA,160309-TH-HVTN100,10.0,14SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HSMB-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20160311;13619;TV1;PLATE1.x,,,0,,05SEP2015,16SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-233,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64011-7,T1,0,v100,SA,160309-TH-HVTN100,10.0,22SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HTGD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160311;13620;TV1;PLATE2.x,,,0,,18SEP2015,29SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-186,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64016-9,T1,0,v100,SA,160308-TH-HVTN100,10.0,27OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08MAR2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXNV-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20160310;13582;TV1;PLATE1.x,,,0,0,18OCT2015,29OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-039,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64017-5,T1,0,v100,SA,160309-TH-HVTN100,10.0,29SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HTWM-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20160311;13621;TV1;PLATE3.x,,,0,,26SEP2015,07OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-013,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64018-3,T1,0,v100,SA,160307-TH-HVTN100,10.0,20NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0J0YX-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20160309;13563;TV1;PLATE1.x,,,0,,17NOV2015,28NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-121,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64020-3,T1,0,v100,SA,151123-TH-HVTN100,10.0,06OCT2015,23NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HVPF-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151125;12444;TV1;PLATE1.x,,,0,,01OCT2015,12OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-087,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64023-2,T1,0,v100,SA,160309-TH-HVTN100,10.0,21OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HX1W-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160311;13620;TV1;PLATE2.x,,,0,,16OCT2015,27OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-100,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64025-8,T1,0,v100,SA,160309-TH-HVTN100,10.0,13OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HWBG-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20160311;13621;TV1;PLATE3.x,,,0,,08OCT2015,19OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-069,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64026-6,T1,0,v100,SA,160309-TH-HVTN100,10.0,07NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ6R-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20160311;13621;TV1;PLATE3.x,,,0,,03NOV2015,14NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-206,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64033-9,T1,0,v100,SA,160309-TH-HVTN100,10.0,20OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08DEC2015,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HWYC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160311;13620;TV1;PLATE2.x,,,0,0,15OCT2015,26OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-047,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64035-1,T1,0,v100,SA,160307-TH-HVTN100,10.0,05NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ01-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160309;13564;TV1;PLATE2.x,,,0,,01NOV2015,12NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-089,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64038-8,T1,0,v100,SA,160307-TH-HVTN100,10.0,25NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J17P-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160309;13565;TV1;PLATE4.x,,,0,,20NOV2015,01DEC2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-139,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64041-8,T1,0,v100,SA,160307-TH-HVTN100,10.0,10NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HZFB-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160309;13565;TV1;PLATE4.x,,,0,,06NOV2015,17NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-080,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64042-9,T1,0,v100,SA,160307-TH-HVTN100,10.0,26OCT2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HXGW-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160309;13564;TV1;PLATE2.x,,,0,,22OCT2015,02NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-210,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64046-5,T1,0,v100,SA,160309-TH-HVTN100,10.0,27OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HXNS-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160311;13620;TV1;PLATE2.x,,,0,,23OCT2015,03NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-162,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64048-2,T1,0,v100,SA,160307-TH-HVTN100,10.0,12NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0J00K-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160309;13565;TV1;PLATE4.x,,,0,,05NOV2015,16NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-246,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64051-0,T1,0,v100,SA,160307-TH-HVTN100,10.0,11NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZP9-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20160309;13566;TV1;PLATE3.x,,,0,,07NOV2015,18NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-223,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64053-6,T1,0,v100,SA,160308-TH-HVTN100,10.0,11NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HZQD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160310;13583;TV1;PLATE2.x,,,0,,07NOV2015,18NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-028,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64055-4,T1,0,v100,SA,160309-TH-HVTN100,10.0,05NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZ03-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20160311;13619;TV1;PLATE1.x,,,0,,01NOV2015,12NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-244,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64059-8,T1,0,v100,SA,160308-TH-HVTN100,10.0,20NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0J0Y2-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20160310;13582;TV1;PLATE1.x,,,0,,17NOV2015,28NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-153,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64061-6,T1,0,v100,SA,160307-TH-HVTN100,10.0,07NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ5Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20160309;13563;TV1;PLATE1.x,,,0,,03NOV2015,14NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-015,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64063-0,T1,0,v100,SA,160307-TH-HVTN100,10.0,19NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0J0WN-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20160309;13563;TV1;PLATE1.x,,,1,,14NOV2015,25NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-252,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64064-3,T1,0,v100,SA,160307-TH-HVTN100,10.0,23NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0ZW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20160309;13566;TV1;PLATE3.x,,,0,,19NOV2015,30NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-211,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64068-4,T1,0,v100,SA,160308-TH-HVTN100,10.0,10NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HZFD-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20160310;13582;TV1;PLATE1.x,,,0,,07NOV2015,18NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-147,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64069-2,T1,0,v100,SA,160308-TH-HVTN100,10.0,16NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J02X-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20160310;13582;TV1;PLATE1.x,,,0,,05NOV2015,16NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-168,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64071-1,T1,0,v100,SA,160308-TH-HVTN100,10.0,12NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZZT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20160310;13582;TV1;PLATE1.x,,,0,,08NOV2015,19NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-203,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64072-2,T1,0,v100,SA,160307-TH-HVTN100,10.0,12NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0HZYT-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,4,,10,3,TH;20160309;13565;TV1;PLATE4.x,,,0,,08NOV2015,19NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-167,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64074-8,T1,0,v100,SA,160308-TH-HVTN100,10.0,18NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0J0LW-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160310;13583;TV1;PLATE2.x,,,0,,17NOV2015,28NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-224,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64075-0,T1,0,v100,SA,160307-TH-HVTN100,10.0,19NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0J0W8-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20160309;13563;TV1;PLATE1.x,,,0,,13NOV2015,24NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-226,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64077-4,T1,0,v100,SA,160307-TH-HVTN100,10.0,19NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0J0QS-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160309;13564;TV1;PLATE2.x,,,0,,15NOV2015,26NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-020,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,199-64079-7,T1,0,v100,SA,160307-TH-HVTN100,10.0,03DEC2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J1WG-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20160309;13566;TV1;PLATE3.x,,,0,,27NOV2015,08DEC2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-065,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64001-1,T1,0,v100,SA,151028-TH-HVTN100,10.0,07SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FCQ6-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20151030;12047;TV1;PLATE5.x,,,0,,05SEP2015,16SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-018,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64002-2,T1,0,v100,SA,160309-VB-HVTN100,10.0,15SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FHFQ-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,3,,10,3,VB;20160311;TV1;13638;PLATE3.x,,,0,,14SEP2015,25SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-096,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64004-8,T1,0,v100,SA,160309-VB-HVTN100,10.0,23OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FW3Z-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,3,,10,3,VB;20160311;TV1;13638;PLATE3.x,,,0,,22OCT2015,02NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-249,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64006-3,T1,0,v100,SA,160308-VB-HVTN100,10.0,22SEP2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FK9S-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,5,,10,3,VB;20160310;TV1;13592;PLATE5.x,,,0,,20SEP2015,01OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-010,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64009-7,T1,0,v100,SA,160309-VB-HVTN100,10.0,22SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FKKP-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,4,,10,3,VB;20160311;TV1;13639;PLATE4.x,,,0,,20SEP2015,01OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-222,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64018-1,T1,0,v100,SA,160309-VB-HVTN100,10.0,30SEP2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FMJB-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,1,,10,3,VB;20160311;TV1;13636;PLATE1.x,,,0,,26SEP2015,07OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-046,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64022-7,T1,0,v100,SA,160309-VB-HVTN100,10.0,16OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FS71-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,4,,10,3,VB;20160311;TV1;13639;PLATE4.x,,,0,,12OCT2015,23OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-037,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64030-7,T1,0,v100,SA,151111-TH-HVTN100,10.0,09OCT2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FQ9L-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151113;12232;TV1;PLATE1.x,,,0,,01OCT2015,12OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-251,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64033-6,T1,0,v100,SA,160308-VB-HVTN100,10.0,19OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HC20FSKN-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,1,,10,3,VB;20160310;TV1;13588;PLATE1.x,,,0,,12OCT2015,23OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-099,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64034-9,T1,0,v100,SA,160308-VB-HVTN100,10.0,08OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FQ46-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,1,,10,3,VB;20160310;TV1;13588;PLATE1.x,,,0,,03OCT2015,14OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-032,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64038-5,T1,0,v100,SA,160308-VB-HVTN100,10.0,26OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FWHM-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,1,,10,3,VB;20160310;TV1;13588;PLATE1.x,,,0,,22OCT2015,02NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-245,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64039-8,T1,0,v100,SA,151111-TH-HVTN100,10.0,15OCT2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FRV7-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151113;12232;TV1;PLATE1.x,,,0,,08OCT2015,19OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-057,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64042-6,T1,0,v100,SA,160309-VB-HVTN100,10.0,22OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FVNV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,2,,10,3,VB;20160311;TV1;13637;PLATE2.x,,,0,,17OCT2015,28OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-055,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64043-1,T1,0,v100,SA,160309-OK-HVTN100,10.0,14OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FRFF-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,2,,10,3,OK;20160310;13628;TV1;PLATE2.x,,,0,,12OCT2015,23OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-021,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64046-7,T1,0,v100,SA,160308-VB-HVTN100,10.0,04NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FZ1Z-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,1,,10,3,VB;20160310;TV1;13588;PLATE1.x,,,0,,01NOV2015,12NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-156,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64049-3,T1,0,v100,SA,160309-VB-HVTN100,10.0,14OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRCW-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,2,,10,3,VB;20160311;TV1;13637;PLATE2.x,,,0,,10OCT2015,21OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-014,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64054-6,T1,0,v100,SA,160309-OK-HVTN100,10.0,23OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FW4N-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,72,Owen Karimanzira,1,,10,3,OK;20160310;13627;TV1;PLATE1.x,,,0,,16OCT2015,27OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-240,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64062-9,T1,0,v100,SA,160308-VB-HVTN100,10.0,27OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FWTX-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,1,,10,3,VB;20160310;TV1;13588;PLATE1.x,,,0,,23OCT2015,03NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-171,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64063-3,T1,0,v100,SA,160309-VB-HVTN100,10.0,14OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FRDV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,2,,10,3,VB;20160311;TV1;13637;PLATE2.x,,,0,,10OCT2015,21OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-068,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64064-1,T1,0,v100,SA,160308-VB-HVTN100,10.0,27OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FWX6-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,2,,10,3,VB;20160310;TV1;13589;PLATE2.x,,,0,,23OCT2015,03NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-062,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64065-7,T1,0,v100,SA,151118-TH-HVTN100,10.0,13OCT2015,18NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FQWN-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151120;12383;TV1;PLATE2.x,,,0,,12OCT2015,23OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-036,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64066-5,T1,0,v100,SA,160309-OK-HVTN100,10.0,16OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FS6F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,2,,10,3,OK;20160310;13628;TV1;PLATE2.x,,,0,,10OCT2015,21OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-095,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64071-4,T1,0,v100,SA,160309-VB-HVTN100,10.0,21OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20FTPM-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,3,,10,3,VB;20160311;TV1;13638;PLATE3.x,,,0,,17OCT2015,28OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-212,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64072-0,T1,0,v100,SA,160308-VB-HVTN100,10.0,02NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FY0T-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,2,,10,3,VB;20160310;TV1;13589;PLATE2.x,,,0,,29OCT2015,09NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-072,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64074-5,T1,0,v100,SA,160309-OK-HVTN100,10.0,20OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FSTR-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,2,,10,3,OK;20160310;13628;TV1;PLATE2.x,,,0,,15OCT2015,26OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-229,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64076-1,T1,0,v100,SA,160308-VB-HVTN100,10.0,07NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20G182-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,2,,10,3,VB;20160310;TV1;13589;PLATE2.x,,,0,,29OCT2015,09NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-217,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64077-2,T1,0,v100,SA,160308-VB-HVTN100,10.0,29OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FXCG-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,2,,10,3,VB;20160310;TV1;13589;PLATE2.x,,,0,,25OCT2015,05NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-149,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64078-6,T1,0,v100,SA,160309-OK-HVTN100,10.0,21OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FTPZ-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,2,,10,3,OK;20160310;13628;TV1;PLATE2.x,,,0,,16OCT2015,27OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-017,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64085-1,T1,0,v100,SA,160309-VB-HVTN100,10.0,20OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FSV2-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,2,,10,3,VB;20160311;TV1;13637;PLATE2.x,,,0,,17OCT2015,28OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-074,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64086-4,T1,0,v100,SA,160308-VB-HVTN100,10.0,30OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FXJC-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,3,,10,3,VB;20160310;TV1;13590;PLATE3.x,,,0,,26OCT2015,06NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-124,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64089-6,T1,0,v100,SA,160308-VB-HVTN100,10.0,28OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX1S-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,3,,10,3,VB;20160310;TV1;13590;PLATE3.x,,,0,,25OCT2015,05NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-004,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64095-6,T1,0,v100,SA,160308-VB-HVTN100,10.0,27OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20FWWD-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,3,,10,3,VB;20160310;TV1;13590;PLATE3.x,,,0,,23OCT2015,03NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-182,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64097-5,T1,0,v100,SA,160308-VB-HVTN100,10.0,06NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G0Z4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,4,,10,3,VB;20160310;TV1;13591;PLATE4.x,,,0,,05NOV2015,16NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-034,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64107-1,T1,0,v100,SA,160308-VB-HVTN100,10.0,07NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20G18P-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,4,,10,3,VB;20160310;TV1;13591;PLATE4.x,,,0,,03NOV2015,14NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-115,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64113-4,T1,0,v100,SA,160308-VB-HVTN100,10.0,30OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FXJP-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,4,,10,3,VB;20160310;TV1;13591;PLATE4.x,,,0,,29OCT2015,09NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-144,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64118-3,T1,0,v100,SA,160308-VB-HVTN100,10.0,10NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20G20Y-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,4,,10,3,VB;20160310;TV1;13591;PLATE4.x,,,0,,07NOV2015,18NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-189,100,"ALVAC mo(0,1) + ALVAC & gp120 & MF59 mo(3,6,12)",T1,IM,IM,IM,ALVAC-HIV,Bivalent subtype C gp1,MF59,1mL,200mcg,NA,0,,1,518-64125-8,T1,0,v100,SA,160308-VB-HVTN100,10.0,12NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20G3XF-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,4,,10,3,VB;20160310;TV1;13591;PLATE4.x,,,0,,12NOV2015,23NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,T1,"TZM-bl, Vaccine Strains"
100-141,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64001-8,P2,1,v100,SA,151028-TH-HVTN100,10.0,23JUL2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20DZ2F-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20151030;12044;TV1;PLATE3.x,,,0,,23JUL2015,03AUG2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-056,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64028-6,P2,1,v100,SA,151028-TH-HVTN100,10.0,04AUG2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,BC20F1PR-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20151030;12047;TV1;PLATE5.x,,,0,,02AUG2015,13AUG2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-154,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64047-1,P2,1,v100,SA,151028-TH-HVTN100,10.0,17AUG2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20F5F9-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20151030;12044;TV1;PLATE3.x,,,0,,13AUG2015,24AUG2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-041,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64059-3,P2,1,v100,SA,151028-TH-HVTN100,10.0,19AUG2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20F64B-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151030;12043;TV1;PLATE2.x,,,0,,15AUG2015,26AUG2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-196,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64085-8,P2,1,v100,SA,151028-TH-HVTN,10.0,07SEP2015,28OCT2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FCQJ-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151030;12042;TV1;PLATE1.x,,,0,,04SEP2015,15SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-200,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64086-6,P2,1,v100,SA,151110-TH-HVTN100,10.0,15SEP2015,10NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20FHG1-08,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151112;12209;TV1;PLATE1.x,,,0,,12SEP2015,23SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-122,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64121-2,P2,1,v100,SA,151110-TH-HVTN100,10.0,29SEP2015,10NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CC20FM29-07,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151112;12208;TV1;PLATE2.x,,,0,,26SEP2015,07OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-199,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,138-64165-3,P2,1,v100,SA,160309-VB-HVTN100,10.0,09NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,KC20G1N0-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,1,,10,3,VB;20160311;TV1;13636;PLATE1.x,,,0,,05NOV2015,16NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-104,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64052-0,P2,1,v100,SA,151125-TH-HVTN100,10.0,06NOV2015,25NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EA60BFW9-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20151127;12497;TV1;PLATE1.x,,,0,,02NOV2015,13NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-086,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64077-3,P2,1,v100,SA,160309-OK-HVTN100,10.0,24NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CA60BGKV-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,5,,10,3,OK;20160310;13631;TV1;PLATE5.x,,,0,,13NOV2015,24NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-012,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,156-64078-5,P2,1,v100,SA,160308-TH-HVTN100,10.0,19NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HA60BGF7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20160310;13586;TV1;PLATE5.x,,,0,,14NOV2015,25NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-214,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64018-8,P2,1,v100,SA,160309-OK-HVTN100,10.0,23SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,08APR2016,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,CAT0552W-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,3,,10,3,OK;20160310;13629;TV1;PLATE3.x,,,0,0,19SEP2015,30SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-238,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64027-2,P2,1,v100,SA,151125-TH-HVTN100,10.0,27OCT2015,25NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,HAT0584P-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20151127;12499;TV1;PLATE3-1,,,0,,23OCT2015,03NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-175,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64030-0,P2,1,v100,SA,160309-TH-HVTN100,10.0,18SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EAT054PV-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,8,,10,3,TH;20160311;13626;TV1;PLATE8.x,,,0,,14SEP2015,25SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-045,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,157-64068-9,P2,1,v100,SA,160309-VB-HVTN100,10.0,26NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FAT05CFM-03,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,5,,10,3,VB;20160311;TV1;13640;PLATE5.x,,,0,,22NOV2015,03DEC2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-191,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64024-7,P2,1,v100,SA,160309-TH-HVTN100,10.0,26OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HXHD-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20160311;13624;TV1;PLATE6.x,,,0,,24OCT2015,04NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-164,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64045-0,P2,1,v100,SA,160307-TH-HVTN100,10.0,16NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0J06D-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20160309;13567;TV1;PLATE6.x,,,0,,14NOV2015,25NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-008,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64049-7,P2,1,v100,SA,160307-TH-HVTN100,10.0,02NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,J7Q0HYLY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20160309;13568;TV1;PLATE5.x,,,0,,29OCT2015,09NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-016,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64051-7,P2,1,v100,SA,160307-TH-HVTN100,10.0,18NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0N9-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,6,,10,3,TH;20160309;13567;TV1;PLATE6.x,,,0,,17NOV2015,28NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-033,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64059-1,P2,1,v100,SA,160307-TH-HVTN100,10.0,12NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HZVY-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,5,,10,3,TH;20160309;13568;TV1;PLATE5.x,,,0,,07NOV2015,18NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-241,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64069-9,P2,1,v100,SA,160308-TH-HVTN100,10.0,10NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,K7Q0HZFJ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160310;13583;TV1;PLATE2.x,,,0,,05NOV2015,16NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-159,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64073-3,P2,1,v100,SA,160308-TH-HVTN100,10.0,27OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,D7Q0HXSP-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20160310;13584;TV1;PLATE3.x,,,0,,26OCT2015,06NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-049,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,175-64083-0,P2,1,v100,SA,160309-OK-HVTN100,10.0,17NOV2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,E7Q0J0CK-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Owen Karimanzira,4,,10,3,OK;20160310;13630;TV1;PLATE4.x,,,0,,14NOV2015,25NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-024,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64008-7,P2,1,v100,SA,160309-TH-HVTN100,10.0,22SEP2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HTD1-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20160311;13619;TV1;PLATE1.x,,,0,,18SEP2015,29SEP2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-143,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64021-9,P2,1,v100,SA,160309-TH-HVTN100,10.0,01OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,G7Q0HV6Q-12,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20160311;13621;TV1;PLATE3.x,,,0,,01OCT2015,12OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-009,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64024-0,P2,1,v100,SA,160309-OK-HVTN100,10.0,21OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FTQC-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,72,Owen Karimanzira,1,,10,3,OK;20160310;13627;TV1;PLATE1.x,,,0,,16OCT2015,27OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-094,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64031-2,P2,1,v100,SA,160307-TH-HVTN100,10.0,07NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,C7Q0HZ68-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20160309;13566;TV1;PLATE3.x,,,0,,03NOV2015,14NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-026,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64034-7,P2,1,v100,SA,160307-TH-HVTN100,10.0,04NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,B7Q0HYZ4-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160309;13564;TV1;PLATE2.x,,,0,,31OCT2015,11NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-166,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64050-7,P2,1,v100,SA,160307-TH-HVTN100,10.0,04NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,F7Q0HYV7-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20160309;13564;TV1;PLATE2.x,,,0,,31OCT2015,11NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-005,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64057-3,P2,1,v100,SA,160307-TH-HVTN100,10.0,04NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,A7Q0HYVZ-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,1,,10,3,TH;20160309;13563;TV1;PLATE1.x,,,0,,30OCT2015,10NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-133,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64060-1,P2,1,v100,SA,160307-TH-HVTN100,10.0,07NOV2015,07MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,H7Q0HZ5H-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,3,,10,3,TH;20160309;13566;TV1;PLATE3.x,,,0,,03NOV2015,14NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-195,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,199-64070-6,P2,1,v100,SA,160309-VB-HVTN100,10.0,09NOV2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,EC20G1M1-01,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,1,,10,3,VB;20160311;TV1;13636;PLATE1.x,,,0,,07NOV2015,18NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-043,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64017-7,P2,1,v100,SA,160309-OK-HVTN100,10.0,13OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,GC20FQTX-11,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,72,Owen Karimanzira,1,,10,3,OK;20160310;13627;TV1;PLATE1.x,,,0,,10OCT2015,21OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-174,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64052-4,P2,1,v100,SA,160309-OK-HVTN100,10.0,23OCT2015,09MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,DC20FW49-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,72,Owen Karimanzira,1,,10,3,OK;20160310;13627;TV1;PLATE1.x,,,0,,19OCT2015,30OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-067,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64073-7,P2,1,v100,SA,151111-TH-HVTN100,10.0,22OCT2015,11NOV2015,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,JC20FVG5-09,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,12NOV2009,200911105183P,48,Tandile Hermanus,2,,10,3,TH;20151113;12233;TV1;PLATE2.x,,,0,,18OCT2015,29OCT2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-213,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64079-9,P2,1,v100,SA,160308-VB-HVTN100,10.0,28OCT2015,08MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,AC20FX13-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,3,,10,3,VB;20160310;TV1;13590;PLATE3.x,,,0,,24OCT2015,04NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
100-250,100,"ALVAC Placebo mo(0,1) + ALVAC Placebo & Placebo mo(3,6,12)",P2,IM,,,Placebo for ALVAC-HIV,,,,,,0,,2,518-64080-5,P2,1,v100,SA,160318-VB-HVTN100,10.0,28OCT2015,18MAR2016,50,10,10,<10.0,5,0.6989700043,0,Titer>10,,,24JUN2016,,Reciproc,VTN_NAB04DU20160202E001_G.TXT,100,NAB,04,FC20FX2K-10,Y,Y,N,,E,,Firefly Luciferase,TZM-bl,,23JUN2016,HVTN,293T/17,SG3 \u0394env,Five Parameter,Pseudovirus,1:70,Dilution,10NOV2009,200911105183P,48,Valerie Bekker,1,,10,3,VB;20160320;TV1;13850;PLATE1.x,,,0,,24OCT2015,04NOV2015,0,182,0,TV1.21,,,,,,,,,,,,,,,,,P2,"TZM-bl, Vaccine Strains"
